
<html lang="en"     class="pb-page"  data-request-id="ce64990b-f5cc-489e-b1a4-a21c52894c05"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.1c00532;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9" /></meta><meta name="dc.Creator" content="Biswajit  Kundu" /></meta><meta name="dc.Creator" content="Deblina  Raychaudhuri" /></meta><meta name="dc.Creator" content="Ayan  Mukherjee" /></meta><meta name="dc.Creator" content="Bishnu Prasad  Sinha" /></meta><meta name="dc.Creator" content="Dipika  Sarkar" /></meta><meta name="dc.Creator" content="Purbita  Bandopadhyay" /></meta><meta name="dc.Creator" content="Sourav  Pal" /></meta><meta name="dc.Creator" content="Nirmal  Das" /></meta><meta name="dc.Creator" content="Debdeep  Dey" /></meta><meta name="dc.Creator" content="Kantubhukta  Ramarao" /></meta><meta name="dc.Creator" content="Kasireddy  Nagireddy" /></meta><meta name="dc.Creator" content="Dipyaman  Ganguly" /></meta><meta name="dc.Creator" content="Arindam  Talukdar" /></meta><meta name="dc.Description" content="Several toll-like receptors (TLRs) reside inside endosomes of specific immune cells—among them, aberrant activation of TLR7 and TLR9 is implicated in myriad contexts of autoimmune diseases, making ..." /></meta><meta name="Description" content="Several toll-like receptors (TLRs) reside inside endosomes of specific immune cells—among them, aberrant activation of TLR7 and TLR9 is implicated in myriad contexts of autoimmune diseases, making ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 18, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00532" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00532" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00532" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00532" /></link>
        
    
    

<title>Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00532" /></meta><meta property="og:title" content="Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0019.jpeg" /></meta><meta property="og:description" content="Several toll-like receptors (TLRs) reside inside endosomes of specific immune cells—among them, aberrant activation of TLR7 and TLR9 is implicated in myriad contexts of autoimmune diseases, making them promising therapeutic targets. However, small-molecule TLR7 and TLR9 antagonists are not yet available for clinical use. We illustrate here the importance of C2, C6, and N9 substitutions in the purine scaffold for antagonism to TLR7 and TLR9 through structure–activity relationship studies using cellular reporter assays and functional studies on primary human immune cells. Further in vitro and in vivo pharmacokinetic studies identified an orally bioavailable lead compound 29, with IC50 values of 0.08 and 2.66 μM against TLR9 and TLR7, respectively. Isothermal titration calorimetry excluded direct TLR ligand–antagonist interactions. In vivo antagonism efficacy against mouse TLR9 and therapeutic efficacy in a preclinical murine model of psoriasis highlighted the potential of compound 29 as a therapeutic candidate in relevant autoimmune contexts." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00532"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00532">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00532&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00532&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00532&amp;href=/doi/10.1021/acs.jmedchem.1c00532" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 9279-9301</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00512" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00534" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Biswajit Kundu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Biswajit Kundu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Biswajit++Kundu">Biswajit Kundu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deblina Raychaudhuri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deblina Raychaudhuri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IICB-Translational Research Unit of Excellence, Department of Cancer Biology and Inflammatory Disorders, CSIR—Indian Institute of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deblina++Raychaudhuri">Deblina Raychaudhuri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ayan Mukherjee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ayan Mukherjee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ayan++Mukherjee">Ayan Mukherjee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bishnu Prasad Sinha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bishnu Prasad Sinha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research, Ghaziabad 201002, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bishnu+Prasad++Sinha">Bishnu Prasad Sinha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dipika Sarkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dipika Sarkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dipika++Sarkar">Dipika Sarkar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Purbita Bandopadhyay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Purbita Bandopadhyay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IICB-Translational Research Unit of Excellence, Department of Cancer Biology and Inflammatory Disorders, CSIR—Indian Institute of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, West Bengal, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research, Ghaziabad 201002, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Purbita++Bandopadhyay">Purbita Bandopadhyay</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sourav Pal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sourav Pal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research, Ghaziabad 201002, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sourav++Pal">Sourav Pal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nirmal Das</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nirmal Das</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research, Ghaziabad 201002, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nirmal++Das">Nirmal Das</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Debdeep Dey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debdeep Dey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Tata Medical Center, Newtown, Kolkata 700160, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debdeep++Dey">Debdeep Dey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kantubhukta Ramarao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kantubhukta Ramarao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kantubhukta++Ramarao">Kantubhukta Ramarao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kasireddy Nagireddy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kasireddy Nagireddy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kasireddy++Nagireddy">Kasireddy Nagireddy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dipyaman Ganguly</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dipyaman Ganguly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IICB-Translational Research Unit of Excellence, Department of Cancer Biology and Inflammatory Disorders, CSIR—Indian Institute of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, West Bengal, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research, Ghaziabad 201002, India</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#64000d141d0509050a240d0d07064a1601174a0d0a"><span class="__cf_email__" data-cfemail="f094998089919d919eb099999392de829583de999e">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dipyaman++Ganguly">Dipyaman Ganguly</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Arindam Talukdar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arindam Talukdar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic and Medicinal Chemistry, CSIR—Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West Bengal, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research, Ghaziabad 201002, India</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#335247525f4658575241735a5a50511d4156401d5a5d"><span class="__cf_email__" data-cfemail="5d3c293c312836393c2f1d34343e3f732f382e733433">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arindam++Talukdar">Arindam Talukdar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-7831-1795" title="Orcid link">https://orcid.org/0000-0002-7831-1795</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00532&amp;href=/doi/10.1021%2Facs.jmedchem.1c00532" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 9279–9301</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 18, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 March 2021</li><li><span class="item_label"><b>Published</b> online</span>18 June 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00532" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00532</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9279%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBiswajit%2BKundu%252C%2BDeblina%2BRaychaudhuri%252C%2BAyan%2BMukherjee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D13%26contentID%3Dacs.jmedchem.1c00532%26title%3DSystematic%2BOptimization%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BPurine%2BScaffold%2Bas%2Ba%2BDual%2BInhibitor%2Bof%2BToll-Like%2BReceptors%2B7%2Band%2B9%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9301%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00532"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">736</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00532" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Biswajit&quot;,&quot;last_name&quot;:&quot;Kundu&quot;},{&quot;first_name&quot;:&quot;Deblina&quot;,&quot;last_name&quot;:&quot;Raychaudhuri&quot;},{&quot;first_name&quot;:&quot;Ayan&quot;,&quot;last_name&quot;:&quot;Mukherjee&quot;},{&quot;first_name&quot;:&quot;Bishnu&quot;,&quot;last_name&quot;:&quot;Prasad Sinha&quot;},{&quot;first_name&quot;:&quot;Dipika&quot;,&quot;last_name&quot;:&quot;Sarkar&quot;},{&quot;first_name&quot;:&quot;Purbita&quot;,&quot;last_name&quot;:&quot;Bandopadhyay&quot;},{&quot;first_name&quot;:&quot;Sourav&quot;,&quot;last_name&quot;:&quot;Pal&quot;},{&quot;first_name&quot;:&quot;Nirmal&quot;,&quot;last_name&quot;:&quot;Das&quot;},{&quot;first_name&quot;:&quot;Debdeep&quot;,&quot;last_name&quot;:&quot;Dey&quot;},{&quot;first_name&quot;:&quot;Kantubhukta&quot;,&quot;last_name&quot;:&quot;Ramarao&quot;},{&quot;first_name&quot;:&quot;Kasireddy&quot;,&quot;last_name&quot;:&quot;Nagireddy&quot;},{&quot;first_name&quot;:&quot;Dipyaman&quot;,&quot;last_name&quot;:&quot;Ganguly&quot;},{&quot;first_name&quot;:&quot;Arindam&quot;,&quot;last_name&quot;:&quot;Talukdar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;9279-9301&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00532&quot;},&quot;abstract&quot;:&quot;Several toll-like receptors (TLRs) reside inside endosomes of specific immune cells—among them, aberrant activation of TLR7 and TLR9 is implicated in myriad contexts of autoimmune diseases, making them promising therapeutic targets. However, small-molecule TLR7 and TLR9 antagonists are not yet available for clinical use. We illustrate here the importance of C2, C6, and N9 substitutions in the purine scaffold for antagonism to TLR7 and TLR9 through structure–activity relationship studies using cellular reporter assays and functional studies on primary human immune cells. Further in vitro and in vivo pharmacokinetic studies identified an orally bioavailable lead compound 29, with IC50 values of 0.08 and 2.66 μM against TLR9 and TLR7, respectively. Isothermal titration calorimetry excluded direct TLR ligand–antagonist interactions. In vivo antagonism efficacy against mouse TLR9 and therapeutic efficacy in a preclinical murine model of psoriasis highlighted the potential of compound 29 as a therapeutic candidate &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00532&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00532" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00532&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00532" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00532&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00532" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00532&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00532&amp;href=/doi/10.1021/acs.jmedchem.1c00532" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00532" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00532" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00532%26sid%3Dliteratum%253Aachs%26pmid%3D34142551%26genre%3Darticle%26aulast%3DKundu%26date%3D2021%26atitle%3DSystematic%2BOptimization%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BPurine%2BScaffold%2Bas%2Ba%2BDual%2BInhibitor%2Bof%2BToll-Like%2BReceptors%2B7%2Band%2B9%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D13%26spage%3D9279%26epage%3D9301%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Several toll-like receptors (TLRs) reside inside endosomes of specific immune cells—among them, aberrant activation of TLR7 and TLR9 is implicated in myriad contexts of autoimmune diseases, making them promising therapeutic targets. However, small-molecule TLR7 and TLR9 antagonists are not yet available for clinical use. We illustrate here the importance of C2, C6, and N9 substitutions in the purine scaffold for antagonism to TLR7 and TLR9 through structure–activity relationship studies using cellular reporter assays and functional studies on primary human immune cells. Further <i>in vitro</i> and <i>in vivo</i> pharmacokinetic studies identified an orally bioavailable lead compound <b>29</b>, with IC<sub>50</sub> values of 0.08 and 2.66 μM against TLR9 and TLR7, respectively. Isothermal titration calorimetry excluded direct TLR ligand–antagonist interactions. <i>In vivo</i> antagonism efficacy against mouse TLR9 and therapeutic efficacy in a preclinical murine model of psoriasis highlighted the potential of compound <b>29</b> as a therapeutic candidate in relevant autoimmune contexts.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human innate immune system is the first line of defense against the invasion of pathogenic microorganisms. Toll-like receptors (TLRs), mostly expressed on antigen-presenting cells such as dendritic cells, are germline-encoded pattern recognition molecules that play key roles in innate immunity by regulating inflammation.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> These innate immune receptors recognize conserved patterns associated with microbes, thus shaping the innate immune response in health and disease.<a onclick="showRef(event, 'ref2 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref5 ref6">(2,5,6)</a> TLRs are transmembrane proteins composed of a ligand-binding ectodomain (ECD) with leucine-rich repeats (LRRs), a transmembrane domain, and an acytoplasmic TIR (Toll/IL-1 receptor) domain responsible for downstream signaling.<a onclick="showRef(event, 'ref2 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8">(2,7,8)</a> To date, four TLRs, namely, TLR3, 7, 8, and 9, have been identified in humans that are located inside the endosomal compartments (pH = 4.5–6.5) of the immune cells.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> Among them, TLR7 and TLR8 recognize single-stranded RNA and TLR9 identifies hypomethylated CpG DNA motifs of both pathogenic origin and self-origin.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13−17)</a> In humans, TLR7 and TLR9 are expressed selectively in plasmacytoid dendritic cells (pDCs) and B lymphocytes. Upon activation, they drive type I interferon (IFN) production from pDCs.<a onclick="showRef(event, 'ref15 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref18 ref19">(15,18,19)</a></div><div class="NLM_p">TLR activation is one of the initial defensive mechanisms utilized by the host to accumulate innate and subsequent adaptive immunity to fight invading pathogens.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> However, when self-origin RNA or DNA molecules get access to endosomes and aberrantly activate TLR7/8/9, it initiates autoreactive inflammation. Considering the pathological role of TLRs in myriad chronic inflammatory disorders and autoimmune diseases, inhibiting endosomal TLRs is considered to be a novel therapeutic approach in these contexts.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28">(23−28)</a></div><div class="NLM_p">TLR7/9 activation by self-nucleic acids leading to type I IFN induction in pDCs is a critical pathogenetic event in the development of autoimmune disorders. In fact, the role of aberrant TLR9 activation mediated by self-DNA molecules is well established in several systematic autoimmunities such as systemic lupus erythematosus (SLE), Sjögren’s syndrome, psoriasis, and systemic sclerosis.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32">(29−32)</a> Hence, inhibition of TLR9 would play an important role in these clinical contexts. Both TLR7 and TLR9 are structurally similar to each other and initiate common downstream signaling upon activation. This results in the recruitment of the transcription factors NF-<span class="smallcaps smallerCapital">k</span>B and IRF7, leading to the induction of inflammatory cytokines as well as type I IFNs. Hence, dual TLR7/9 antagonists would be useful for inhibiting aberrant signaling and type I IFN induction in disease conditions.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></div><div class="NLM_p">Exploration of potent and selective small-molecule TLR7 and TLR9 antagonists as therapeutic agents in several clinical contexts is of great interest, although as of now none of them are available for clinical use. Nonselective small-molecule CpG-52364 and oligonucleotide IMO-8400 manifesting both TLR7 and TLR9 antagonism entered clinical trial to evaluate their safety and efficacy in patients. However, CpG-52364 with the quinazoline scaffold failed to achieve the desired therapeutic outputs.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Some of the recent studies, including those from our group, have investigated the potency of benzoxazole and quinazoline scaffolds for the development of selective small-molecule TLR9 antagonists.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37−39)</a> The design and development of small-molecule dual TLR7/9 and TLR9 antagonists have been primarily through empirical screening and an activity-guided approach.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> In our previous study, we had demonstrated a chemical switch in the purine scaffold leading to a switch from TLR7 agonism to antagonism.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In the present study, we report a strategy for the design, synthesis, and study of the inhibitory activity of dual and potent TLR7/9 antagonists based on inhibition in primary human immune cells and reporter cells. Through structure–activity relationship (SAR) development, we identified the chemical features required for exhibiting dual TLR7/9 antagonism and subsequently how potent TLR9 antagonists can be obtained by modulating these features. We found that different substituents at C2, C6, and N9 positions in the purine scaffold act in a concerted manner to modify the inhibition of TLR7/9 activity as well as to impart selectivity against TLR7. We also report here the favorable <i>in vitro</i> and <i>in vivo</i> pharmacokinetic parameters, the <i>in vivo</i> TLR9 antagonism efficacy with a promising ADME profile, as well as the therapeutic potential in a preclinical murine model for the selected lead TLR7/9 antagonist (compound <b>29</b>). Due to the structural similarity of endosomal TLRs, we also checked the TLR8 antagonism of compound <b>29</b> and did not find any significant inhibition up to 30 μM. Our systematic SAR can be considered as a template for the development of potent TLR7 and TLR9 antagonists (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cascade development of potent dual TLR7/9 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60431" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60431" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the designed purine analogs is described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Trisubstituted purine derivatives were prepared from commercially available 2-amino-6-chloropurine (<b>2</b>) using a conventional reaction strategy. To start with, we did selective C6 substitution of 2-amino-6-chloropurine with ethyl piperazine and cyclopentyl piperazine refluxing the reaction mixture for 4 h in acetonitrile (ACN) solvent using potassium carbonate as the base. This substitution reaction led to compounds <b>3</b> and <b>4</b>, which were further substituted at the N9 position by heating with 1-(3-chloropropyl)-4-ethylpiperazine for 12 h in dimethylformamide (DMF) solvent using K<sub>2</sub>CO<sub>3</sub> as the base to obtain two crucial intermediates <b>5</b> and <b>6</b>, respectively. The amine group at the C2 position of intermediates <b>5</b> and <b>6</b> was then substituted with different benzyl groups via reductive amination, using appropriate aldehyde and sodium triacetoxyborohydride as a reducing agent, to obtain compounds <b>7</b>–<b>10</b> and <b>13</b>–<b>15</b>. Compound <b>5</b> on treatment with 1,3-dibromopropane and sodium hydride provided compound <b>12</b> via S<sub>N</sub>2-mediated intramolecular cyclization reaction. Conventional amide formation reactions did not proceed at the C2 position due to the lack of nucleophilicity of the aromatic amine group. The C2 amino group was reacted with suitable carboxylic acids in the presence of POCl<sub>3</sub> to provide compounds <b>11</b> and <b>16</b> in good yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Reagents and Conditions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1-Ethylpiperazine (1.5 equiv, for compound <b>3</b>) or 1-cyclopentylpiperazine (1.5 equiv, for compound <b>4</b>), K<sub>2</sub>CO<sub>3</sub> (2 equiv), ACN, reflux, 4–6 h; (b) 1-(3-chloropropyl)-4-ethylpiperazine (1.5 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF, 100 °C, 12 h; (c) (i) various aromatic aldehydes (1.2 equiv), toluene, reflux, 12 h; (ii) sodium triacetoxyborohydride (2 equiv), dichloroethane (DCE), rt, 2 h; (d) benzoyl chloride (3 equiv), pyridine (6.0 equiv), DCM, rt, 10 h; (e) 1,4-dibromobutane (1.2 equiv), sodium hydride (1.5 equiv), DMF, 80 °C, 12 h; and (f) 4-((dimethylamino)methyl)benzoic acid (1.2 equiv), POCl<sub>3</sub> (1.5 equiv), pyridine, rt, 2 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Reagents and Conditions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1-(3-Chloropropyl)-4-ethylpiperazine (1.5 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF, 80 °C, 12 h; (b) phenyl(piperazin-1-yl)methanone (1.5 equiv, for compound <b>18</b>), cyclopentyl(piperazin-1-yl)methanone (1.5 equiv, for compound <b>19</b>), potassium carbonate (2 equiv), ACN, reflux, 4 h; (c) (i) appropriate aromatic aldehydes (1.2 equiv), toluene, 12 h, reflux, (ii) sodium triacetoxyborohydride (2 equiv), DCE, 2 h, rt; and (d) 1,4-dibromobutane (1.2 equiv), sodium hydride (1.5 equiv), DMF, 80 °C, 12 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Reagents and Conditions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1-(3-Chloropropyl)pyrrolidine (1.5 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF, 80 °C, 12 h; (b) (i) various aromatic aldehydes (1.2 equiv), toluene, 12 h, reflux; (ii) sodium triacetoxyborohydride (2 equiv), DCE, 1–2 h, rt; and (c) 4-((dimethylamino)methyl)benzoic acid (1.2 equiv), POCl<sub>3</sub> (1.5 equiv), pyridine, rt, 2 h.</p></p></figure><div class="NLM_p">As depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, we prepared purine analogs having small aromatic and aliphatic amide attached with the piperazine ring at the C6 position. First, the common intermediate <b>17</b> was synthesized by heating 2-amino-6-chloropurine (<b>2</b>) with 1-(3-chloropropyl)-4-ethylpiperazine at 80 °C for 12 h in DMF solvent using potassium carbonate as the base. Compound <b>17</b> was subjected to substitution reactions with suitable piperazine derivatives at the C6 position to obtain the prefinal compounds <b>18</b> and <b>19</b>. A set of benzylamine-substituted purine derivatives at the C2 position was prepared by refluxing compound <b>18</b> with various para-substituted benzaldehydes in toluene for 12 h followed by reaction with sodium triacetoxyborohydride in DCE for 2 h. A similar reaction protocol was followed with compound <b>19</b> to afford compounds <b>24</b>–<b>26</b>. Further, a pyrrolidine substituted purine analog at C2 was synthesized by heating compound <b>18</b> with 1,4-dibromobutane in the presence of sodium hydride as the base at 80 °C in DMF solvent for 12 h. In <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, a similar pattern of reaction sequence as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was followed to prepare two key intermediates <b>27</b> and <b>28</b>. They were then subjected to reductive amination with the same set of aromatic aldehydes as already discussed before to obtain compounds <b>29</b>–<b>32</b>. Finally, coupling reactions were performed by reacting intermediates <b>27</b> and <b>28</b> with <i>p</i>-dimethylaminomethyl benzoic acid in the presence of POCl<sub>3</sub> to afford compounds <b>33</b> and <b>34</b>.</div><div class="NLM_p last">While synthesizing compound <b>27</b>, there is a mechanistic possibility of forming both N7 and N9 isomers.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> We performed two-dimensional (2D) NMR experiments (nuclear Overhauser effect spectroscopy (NOESY) and heteronuclear multiple bond correlation (HMBC)) to determine the regioselective substitution at the N9 position (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Page S65</a>). We followed a similar procedure here to accomplish selective substitution at the N9 position in the purine scaffold over the N7 position.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Activity-Guided Design of Antagonists</h3><div class="NLM_p">The rational development of the TLR7 and TLR9 antagonists was guided by their activity profile as measured in <i>in vitro</i> assays using TLR-reporter cell lines, namely, a TLR9 reporter HEK293 cell line as well as a TLR7 reporter HEK293 cell line, both of which report TLR-induced NF-κB activation in a colorimetric assay. CpGB and CL264 were used as TLR9 and TLR7 ligands, respectively, for the reporter assay, against which the inhibitory activity of the compounds (evaluated in terms of the IC<sub>50</sub> value) was monitored (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figures S1 and S2</a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> To further ensure the ability of these compounds to inhibit TLR9 in a more physiologically relevant setting, we studied the impact of the TLR9 antagonists (as selected on the basis of reporter assays) upon TLR9-induced IFNα induction in human peripheral blood mononuclear cells (PBMCs).<a onclick="showRef(event, 'ref33 ref45'); return false;" href="javascript:void(0);" class="ref ref33 ref45">(33,45)</a> Of note here, pDCs are the major source of IFNα production in human PBMC culture in response to TLR9 activation (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figure S4</a>).</div><div class="NLM_p">In our previous findings,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> we identified a chemical switch at the C2 position of the purine ring that could transform a TLR7 agonist into a TLR7 antagonist. Subsequent modifications had led to the development of potent TLR7 antagonist <b>1</b>, which showed excellent selectivity against homologous endosomal TLR8.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Next, we checked the antagonistic potential of this compound against TLR9 since it is also localized in endosomes and shares the downstream signaling pathways as well as the functional outcomes.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> Interestingly, TLR7 antagonist <b>1</b> (IC<sub>50</sub> = 4.78 μM) was also found to inhibit TLR9 with an IC<sub>50</sub> value of 1.18 μM. Thus, compound <b>1</b> can be considered as a dual TLR7/9 antagonist and served as the starting point of SAR development in the present study. To understand the structural requirements for the antagonism of TLR7 and TLR9,<a onclick="showRef(event, 'ref33 ref37 ref48'); return false;" href="javascript:void(0);" class="ref ref33 ref37 ref48">(33,37,48)</a> we initially prepared a trisubstituted purine analog by substituting at the C2 position of the purine ring keeping the other substitutions constant. It was exciting to find that substituting the C2 position with a simple amine group alters the TLR7 vs TLR9 antagonism profile. Compound <b>5</b> with amine substitution at the C2 position exhibited potent TLR9 antagonism with an IC<sub>50</sub> value of 0.26 μM, whereas TLR7 inhibition was observed at a much higher dose (IC<sub>50</sub> = 16.22 μM) compared to the dose of compound <b>1</b> required for a similar antagonism (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Notably, we had previously reported the importance of C2 modification with the guanidine type of moiety in the quinazoline scaffold for the difference in TLR7 vs TLR9 antagonism.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Modification to the N9 Ethyl Piperazine Substituted Purine Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The IC<sub>50</sub> values were derived from reporter assays using HEK293 cells transfected with hTLR9 (mean ± SD, <i>n</i> = 3).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The IC<sub>50</sub> values were derived from reporter assays using HEK293 cells transfected with hTLR7 (mean ± SD, <i>n</i> = 3). TLR8 reporter assay of compound <b>16</b> was performed using HEK293 cells transfected with hTLR8 (mean ± SD, <i>n</i> = 3). The IC<sub>50</sub> value was found to be >30 μM. Commercially available TLR agonists (CpGB for TLR9, CL264 for TLR7, and CL075 for TLR8) were used as positive controls.</p></div></div><div></div></div><div class="NLM_p">To visualize the reason behind the drastic change in TLR7 antagonism of compound <b>5</b>, we built a homology model structure of human TLR7 and performed a molecular docking study using GOLD software. As reported previously,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> the docking analysis of antagonist <b>1</b> reveals that the purine ring forms π–π stacking with two hydrophobic residues Phe327 and Tyr1374* (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). Hydrogen-bonding interaction between the ethylpiperazine at the C–6 position of compound <b>1</b> and the hydroxyl group of Ser452 was found to be one of the crucial interactions signifying the importance of terminal nitrogen in the piperazine group as observed in the SAR development. Moreover, the N9 position of the alkyl linker attached to ethyl piperazine at the terminal is stabilized by the hydrophobic environment of Leu331 and Phe329. Significantly, in the energetically favorable docking pose, we had observed that the C2 position in compound <b>1</b> is flanked by hydrophobic residues such as Phe329 and Gly357. Thus, in the current study, the introduction of the hydrophilic −NH<sub>2</sub> group at the C2 position in compound <b>5</b> leads to the flipping of the molecule (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), resulting in loss of necessary interactions required for TLR7 antagonism. A similar docking result was observed for compound <b>6</b> as well. Substituting the C2 −NH<sub>2</sub> with hydrophobic para-substituted benzylamine in compound <b>10</b> resulted in a similar conformation as that of compound <b>1</b> with the C2 substituent occupying the hydrophobic space (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). This could be the probable reason for the similar TLR7 antagonism of compound <b>10</b> as that of compound <b>1</b>.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Molecular interaction between the homology model of the homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>1</b>. (B) Molecular overlapping of the docked conformation of compound <b>1</b> and compound <b>5</b>. Compound <b>1</b> is represented as a yellowish-orange stick representation, whereas the green stick representation depicts compound <b>5</b>. (C) Interaction between the TLR7 ectodomain and compound <b>10</b>. Hydrogen bonds and hydrophobic interactions are shown by green dashed lines and gray dashed lines, respectively. *Indicates residues in chain B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our next set of SAR development, we extended the amine substitution at C2 further by introducing benzyl and para-substituted benzyl derivatives in compounds <b>7</b>–<b>10</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). It was observed that compound <b>7</b> with benzyl substitution showed better TLR7 and TLR9 antagonism (IC<sub>50</sub> = 7.6 μM against TLR7 and IC<sub>50</sub> = 0.14 μM against TLR9) compared to compound <b>5</b>. The para-substituted benzyl derivatives (<b>8</b>–<b>10</b>) exhibited similar TLR9 inhibitory activity with 4-methoxybenzyl in compound <b>8</b> (IC<sub>50</sub> = 0.20 μM), 4-fluorobenzyl in compound <b>9</b> (IC<sub>50</sub> = 0.47 μM), and compound <b>10</b> (IC<sub>50</sub> = 0.44 μM) with the <i>N</i>,<i>N</i>-diethylbenzyl group (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). When tested for TLR7 antagonism,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> compounds <b>8</b>, <b>9</b>, and <b>10</b> were found to show significant TLR7 inhibition with IC<sub>50</sub> values of 5.22, 10.14, and 2.70 μM, respectively. To explore the C2 position further, we introduced a benzamide group in place of the benzyl group. This modification resulted in compound <b>11</b> with an IC<sub>50</sub> value of 0.34 μM against TLR9 and 7.74 μM against TLR7. A comparison was drawn between compounds <b>7</b> and <b>11</b> because of their structural similarity. Compound <b>7</b> with benzylamine substitution at the C2 position was found to exhibit a slightly better TLR9 inhibition as compared to compound <b>11</b>. Next, we capped the −NH<sub>2</sub> group at C2 by reacting with 1,4-dibromobutane to form a pyrrolidine. This modification was found to be futile as the resulting compound <b>12</b> did not manifest in any improvement in the inhibitory profile (IC<sub>50</sub> = 8.49 μM against TLR7 and IC<sub>50</sub> = 0.50 μM against TLR9). Thus, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> depicts that most of the compounds in this series are found to be dual inhibitors of TLR7 and TLR9.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a></div><div class="NLM_p">Looking at the selectivity profile of the initial set of compounds, we observed that this set of compounds exhibited significant selectivity toward TLR9 against TLR7. It should also be mentioned that although compound <b>7</b> with benzylamine at the C2 position exhibited moderate TLR7 antagonism, yet it showed 54-fold selectivity for TLR9 as compared to TLR7 because of its excellent TLR9 antagonistic activity. This data prompted us to explore the selectivity aspect in the purine scaffold by keeping substituted benzylamine at the C2 position.</div><div class="NLM_p">Next, by keeping the −NH<sub>2</sub> group at C2, we increased the hydrophobic bulk by introducing the cyclopentyl piperazine at the C6 position to afford intermediate <b>6</b>, which moderately improved the TLR9 inhibition (IC<sub>50</sub> = 0.279 μM) as compared to compound <b>5</b>. Comparison of TLR7 inhibition among compounds <b>1</b>, <b>5</b>, and <b>6</b> revealed that the introduction of the −NH<sub>2</sub> group at C2 markedly increased the selectivity between TLR7 and TLR9 antagonism. Therefore, similar substituents, as observed in the previous set of compounds, were introduced at C2 in compound <b>6</b> to obtain compounds <b>13</b>, <b>14</b>, and <b>15</b> with the 4-methoxybenzyl group, the 4-fluorobenzyl group, and the <i>N</i>,<i>N</i>-diethylbenzyl group, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). To our satisfaction, these compounds showed better TLR9 inhibitory activity compared to their ethyl substituted counterparts at the C6 position in compounds <b>8</b>, <b>9</b>, and <b>10</b>. Expectedly, compound <b>15</b> exhibited dual inhibition against TLR7 and TLR9 with a moderate IC<sub>50</sub> value of 8.13 μM in TLR7 as compared to the inhibitory activity profile of its counterpart compound <b>10</b> with ethyl piperazine at C6. Interestingly, compound <b>16</b> with a methylene bridge at the para position in the 4-((dimethylamino)methyl)benzamide moiety manifested excellent TLR9 antagonism with an IC<sub>50</sub> value of 0.056 μM and 130-fold selectivity against TLR7 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Taking together all of the data from these studies, we could identify the nature of substituents at different positions in the purine scaffold that can modulate TLR9 and TLR7 inhibition and selectivity against TLR7.</div><div class="NLM_p">To look into the effect of the C6 position of the purine scaffold, we investigated the influence of piperazine substitution at C6 in our next series of compounds <b>18</b>–<b>26</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). We had observed that the C6 position plays an important role in regulating the activity. The replacement of the ethyl and cyclopentyl groups with small aromatic and aliphatic amides in the piperazine group at the C6 position resulted in a drastic decrease in both TLR9 and TLR7 inhibitory activities. All of the compounds in this series other than compounds <b>22</b> (IC<sub>50</sub> = 3.4 μM against TLR9) and <b>26</b> (IC<sub>50</sub> = 8.80 μM against TLR9) did not manifest any significant TLR9 inhibition at 30 μM. Moreover, both of them also exhibited promising TLR7 antagonism with IC<sub>50</sub> values of 8.40 μM and 9.79 μM, respectively. Notably, both compounds <b>22</b> and <b>26</b> have diethylamino substituted benzylamines at C2 of the purine ring. It is worthwhile to mention that an amide group at the C2 position led to a significant increase in TLR9 antagonism as well as deriving moderate TLR7-targeted activity in compounds <b>11</b> and <b>16</b>. On the other hand, amide substituents at the C6 position with the piperazine group resulted in a drastic reduction in both TLR9 and TLR7 antagonism. In summary, the SAR analysis so far reveals that aliphatic substitutions on the piperazine ring at the C6 position are well-tolerated, whereas compounds with electron-withdrawing functionality such as amides at this position do not show any significant inhibition at 30 μM. Different structural modifications revealed that compound <b>10</b> exhibited significant dual antagonism against both TLR9 and TLR7, whereas compound <b>16</b> was found to be the most potent TLR9 antagonist with 130-fold selectivity over TLR7 antagonism (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">The TLR8 reporter assay of compound <b>16</b> was performed using HEK293 cells transfected with hTLR8 (mean ± SD, <i>n</i> = 3). The IC<sub>50</sub> value was found to be >30 μM.</div><div class="NLM_p">Commercially available TLR agonists (CpGB for TLR9, CL264 for TLR7, and CL075 for TLR8) were used as positive controls.</div><div class="NLM_p">As endosomal TLRs are present inside acidic compartments, compounds with variable protonation centers can greatly influence the internalization and endosomal sequestration.<a onclick="showRef(event, 'ref11 ref52'); return false;" href="javascript:void(0);" class="ref ref11 ref52">(11,52)</a> We have observed earlier that changing the substitution pattern at the three-carbon alkyl substitution at the N9 position can greatly influence the TLR7 antagonism.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> As further optimization, we focused our attention on the N9 position by replacing the ethylpiperazine group with a less bulky pyrrolidine group. In the next step of SAR development (compounds <b>27</b>–<b>34</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), we fixed the propylpyrrolidine linker at the N9 position while keeping favorable substituents at C2 and C6 positions, resulting in promising TLR9 and TLR7 antagonism. It is worthwhile to mention that compounds <b>27</b> and <b>28</b> with the propylpyrrolidine linker at the N9 position were the first set of compounds with the −NH<sub>2</sub> group at C2 to show significant TLR7 antagonism with IC<sub>50</sub> values of 4.94 μM and 4.88 μM, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). On the other hand, compounds <b>5</b> and <b>6</b> having ethyl piperazine substitution at N9 showed lesser TLR7 inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The docking study of compound <b>27</b> provided an interesting insight into the binding nature of N9 substituents in the hydrophobic cavity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). It was found that due to the presence of a less bulky pyrrolidine group at the N9 position in compound <b>27</b>, the compound can slightly reorganize itself in the hydrophobic cavity of the TLR7 active site (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), retaining similar conformation as that of compound <b>1</b> with a root-mean-square-deviation (RMSD) value of 3.71 Å. This reorganization enables the amine group at C2 in compound <b>27</b> to be stabilized by hydrophilic amino acid residues such as Gln301, which is situated close to the hydrophobic zone as observed in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B. The N9 substituents fit into the hydrophobic pocket, and C6 ethyl piperazine attains hydrogen-bonding interaction with the important Ser452 residue (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). It is worth mentioning that a similar docking experiment with a bulkier ethylpiperazine group having a flexible linker at N9 in compound <b>5</b> did not allow this reorganization in the active site of TLR7 and resulted in a completely flipped conformation. Comparing the TLR7 activities of compounds <b>5</b>, <b>6</b>, <b>27</b>, and <b>28</b>, we can state that the bulky nature of the substituents at C6 does not modulate the TLR7 inhibition, whereas the nature of N9 substituents plays an important role.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Molecular interaction between the homology-built homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>27</b>. The two chains are represented by teal and pink cartoon representations, respectively. Hydrogen bonds and hydrophobic interactions are shown by green dashed lines and gray dashed lines, respectively. (B) Molecular overlapping of the docked conformation of compound <b>1</b> and compound <b>27</b>. Compound <b>1</b> is represented as a yellowish-orange stick representation, whereas the pale-green stick representation depicts compound <b>27</b>. *Indicates residues in chain B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Modification to the N9 Pyrrolidine Substituted Purine Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The IC<sub>50</sub> values were derived from reporter assays using HEK293 cells transfected with hTLR9 (mean ± SD, <i>n</i> = 3).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The IC<sub>50</sub> values were derived from reporter assays using HEK293 cells transfected with hTLR7 (mean ± SD, <i>n</i> = 3). TLR8 reporter assays of compound <b>29</b>, <b>30</b>, and <b>32</b> were performed using HEK293 cells transfected with hTLR8 (mean ± SD, <i>n</i> = 3). The IC<sub>50</sub> value of all of them was found to be >30 μM. Commercially available TLR agonists (CpGB for TLR9, CL264 for TLR7, and CL075 for TLR8) were used as positive controls.</p></div></div><div></div></div><div class="NLM_p">To continue the study further, we kept the same two types of substitutions at the C2 position like in the previous set of compounds such as the 4-methoxybenzyl group in <b>29</b> and <b>31</b> and the 4-fluorobenzyl group in <b>30</b> and <b>32</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). To our satisfaction, all of these compounds were found to manifest excellent TLR9 antagonism with compound <b>29</b> being a dual TLR7/9 antagonist and compound <b>30</b> having maximum TLR9 inhibition (IC<sub>50</sub> = 0.036 μM) as well as significant selectivity against TLR7. In comparison to its counterparts having an ethyl piperazine group at the N9 position (compounds <b>8</b>, <b>9</b> and <b>13</b>, <b>14</b>), compounds <b>29</b>–<b>32</b> with the pyrrolidine group at N9 exhibited better TLR9 inhibition with higher selectivity against TLR7 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reporter assays of potent TLR7 and TLR9 antagonists. (A) The compounds were assessed for dose-dependent inhibition of TLR7, using a HEK-Blue TLR7 cell line expressing a TLR7-responsive, NF-κB-inducible SEAP. Data are shown as mean ± SD, <i>n</i> = 3. (B) The compounds were assessed for dose-dependent inhibition of TLR9, using a HEK-Blue TLR9 cell line expressing a TLR9-responsive, NF-κB-inducible SEAP. Data are shown as mean ± SD, <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our previous series (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), compound <b>16</b> with the ((dimethylamino)methyl)benzamide moiety at the C2 position showed excellent TLR9 inhibition (IC<sub>50</sub> = 0.056 μM). As a logical extension, we incorporated similar substituents at C2 in compounds <b>33</b> and <b>34</b> keeping the propylpyrrolidine group at the N9 position (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Both compounds showed very potent TLR9 inhibition with more than 200-fold selectivity against TLR7 antagonism. Compound <b>34</b> showed the best TLR9 inhibition among all of the compounds with an IC<sub>50</sub> value of 0.007 μM and that of 9.25 μM against TLR7. Notably, all three compounds <b>16</b>, <b>33</b>, and <b>34</b> with the ((dimethylamino)methyl)benzamide moiety at the C2 position of the purine scaffold showed the most potent TLR9 antagonism among all of the compounds (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">TLR8 reporter assays of compounds <b>29</b>, <b>30</b>, and <b>32</b> were performed using HEK293 cells transfected with hTLR8 (mean ± SD, <i>n</i> = 3). The IC<sub>50</sub> values of all of them were found to be >30 μM.</div><div class="NLM_p last">Commercially available TLR agonists (CpGB for TLR9, CL264 for TLR7, and CL075 for TLR8) were used as positive controls.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Selectivity of Antagonists against TLR8</h3><div class="NLM_p">The crystal structure of monkey TLR7 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMF">5GMF</a>) revealed two distinct binding sites.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Small-molecule ligands bind to the first site (binding site 1), whereas truncated polyU only binds to the second site (binding site 2).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The proposed antagonistic binding site 1 of TLR7 consists of LRR11–13 on one side and LRR15*-16* on another side of the homodimeric ectodomain. It is observed that the active site domain of binding site 1 of human TLR7 consisting of His 276, Phe327, Phe329, Leu331, Ser452, Glu1248*, and Tyr1374* is not aligned with the corresponding amino acid residues of monkey TLR7 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figures S5 and S6</a>). The crystal structure of human TLR8 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) was chosen as the template for building the human TLR7 homology model as the homodimeric chains of both structures are aligned with each other (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figure S7A</a>).<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> Although the conserved antagonist binding domains (binding site 1) of TLR7 and TLR8 reside nearby, the structural and sequential alignment revealed that some of the antagonistic binding residues, such as polar Thr384 of TLR7, are not similar to that of the human TLR8. Polar residue Thr384 in TLR7 is replaced with nonpolar bulky Ile403 in TLR8.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Additionally, Ser452 and Glu459 are also not able to align with any comparable amino acids from TLR8 ectodomains (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figure S7B</a>). It can be perceived that this difference in the nature of the amino acids plays a pivotal role in imparting selective antagonistic activity between TLR7 and TLR8. Docking of our lead antagonists (compounds <b>29</b> and <b>30</b>) in the homology model of the homodimerized TLR7 ectodomain manifests in conserved hydrogen bonding with Ser452 and the important π–π interaction with Tyr1374* (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). However, docking of these two antagonists with the TLR8 ectodomain does not exhibit similar interactions due to a change in binding conformation. This could be the plausible explanation for the selectivity of these antagonists against the TLR8 protein.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Molecular interaction between the homology-built homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>29</b>. The two chains are represented by teal and pink cartoon representations, respectively. Hydrogen bonds and hydrophobic interactions are shown by the green dashed line and the gray dashed line, respectively. (B) Molecular interaction between the homology-built homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>30</b>. The two chains are represented by teal and pink cartoon representations, respectively. Hydrogen bonds, halogen bonds, and hydrophobic interactions are shown by green and magenta dashed lines and gray dashed lines, respectively. *Indicates residues in chain B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Isothermal Titration Calorimetry (ITC) Experiment</h3><div class="NLM_p last">Exclusion of direct interaction of compound <b>29</b>/<b>30</b> with TLR9/7 agonists CpGB/CL264 by isothermal titration calorimetry (ITC) was used to indirectly establish the binding of compounds <b>29</b> and <b>30</b> to human TLR7/TLR9. The titration of both antagonists <b>29</b> and <b>30</b> into CpGB (commercially available TLR9 agonist) did not yield sufficient changes in heat signals, indicating that there is negligible interaction between both antagonists and CpGB (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figure S8A,C</a>). Additionally, we assessed the binding capacities of these two antagonists with CL264 (commercially available TLR7 agonist). The heat signals obtained during the titration of the antagonists into CL264 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figure S8B,D</a>) exhibited results similar to those obtained for CpGB. Hence, we were able to conclusively rule out any role of compound–agonist binding as the reason behind the observed antagonistic activity of the compounds. Furthermore, by logical extrapolation of these findings, we can conclude that the TLR7/9 antagonism shown by the antagonists is most likely the result of the interaction between the antagonists with the respective TLR protein.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vitro</i> ADME Study</h3><div class="NLM_p">The <i>in vitro</i> pharmacokinetic properties of five of the most potent TLR9 antagonists (<b>29</b>, <b>30</b>, <b>32</b>, <b>33</b>, and <b>34</b>) were evaluated in a panel of <i>in vitro</i> ADME assays (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>–<named-content content-type="anchor" rid="tbl4" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> All of these compounds having structural similarity at N9 with variation at the C6-piperazine and para position of the C2 phenyl ring were assessed through a series of established assays, providing us insights into how <i>in vitro</i> pharmacokinetic properties are affected by structural modifications in the scaffold. We initiated ADME profile inspection with the <i>in silico</i> calculation of some key physicochemical properties such as polar surface area and clogP (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). We investigated kinetic solubility at pH 7.4, plasma (human and mouse) stability, microsomal (human and mouse) stability, and Caco-2 permeability through a series of established <i>in vitro</i> assays.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> The aqueous solubility of all of the compounds was found to range from moderate to excellent. To our satisfaction, all of the selected compounds exhibited significant Caco-2 cell permeability with an efflux ratio of less than 2, suggesting that these molecules are not substrates of P-gp (P-glycoprotein) and are expected to be absorbed well in the gastrointestinal tract. However, out of the five compounds, compounds <b>29</b> and <b>30</b> demonstrated the highest human plasma stability at 2 h. In the human and mouse microsomal stability assay, compound <b>29</b> showed <i>T</i><sub>1/2</sub> values of 60 and 48 min, respectively. In contrast, compound <b>30</b> had moderate human microsomal stability and 4 times half-life variation in human and mouse metabolic stability. Although compound <b>33</b> has promising metabolic stability, its poor plasma stability in mouse made it a weak contender in selection for <i>in vivo</i> studies. Although compound <b>34</b> showed the lowest IC<sub>50</sub> value (5.0 nM) against TLR9, it was not considered for further study due to poor plasma stability in both mice and humans. Considering all of the above parameters, we finally decided to carry forward <i>in vivo</i> studies with compound <b>29</b> as all of the <i>in vitro</i> pharmacokinetic parameters of this compound are in the ideal range. In the next study, we have explored the <i>in vivo</i> pharmacokinetic profile of compound <b>29</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Pharmacokinetic Profile of Potent Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">plasma stability<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd.</th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">clogP</th><th class="colsep0 rowsep0" align="center" char=".">aq solubility pH = 7.4 (μg/mL)</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">52.6</td><td class="colsep0 rowsep0" align="char" char=".">1.38</td><td class="colsep0 rowsep0" align="char" char=".">200.3</td><td class="colsep0 rowsep0" align="char" char=".">95.0</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">74.6</td><td class="colsep0 rowsep0" align="char" char=".">3.95</td><td class="colsep0 rowsep0" align="char" char=".">49.4</td><td class="colsep0 rowsep0" align="char" char=".">89.9</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">65.4</td><td class="colsep0 rowsep0" align="char" char=".">4.05</td><td class="colsep0 rowsep0" align="char" char=".">218.0</td><td class="colsep0 rowsep0" align="char" char=".">100.0</td><td class="colsep0 rowsep0" align="char" char=".">97.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">65.4</td><td class="colsep0 rowsep0" align="char" char=".">5.08</td><td class="colsep0 rowsep0" align="char" char=".">28.2</td><td class="colsep0 rowsep0" align="char" char=".">75.6</td><td class="colsep0 rowsep0" align="char" char=".">20.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">85.7</td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char=".">136.0</td><td class="colsep0 rowsep0" align="char" char=".">58.7</td><td class="colsep0 rowsep0" align="char" char=".">22.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">85.7</td><td class="colsep0 rowsep0" align="char" char=".">4.35</td><td class="colsep0 rowsep0" align="char" char=".">47.5</td><td class="colsep0 rowsep0" align="char" char=".">50.2</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Polar surface area.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Mean % remaining after 2 h.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Caco-2 Permeability of the Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">mean parameters</th></tr><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center" char=".">apical to basal</th><th class="colsep0 rowsep0" align="center" char=".">basal to apical</th><th class="colsep0 rowsep0" align="center" char=".">efflux ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">3.57</td><td class="colsep0 rowsep0" align="char" char=".">9.28</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">37.99</td><td class="colsep0 rowsep0" align="char" char=".">68.59</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">64.33</td><td class="colsep0 rowsep0" align="char" char=".">61.21</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">32.74</td><td class="colsep0 rowsep0" align="char" char=".">61.96</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">92.22</td><td class="colsep0 rowsep0" align="char" char=".">61.23</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">32.37</td><td class="colsep0 rowsep0" align="char" char=".">68.25</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">propranolol<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">14.36</td><td class="colsep0 rowsep0" align="char" char=".">17.30</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atenolol<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">1.50</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Propranolol and atenolol were taken as standards.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>In Vitro</i> Microsomal Stability of the Potent Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">% remaining at 60 min</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">CL<sub>int</sub>protein (μL/min/mg protein)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">%QH</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">90.3</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">75.79</td><td class="colsep0 rowsep0" align="char" char=".">65.09</td><td class="colsep0 rowsep0" align="char" char=".">7.81</td><td class="colsep0 rowsep0" align="char" char=".">6.21</td><td class="colsep0 rowsep0" align="char" char=".">26.5</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">60.1</td><td class="colsep0 rowsep0" align="char" char=".">47.6</td><td class="colsep0 rowsep0" align="char" char=".">41.4</td><td class="colsep0 rowsep0" align="char" char=".">38.6</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="char" char=".">14.62</td><td class="colsep0 rowsep0" align="char" char=".">34.9</td><td class="colsep0 rowsep0" align="char" char=".">28.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">35.1</td><td class="colsep0 rowsep0" align="char" char=".">144.5</td><td class="colsep0 rowsep0" align="char" char=".">27.9</td><td class="colsep0 rowsep0" align="char" char=".">78.4</td><td class="colsep0 rowsep0" align="char" char=".">19.7</td><td class="colsep0 rowsep0" align="char" char=".">2.61</td><td class="colsep0 rowsep0" align="char" char=".">47.8</td><td class="colsep0 rowsep0" align="char" char=".">6.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">17.9</td><td class="colsep0 rowsep0" align="char" char=".">30.2</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">23.7</td><td class="colsep0 rowsep0" align="char" char=".">38.8</td><td class="colsep0 rowsep0" align="char" char=".">23.08</td><td class="colsep0 rowsep0" align="char" char=".">64.2</td><td class="colsep0 rowsep0" align="char" char=".">38.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">112.1</td><td class="colsep0 rowsep0" align="char" char=".">144.5</td><td class="colsep0 rowsep0" align="char" char=".">50.7</td><td class="colsep0 rowsep0" align="char" char=".">79.1</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">4.74</td><td class="colsep0 rowsep0" align="char" char=".">24.1</td><td class="colsep0 rowsep0" align="char" char=".">11.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">51.6</td><td class="colsep0 rowsep0" align="char" char=".">86.0</td><td class="colsep0 rowsep0" align="char" char=".">40.2</td><td class="colsep0 rowsep0" align="char" char=".">58.6</td><td class="colsep0 rowsep0" align="char" char=".">13.6</td><td class="colsep0 rowsep0" align="char" char=".">8.38</td><td class="colsep0 rowsep0" align="char" char=".">38.5</td><td class="colsep0 rowsep0" align="char" char=".">18.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Verapamil</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">0.0</td><td class="colsep0 rowsep0" align="char" char=".">107.6</td><td class="colsep0 rowsep0" align="char" char=".">127.1</td><td class="colsep0 rowsep0" align="char" char=".">83.3</td><td class="colsep0 rowsep0" align="char" char=".">77.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Verapamil was taken as the standard.</p></div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>In Vivo</i> Pharmacokinetic Study</h3><div class="NLM_p">Finally, to evaluate the <i>in vivo</i> applicability of the potent TLR9 antagonist <b>29</b>, we performed the <i>in vivo</i> pharmacokinetics of the compound by administering 10 mg/kg through both the oral route and the intravenous route of administration in C57BL/6 mice (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The compound was found to be rapidly absorbed into the blood with a half-life of 3.4 h upon oral administration. It was also found that the maximum plasma concentration (<i>C</i><sub>max</sub>) surpassed the <i>in vitro</i> IC<sub>50</sub> against TLR9 at 10 mg/kg oral dose. The volume of distribution (<i>V</i><sub>ss</sub>) of compound <b>29</b> was assessed at 14.1 L/kg, which is consistent with the basic nature of the compound. Moreover, average aqueous solubility (49.4 μg/mL at pH = 7.4) and good lipophilicity of the compound also contribute to its high volume of distribution. All of these <i>in vitro</i> and <i>in vivo</i> pharmacokinetic parameters of compound <b>29</b> sum up to provide moderate oral bioavailability (<i>F</i> = 38%).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>In Vivo</i> Pharmacokinetic Parameters of Compound <b>29</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">route of administration<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–24h</sub> (ng h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.76</td><td class="colsep0 rowsep0" align="char" char=".">780.2</td><td class="colsep0 rowsep0" align="char" char=".">213.6</td><td class="colsep0 rowsep0" align="char" char=".">14.1</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">62.3</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">296.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Compounds were administered at 10 mg/kg in mice (<i>n</i> = 3). Here, <i>C</i><sub>max</sub> is the maximum concentration of drug in plasma/blood, <i>t</i><sub>max</sub> is the time required to reach <i>C</i><sub>max</sub>, <i>t</i><sub>1/2</sub> is the half-life, AUC is the area under the curve, CL is the rate of clearance, and <i>V</i><sub>ss</sub> is the volume of distribution.</p></div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>In Vitro</i> Cellular Toxicity Assay</h3><div class="NLM_p">From our library, we selected six hit compounds <b>16</b>, <b>29</b>, <b>30</b>, <b>32</b>, <b>33</b>, and <b>34</b> for cytotoxicity assessment. We checked the <i>in vitro</i> toxicity in various cell lines of different tissue origins such as human peripheral blood mononuclear cells (hematopoietic origin), HCT116 (a colon cancer cell line representing the gut epithelium of an endodermal origin), HepG2 (a hepatocellular carcinoma cell line representing hepatocytes of a mesodermal origin), and H9C2 (a rat cardiomyoblast cell line representing a mesodermal origin) by propidium iodide staining. To our satisfaction, none of our hit molecules showed appreciable toxicity in the above-mentioned cell lines up to 20 μM concentration of the compounds (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A–D).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Determination of <i>in vitro</i> cytotoxicity of potent TLR9 antagonists. (A) Human PBMCs, (B) HCT116, (C) HepG2, and (D) H9C2 cells were treated with mentioned concentrations of the compounds overnight and assessed by propidium iodide staining and flow cytometry to determine the percentage of live/dead cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>In Vivo</i> TLR9 Antagonism Efficacy</h3><div class="NLM_p">Aberrant TLR9 activation in tissue-recruited pDCs, caused by the buildup of abundant self-DNA in a confined space, leads to excessive type I IFN induction, which plays a crucial pathogenetic role in clinical contexts of autoimmune diseases. Expressions of interferon signature genes (ISGs) in tissues are reliable biomarkers of IFN signaling and are associated with disease activity in clinical contexts.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> These also serve as reliable surrogates for assessing local induction of type I IFNs. To estimate the <i>in vivo</i> efficacy of a representative TLR9 antagonist <b>29</b>, we used a clinically relevant murine model reported in one of our previous studies (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> We administered a mixture of CpGA and CpGB, the <i>bona fide</i> TLR9 ligand, to the peritoneal cavity of C57BL/6 mice, which caused immune cell (including pDC) infiltration into the peritoneum (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), followed by IFNα induction. To analyze and compare the local induction of type I IFNs in the peritoneum of mice fed or not fed with compound <b>29</b>, we directly quantified the protein concentration of IFNα in the peritoneal fluid (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C) and also evaluated the mRNA expressions of two interferon signature genes (reliable biomarkers of IFN signaling, associated with disease activity in clinical contexts), IFIT1 and ISG15, in the cells recovered from the inflamed peritoneal cavity (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D,E). The significant depletion of the type I IFN protein in the peritoneal fluid, as well as the mRNA expression levels of both ISGs, established the <i>in vivo</i> efficacy of our potent antagonist <b>29</b>.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Study of <i>in vivo</i> efficacy of compound <b>29</b>. (A) Oral administration of compound <b>29</b> at a dose of 10 mg/kg body weight of mice was performed in the target group of mice 1 h before ip injection of a mixture of CpGA and CpGB. After 18 h, the peritoneal wash was collected. The IFNα enzyme-linked immunosorbent assay (ELISA) was performed using the peritoneal fluid, while the expression of target genes was monitored in the cellular component. (B) Flow cytometric analysis of a cellular component of peritoneal wash was performed to determine the infiltration of immune cells, especially pDCs into mouse peritoneum. (C) The concentration of IFNα in mice peritoneal fluid w/o administration of compound <b>29</b> was measured by IFNα ELISA (two independent experiments). (D, E) The mRNA expression levels of IFIT1 (D) and ISG15 (E) in the peritoneal infiltrating cells of mice w/o exposure to compound <b>29</b> were quantified by real-time polymerase chain reaction (PCR; two independent experiments).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>In Vivo</i> Therapeutic Efficacy Study</h3><div class="NLM_p">To study the efficacy of compound <b>29</b> as a dual TLR7/9 antagonist in the context of a TLR7/9-mediated autoimmune disease <i>in vivo</i>, we used a preclinical model of murine psoriasis. This model bears a strong resemblance to human psoriasis<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and has been used in multiple studies to explore the pathogenesis of the disease.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The model was developed as previously reported<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and displayed all morphological features associated with psoriasiform inflammation (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Daily oral administration of the compound led to drastic ablation of psoriasis-like cutaneous morphology (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). Moreover, histopathologic exploration of psoriatic skin sections from control and treated mice revealed stark differences, with treated skin resembling normal skin to a greater extent (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). A scoring system of each pathognomonic feature such as hyperkeratosis, parakeratosis, acanthosis, papillomatosis, suprapapilary thinning, and vascular dilatation with the highest severity given a score of 3 and least severity given a score of 1 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C) indicated a significant reduction in disease severity in response to treatment with compound (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D,E). Thus, the ability of compound <b>29</b> to significantly reduce disease severity of a TLR7/9-driven autoimmune disease <i>in vivo</i> could be established similarly.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Efficacy of compound <b>29</b> in preventing psoriasis-like inflammation in a rodent model. (A) (Left) Representative image of murine skin before starting of imiquimod application (on day 0). (Middle) Representative image of control murine skin on day 7 following topical application of imiquimod for 6 days and oral administration of vehicle for 7 days, showing extensive scale formation on skin. (Right) Posterior skin of mouse on day 7 following 6 days of imiquimod application and 7 days of compound <b>29</b> administration showing drastic reduction of scale formation. (B) (Left) H&E-stained section from imiquimod-exposed skin of vehicle-treated mouse showing remarkable broadening of the epidermal layer, (right) H&E-stained section from imiquimod-exposed skin of mouse treated with compound <b>29</b>, showing lesser broadening of the epidermis compared to the vehicle-treated group (objective magnification 20×). (C) Severity of psoriasis was scored based on clinically relevant histopathological features (where 1 is the least severe and 3 is the most severe). (D) Difference in scores representing the severity of indicated histopathological parameters in psoriatic skin sections derived from seven control mice and six compound-treated mice. The Mann–Whitney test was performed (*<i>p</i> < 0.05, **<i>p</i> < 0.01). (E) Plotting of overall severity scores for each mouse of both control and treatment groups based on all evaluated histopathological features. Unpaired <i>t</i>-test was done (*<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Short-Term Visceral Toxicity Assessment</h3><div class="NLM_p">Histomorphological evaluation of murine lung, liver, and kidney specimens was done to rule out any deleterious impact of compound <b>29</b> on these major organs. Hematoxylin and eosin-stained sections of the liver, lung, and kidney did not show any major morphologic changes upon oral administration of 20 mg of compound <b>29</b> per kg body weight of mice (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B,D,F) for 7 consecutive days in comparison to mice treated only with vehicle (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,C,E). Morphology of hepatocytes was normal in liver sections of both vehicle-treated (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A) and compound-treated (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B) mice. The absence of microvesicular steatosis, as well as lack of inflammatory cell aggregation, indicated a lack of short-term toxicity of compound <b>29</b> on the murine liver. Similarly, no major inflammatory cell infiltration was observed in any of the murine lung sections, and the alveolar sac histologies of both vehicle-treated (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C) and compound-treated (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>D) mice were comparable. Finally, examination of kidney sections revealed normal morphology of glomerular and tubular structures, as well as the mesangial cells in compound-treated mice (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>F), and no observable difference could be seen with that of the control group (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>E). At the same time, no behavioral or physiological changes were observed in any of the animals during the experimental period. Postmortem observations also did not reveal any macroscopic abnormalities in any of the animals. All of these observations cumulatively indicated the lack of short-term toxicity of compound <b>29</b> following oral administration for 7 consecutive days in C57BL/6 mice.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Short-term toxicity evaluation for control and compound-treated mice. (A–F) Representative images showing H&E-stained sections of indicated organs of mice, which have received either vehicle (A, C, E) or compound <b>29</b> (B, D, F) for 7 consecutive days (objective magnification 10×).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the present study, we have reported strategies for the systematic development of potent dual TLR7/9 antagonists as well as factors modulating selective TLR9 antagonism. The SAR analysis revealed that there exist concerted relationships between the nature of substituents at C2, C6, and N9 positions. Various substituents with suitable basicity and lipophilicity at C2, C6, and N9 of the purine ring have shown potent TLR9 antagonism with IC<sub>50</sub> < 100 nM and high selectivity against TLR7 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). At the C2 position, suitable substitutions such as −NH<sub>2</sub>, substituted benzylamines, and benzamides are well-tolerated for TLR9 inhibition. On the other hand, when −NH<sub>2</sub> substitution is present at the C2 position, suitable N9 substituents can modulate TLR7 inhibition. At the C6 position, piperazine with hydrophobic ethyl and cyclopentyl groups are favorable as compared to electron-withdrawing amides. At N9, both ethyl piperazine and pyrrolidine groups can manifest promising TLR9 antagonism with high selectivity against TLR7. The selection of compound <b>29</b> as the lead (from among the set of hit compounds obtained from reporter assays) was done based on various <i>in vitro</i> pharmacokinetic assays. In an alternative approach, ITC experiments could rule out possible antagonism caused by binding of target compounds directly to the TLR ligands, thus indicating that the antagonism manifested by the lead candidates <b>29</b> and <b>30</b> is the result of the interaction between the antagonists and the respective TLR protein. Notably, compound <b>29</b> did not exhibit any significant TLR8 inhibition up to 30 μM (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">Figure S3</a>). The lead compound <b>29</b> showed moderate aqueous solubility at pH 7.4, good Caco-2 permeability, as well as excellent plasma and microsomal stability in both mice and human. The <i>in vivo</i> pharmacokinetic parameters of this compound in mice revealed 38% oral bioavailability. In the <i>in vivo</i> efficacy model, compound <b>29</b> was found to be efficacious (at a considerably low dose of 10 mg/kg body weight) in inhibiting TLR9 activation as measured by its ability to efficiently suppress the TLR9-mediated type I IFN response. Finally, the <i>in vivo</i> therapeutic efficacy of the lead compound <b>29</b> was established in a preclinical murine model of psoriasis. Histomorphological evaluation of the lung, liver, and kidney did not show any major morphologic changes following oral administration of compound <b>29</b>. These results provide compelling evidence, which advocates compound <b>29</b> as a potential candidate for future development into a clinically relevant therapeutic molecule. The systematic SAR analysis described in the manuscript can be regarded as a benchmark to develop potent TLR7 and TLR9 antagonists in various scaffolds in the future.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Aqueous Solubility Assay</h3><div class="NLM_p last">A total of 5 μL of 20 mM dimethyl sulfoxide (DMSO) stock solution was added to the reaction deep well plate containing 495 μL of pH 7.4 pION buffer, including the DMSO control. The samples were mixed and incubated for 18 h. The plate was sealed well during the incubation process. The DMSO content in the sample was <1.0%. The deep well plate contained solution having a concentration of 200 μM. Then, 4 μL of 20 mM stock (including the DMSO control) to 996 μL of acetonitrile was added to prepare a working stock plate. A total of 75 μL of the working stock was added to 75 μL of the blank buffer and read on a spectrophotometer with a reference plate at 240 nm. A filter plate was used to vacuum-filter 100 μL of the sample from the storage plate after the incubation period was completed. The filtrate was discarded when filters became completely wet. A new filter collection plate was taken, and another 200 μL of the sample from a deep well plate was vacuum-filtered into it. The filtrate (75 μL) from the filter collection plate was transferred to a UV sample plate. Acetonitrile (75 μL) was added to this UV plate and mixed properly, and the spectrum was read using the UV spectrophotometer at 240 nm. Plates were read on spectramax using SoftMax Pro software version 5.3.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Caco-2 Permeability Assay</h3><div class="NLM_p last">A total of 10 mM stock of the compound in DMSO was diluted with Hank’s balanced salt solution (HBSS) buffer at pH 7.4 to a final concentration of 10 μM. To proliferate the cells, 250 μL of Dulbecco’s modified Eagle’s medium (DMEM) was added to the basal compartment of a 96-well multiscreen Caco-2 plate and seeded at 12 000 cells/well (0.16 × 10<sup>6</sup> cells/mL) in all of the apical wells, which were placed in a CO<sub>2</sub> incubator at 37 °C. On the day of the experiment, the medium was taken out and washed twice with HBSS buffer. A total of 250 μL of the buffer with 2% bovine serum albumin (BSA) was added to basal wells, and 75 μL of the test compound was added to apical wells. Then, 25 μL of basal samples was collected at 120 min and processed as follows. A total of 250 μL of the test compound and 75 μL of HBSS buffer with 2% BSA were added to basal wells and apical wells, respectively. At 120 min, apical samples (25 μL) were collected and processed as mentioned below. A single-point calibration curve in the buffer with 2% BSA was used. Donor and receiver samples were diluted 1:1 with the buffer separately, while the former contains 2% BSA. It was precipitated with 200 μL of acetonitrile containing an internal standard and vortexed for 5 min at 1000 rpm and then further centrifuged at 4000 rpm for 10 min. Finally, 100 μL of the supernatant was diluted with 200 μL of water and analyzed in liquid chromatography–mass spectrometry (LC–MS)/MS analysis.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Plasma Stability Assay</h3><div class="NLM_p last">A total of 10 mM stock solution in DMSO was prepared and stored at 4 °C. Then, 25 μM stock solution of the test compound was prepared in ACN/water by diluting the previously prepared 10 mM stock, i.e., 2.5 μL of the 10 mM stock solution was added to 997.5 μL of acetonitrile/water (50:50). The frozen plasma was thawed at room temperature and centrifuged at 1400× relative centrifugal force (RCF) at 4 °C for 15 min. Approximately 90% of the clear supernatant fraction was transferred to a separate tube and was then used for the experiment. For 0 min samples, plasma was heat-inactivated at 56 °C for 45 min. Then, 3 μL of the 25 μM test compound was added to 72 μL of heat-inactivated plasma. An aliquot of 25 μL of the mixture was taken and crashed with 200 μL of acetonitrile containing the internal standard and further processed along with other time points. A final working stock solution of 1 μM was prepared by diluting samples in plasma for other time points (i.e., 8 μL of 25 μM acetonitrile/water stock was added to 192 μL of plasma). A total of 200 μL of plasma containing the test compound was incubated for 2 h at 37 °C in a shaker water bath with gentle shaking. An aliquot of 25 μL of the sample at 0, 15, 30, 60, and 120 min was precipitated immediately with 200 μL of acetonitrile containing the internal standard and centrifuged at 4000× RCF, 4 °C for 20 min. Then, 150 μL of the supernatant was diluted with 150 μL of water and analyzed on liquid chromatography–mass spectrometry (LC–MS)/MS.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Microsomal Stability Assay</h3><div class="NLM_p last">A total of 10 mM stock solution of the test compound in DMSO was diluted with 1:1 water and acetonitrile to afford a 200 μL of 1 mM stock solution. Then, 100 μM working concentration of the test compound was prepared by diluting 1 mM stock solution of the test compound in DMSO with ACN/water (1:1). Nicotinamide adenine dinucleotide phosphate (NADPH) cofactor solution (2.5 mM) was prepared from a 16 mM stock solution, and a 3.33 mg/mL working stock of liver microsomes was prepared from a 20 mg/mL liver microsome master stock solution. A total of 85 μL of phosphate buffer of pH 7.4 was mixed with 2.5 μL of the 100 μM test compound and 75 μL of 3.33 mg/mL HLM in a deep well plate for preincubation of 10 min at 37 °C. Then, 32.5 μL of the mixture was added to 17.5 μL of buffer and incubated for 60 min without the NADPH cofactor. For the 0 min sample, 16.5 μL of the preincubated mixture was crashed with 200 μL of acetonitrile and 8.75 μL of cofactor was added to it. After this, 62 μL of the NADPH cofactor was added to the remaining incubation mixture and kept for 60 min at 37 °C. For other time point samples, 25 μL of the incubation mixture at 5, 10, 30, 60, and 60 min without the cofactor was precipitated immediately with 200 μL of acetonitrile containing the internal standard and vortexed for 5 min at 1200 rpm. The samples were centrifuged at 4000× RCF at 4 °C for 10 min. The supernatant (150 μL) was diluted with 150 μL of water and processed on LC–MS/MS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Isothermal Titration Calorimetry</h3><div class="NLM_p last">ITC experiments were performed in a buffer composed of 25 mM 4-morpholineethansulfonic acid (MES) pH 5.5, 0.20 M NaCl, and 1% DMSO at 298 K using a MicroCal iTC200 (GE Healthcare). The titration sequence included a single 0.4 μL injection followed by 20 injections, 2 μL each, with a spacing of 120 s between the injections. The titration conditions were as follows: 100 μM compound <b>29</b> into 10 μM CpGB; 100 μM compound <b>29</b> into 10 μM CL264. OriginLab software (GE Healthcare) was used to analyze the raw ITC data.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Reporter Assay to Measure TLR9, TLR7, and TLR8 Antagonism</h3><div class="NLM_p last">To monitor the antagonistic efficacy of the synthesized compounds against TLR9, TLR7, and TLR8, HEK-BlueTLR9, HEK-BlueTLR7, and HEK-BlueTLR8 reporter cell lines (Invivogen) were used, respectively. The principle behind the assay involves TLR agonist/antagonist-mediated NF-κB activation/inhibition, which in turn causes/inhibits SEAP production, secretion into the culture supernatant, and color change of the detection media—ultimately indicating whether TLR activation is successful or not. Approximately 70 000 cells were seeded in complete DMEM media and incubated for 5 h at 37 °C and 5% CO<sub>2</sub> before indicated concentrations of mentioned compounds were added to the wells. After 1 h of compound addition, indicated doses of commercially available TLR agonists (CpGB for TLR9, CL264 for TLR7, and CL075 for TLR8—Invivogen), used as positive controls and against which the inhibitory activity of the compounds was tested, were added in the required wells. Cells were incubated overnight, and on the next day, the culture supernatant was added to Quanti-Blue detection media and once again incubated with periodic monitoring for color changes. Upon color change, spectrophotometric reading of the OD value at 650 nm wavelength was recorded.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> TLR9 Antagonism Assay in Human PBMCs</h3><div class="NLM_p last">Blood was drawn from healthy donors after obtaining informed consent as well as approval from the institutional ethics board. PBMCs were isolated from the blood using density gradient centrifugation. A total of 200 000 PBMCs/well were cultured and treated with indicated doses of compounds for 1 h before CpGA (TLR9 agonist—Invivogen) was added for overnight incubation. The next day, the culture supernatants were collected and subjected to IFNα ELISA according to the manufacturer’s protocol (Mabtech, Sweden).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Molecular Docking Study</h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Ligand Preparation</h4><div class="NLM_p last">The two-dimensional (2D) form of the structurally diverse purine class of the TLR7/9 antagonist molecules was drawn on ChemDraw Ultra and converted to their three-dimensional (3D) structures by Accelrys Discovery Studio 4.1 (DS). All of the compounds were energy-minimized by performing 2000 steps of steepest descent followed by conjugate gradient algorithms, which conserved the RMSD gradient of 0.01 Å.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> All of the compounds were processed at pH 5.5–6.5.</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Protein Preparation</h4><div class="NLM_p last">The human TLR7 ectodomain 3D structure used in the docking calculation was solved by homology building using the template hTLR8 crystal structure by the Discovery Studio MODELER suite. The human TLR8 ectodomain crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) was extracted out from the protein data bank (PDB). The co-crystallized water and heteroatoms were removed. The protein was prepared by maintaining the protonation state at pH 5.5–6.5 using the CHARMm force field.</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Molecular Docking</h4><div class="NLM_p">Molecular docking of the designed compounds was accomplished on the hTLR7 using the GOLD2020.1 suite. Molecules were docked on the pre-described active site<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> on the homodimeric interface with a 6 Å radius sphere by selecting the active site residues of the protein. The default Genetic Algorithm module was implemented during the docking program for exploring probable ligand conformational flexibility and rotational flexibilities of the receptor hydrogen for hydrogen bonding into the binding sites.<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64,65)</a> In GOLD, docking was accomplished using a chemscore_kinase template with the ligand having 100% search efficiency, which indicates a ligand with five rotatable bonds having around 30000 GA operations.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> “Early termination” was turned off, which specifies that the GOLD program will not be ended until it completes all of the GA operations. A cluster of 40 solutions was saved for each ligand having an RMSD cutoff of 1.7 Å. The GOLD docking program was used by GoldScore and ChemScore fitness function. GoldScore is a molecular mechanistic function that is specialized for the spatial binding of the ligand. The scoring function considers van der Waals energy, H-bonding energy, torsional strain, and potential metal interaction for the proper estimation of the ligand-binding conformation.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p last">Molecular docking of the best active compound <b>29</b> was performed on the active site of the hTLR8 crystal structure. Molecules were docked on the co-crystallized antagonist binding site<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> in between the homodimeric interface with a grid size of 7.4 Å radius sphere around the active site residues of the protein. The default genetic algorithm was implemented during the docking program for allowing the probable ligand conformational and rotational flexibilities, which leads to the formation of hydrogen bonding with the binding site residues by following the CHARMm force field.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Probable binding conformation of the selected ligand was chosen among the cluster of 20 conformations.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Cytotoxicity Assay in PBMCs</h3><div class="NLM_p last">The cytotoxic effects of indicated compounds were assayed in primary PBMCs. PBMCs were isolated from the blood of healthy donors after obtaining informed consent, using density gradient centrifugation. PBMCs (2 × 10<sup>5</sup>) resuspended in complete RPMI medium were treated with 1, 5, 10, and 20 mM of the compounds overnight. Next morning, cells were harvested, resuspended in fresh phosphate-buffered saline (PBS), and stained by the addition of 2.5 μg/mL propidium iodide for 1 min before acquisition in a flow cytometer. Around 25% of DMSO was used as a positive control. The abundance of PI positive cells indicated the number of dead cells.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Cytotoxicity Assay in HepG2, HCT116, and H9C2 Cell Lines</h3><div class="NLM_p last">The cytotoxicity of the compounds was assayed against HepG2 liver cancer cells of epithelial origin, H9C2 rat cardiomyocytes, and HCT116 colorectal cancer cells. A total of 6 × 10<sup>4</sup> cancer cells were incubated overnight in complete DMEM medium at 37 °C and 5% CO<sub>2</sub>. Next morning, 1, 5, 10, and 20 mM of the indicated compounds were added and incubated overnight once again, following which cells were harvested by gentle trypsinization, resuspended in fresh PBS, and stained by the addition of 2.5 mg/mL propidium iodide 1 min before acquisition in a flow cytometer. The PI positive population of cells provides a measure of dying cells. Around 25% of DMSO was used as a positive control.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>In Vivo</i> Pharmacokinetic Experiment</h3><div class="NLM_p last">Eight 8–10 weeks old male C57BL/6 mice were taken for the <i>in vivo</i> pharmacokinetic experiment. They were divided into two groups each having four mice. Compound <b>29</b> was reconstituted in 2% ethanol in PBS (0.01 M, pH = 7.4). The mice of the first group were orally administered compound <b>29</b> at 10 mg/kg dose, and the mice belonging to the second group were given intravenous injections of 10 mg/kg compound. Blood samples were collected at 0, 0.5, 1, 2, 4, 6, 12, and 24 h after oral administration of the compound, and serum was isolated with the compound. On the other hand, blood samples were drawn at 0, 0.25, 0.5, 1, 2, 4, 6, 12, and 24 h after intravenous administration of the compound and serum was isolated. For the pharmacokinetic study, 10 μL of serum samples from mice was extracted with 40 μL of LC/MS-grade acetonitrile + 0.1% formic acid (1:5 dilution) and incubated on ice for 15 min with intermittent vortexing and then centrifuged at 14 000 rpm for 10 min. Thereafter, the supernatant was collected and analyzed by LC–MS/MS to measure the concentration of compound <b>29</b> in the serum. Standards of the compound ranging from 24.784 to 2794 pg were prepared in the serum and extracted in acetonitrile + 0.1% formic acid in the same way. Mass spectrometry was performed in LTQ ORBITRAP XL using the Hypersil Gold C18 column having a diameter of 100 × 2.1 mm<sup>2</sup> with a particle size of 1.9 μm. The column formed the stationary phase, and a mixture of solution A (acetonitrile + 0.1% formic acid) and solution B (HPLC-grade H<sub>2</sub>O + 0.1% formic acid) formed the mobile phase. Liquid chromatography (injection volume 5 μL) was performed using an isocratic solution containing 40% acetonitrile and 0.1% formic acid. The intact compound had a retention time of 0.75 min and (<i>m</i>/<i>z</i>) of 479.3195, while (<i>m</i>/<i>z</i>) of the fragmented compound after MS/MS was 408.2512. All data were analyzed using Thermo Xcalibur software.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>In Vivo</i> Inhibition Assay</h3><div class="NLM_p last"><i>In vivo</i> studies in mice were performed after obtaining approval from the Animal Ethics Committee of CSIR-IICB. For the <i>in vivo</i> efficacy assay, 6–8 weeks old female C57BL/6 mice were recruited and divided into three groups. There were 4–5 mice in each of the three groups. The first group was given intraperitoneal injections of PBS (vehicle). The second group was injected IP with mouse 25 μg of CpGA + 25 μg of mouse CpGB. The third group members were orally administered with 10 mg/kg of the compound 1 h before IP injection with the CpGA/CpGB mixture. The mice were left overnight, and the next day all of the mice were sacrificed and the peritoneal fluid along with intraperitoneal cells was collected. The peritoneal fluid was subjected to IFNα ELISA, while the peritoneal cells were subjected to gene expression studies.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Mouse IFNα ELISA</h3><div class="NLM_p last">The concentration of IFNα in mouse peritoneal fluid was estimated by sandwich ELISA. For this, 1:1000 times diluted RMMA-1 primary antibody from the pbl interferon source was used, before the addition of peritoneal fluid samples and incubation for 2 h. The secondary antibody used in this case for detection was 1:500 times diluted polyclonal rabbit IgG antibody detecting mouse IFNα. Once again after incubation and washing 1:10 000 times diluted tertiary antibody (horseradish peroxidase (HRP) conjugated antirabbit IgG) was added. In the final step, detection was done using the TMB substrate and OD values were measured as described above.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Quantitative PCR</h3><div class="NLM_p last">Total RNA was isolated from peritoneal cells according to the TRIzol (Invitrogen) method and reverse-transcribed into cDNA (High-Capacity cDNA Reverse Transcription Kit, Applied Bisosystems). qPCR was performed in a Quant-studio 3 PCR machine using BioRadSyBR Green to monitor the expression of the indicated genes: MuISG15 (forward primer: ACGGTCTTACCCTTTCCAGTC; reverse primer: CCCCTTTCGTTCCTCACCAG), MuIFIT (forward primer: AGGCTGGAGTGTGCTGAGAT; reverse primer: TCTGGATTTAACCGGACAGC), and Mu18S (forward primer: GTTGGTTTTCGGAACTGAGG; reverse primer: TCGTTTATGGTCGGAACTACG, housekeeping gene).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Flow Cytometry</h3><div class="NLM_p last">Antimouse CD45 PE, TCRb APC-Cy7, Bst2 APC, and SiglecH BV421 fluorophore conjugated antibodies were used to stain peritoneal cells followed by acquisition in a BD Fortessa flow cytometer to determine the presence of pDCs in peritoneal infiltrates. FlowJo software Version 10 was used for the analysis.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>In Vivo</i> Efficacy Study</h3><div class="NLM_p last">Thirteen wild-type C57BL/6 male mice aged 8–10 weeks, provided by the CSIR-IICB animal house facility, were divided into two groups: (1) the control group containing seven mice with induced psoriasis, treated with 2% ethanol in sterile PBS (0.01 M, pH = 7.4) (vehicle); and (2) the treatment group containing six mice with induced psoriasis treated with compound <b>29</b>. Psoriasis was induced by daily topical application of 62.5 mg of 5% w/w imiquimod cream (Imiquad; Glenmark, India) on a patch of shaved dorsal skin of the mice for 6 consecutive days. Vehicle and compound (20 mg/kg) were administered orally daily for 7 days, beginning 1 day prior to the start of imiquimod application. The experimental animals were sacrificed on the 7th day of imiquimod application, and portions of affected skin were collected from each animal (in 4% paraformaldehyde) for histopathological evaluation by hematoxylin and eosin (H&E) staining. All animal handling and mouse experiments were conducted in accordance with national and international guidelines and upon approval from the institutional ethics committee. All recommendations enlisted in the ACS Ethical Guidelines were followed while performing the mouse experiments.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Short-Term Toxicity Evaluation</h3><div class="NLM_p last">Short-term toxicity evaluation was performed by comparing histomorphological features of visceral organ specimens obtained from vehicle-treated and compound-treated mice. Lung, liver, and kidney specimens were harvested and preserved in 10% formalin on day 7, following oral administration of 20 mg/kg body weight of compound <b>29</b> or vehicle for 7 consecutive days. Histomorphological evaluation was done after H&E staining of the tissue sections. A Magnus MLXi Plus pathology microscope (objective magnification 10×) was used for image acquisition.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Chemical Synthesis and Methods: General Methods</h3><div class="NLM_p last">All starting materials, reagents, and solvents were purchased from commercial suppliers and used without further purification. Air-sensitive reactions were carried out under dry nitrogen or argon atmosphere. For thin-layer chromatography (TLC), silica gel plates (Merck silica gel 60, F254) were used. RediSepRf silica gel columns were used for column chromatographic purification on the Teledyne ISCO CombiFlash Rf system using 230–400 mesh silica gel. <sup>1</sup>H NMR was recorded at 300 MHz (Bruker-DPX), 400 MHz (Jeol), and 600 MHz (Bruker-Avance) frequencies and <sup>13</sup>C NMR spectra were recorded at 75 MHz (Bruker-DPX), 100 MHz (Jeol), and 150 MHz (Bruker-Avance) frequencies using tetramethylsilane (TMS) as the internal standard. High-resolution mass spectra, HRMS (<i>m</i>/<i>z</i>), were measured using EI (Jeol-JMS 700 mass spectrometer), ESI (Q-Tof Micro mass spectrometer), and ESI (LTQ Orbitrap XL mass spectrometer) techniques. The purity of all of the compounds was determined to be >95%, analyzed by Hitachi HPLC using column Xtimate C18 (4.6 mm × 150 mm, 5.0 μm) using gradient elution of acetonitrile in water 0–90% for 12 min and flow rate 1 mL/min with detection at 254 nm wavelength.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> General Procedure A: Reductive Amination</h3><div class="NLM_p last">Appropriate amine (1.0 equiv) and aromatic aldehyde (1.2 equiv) were dissolved in toluene in the presence of molecular sieves (3A powder). The reaction mixture was refluxed at 110 °C under a N<sub>2</sub> atmosphere for 12 h. Toluene was evaporated, and to it, dichloroethane (DCE) and sodium triacetoxyborohydride (2 equiv) were added. The reaction was stirred at room temperature for 2 h. The reaction mixture was neutralized with NaHCO<sub>3</sub> solution and extracted with a CHCl<sub>3</sub> system. Column chromatography was performed using the CHCl<sub>3</sub>/CH<sub>3</sub>OH system to obtain the pure product.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Procedure B: Amidation Using POCl<sub>3</sub></h3><div class="NLM_p last">A mixture of appropriate amine (1.0 equiv) and 4-((dimethylamino)methyl)benzoic acid (1.2 equiv) was dissolved in dry pyridine (5 mL). POCl<sub>3</sub> (1.5 equiv) was added to the solution at 0 °C, and the reaction mixture was stirred for 2 h. The reaction mixture was poured into crushed ice and neutralized with saturated Na<sub>2</sub>CO<sub>3</sub> solution. The aqueous layer was extracted with chloroform, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under vacuum. The residue was purified by silica gel column chromatography to give the pure product.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Synthesis of 6-(4-Ethylpiperazine-1-yl)-9<i>H</i>-purin-2-amine (<b>3</b>)</h3><div class="NLM_p last">1-Ethyl piperazine (1.12 mL, 8.84 mmol) was added to a stirred suspension of 6-chloro-9<i>H</i>-purin-2-amine <b>2</b> (1.0 g, 5.89 mmol) and potassium carbonate (1.63 g, 11.78 mmol) in dry acetonitrile. The mixture was refluxed for 4 h. Acetonitrile was removed under vacuum. The residue was washed with water, followed by filtration, and dried to obtain compound <b>3</b> as an off-white solid (89.6%, mp 230 °C). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.69 (s, 1H), 4.23–4.19 (m, 4H), 2.58 (t, <i>J</i> = 4.8 Hz, 4H), 2.49 (q, <i>J</i> = 7.2 Hz, 2H), 1.16 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 159.8, 154.2, 153.1, 135.3, 113.3, 52.5, 52.0, 44.3, 10.5. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>11</sub>H<sub>18</sub>N<sub>7</sub>, 248.1618; found, 248.1622.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Synthesis of 6-(4-Cyclopentylpiperazin-1-yl)-9<i>H</i>-purin-2-amine (<b>4</b>)</h3><div class="NLM_p last">Compound <b>2</b> (1.0 g, 5.89 mmol) was dissolved in acetonitrile (8 mL), and potassium carbonate (1.63 g, 11.78 mmol) and 1-cyclopentylpiperazine (1.38 mL, 8.84 mmol) were added. The reaction mixture was refluxed for 6 h. The organic layer was extracted with the CHCl<sub>3</sub> system and column chromatography was performed using the CH<sub>3</sub>OH and CHCl<sub>3</sub> system to give compound <b>4</b> as a white solid (78%, mp > 250 °C). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.2 (br. s, −NH), 7.66 (s, 1H), 5.72 (s, −NH<sub>2</sub>), 4.09 (m, 4H), 2.46 (t, <i>J</i> = 4.2 Hz, 4H), 2.42–2.34 (m, 1H), 1.83–1.74 (m, 2H), 1.65–1.56 (m, 2H), 1.53–1.44 (m, 2H), 1.41–1.29 (m, 2H). <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): δ 160.0, 154.3, 154.0, 135.2, 113.7, 67.3, 52.4, 30.3, 30.1, 24.1. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>14</sub>H<sub>22</sub>N<sub>7</sub>, 288.1931; found, 288.1929.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Synthesis of 6-(4-Ethylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-amine (<b>5</b>)</h3><div class="NLM_p last">1-(3-Chloropropyl)-4-ethylpiperazine (1.16 g, 6.06 mmol) was added to a stirred suspension of compound <b>3</b> (1.0 g, 4.04 mmol) and potassium carbonate (1.12 g, 8.08 mmol) in dry DMF, and the reaction mixture was heated for 12 h at 100 °C. Water was added to the reaction mixture. The aqueous solution was extracted with chloroform, and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated under vacuum. The residue was purified by silica gel column chromatography eluting with 8% methanol in chloroform to give compound <b>5</b> as a light-brown liquid (65%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.49 (s, 1H), 4.59 (s, 2H), 4.32–4.20 (m, 4H), 4.08 (t, <i>J</i> = 7.2 Hz, 2H), 2.56–2.55 (m, 6H), 2.48–2.45 (m, 8H), 2.32 (t, <i>J</i> = 7.2 Hz, 2H), 2.01–1.97 (m, 2H), 1.14–1.10 (m, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 159.2, 154.2, 153.0, 136.7, 115.0, 54.5, 53.0, 52.7, 52.5, 52.3, 41.1, 26.4, 11.9, 11.8. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>20</sub>H<sub>36</sub>N<sub>9</sub>, 402.3088; found, 402.3077. HPLC purity 98.55%.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 6-(4-Cyclopentylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-amine (<b>6</b>)</h3><div class="NLM_p last">Compound <b>4</b> (1 g, 3.48 mmol) was dissolved in DMF solvent, and to it, 1-(3-chloropropyl)-4-ethylpiperazine (1 g, 5.22 mmol) and potassium carbonate (0.96 g, 6.96 mmol) were added. The reaction mixture was heated at 100 °C for 12 h. Water was added to the reaction mixture, the aqueous solution was extracted with CHCl<sub>3</sub>, and column chromatography was performed using the CH<sub>3</sub>OH and CHCl<sub>3</sub> system to afford compound <b>6</b> as a brown liquid (84%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45 (s, 1H), 4.61 (s, 2H), 4.28–4.15 (m, 4H), 4.04 (t, <i>J</i> = 6.8 Hz, 2H), 2.87 (t, <i>J</i> = 4.8 Hz, 2H), 2.56 (t, <i>J</i> = 5.2 Hz, 4H), 2.47–2.42 (m, 5H), 2.40–2.34 (m, 4H), 2.27 (t, <i>J</i> = 6.8 Hz, 4H), 1.98–1.91 (m, 2H), 1.86–1.81 (m, 2H), 1.69–1.63 (m, 2H), 1.54–1.49 (m, 2H), 1.04 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 159.3, 154.2, 153.1, 136.7, 115.0, 68.1, 67.6, 54.6, 53.6, 53.1, 52.9, 52.5, 52.4, 46.1, 41.1, 30.4, 30.3, 26.5, 24.2, 24.1, 12.0. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) cald for C<sub>23</sub>H<sub>40</sub>N<sub>9</sub>, 442.3401; found, 442.3405. HPLC purity 98.53%.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Synthesis of <i>N</i>-Benzyl-6-(4-ethylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-amine (<b>7</b>)</h3><div class="NLM_p last">Compound <b>5</b> (0.18 g, 0.44 mmol) and benzaldehyde (0.06 mL, 0.53 mmol) were dissolved in 5 mL of toluene, and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to produce compound <b>7</b> as a semisolid (50%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.46 (s, 1H), 7.37 (d, <i>J</i> = 7.2 Hz, 2H), 7.30 (t, <i>J</i> = 7.2 Hz, 2H), 7.23 (t, <i>J</i> = 7.2 Hz, 1H), 5.03 (t, <i>J</i> = 5.4 Hz, 1H), 4.62 (d, <i>J</i> = 6 Hz, 2H), 4.29–4.16 (m, 4H), 4.07 (t, <i>J</i> = 6.6 Hz, 2H), 2.54–2.52 (m, 6H), 2.45–2.40 (m, 10H), 2.30 (t, <i>J</i> = 6.6 Hz, 2H), 1.99–1.95 (m, 2H), 1.12 (t, <i>J</i> = 7.2 Hz, 3H), 1.08 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 159.0, 154.2, 153.4, 140.6, 136.5, 128.5, 127.7, 127.0, 114.9, 54.7, 53.1, 52.9, 52.8, 52.6, 52.4, 46.2, 41.2, 26.6, 12.0. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>27</sub>H<sub>42</sub>N<sub>9</sub>, 492.3558; found, 492.3558. HPLC purity 99.94%.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Synthesis of 6-(4-Ethylpiperazin-1-yl)-9-(-3-(4-ethylpiperazin-1-yl)propyl)-<i>N</i>-(4-methoxybenzyl)-9<i>H</i>-purin-2-amine <b>(8)</b></h3><div class="NLM_p last">Compound <b>5</b> (0.30 g, 0.74 mmol) and 4-methoxybenzaldehyde (0.10 mL, 0.89 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. Column chromatography was performed to obtain the pure product of <b>8</b> as a semisolid (46%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.46 (s, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 6.84 (d, <i>J</i> = 8.4 Hz, 2H), 4.96 (t, <i>J</i> = 5.7 Hz, 1H), 4.53 (d, <i>J</i> = 5.7 Hz, 2H), 4.32–4.14 (m, 4H), 4.07 (t, <i>J</i> = 6.6 Hz, 2H), 3.78 (s, 3H), 2.54–2.51 (m, 4H), 2.46–2.37 (m, 10H), 2.30 (t, <i>J</i> = 6.6 Hz, 2H), 2.13–2.03 (m, 2H), 2.01–1.93 (m, 2H), 1.12–1.04 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 158.8, 158.5, 153.9, 153.2, 136.2, 132.4, 128.8, 114.6, 113.7, 55.2, 54.6, 52.9, 52.6, 52.5, 52.4, 52.2, 45.3, 41.0, 26.3, 11.8, 11.6. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>28</sub>H<sub>44</sub>N<sub>9</sub>O, 522.3663; found, 522.3663. HPLC purity 99.80%.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Synthesis of 6-(4-Ethyl piperazin-1-yl)-9(3-(4-ethylpiperazin-1-yl)propyl)-<i>N</i>-(4 fluorobenzyl)-9<i>H</i>-purin-2-amine (<b>9</b>)</h3><div class="NLM_p last">Compound <b>5</b> (0.30 g, 0.74 mmol) and 4-fluorobenzaldehyde (0.23 g, 0.88 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to the general procedure A. Column chromatography was performed using the CHCl<sub>3</sub>/MeOH system to obtain the pure product of <b>9</b> as a semisolid (42%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.46 (s, 1H), 7.33 (dd, <i>J</i> = 6.9 Hz, 3.0 Hz, 2H), 6.99 (t, <i>J</i> = 9.0 Hz, 2H), 5.03 (t, <i>J</i> = 6.0 Hz, 1H), 4.57 (d, <i>J</i> = 6.0 Hz, 2H), 4.3–4.15 (m, 4H), 4.07 (t, <i>J</i> = 6.6 Hz, 2H), 2.54–2.53 (m, 6H), 2.48–2.44 (m, 10H), 2.32 (t, <i>J</i> = 6.6 Hz, 2H), 1.99–1.95 (m, 2H), 1.14–1.10 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 162.8, 161.2, 158.9, 154.2, 153.3, 136.5, 129.2, 115.3, 115.2, 54.7, 53.0, 52.8, 52.7, 52.6, 52.4, 45.4, 41.3, 26.5, 11.9, 11.8. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>27</sub>H<sub>41</sub>FN<sub>9</sub>, 510.3463; found, 510.3473. HPLC purity 99.91%.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Synthesis of <i>N</i>-(4-(Diethylamino)benzyl)-6-(4-ethylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(10)</b></h3><div class="NLM_p last">Compound <b>5</b> (0.18 g, 0.44 mmol) and 4-diethylamino benzaldehyde (0.06 mL, 0.53 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to produce compound <b>10</b> as a semisolid (48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45 (s, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 2H), 6.63 (d, <i>J</i> = 8.4 Hz, 2H), 4.89 (t, <i>J</i> = 5.6 Hz, 1H), 4.48 (d, <i>J</i> = 6.0 Hz, 2H), 4.30–4.20 (m, 4H), 4.09 (t, <i>J</i> = 6.6 Hz, 2H), 3.33 (q, <i>J</i> = 7.2 Hz, 4H), 2.61–2.52 (m, 8H), 2.50–2.46 (m, 8H), 2.34 (t, <i>J</i> = 6.8 Hz, 2H), 2.03–1.96 (m, 2H), 1.16–1.11 (m, 12H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 161.3, 158.5, 148.3, 143.5, 136.1, 130.0, 128.9, 111.8, 52.9, 52.8, 52.5, 52.4, 52.2, 44.4, 41.0, 28.9, 19.8, 12.5. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>31</sub>H<sub>51</sub>N<sub>10</sub>, 563.4293; found, 563.4305. HPLC purity 97.48%.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Synthesis of <i>N</i>-(6-(4-Ethylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-yl)benzamide (<b>11</b>)</h3><div class="NLM_p last">Benzoyl chloride (0.17 mL, 1.50 mmol) was added to a stirred solution of compound <b>5</b> (0.20 g, 0.50 mmol) and pyridine (0.24 mL, 3.0 mmol) in DCM. The mixture was stirred at room temperature for 10 h. The solvent was removed under vacuum, extracted with chloroform, washed with NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated under vacuum. The residue was purified by silica gel column chromatography to provide compound <b>11</b> as a semisolid (60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (s, 1H), 7.85 (d, <i>J</i> = 8.4 Hz, 2H), 7.63 (s, 1H), 7.51–7.47 (m, 1H), 7.43–7.40 (m, 2H), 4.40–4.25 (m, 4H), 4.15 (t, <i>J</i> = 6.8 Hz, 2H), 2.53–2.51 (m, 8H), 2.45–2.37 (m, 8H), 2.28 (t, <i>J</i> = 6.8 Hz, 2H), 2.03–1.98 (m, 2H), 1.10–1.03 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 165.5, 153.8, 152.3, 138.6, 135.3, 131.9, 128.7, 127.5, 117.3, 54.5, 52.9, 52.8, 52.7, 52.5, 52.3, 41.5, 26.4, 11.9, 11.8. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>27</sub>H<sub>40</sub>N<sub>9</sub>O, 506.3350; found, 506.3338. HPLC purity 99.96%.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Synthesis of 6-(4-Ethylpiperazin-1-yl)-9(-3-(4-ethylpiperazin-1-yl))propyl-2-(pyrrolidin-1-yl)-9<i>H</i>-purine (<b>12</b>)</h3><div class="NLM_p last">Compound <b>5</b> (0.20 g, 0.50 mmol) was dissolved in DMF (5 mL), cooled to 0 °C, and NaH (0.02 g, 0.75 mmol) was added to the solution. After 1 h, 1,4-dibromobutane (0.07 mL, 0.60 mmol) was added and the reaction was stirred under the N<sub>2</sub> atmosphere condition at 80 °C for 12 h. Water was added to the reaction mixture and extracted with CHCl<sub>3</sub>. Column chromatography was performed using the CHCl<sub>3</sub> system to obtain the compound <b>12</b> as a semisolid (30%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.41 (s, 1H), 4.37–4.20 (m, 4H), 4.07 (t, <i>J</i> = 6.9 Hz, 2H), 3.57–3.48 (m, 4H), 2.56–2.53 (m, 6H), 2.48–2.39 (m, 10H), 2.31 (t, <i>J</i> = 6.9 Hz, 2H), 2.04–1.97 (m, 2H), 1.97–1.89 (m, 4H), 1.13–1.06 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 157.7, 153.9, 135.9, 113.7, 54.8, 53.1, 52.8, 52.7, 52.6, 52.4, 46.8, 44.8, 41.1, 26.5, 25.7, 11.4. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>24</sub>H<sub>42</sub>N<sub>9</sub>, 456.3558; found, 456.3558. HPLC purity 99.98%.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Synthesis of 6-(4-Cyclopentylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-<i>N</i>-(4-methoxybenzyl)-9<i>H</i>-purin-2-amine <b>(13)</b></h3><div class="NLM_p last">Compound <b>6</b> (0.20 g, 0.45 mmol) and 4-methoxybenzaldehyde (0.06 mL, 0.54 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to afford compound <b>13</b> as a semisolid (51%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.45 (s, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 6.85 (d, <i>J</i> = 8.4 Hz, 2H), 5.00 (t, <i>J</i> = 5.4 Hz, 1H), 4.54 (d, <i>J</i> = 5.7 Hz, 2H), 4.35–4.21 (m, 4H), 4.08 (t, <i>J</i> = 6.9 Hz, 2H), 3.80 (s, 3H), 2.65 (m, 4H), 2.57–2.53 (m, 8H), 2.35 (t, <i>J</i> = 6.6 Hz, 2H), 2.03–1.97 (m, 3H), 1.92–1.90 (m, 2H), 1.76–1.71 (m, 2H), 1.58–1.50 (m, 4H), 1.16 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 158.8, 158.6, 153.9, 153.2, 136.3, 132.5, 128.9, 114.7, 113.8, 67.6, 55.3, 54.6, 52.6, 52.5, 52.4, 52.3, 45.5, 41.1, 30.3, 29.7, 26.4, 24.1, 11.6. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>31</sub>H<sub>48</sub>N<sub>9</sub>O, 562.3976; found, 562.3967. HPLC purity 98.74%.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Synthesis of 6-(4-Cyclopentylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-<i>N</i>-(4-fluorobenzyl)-9<i>H</i>-purin-2-amine (<b>14</b>)</h3><div class="NLM_p last">Compound <b>6</b> (0.20 g, 0.45 mmol) and 4-flurobenzaldehyde (0.06 mL, 0.54 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. The residue was purified by silica gel column chromatography to produce compound <b>14</b> (56.5%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.46 (s, 1H), 7.33 (dd, <i>J</i> = 7.1 Hz, 2.4 Hz, 2H), 6.98 (t, <i>J</i> = 8.7 Hz, 2H), 5.04 (t, <i>J</i> = 6.0 Hz, 1H), 4.57 (d, <i>J</i> = 6.0 Hz, 2H), 4.12–4.33 (m, 4H), 4.07 (t, <i>J</i> = 6.6 Hz, 2H), 2.59–2.56 (m, 4H), 2.47–2.37 (m, 11H), 2.30 (t, <i>J</i> = 7.2 Hz, 2H), 2.00–1.94 (m, 2H), 1.75–1.68 (m, 2H), 1.59–1.40 (m, 6H), 1.77 (t, <i>J</i> = 7.2, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 158.8, 154.0, 153.2, 136.4, 136.3, 129.2, 129.1, 115.3, 115.1, 67.6, 54.7, 52.9, 52.8, 52.7, 52.3, 45.4, 41.2, 30.4, 26.5, 24.2, 11.9. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>30</sub>H<sub>45</sub>FN<sub>9</sub>, 550.3776; found, 550.3781. HPLC purity 98.98%.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Synthesis of 6-((4-Cyclopentylpiperazin-1-yl)-<i>N</i>-(4-diethylamino)benzyl)-9-(3-(4-ethylpiperazine-1-yl)propyl)-9<i>H</i>-purine-2-amine (<b>15</b>)</h3><div class="NLM_p last">Compound <b>6</b> (0.20 g, 0.45 mmol) and 4-diethyl aminobenzaldehyde (0.20 g, 0.54 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. Column chromatography was performed using the CHCl<sub>3</sub>/CH<sub>3</sub>OH system to obtain the pure product of <b>15</b> as a semisolid (55%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.45 (s, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 6.62 (d, <i>J</i> = 8.7 Hz, 2H), 4.94 (t, <i>J</i> = 5.4 Hz, 1H), 4.47 (d, <i>J</i> = 5.7 Hz, 2H), 4.39–4.20 (m, 4H), 4.09 (t, <i>J</i> = 6.6. Hz, 2H), 3.33 (q, <i>J</i> = 6.9 Hz, 4H), 2.74–2.61 (m, 6H), 2.56–2.44 (m, 9H), 2.36 (t, <i>J</i> = 6.6 Hz, 2H), 2.02–1.95 (m, 2H), 1.90–1.80 (m, 2H), 1.76–1.70 (m, 2H), 1.58–1.48 (m, 4H), 1.21–1.11 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 158.9, 147.5, 146.9, 136.2, 128.9, 126.7, 114.6, 111.9, 67.7, 54.5, 52.3, 52.2, 52.1, 51.9, 45.5, 44.4, 30.1, 26.3, 24.0, 12.5. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>34</sub>H<sub>55</sub>N<sub>10</sub> 603.4606; found, 603.4586. HPLC purity 97.60%.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Synthesis of <i>N</i>-(6-(4-Cyclopentylpiperazin-1-yl)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-yl)-4-((dimethylamino)methyl)benzamide <b>(16)</b></h3><div class="NLM_p last">A mixture of compound <b>6</b> (0.20 g, 0.45 mmol) and 4-((dimethylamino)methyl)benzoic acid (0.10 g, 0.54 mmol) was dissolved in dry pyridine (5 mL). POCl<sub>3</sub> (0.06 mL, 0.68 mmol) was added to the solution at 0 °C, and the reaction was performed according to general procedure B. The residue was purified by silica gel column chromatography to give compound <b>16</b> as a gummy compound (53%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.30 (s, −NH), 7.87 (d, <i>J</i> = 8.1 Hz, 2H), 7.67 (s, 1H), 7.43 (d, <i>J</i> = 7.8 Hz, 2H), 4.22 (t, <i>J</i> = 6.6 Hz, 2H), 3.65 (s, 1H), 3.50 (s, 2H), 2.64–2.63 (m, 8H), 2.57–2.53 (m, 8H), 2.37 (t, <i>J</i> = 6.6 Hz, 2H), 2.27 (s, 6H), 2.06 (t, <i>J</i> = 6.6 Hz, 2H), 1.95–1.82 (m, 4H), 1.77–1.67 (m, 2H), 1.59–1.44 (m, 4H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ153.6, 152.3, 138.4, 129.4, 127.5, 122.6, 121.1, 117.3, 116.3, 67.6, 63.8, 62.9, 52.4, 52.2, 45.3, 41.4, 37.1, 32.0, 30.3, 30.1, 29.7, 29.4, 26.4, 24.1, 22.7, 14.1. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>34</sub>H<sub>55</sub>N<sub>10</sub>, 603.4242; found, 603.4233. HPLC purity 99.29%.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Synthesis of 6-Chloro-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-2-amine (<b>17</b>)</h3><div class="NLM_p last">Compound <b>2</b> (1.0 g, 5.90 mmol) was dissolved in DMF (8 mL) and stirred for 2–3 h under a N<sub>2</sub> atmosphere condition at 120 °C to obtain a clear solution. 1-(3-Chloropropyl)-4-ethylpiperazine (1.69 g, 8.85 mmol) and potassium carbonate (1.63 g, 11.80 mmol) were added to the reaction mixture and stirred for 12 h. Water was added to the reaction, and the organic layer was separated with CHCl<sub>3</sub>. Column chromatography was performed using the CHCl<sub>3</sub>/CH<sub>3</sub>OH system to obtain the compound <b>17</b> as a thick gummy liquid (65%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.07 (s, 1H), 6.85 (s, 2H), 4.04 (t, <i>J</i> = 6.6 Hz, 2H), 2.25 (q, <i>J</i> = 7.2 Hz, 2H), 2.21 (t, <i>J</i> = 6.6 Hz, 3H), 1.92–1.88 (m, 2H), 0.94 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.2, 154.7, 149.7, 143.9, 123.9, 55.2, 53.0, 52.7, 52.1, 42.0, 26.2, 12.4. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>14</sub>H<sub>23</sub>ClN<sub>7</sub>, 324.1698; found, 324.1702.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Synthesis of (4-(2-Amino-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-6-yl)piperazin-1-yl)(phenyl)methanone (<b>18</b>)</h3><div class="NLM_p last">Compound <b>17</b> (2.0 g, 6.18 mmol) was dissolved in acetonitrile (10 mL). To the solution, phenyl(piperazine-1-yl) methanone (1.76 g, 9.27 mmol) and potassium carbonate (1.71 g, 12.36 mmol) were added. The reaction was refluxed for 4 hours. Completion of the reaction was monitored by TLC. Acetonitrile was evaporated and the reaction mixture was extracted using CHCl<sub>3</sub> followed by column chromatography to obtain the pure product <b>18</b> as a liquid (86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.48 (s, 1H), 7.44–7.37 (m, 5H), 4.68 (s, 2H), 4.40–4.13 (m, 4H), 4.08 (t, <i>J</i> = 6.6 Hz, 2H), 3.95–3.78 (m, 2H), 3.67–3.46 (m, 2H), 2.60–2.41 (m, 10H), 2.31 (t, <i>J</i> = 6.6 Hz, 2H), 2.03–1.94 (m, 2H), 1.09 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 170.6, 159.1, 154.2, 153.2, 137.0, 135.6, 129.9, 128.6, 127.1, 115.1, 54.4, 52.5, 52.4, 52.3, 52.2, 41.1, 26.3, 11.6. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>25</sub>H<sub>36</sub>N<sub>9</sub>O, 478.3037; found, 478.3024. HPLC purity 99.88%.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Synthesis of (4-(2-Amino-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-6-yl)piperazin-1-yl)(cyclopentyl)methanone (<b>19</b>)</h3><div class="NLM_p last">Compound <b>17</b> (2.0 g, 6.18 mmol) was dissolved in acetonitrile (10 mL), and to the solution were added cyclopentyl(piperazine-1-yl)methanone (1.69 g, 9.27 mmol) and potassium carbonate (1.71 g, 12.36 mmol). The reaction was refluxed for 4 h. Acetonitrile was evaporated and the reaction mixture was extracted using CHCl<sub>3</sub> followed by column chromatography to afford compound <b>19</b> as a gummy compound (78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.48 (s, 1H), 4.63 (s, 2H), 4.26–4.19 (m, 4H), 4.07 (t, <i>J</i> = 6.8 Hz, 2H), 3.73–3.68 (m, 2H), 3.64–3.57(m, 2H), 2.94–2.85 (m, 1H), 2.57–2.44 (m, 8 H), 2.32 (t, <i>J</i> = 6.8 Hz, 2H), 2.25–2.15 (m, 2 H), 2.00–1.95 (m, 2H), 1.85–1.79 (m, 4H), 1.74–1.70 (m, 2H), 1.59–1.52 (m, 2H), 1.09 (t, <i>J</i> = 6.01, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 159.2, 154.3, 153.2, 137.0, 115.1, 54.5, 52.7, 52.6, 52.3, 41.2, 30.2, 26.4, 26.2, 11.7. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>24</sub>H<sub>40</sub>N<sub>9</sub>O, 470.3350; found, 470.3331. HPLC purity 99.89%.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Synthesis of (4-(9-(3-(4-Ethylpiperazin-1-yl)propyl)-2-((4-methoxybenzyl)amino)-9<i>H</i>-purin-6-yl)piperazin-1-yl)(phenyl)methanone <b>(20)</b></h3><div class="NLM_p last">Compound <b>18</b> (0.20 g, 0.42 mmol) and 4-methoxybenzaldehyde (0.05 mL, 0.51 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. The residue was purified by silica gel column chromatography to afford compound <b>20</b> as a semisolid (66%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.28 (s, 1H), 7.27–7.25 (m, 5H), 7.11 (d, <i>J</i> = 8.4 Hz, 2H), 6.67 (d, <i>J</i> = 8.7 Hz, 2H), 5.09 (s, 1H), 4.36 (d, <i>J</i> = 5.4 Hz, 2H), 4.22–4.04 (m, 4H), 3.91 (t, <i>J</i> = 6.6 Hz, 2H), 3.78–3.68 (m, 2H), 3.62 (s, 3 H), 3.42–3.24 (m, 2H), 2.59–2.34 (m, 10H), 2.18 (t, <i>J</i> = 6.6 Hz, 2H), 1.82–1.69 (m, 2H), 0.96 (t, <i>J</i> = 7.2, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub> + 1 drop CD<sub>3</sub>OD): δ 176.5, 171.0, 158.7, 158.6, 154.0, 153.1, 136.8, 135.2, 132.3, 130.1, 128.6, 127.0, 114.4, 113.8, 55.3, 54.3, 51.7, 51.3, 50.9, 45.2, 41.2, 26.1, 22.3, 10.1. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>33</sub>H<sub>44</sub>N<sub>9</sub>O<sub>2</sub>, 598.3612; found, 598.3597. HPLC purity 97.97%.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Synthesis of (4-(9-(3-(4-Ethylpiperazin-1-yl)propyl)-2-((4-fluorobenzyl)amino)-9<i>H</i>-purin-6-yl)piperazin-1-yl)(phenyl)methanone <b>(21)</b></h3><div class="NLM_p last">Compound <b>18</b> (0.20 g, 0.42 mmol) and 4-flurobenzaldehyde (0.06 mL, 0.51 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to produce compound <b>21</b> as a semisolid (70%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.47–7.39 (m, 6 H), 7.31 (dd, <i>J</i> = 6.9 Hz, 3.0 Hz, 2H), 7.00 (t, <i>J</i> = 8.7 Hz, 2H), 5.29 (t, <i>J</i> = 4.5 Hz, 1H), 4.55 (d, <i>J</i> = 5.7 Hz, 2H), 4.34–4.16 (m, 4H), 4.07 (t, <i>J</i> = 6.6 Hz, 2H), 3.89–3.79 (m, 2H), 3.59–3.46 (m, 2H), 2.81–2.77 (m, 4H), 2.69–2.63 (m, 6H), 2.40 (t, <i>J</i> = 6.6 Hz, 2H), 2.02–1.95 (m, 2H), 1.28 (t, <i>J</i> = 7.2, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub> + 1 drop CD<sub>3</sub>OD): δ 171.1, 163.0, 160.6, 158.6, 154.0, 153.1, 136.9, 136.0, 135.9, 135.1, 130.1, 128.8, 128.7, 128.6, 127.0, 115.2, 115.0, 114.5, 54.3, 51.9, 51.6, 50.9, 45.0, 41.2, 26.1, 21.7, 10.1. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>32</sub>H<sub>41</sub>FN<sub>9</sub>O, 586.3413; found, 586.3394. HPLC purity 99.26%.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (4-(2-(4-(Diethylamino)benzyl)amino-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purine-6-yl)piperazin-1-yl)(phenyl)methanone <b>(22)</b></h3><div class="NLM_p last">Compound <b>18</b> (0.20 g, 0.42 mmol) and 4-diethyl aminobenzaldehyde (0.10 g, 0.51 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. The residue was purified by silica gel column chromatography to give compound <b>22</b> as a semisolid (52%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.45 (br. s, 6 H), 7.22 (d, <i>J</i> = 7.8 Hz, 2H), 6.65 (d, <i>J</i> = 8.4 Hz, 2H), 5.06 (s, 1H), 4.49 (d, <i>J</i> = 4.2 Hz, 2H), 4.38–4.17 (m, 4H), 4.11 (t, <i>J</i> = 6.6 Hz, 2H), 3.96–3.85 (m, 2H), 3.60–3.50 (m, 2H), 3.35 (q, <i>J</i> = 6.0, 4H), 2.73–2.53 (m, 10H), 2.34 (t, <i>J</i> = 5.4 Hz, 2H), 2.05–2.02 (m, 2H), 1.19–1.15 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 170.7, 158.9, 153.4, 147.0, 136.5, 135.7, 129.9, 128.9, 128.6, 127.2, 126.7, 112.0, 54.5, 52.0, 51.8, 51.5, 45.6, 44.5, 41.2, 29.8, 26.3, 12.6, 10.8. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>36</sub>H<sub>51</sub>N<sub>10</sub>O, 639.4242; found, 639.4271. HPLC purity 96.80%.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Synthesis of (4-(9-(3-(4-Ethylpiperazin-1-yl)propyl)-2-(pyrrolidin-1-yl)-9<i>H</i>-purin-6-yl)piperazin-1-yl)(phenyl)methanone (<b>23</b>)</h3><div class="NLM_p last">Compound <b>18</b> (0.25 g, 0.52 mmol) was dissolved in dry DMF (5 mL), and the reaction mixture was cooled to −10 °C. To the mixture was added NaH (0.02 g, 1.4 mmol). The reaction mixture was allowed to stir for 1 hour at the cold condition. Then, 1,4-dibromobutane (0.06 g, 0.52 mmol) was added to it and allowed to stir for a further 12 h under a N<sub>2</sub> atmosphere at 80 °C. Water was added to the reaction mixture, and it was extracted with CHCl<sub>3</sub>. Column chromatography was performed using the CHCl<sub>3</sub> system to obtain compound <b>23</b> as a semisolid (35%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.47–7.39 (m, 6H), 4.37–4.18 (m, 4H), 4.09 (t, <i>J</i> = 6.9, 2H), 3.94–3.81 (m, 2H), 3.64–3.43 (m, 6H), 2.59–2.42 (m, 10H), 2.32 (t, <i>J</i> = 6.9, 2H), 2.03–1.99 (m, 2H), 1.96–1.89 (m, 4H), 1.0 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 170.6, 153.8, 145.5, 141.5, 136.0, 135.6, 129.8, 128.5, 127.1, 56.5, 56.4, 54.4, 52.3, 52.1, 52.0, 51.8, 49.8, 46.7, 41.0, 26.1, 25.6, 12.6. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>29</sub>H<sub>42</sub>N<sub>9</sub>O, 532.3507; found, 532.3517. HPLC purity 99.63%.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Synthesis of Cyclopentyl (4-(9-(3-(4-Ethylpiperazin-1-yl)propyl)-2-((4-methoxybenzyl)amino)-9<i>H</i>-purin-6-yl)piperazin-1-yl)methanone <b>(24)</b></h3><div class="NLM_p last">Compound <b>19</b> (0.20 g, 0.43 mmol) and 4-methoxybenzaldehyde (0.05 mL, 0.51 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. The residue was purified by silica gel column chromatography to afford compound <b>24</b> as a semisolid (59%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.48 (s, 1 H), 7.30 (d, <i>J</i> = 8.7 Hz, 2H), 6.87 (d, <i>J</i> = 8.4 Hz, 2H), 5.05 (t, <i>J</i> = 6.3 Hz, 1H), 4.55 (d, <i>J</i> = 5.7 Hz, 2H), 4.28–4.19 (m, 4H), 4.10 (t, <i>J</i> = 6.6 Hz, 2H), 3.81 (s, 3H), 3.77–3.72 (m, 2H), 3.67–3.59 (m, 2H), 2.96–2.84 (m, 1H), 2.66–2.53 (m, 10H), 2.38 (t, <i>J</i> = 6.9 Hz, 2H), 2.06–1.99 (m, 2H), 1.87–1.74 (m, 4H), 1.66–1.57 (m, 4H), 1.20 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 174.9, 158.9, 158.7, 154.1, 153.4, 136.7, 132.4, 128.8, 114.8, 113.9, 55.4, 54.6, 52.6, 52.5, 52.3, 45.5, 41.2, 30.2, 26.5, 26.1, 11.6. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>32</sub>H<sub>48</sub>N<sub>9</sub>O<sub>2</sub>, 590.3925; found, 590.3907. HPLC purity 97.75%.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Synthesis of Cyclopentyl(4-(9-(3-(4-ethylpiperazin-1-yl)propyl)-2-((4-fluorobenzyl)amino)-9<i>H</i>-purin-6-yl)piperazin-1-yl)methanone <b>(25)</b></h3><div class="NLM_p last">Compound <b>19</b> (0.20 g, 0.43 mmol) and 4-flurobenzaldehyde (0.05 mL, 0.51 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to produce compound <b>24</b> as a semisolid (59%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.46 (s, 1 H), 7.33 (dd, <i>J</i> = 5.7 Hz, 2.7 Hz, 2H), 7.00 (d, <i>J</i> = 8.4 Hz, 2H), 5.09 (t, <i>J</i> = 5.7 Hz, 1H), 4.57 (d, <i>J</i> = 6.0 Hz, 2H), 4.27–4.12 (m, 4H), 4.08 (t, <i>J</i> = 6.6 Hz, 2H), 3.78–3.67 (m, 2H), 3.64–3.56 (m, 2H), 2.97–2.86 (m, 1H), 2.75–2.47 (m, 10H), 2.34 (t, <i>J</i> = 6.9 Hz, 2H), 2.04–1.98 (m, 2H), 1.90–1.81 (m, 4H), 1.64–1.54 (m, 4H), 1.16 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 174.9, 158.7, 154.1, 153.3, 136.7, 129.1, 129.0, 115.3, 115.1, 54.6, 52.2, 51.9, 45.3, 41.2, 30.2, 26.1, 11.1. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) cald for C<sub>31</sub>H<sub>45</sub>FN<sub>9</sub>O, 578.3726; found, 578.3712. HPLC purity 95.53%.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Synthesis of Cyclopentyl(4-(2-((4-(diethylamino)benzyl)amino)-9-(3-(4-ethylpiperazin-1-yl)propyl)-9<i>H</i>-purin-6-yl)piperazin-1-yl)methanone <b>(26)</b></h3><div class="NLM_p last">Compound <b>19</b> (0.20 g, 0.43 mmol) and 4-diethyl aminobenzaldehyde (0.10 g, 0.52 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to afford compound <b>26</b> as a semisolid (59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.44 (s, 1 H), 7.18 (d, <i>J</i> = 8.8 Hz, 2H), 6.61 (d, <i>J</i> = 8.8 Hz, 2H), 4.99 (t, <i>J</i> = 5.6 Hz, 1H), 4.46 (d, <i>J</i> = 5.6 Hz, 2H), 4.26–4.13 (m, 4H), 4.08 (t, <i>J</i> = 6.8 Hz, 2H), 3.73–3.69 (m, 2H), 3.62–3.57 (m, 2H), 3.31 (q, <i>J</i> = 7.2 Hz, 4H), 2.94–2.86 (m, 1H), 2.66–2.46 (m, 10H), 2.33 (t, <i>J</i> = 5.6 Hz, 2H), 2.01–1.95 (m, 2H), 1.83–1.79 (m, 4H), 1.74–1.70 (m, 2H), 1.59–1.55 (m, 2H), 1.14–1.09 (m, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 174.8, 158.9, 154.1, 153.5, 147.1, 136.5, 128.9, 127.9, 126.7, 125.8, 114.7, 111.9, 54.6, 52.5, 52.3, 45.6, 44.5, 41.2, 30.2, 26.1, 12.6, 11.5. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>35</sub>H<sub>55</sub>N<sub>10</sub>O, 631.4555; found, 631.4545. HPLC purity 98.53%.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Synthesis of 6-(4-Ethylpiperazin-1-yl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(27)</b></h3><div class="NLM_p last">Compound <b>4</b> (1.0 g, 4.04 mmol) and 1-(3-chloropropyl)pyrrolidine (0.89 g, 6.06 mmol) were dissolved in dry DMF. To the reaction mixture was added potassium carbonate (1.12 g, 8.08 mmol). The mixture was heated at 80 °C for 12 h. Water was added to the reaction mixture. The aqueous solution was extracted with chloroform. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated under vacuum. The residue was purified by silica gel column chromatography to provide compound <b>27</b> as a light-brown liquid (72%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.49 (s, 1H), 4.69 (s, −NH<sub>2</sub>), 4.29–4.20 (m, 4H), 4.09 (t, <i>J</i> = 7.2 Hz, 2H), 2.53 (t, <i>J</i> = 4.8 Hz, 4H), 2.48 (m, 4H), 2.46–2.41 (m, 4H), 2.02–1.97 (m, 2H), 1.79–1.73 (m, 4H), 1.11 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 159.2, 154.2, 152.9, 136.5, 114.9, 54.0, 52.9, 52.7, 52.4, 41.2, 28.7, 23.4, 11.9. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>18</sub>H<sub>31</sub>N<sub>8</sub>, 359.2666; found, 359.2673. HPLC purity 98.31%.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Synthesis of 6-(4-Cyclopentylpiperazin-1-yl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(28)</b></h3><div class="NLM_p last">Compound <b>4</b> (1.0 g, 3.48 mmol) and 1-(3-chloropropyl)pyrrolidine (0.77 g, 5.22 mmol) were dissolved in dry DMF. To the reaction mixture was added potassium carbonate (0.96 g, 6.96 mmol). The mixture was heated at 80 °C for 12 h. Water was added to the reaction mixture. The aqueous solution was extracted with chloroform. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated under vacuum. The residue was purified by silica gel column chromatography to afford compound <b>28</b> as a colorless liquid (70%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.49 (s, 1H), 4.63 (s, −NH<sub>2</sub>), 4.28–4.17 (m, 4H), 4.09 (t, <i>J</i> = 6.9 Hz, 2H), 2.59 (t, <i>J</i> = 5.1 Hz, 4H), 2.53–2.48 (m, 5H), 2.44 (t, <i>J</i> = 7.2 Hz, 4H), 2.06–1.97 (m, 2H), 1.87–1.83 (m, 2H), 1.80–1.77 (m, 4H), 1.72–1.64 (m, 2H), 1.58–1.51 (m, 2H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 159.2, 154.1, 153.0, 136.6, 114.9, 67.6, 54.1, 52.7, 52.5, 41.2, 30.4, 28.7, 24.1, 23.5. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>8</sub>, 399.2979; found, 399.2968. HPLC purity 99.00%.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Synthesis of 6-(4-Ethylpiperazin-1-yl)-<i>N</i>-(4-methoxybenzyl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(29)</b></h3><div class="NLM_p last">Compound <b>27</b> (0.20 g, 0.56 mmol) and 4-methoxybenzaldehyde (0.08 mL, 0.67 mmol) were dissolved in toluene (5 mL), and the reaction was performed using general procedure A. The residue was purified by silica gel column chromatography to afford compound <b>29</b> as a semisolid (58%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.47 (s, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 2H), 6.85 (d, <i>J</i> = 8.4 Hz, 2H), 4.98 (t, <i>J</i> = 6.0 Hz, −NH), 4.54 (d, <i>J</i> = 5.4 Hz, 2H), 4.38–4.15 (m, 4H), 4.11 (t, <i>J</i> = 7.2 Hz, 2H), 3.79 (s, 3H), 2.55–2.52 (m, 8H), 2.47–2.44 (m, 4H), 2.07–2.02 (m, 2H), 1.81–1.77 (m, 4H), 1.12 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 158.9, 158.6, 154.0, 153.2, 136.2, 132.5, 128.9, 114.7, 113.7, 55.3, 54.0, 53.0, 52.9, 52.5, 45.5, 41.2, 28.6, 23.5, 11.9. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>26</sub>H<sub>39</sub>N<sub>8</sub>O, 479.3241; found, 479.3248. HPLC purity 98.37%.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Synthesis of 6-(4-Ethylpiperazin-1-yl)-<i>N</i>-(4-fluorobenzyl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(30)</b></h3><div class="NLM_p last">Compound <b>27</b> (0.20 g, 0.56 mmol) and 4-fluorobenzaldehyde (0.07 mL, 0.67 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. Then, column chromatography was performed using the CHCl<sub>3</sub>/MeOH system to obtain the pure product <b>30</b> as a brown gummy compound (56%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.74 (s, 1H), 7.35–7.32 (m, 2H), 7.03–7.00 (m, 2H), 4.75 (br. s, 2H), 4.60 (s, 2H), 4.39 (s, 2H), 3.93 (s, 1H), 2.60 (m, 10H), 2.47–2.43 (m, 4H), 2.27–2.25 (m, 2H), 1.67 (m, 4H), 1.11 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 162.8, 161.2, 151.9, 149.9, 134.9, 128.7, 128.6, 115.4, 115.2, 53.2, 52.3, 45.7, 43.1, 29.7, 23.3, 11.8. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>25</sub>H<sub>36</sub>FN<sub>8</sub>, 467.3041; found, 467.3033. HPLC purity 99.30%.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Synthesis of 6-(4-Cyclopentylpiperazin-1-yl)-<i>N</i>-(4-methoxybenzyl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(31)</b></h3><div class="NLM_p last">Compound <b>28</b> (0.20 g, 0.50 mmol) and 4-methoxybenzaldehyde (0.07 mL, 0.60 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. Then, column chromatography was performed using the CHCl<sub>3</sub>/MeOH system to afford the pure product <b>31</b> as a brown gummy compound (59%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.47 (s, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 6.84 (d, <i>J</i> = 9.0 Hz, 2H), 5.00 (t, <i>J</i> = 6.0 Hz, −NH), 4.54 (d, <i>J</i> = 6.0 Hz, 2H), 4.25 (m, 4H), 4.11 (t, <i>J</i> = 7.2 Hz, 2H), 3.79 (s, 3H), 2.61–2.59 (m, 8H), 2.52 (t, <i>J</i> = 7.2 Hz, 4H), 2.10 (t, <i>J</i> = 7.2 Hz, 1H), 1.91–1.86 (m, 2H), 1.82 (m, 4H), 1.74–1.69 (m, 2H), 1.57–1.54 (m, 2H), 1.49–1.44 (m, 2H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 158.9, 158.6, 154.0, 153.2, 136.1, 132.5, 128.8, 114.7, 113.8, 67.6, 55.3, 54.0, 52.9, 52.5, 45.4, 41.1, 30.4, 24.1, 23.4. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>29</sub>H<sub>43</sub>N<sub>8</sub>O, 519.3554; found, 519.3564. HPLC purity 95.56%.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Synthesis of 6-(4-Cyclopentylpiperazin-1-yl)-<i>N</i>-(4-fluorobenzyl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-amine <b>(32)</b></h3><div class="NLM_p last">Compound <b>28</b> (0.20 g, 0.50 mmol) and 4-fluorobenzaldehyde (0.07 mL, 0.60 mmol) were dissolved in toluene (5 mL), and the reaction was performed according to general procedure A. Then, column chromatography was performed using the CHCl<sub>3</sub>/MeOH system to afford the pure product <b>32</b> as a brown gummy compound (62%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.47 (s, 1H), 7.34–7.32 (m, 2H), 7.00–6.97 (m, 2H), 5.10 (t, <i>J</i> = 6.0 Hz, −NH), 4.57 (d, <i>J</i> = 6.0 Hz, 2H), 4.33–4.21 (m, 4H), 4.10 (t, <i>J</i> = 7.2 Hz, 2H), 2.59–2.58 (m, 6H), 2.50 (t, <i>J</i> = 7.2 Hz, 4H), 2.09–2.04 (m, 2H), 1.88 (m, 3H), 1.81 (m, 4H), 1.72–1.68 (m, 2H), 1.48–1.44 (m, 2H), 0.89–0.84 (m, 2H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 161.0, 158.7, 153.9, 153.1, 136.2, 129.0, 115.1, 115.0, 114.7, 67.5, 53.8, 52.7, 52.3, 45.2, 41.1, 30.3, 29.7, 28.2, 24.1, 23.4. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>28</sub>H<sub>40</sub>FN<sub>8</sub>, 507.3354; found, 507.3341. HPLC purity 99.04%.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Synthesis of 4-((Dimethylamino)methyl)-<i>N</i>-(6-(4-ethylpiperazin-1-yl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-yl)benzamide <b>(33)</b></h3><div class="NLM_p last">A mixture of compound <b>27</b> (0.20 g, 0.56 mmol) and 4-((dimethylamino)methyl)benzoic acid (0.12 g, 0.67 mmol) was dissolved in dry pyridine (5 mL). POCl<sub>3</sub> (0.08 mL, 0.84 mmol) was added to the solution at 0 °C, and the reaction was performed according to general procedure B. The residue was purified by silica gel column chromatography to afford compound <b>33</b> as a gummy compound (59%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.35 (s, −NH), 7.86 (d, <i>J</i> = 7.8 Hz, 2H), 7.69 (s, 1H), 7.43 (d, <i>J</i> = 8.4 Hz, 2H), 4.24 (t, <i>J</i> = 6.6 Hz, 2H), 3.49 (s, 2H), 2.75 (m, 6H), 2.57 (m, 4H), 2.47 (q, <i>J</i> = 7.2 Hz, 2H), 2.26 (s, 6H), 2.20 (t, <i>J</i> = 7.2 Hz, 2H), 1.88 (m, 4H), 1.25 (m, 4H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 165.1, 153.8, 152.3, 152.0, 143.3, 138.5, 133.8, 129.3, 127.5, 117.3, 63.9, 53.9, 52.9, 52.7, 52.4, 45.4, 29.7, 28.1, 23.5, 11.9. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>28</sub>H<sub>42</sub>N<sub>9</sub>O, 520.3507; found, 520.3517. HPLC purity 95.59%.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Synthesis of <i>N</i>-(6-(4-Cyclopentylpiperazin-1-yl)-9-(3-(pyrrolidin-1-yl)propyl)-9<i>H</i>-purin-2-yl)-4-((dimethylamino)methyl)benzamide <b>(34)</b></h3><div class="NLM_p last">A mixture of compound <b>28</b> (0.20 g, 0.50 mmol) and 4-((dimethylamino)methyl)benzoic acid (0.11 g, 0.60 mmol) was dissolved in dry pyridine (5 mL). POCl<sub>3</sub> (0.07 mL, 0.75 mmol) was added to the solution at 0 °C, and the reaction was performed according to general procedure B. The residue was purified by silica gel column chromatography to get compound <b>34</b> as a semisolid compound (56%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.32 (s, −NH), 7.86 (d, <i>J</i> = 7.8 Hz, 2H), 7.69 (s, 1H), 7.43 (d, <i>J</i> = 7.8 Hz, 2H), 4.25 (t, <i>J</i> = 6.6 Hz, 2H), 3.48 (s, 2H), 2.82 (m, 4H), 2.63 (s, 4H), 2.56–2.50 (m, 1H), 2.25 (s, 6H), 1.91–1.86 (m, 6H), 1.72–1.69 (m, 2H), 1.61–1.52 (m, 4H), 1.48–1.40 (m, 4H), 0.84–0.81 (m, 4H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 165.1, 153.7, 152.2, 152.0, 143.3, 138.4, 133.8, 129.3, 127.4, 117.3, 67.5, 63.9, 53.9, 52.8, 52.4, 45.5, 41.6, 30.4, 29.7, 24.1, 23.5. HRMS (ESI) <i>m</i>/<i>z</i> (M + H) calcd for C<sub>31</sub>H<sub>46</sub>N<sub>9</sub>O, 560.3820; found, 560.3841. HPLC purity 96.70%.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00532" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00532?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00532</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">TLR9 antagonistic reporter assay, TLR7 antagonistic reporter assay, TLR8 antagonistic reporter assay, TLR9 antagonism assay in human PBMCs, molecular docking score table, selectivity against TLR8 through computational study, aqueous solubility assay data, plasma stability assay data, Caco-2 permeability assay data, microsomal stability assay data, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of compounds <b>3</b>–<b>34</b>, 2D NMR data of compound <b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">TLR7_Homology model (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf">jm1c00532_si_001.pdf (5.22 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_002.pdb">jm1c00532_si_002.pdb (2.02 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_003.csv">jm1c00532_si_003.csv (2.82 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00532" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dipyaman Ganguly</span> - <span class="hlFld-Affiliation affiliation">IICB-Translational
Research Unit of Excellence, Department of Cancer Biology and Inflammatory
Disorders, CSIR—Indian Institute
of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, West Bengal, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, Ghaziabad 201002, India</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#87e3eef7fee6eae6e9c7eeeee4e5a9f5e2f4a9eee9"><span class="__cf_email__" data-cfemail="bcd8d5ccc5ddd1ddd2fcd5d5dfde92ced9cf92d5d2">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arindam Talukdar</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, Ghaziabad 201002, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-7831-1795" title="Orcid link">https://orcid.org/0000-0002-7831-1795</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#036277626f7668676271436a6a60612d7166702d6a6d"><span class="__cf_email__" data-cfemail="a1c0d5c0cdd4cac5c0d3e1c8c8c2c38fd3c4d28fc8cf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Biswajit Kundu</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deblina Raychaudhuri</span> - <span class="hlFld-Affiliation affiliation">IICB-Translational
Research Unit of Excellence, Department of Cancer Biology and Inflammatory
Disorders, CSIR—Indian Institute
of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, West Bengal, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayan Mukherjee</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bishnu Prasad Sinha</span> - <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, Ghaziabad 201002, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dipika Sarkar</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Purbita Bandopadhyay</span> - <span class="hlFld-Affiliation affiliation">IICB-Translational
Research Unit of Excellence, Department of Cancer Biology and Inflammatory
Disorders, CSIR—Indian Institute
of Chemical Biology, CN6, Sector V, Salt Lake, Kolkata 700091, West Bengal, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, Ghaziabad 201002, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sourav Pal</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, Ghaziabad 201002, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nirmal Das</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research, Ghaziabad 201002, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debdeep Dey</span> - <span class="hlFld-Affiliation affiliation">Tata
Medical Center, Newtown, Kolkata 700160, West Bengal, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kantubhukta Ramarao</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kasireddy Nagireddy</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic and Medicinal Chemistry, CSIR—Indian
Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, West
Bengal, India</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>B.K., D.R., A.M., and B.P.S. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5095-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The project was supported by grant no. EMR/2016/003021 from the Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India, to D.G. and A.T. B.K., A.M., and D.S. acknowledge the University Grant Commission (UGC), Government of India, for fellowship. D.R. would like to acknowledge the Council of Scientific and Industrial Research (CSIR) for her SPM senior research fellowship. N.D. and P.B. would like to thank the Council of Scientific and Industrial Research (CSIR) for the fellowship. S.P. would like to thank ICMR for SRF. B.P.S. is supported by the SyMeCBiocluster project from Department of Biotechnology (DBT), Government of India. K.R. and K.N. would like to acknowledge NIPER Kolkata. The authors would like to acknowledge the Central Instrument Facility of CSIR-IICB and Santu Paul for the LTQ Orbitrap XL mass spectrometer.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank’s balanced salt solution</p></td></tr><tr><td class="NLM_term">hPBMC</td><td class="NLM_def"><p class="first last">human peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">ISG15</td><td class="NLM_def"><p class="first last">interferon-stimulated gene 15</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">pDC</td><td class="NLM_def"><p class="first last">plasmacytoid dendritic cell</p></td></tr><tr><td class="NLM_term">SEAP</td><td class="NLM_def"><p class="first last">secreted alkaline phosphatase</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematosus</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 68 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">Toll-Like Receptors</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.21.120601.141126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1146%2Fannurev.immunol.21.120601.141126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=12524386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtF2isrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=335-376&author=K.+Takedaauthor=T.+Kaishoauthor=S.+Akira&title=Toll-Like+Receptors&doi=10.1146%2Fannurev.immunol.21.120601.141126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors</span></div><div class="casAuthors">Takeda, Kiyoshi; Kaisho, Tsuneyasu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-376</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The innate immune system in drosophila and mammals senses the invasion of microorganisms using the family of Toll receptors, stimulation of which initiates a range of host defense mechanisms.  In drosophila antimicrobial responses rely on two signaling pathways: the Toll pathway and the IMD pathway.  In mammals there are at least 10 members of the Toll-like receptor (TLR) family that recognize specific components conserved among microorganisms.  Activation of the TLRs leads not only to the induction of inflammatory responses but also to the development of antigenspecific adaptive immunity.  The TLR-induced inflammatory response is dependent on a common signaling pathway that is mediated by the adaptor mol. MyD88.  However, there is evidence for addnl. pathways that mediate TLR ligand-specific biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnTUaIjFGoVrVg90H21EOLACvtfcHk0lgcrT1EuCm60A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtF2isrg%253D&md5=e757bd9618284b2883d6314729712967</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.21.120601.141126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.21.120601.141126%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DToll-Like%2520Receptors%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D21%26spage%3D335%26epage%3D376%26doi%3D10.1146%2Fannurev.immunol.21.120601.141126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, O.</span></span> <span> </span><span class="NLM_article-title">Pathogen Recognition and Innate Immunity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.cell.2006.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=16497588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Kltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=783-801&author=S.+Akiraauthor=S.+Uematsuauthor=O.+Takeuchi&title=Pathogen+Recognition+and+Innate+Immunity&doi=10.1016%2Fj.cell.2006.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogen recognition and innate immunity</span></div><div class="casAuthors">Akira, Shizuo; Uematsu, Satoshi; Takeuchi, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">783-801</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Microorganisms that invade a vertebrate host are initially recognized by the innate immune system through germline-encoded pattern-recognition receptors (PRRs).  Several classes of PRRs, including Toll-like receptors and cytoplasmic receptors, recognize distinct microbial components and directly activate immune cells.  Exposure of immune cells to the ligands of these receptors activates intracellular signaling cascades that rapidly induce the expression of a variety of overlapping and unique genes involved in the inflammatory and immune responses.  New insights into innate immunity are changing the way we think about pathogenesis and the treatment of infectious diseases, allergy, and autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEZpCMLVNgq7Vg90H21EOLACvtfcHk0lgcrT1EuCm60A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Kltb8%253D&md5=8b85d998957b36d67865ca30dbfedfbd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DO.%26atitle%3DPathogen%2520Recognition%2520and%2520Innate%2520Immunity%26jtitle%3DCell%26date%3D2006%26volume%3D124%26spage%3D783%26epage%3D801%26doi%3D10.1016%2Fj.cell.2006.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptor Signalling</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nri1391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri1391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=15229469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Cqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=499-511&author=S.+Akiraauthor=K.+Takeda&title=Toll-like+Receptor+Signalling&doi=10.1038%2Fnri1391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor signalling</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-511</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One of the mechanisms by which the innate immune system senses the invasion of pathogenic microorganisms is through the Toll-like receptors (TLRs), which recognize specific mol. patterns that are present in microbial components.  Stimulation of different TLRs induces distinct patterns of gene expression, which not only leads to the activation of innate immunity but also instructs the development of antigen-specific acquired immunity.  Here, the authors review the rapid progress that has recently improved the authors' understanding of the mol. mechanisms that mediate TLR signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCtsuKm49fcLVg90H21EOLACvtfcHk0lgcrT1EuCm60A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Cqur0%253D&md5=979700b403e0f8b062b69906cf07b289</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri1391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1391%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26atitle%3DToll-like%2520Receptor%2520Signalling%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2004%26volume%3D4%26spage%3D499%26epage%3D511%26doi%3D10.1038%2Fnri1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors: Critical Proteins Linking Innate and Acquired Immunity</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1038/90609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2F90609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=11477402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=675-680&author=S.+Akiraauthor=K.+Takedaauthor=T.+Kaisho&title=Toll-like+Receptors%3A+Critical+Proteins+Linking+Innate+and+Acquired+Immunity&doi=10.1038%2F90609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: Critical proteins linking innate and acquired immunity</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi; Kaisho, Tsuneyasu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-680</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review with 84 refs.  Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs).  These receptors recognize conserved mol. patterns (pathogen-assocd. mol. patterns), which are shared by large groups of microorganisms.  Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components.  The TLRs may also recognize endogenous ligands induced during the inflammatory response.  Similar cytoplasmic domains allow TLRs to use the same signaling mols. used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R-assocd. protein kinase and tumor necrosis factor receptor-activated factor 6.  However, evidence is accumulating that the signaling pathways assocd. with each TLR are not identical and may, therefore, result in different biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8I2sSl7FK7Vg90H21EOLACvtfcHk0lgiUHST4HXCdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D&md5=3fd5a975d63e0384c8cffa960159b063</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F90609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F90609%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26atitle%3DToll-like%2520Receptors%253A%2520Critical%2520Proteins%2520Linking%2520Innate%2520and%2520Acquired%2520Immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D675%26epage%3D680%26doi%3D10.1038%2F90609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gay, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symmons, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangloff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, C. E.</span></span> <span> </span><span class="NLM_article-title">Assembly and Localization of Toll-like Receptor Signalling Complexes</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/nri3713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri3713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=25060580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1WksbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=546-558&author=N.+J.+Gayauthor=M.+F.+Symmonsauthor=M.+Gangloffauthor=C.+E.+Bryant&title=Assembly+and+Localization+of+Toll-like+Receptor+Signalling+Complexes&doi=10.1038%2Fnri3713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly and localization of Toll-like receptor signalling complexes</span></div><div class="casAuthors">Gay, Nicholas J.; Symmons, Martyn F.; Gangloff, Monique; Bryant, Clare E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">546-558</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Signal transduction by the Toll-like receptors (TLRs) is central to host defense against many pathogenic microorganisms and also underlies a large burden of human disease.  Thus, the mechanisms and regulation of signalling by TLRs are of considerable interest.  In this Review, we discuss the mol. basis for the recognition of pathogen-assocd. mol. patterns, the nature of the protein complexes that mediate signalling, and the way in which signals are regulated and integrated at the level of allosteric assembly, post-translational modification and subcellular trafficking of the components of the signalling complexes.  These fundamental mol. mechanisms det. whether the signalling output leads to a protective immune response or to serious pathologies such as sepsis.  A detailed understanding of these processes at the mol. level provides a rational framework for the development of new drugs that can specifically target pathol. rather than protective signalling in inflammatory and autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwmfOHjdJ29rVg90H21EOLACvtfcHk0lgiUHST4HXCdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1WksbnN&md5=7370b6f825d2a8070806850d43566ec4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnri3713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3713%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DN.%2BJ.%26aulast%3DSymmons%26aufirst%3DM.%2BF.%26aulast%3DGangloff%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DC.%2BE.%26atitle%3DAssembly%2520and%2520Localization%2520of%2520Toll-like%2520Receptor%2520Signalling%2520Complexes%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D546%26epage%3D558%26doi%3D10.1038%2Fnri3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gay, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangloff, M.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Toll Receptors and Their Ligands</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.76.060305.151318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1146%2Fannurev.biochem.76.060305.151318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17362201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=141-165&author=N.+J.+Gayauthor=M.+Gangloff&title=Structure+and+Function+of+Toll+Receptors+and+Their+Ligands&doi=10.1146%2Fannurev.biochem.76.060305.151318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of Toll receptors and their ligands</span></div><div class="casAuthors">Gay, Nicholas J.; Gangloff, Monique</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-165</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The Toll family of class I transmembrane receptors recognizes and responds to diverse structures assocd. with pathogenic microorganisms.  These receptors mediate initial responses in innate immunity and are required for the development of the adaptive immune response.  Toll receptor signaling pathways are also implicated in serious autoimmune diseases such as endotoxic shock and thus are important therapeutic targets.  In this review we discuss how microbial structures as different as nucleic acids and lipoproteins can be recognized by the extracellular domains of Toll receptors.  We review recent evidence that the mechanism of signal transduction is complex and involves sequential changes in the conformation of the receptor induced by binding of the ligand.  Finally, we assess the emerging area of cross talk in the Toll pathways.  Recent work suggests that signaling through TLR4 in response to endotoxin is modified by inputs from at least two other pathways acting through β2 integrins and protein kinase Cε.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn3CtNWyA1pLVg90H21EOLACvtfcHk0lgiUHST4HXCdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7J&md5=8500c7f551b106bc0ca7266d8ced1821</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.060305.151318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.060305.151318%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DN.%2BJ.%26aulast%3DGangloff%26aufirst%3DM.%26atitle%3DStructure%2520and%2520Function%2520of%2520Toll%2520Receptors%2520and%2520Their%2520Ligands%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D141%26epage%3D165%26doi%3D10.1146%2Fannurev.biochem.76.060305.151318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowie, A. G.</span></span> <span> </span><span class="NLM_article-title">The History of Toll-like Receptors — Redefining Innate Immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1038/nri3446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri3446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=23681101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslaisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=453-460&author=L.+A.+J.+O%E2%80%99Neillauthor=D.+Golenbockauthor=A.+G.+Bowie&title=The+History+of+Toll-like+Receptors+%E2%80%94+Redefining+Innate+Immunity&doi=10.1038%2Fnri3446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The history of Toll-like receptors - redefining innate immunity</span></div><div class="casAuthors">O'Neill, Luke A. J.; Golenbock, Douglas; Bowie, Andrew G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of Toll-like receptors (TLRs) was an important event for immunol. research and was recognized as such with the awarding of the 2011 Nobel Prize in Physiol. or Medicine to Jules Hoffmann and Bruce Beutler, who, together with Ralph Steinman, the third winner of the 2011 Nobel Prize and the person who discovered the dendritic cell, were pioneers in the field of innate immunity.  TLRs have a central role in immunity - in this Timeline article, we describe the landmark findings that gave rise to this important field of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNQuHgmx29MrVg90H21EOLACvtfcHk0liLWjqloX9LOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslaisLc%253D&md5=4d5ca89abf3932000ae422d79ecbe93f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnri3446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3446%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26aulast%3DGolenbock%26aufirst%3DD.%26aulast%3DBowie%26aufirst%3DA.%2BG.%26atitle%3DThe%2520History%2520of%2520Toll-like%2520Receptors%2520%25E2%2580%2594%2520Redefining%2520Innate%2520Immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26spage%3D453%26epage%3D460%26doi%3D10.1038%2Fnri3446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">Signaling Pathways Activated by Microorganisms</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2007.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ceb.2007.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17303405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=185-191&author=O.+Takeuchiauthor=S.+Akira&title=Signaling+Pathways+Activated+by+Microorganisms&doi=10.1016%2Fj.ceb.2007.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling pathways activated by microorganisms</span></div><div class="casAuthors">Takeuchi, Osamu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-191</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Invasion of viruses and bacteria is initially sensed by the host innate immune system, and evokes a rapid inflammatory response.  Nucleotides from RNA viruses are recognized by retinoic-acid-inducible gene I-like helicases and Toll-like receptors, and this recognition triggers signaling cascades that induce antiviral mediators such as type I interferons.  By contrast, Toll-like receptors recognizing bacterial components induce the expression of proinflammatory cytokines.  Furthermore, recent studies suggest that viral and bacterial DNA also induce interferons in a Toll-independent mechanism, possibly through unidentified cytoplasmic receptor(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVjTX-dD6TtbVg90H21EOLACvtfcHk0liLWjqloX9LOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu7c%253D&md5=86991f25b0d7e6b164e3f327b193fe3c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2007.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2007.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DSignaling%2520Pathways%2520Activated%2520by%2520Microorganisms%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2007%26volume%3D19%26spage%3D185%26epage%3D191%26doi%3D10.1016%2Fj.ceb.2007.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barchet, W.</span></span> <span> </span><span class="NLM_article-title">Translating Nucleic Acid-Sensing Pathways into Therapies</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/nri3875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri3875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=26292638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=529-544&author=T.+Juntauthor=W.+Barchet&title=Translating+Nucleic+Acid-Sensing+Pathways+into+Therapies&doi=10.1038%2Fnri3875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Translating nucleic acid-sensing pathways into therapies</span></div><div class="casAuthors">Junt, Tobias; Barchet, Winfried</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">529-544</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleic acid sensing by innate receptors initiates immune defences against viruses and other pathogens.  A hallmark of this response is the release of interferons (IFNs), which promote protective immunity by inducing IFN-stimulated genes (ISGs).  A similar ISG signature is found in autoinflammatory and autoimmune conditions, indicating that chronic activation of nucleic acid-sensing pathways may contribute to these diseases.  Here, we review how nucleic acid-sensing pathways are currently being targeted pharmacol. with both agonists and antagonists.  We discuss how an improved understanding of the biol. of these pathways is leading to novel therapies for infections, cancer, and autoimmune and autoinflammatory disorders, and how new therapeutics will, in turn, generate a deeper understanding of these complex diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYKnDGOTSvbVg90H21EOLACvtfcHk0lj6WpvxF-WtQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM&md5=3afa98f84abcce81338604d3c3c5075c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnri3875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3875%26sid%3Dliteratum%253Aachs%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DBarchet%26aufirst%3DW.%26atitle%3DTranslating%2520Nucleic%2520Acid-Sensing%2520Pathways%2520into%2520Therapies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D529%26epage%3D544%26doi%3D10.1038%2Fnri3875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Potential Therapeutic Targets in the Process of Nucleic Acid Recognition: Opportunities and Challenges</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.tips.2014.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=25479797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2mt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=51-64&author=S.+Heauthor=X.+Maoauthor=H.+Sunauthor=T.+Shirakawaauthor=H.+Zhangauthor=X.+Wang&title=Potential+Therapeutic+Targets+in+the+Process+of+Nucleic+Acid+Recognition%3A+Opportunities+and+Challenges&doi=10.1016%2Fj.tips.2014.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic targets in the process of nucleic acid recognition: opportunities and challenges</span></div><div class="casAuthors">He, Shaoheng; Mao, Xiaoquan; Sun, Hongzhi; Shirakawa, Taro; Zhang, Huiyun; Wang, Xiangdong</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nucleic acid recognition or sensing (NAS) is accepted as a fundamental function in the host defense against self or foreign genetic elements.  Abnormal recognition or interpretation of microbial-origin pathogen-assocd. mol. patterns (PAMPs) or damage-assocd. mol. patterns (DAMPs) can lead to infections or autoimmune diseases (ADs).  Modulation of the NAS process represents a path toward the development of novel vaccines or drugs, through targets such as myeloid differentiation primary-response protein 88 (MyD88) and tumor necrosis factor (TNF) receptor-assocd. factor (TRAF) 3 and 6 in Toll-like receptor (TLR)-mediated signaling pathways.  DNA helicases can be targeted by arresting replication and the breakage of DNA double strands.  Stimulator of interferon (IFN) genes (STING) may act as a therapeutic target by upregulation of the STING-dependent pathway or vaccination with cyclic GMP-AMP (cGAMP) synthase (cGAS)-catalyzed reaction products.  Several challenges are faced before and during clin. therapy.  NAS can be an important breakthrough for mol. targets and therapies.  The specificity of drug delivery, potential of long-term genotoxicity, risk of tumorigenesis, duration of drug efficacy, and drug metab. should be further validated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJyrw2cvLTrrVg90H21EOLACvtfcHk0lj6WpvxF-WtQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2mt7jE&md5=1cb8ef263c2ead972f6bf854ebd527e9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShirakawa%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DPotential%2520Therapeutic%2520Targets%2520in%2520the%2520Process%2520of%2520Nucleic%2520Acid%2520Recognition%253A%2520Opportunities%2520and%2520Challenges%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D51%26epage%3D64%26doi%3D10.1016%2Fj.tips.2014.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, G. M.</span></span> <span> </span><span class="NLM_article-title">Trafficking of Endosomal Toll-like Receptors</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2013.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.tcb.2013.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24439965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Kjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=360-369&author=B.+L.+Leeauthor=G.+M.+Barton&title=Trafficking+of+Endosomal+Toll-like+Receptors&doi=10.1016%2Fj.tcb.2013.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Trafficking of endosomal Toll-like receptors</span></div><div class="casAuthors">Lee, Bettina L.; Barton, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">360-369</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade we have learned much about nucleic acid recognition by the innate immune system and in particular by Toll-like receptors (TLRs).  These receptors localize to endosomal compartments where they are poised to recognize microbial nucleic acids.  Multiple regulatory mechanisms function to limit responses to self DNA or RNA, and breakdowns in these mechanisms can contribute to autoimmune or inflammatory disorders.  In this review we discuss our current understanding of the cell biol. of TLRs involved in nucleic acid recognition and how localization and trafficking of these receptors regulates their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYP1LYUhAD17Vg90H21EOLACvtfcHk0lj6WpvxF-WtQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Kjs7g%253D&md5=9716c3b0ddd6a8f8427eecd31f7f0acf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2013.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BL.%26aulast%3DBarton%26aufirst%3DG.%2BM.%26atitle%3DTrafficking%2520of%2520Endosomal%2520Toll-like%2520Receptors%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26spage%3D360%26epage%3D369%26doi%3D10.1016%2Fj.tcb.2013.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dammer, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, R.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">The Endosomal-Lysosomal System: From Acidification and Cargo Sorting to Neurodegeneration</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">18</span> <span class="refDoi"> DOI: 10.1186/s40035-015-0041-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1186%2Fs40035-015-0041-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=26448863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&author=Y.-B.+Huauthor=E.+B.+Dammerauthor=R.-J.+Renauthor=G.+Wang&title=The+Endosomal-Lysosomal+System%3A+From+Acidification+and+Cargo+Sorting+to+Neurodegeneration&doi=10.1186%2Fs40035-015-0041-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</span></div><div class="casAuthors">Hu, Yong-Bo; Dammer, Eric B.; Ren, Ru-Jing; Wang, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18/1-18/10</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The endosomal-lysosomal system is made up of a set of intracellular membranous compartments that dynamically interconvert, which is comprised of early endosomes, recycling endosomes, late endosomes, and the lysosome.  In addn., autophagosomes execute autophagy, which delivers intracellular contents to the lysosome.  Maturation of endosomes and/or autophagosomes into a lysosome creates an unique acidic environment within the cell for proteolysis and recycling of unneeded cellular components into usable amino acids and other biomol. building blocks.  In the endocytic pathway, gradual maturation of endosomes into a lysosome and acidification of the late endosome are accompanied by vesicle trafficking, protein sorting and targeted degrdn. of some sorted cargo.  Two opposing sorting systems are operating in these processes: the endosomal sorting complex required for transport (ESCRT) supports targeted degrdn. and the retromer supports retrograde retrieval of certain cargo.  The endosomal-lysosomal system is emerging as a central player in a host of neurodegenerative diseases, demonstrating potential roles which are likely to be revealed in pathogenesis and for viable therapeutic strategies.  Here we focus on the physiol. process of endosomal-lysosomal maturation, acidification and sorting systems along the endocytic pathway, and further discuss relationships between abnormalities in the endosomal-lysosomal system and neurodegenerative diseases, esp. Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79sz_jogdArVg90H21EOLACvtfcHk0lj6WpvxF-WtQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D&md5=819113d11b363b56845873309c4219ef</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs40035-015-0041-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-015-0041-1%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.-B.%26aulast%3DDammer%26aufirst%3DE.%2BB.%26aulast%3DRen%26aufirst%3DR.-J.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DThe%2520Endosomal-Lysosomal%2520System%253A%2520From%2520Acidification%2520and%2520Cargo%2520Sorting%2520to%2520Neurodegeneration%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2015%26volume%3D4%26doi%3D10.1186%2Fs40035-015-0041-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochrein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ampenberger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschning, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span> <span> </span><span class="NLM_article-title">Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1526</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.1126/science.1093620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscience.1093620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=14976262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslCgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1526-1529&author=F.+Heilauthor=H.+Hemmiauthor=H.+Hochreinauthor=F.+Ampenbergerauthor=C.+Kirschningauthor=S.+Akiraauthor=G.+Lipfordauthor=H.+Wagnerauthor=S.+Bauer&title=Species-Specific+Recognition+of+Single-Stranded+RNA+via+Toll-like+Receptor+7+and+8&doi=10.1126%2Fscience.1093620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8</span></div><div class="casAuthors">Heil, Florian; Hemmi, Hiroaki; Hochrein, Hubertus; Ampenberger, Franziska; Kirschning, Carsten; Akira, Shizuo; Lipford, Grayson; Wagner, Hermann; Bauer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5663</span>),
    <span class="NLM_cas:pages">1526-1529</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Double-stranded RNA (dsRNA) serves as a danger signal assocd. with viral infection and leads to stimulation of innate immune cells.  In contrast, the immunostimulatory potential of single-stranded RNA (ssRNA) is poorly understood and innate immune receptors for ssRNA are unknown.  The authors report that guanosine (G)- and uridine (U)-rich ssRNA oligonucleotides derived from human immunodeficiency virus-1 (HIV-1) stimulate dendritic cells (DC) and macrophages to secrete interferon-α and proinflammatory, as well as regulatory, cytokines.  By using Toll-like receptor (TLR)-deficient mice and genetic complementation, the authors show that murine TLR7 and human TLR8 mediate species-specific recognition of GU-rich ssRNA.  These data suggest that ssRNA represents a physiol. ligand for TLR7 and TLR8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaDTp7TLlTxLVg90H21EOLACvtfcHk0lg6p3KdwvMDyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslCgsLc%253D&md5=33596446b6a66f5d3f9137eb83aaa242</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1093620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1093620%26sid%3Dliteratum%253Aachs%26aulast%3DHeil%26aufirst%3DF.%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DHochrein%26aufirst%3DH.%26aulast%3DAmpenberger%26aufirst%3DF.%26aulast%3DKirschning%26aufirst%3DC.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DLipford%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DH.%26aulast%3DBauer%26aufirst%3DS.%26atitle%3DSpecies-Specific%2520Recognition%2520of%2520Single-Stranded%2520RNA%2520via%2520Toll-like%2520Receptor%25207%2520and%25208%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1526%26epage%3D1529%26doi%3D10.1126%2Fscience.1093620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis e Sousa, C.</span></span> <span> </span><span class="NLM_article-title">Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.1126/science.1093616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscience.1093616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=14976261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1529-1531&author=S.+S.+Dieboldauthor=T.+Kaishoauthor=H.+Hemmiauthor=S.+Akiraauthor=C.+Reis+e+Sousa&title=Innate+Antiviral+Responses+by+Means+of+TLR7-Mediated+Recognition+of+Single-Stranded+RNA&doi=10.1126%2Fscience.1093616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA</span></div><div class="casAuthors">Diebold, Sandra S.; Kaisho, Tsuneyasu; Hemmi, Hiroaki; Akira, Shizuo; Reis e Sousa, Caetano</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5663</span>),
    <span class="NLM_cas:pages">1529-1532</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Interferons (IFNs) are crit. for protection from viral infection, but the pathways linking virus recognition to IFN induction remain poorly understood.  Plasmacytoid dendritic cells produce vast amts. of IFN-α in response to the wild-type influenza virus.  Here, the authors show that this requires endosomal recognition of influenza genomic RNA and signaling by Toll-like receptor 7 (TLR7) and MyD88.  Single-stranded RNA (ssRNA) mols. of nonviral origin also induce TLR7-dependent prodn. of inflammatory cytokines.  These results identify ssRNA as a ligand for TLR7 and suggest that cells of the innate immune system sense endosomal ssRNA to detect infection by RNA viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtBc4fjjNOxLVg90H21EOLACvtfcHk0lg6p3KdwvMDyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb4%253D&md5=0cda7727b7f1dfc08f183bc23c0224d2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1093616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1093616%26sid%3Dliteratum%253Aachs%26aulast%3DDiebold%26aufirst%3DS.%2BS.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DReis%2Be%2BSousa%26aufirst%3DC.%26atitle%3DInnate%2520Antiviral%2520Responses%2520by%2520Means%2520of%2520TLR7-Mediated%2520Recognition%2520of%2520Single-Stranded%2520RNA%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1529%26epage%3D1531%26doi%3D10.1126%2Fscience.1093616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hemmi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanjo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">A Toll-like Receptor Recognizes Bacterial DNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1038/35047123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2F35047123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=11130078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVCqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=740-745&author=H.+Hemmiauthor=O.+Takeuchiauthor=T.+Kawaiauthor=T.+Kaishoauthor=S.+Satoauthor=H.+Sanjoauthor=M.+Matsumotoauthor=K.+Hoshinoauthor=H.+Wagnerauthor=K.+Takedaauthor=S.+Akira&title=A+Toll-like+Receptor+Recognizes+Bacterial+DNA&doi=10.1038%2F35047123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Toll-like receptor recognizes bacterial DNA</span></div><div class="casAuthors">Hemmi, Hiroaki; Takeuchi, Osamu; Kawai, Taro; Kaisho, Tsuneyasu; Sato, Shintaro; Sanjo, Hideki; Matsumoto, Makoto; Hoshino, Katsuaki; Wagner, Hermann; Takeda, Kiyoshi; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6813</span>),
    <span class="NLM_cas:pages">740-745</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">DNA from bacteria has stimulatory effects on mammalian immune cells, which depend on the presence of unmethylated CpG dinudeotides in the bacterial DNA.  In contrast, mammalian DNA has a low frequency of CpG dinucleotides, and these are mostly methylated; therefore, mammalian DNA does not have immuno-stimulatory activity.  CpG DNA induces a strong T-helper-1-like inflammatory response.  Accumulating evidence has revealed the therapeutic potential of CpG DNA as adjuvants for vaccination strategies for cancer, allergy and infectious diseases.  Despite its promising clin. use, the mol. mechanism by which CpG DNA activates immune cells remains unclear.  Here the authors show that cellular response to CpG DNA is mediated by a Toll-like receptor, TLR9.  TLR9-deficient (TLR9-/-) mice did not show any response to CpG DNA, including proliferation of splenocytes, inflammatory cytokine prodn. from macrophages and maturation of dendritic cells.  TLR9-/- mice showed resistance to the lethal effect of CpG DNA without any elevation of serum pro-inflammatory cytokine levels.  The in vivo CpG-DNA-mediated T-helper type-1 response was also abolished in TLR9-/- mice.  Thus, vertebrate immune systems appear to have evolved a specific Toll-like receptor that distinguishes bacterial DNA from self-DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOZ-nQmoTgLVg90H21EOLACvtfcHk0lg6p3KdwvMDyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVCqsL0%253D&md5=70d56020c85d5754be6ff47a17eb19e1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F35047123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35047123%26sid%3Dliteratum%253Aachs%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DA%2520Toll-like%2520Receptor%2520Recognizes%2520Bacterial%2520DNA%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D740%26epage%3D745%26doi%3D10.1038%2F35047123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krayukhina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of CpG and Inhibitory DNA Recognition by Toll-like Receptor 9</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>520</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/nature14138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnature14138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=25686612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1Snurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=520&publication_year=2015&pages=702-705&author=U.+Ohtoauthor=T.+Shibataauthor=H.+Tanjiauthor=H.+Ishidaauthor=E.+Krayukhinaauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Basis+of+CpG+and+Inhibitory+DNA+Recognition+by+Toll-like+Receptor+9&doi=10.1038%2Fnature14138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9</span></div><div class="casAuthors">Ohto, Umeharu; Shibata, Takuma; Tanji, Hiromi; Ishida, Hanako; Krayukhina, Elena; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">520</span>
        (<span class="NLM_cas:issue">7549</span>),
    <span class="NLM_cas:pages">702-705</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Innate immunity serves as the first line of defense against invading pathogens such as bacteria and viruses.  Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific mol. patterns from pathogens and activate immune responses.  TLR9 recognizes bacterial and viral DNA contg. the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif.  The mol. basis by which CpG-contg. DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated.  Here the authors show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA).  Agonistic-CpG-DNA-bound TLR9 formed a sym. TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer.  CpG-DNA was recognized by both protomers in the dimer, in particular by the N-terminal fragment (LRRNT-LRR10) from one protomer and the C-terminal fragment (LRR20-LRR22) from the other.  The iDNA, which formed a stem-loop structure suitable for binding by intramol. base pairing, bound to the concave surface from LRR2-LRR10.  This structure serves as an important basis for improving the authors' understanding of the functional mechanisms of TLR9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXq7p7veo0T7Vg90H21EOLACvtfcHk0liDQBYV5_Uuxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1Snurw%253D&md5=beb602641357658548c28edc0526a91d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature14138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14138%26sid%3Dliteratum%253Aachs%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Basis%2520of%2520CpG%2520and%2520Inhibitory%2520DNA%2520Recognition%2520by%2520Toll-like%2520Receptor%25209%26jtitle%3DNature%26date%3D2015%26volume%3D520%26spage%3D702%26epage%3D705%26doi%3D10.1038%2Fnature14138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanisms Controlling Nucleic Acid-Sensing Toll-like Receptors</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxy016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1093%2Fintimm%2Fdxy016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=29452403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGrsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2018&pages=43-51&author=K.+Miyakeauthor=T.+Shibataauthor=U.+Ohtoauthor=T.+Shimizuauthor=S.-I.+Saitohauthor=R.+Fukuiauthor=Y.+Murakami&title=Mechanisms+Controlling+Nucleic+Acid-Sensing+Toll-like+Receptors&doi=10.1093%2Fintimm%2Fdxy016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms controlling nucleic acid-sensing Toll-like receptors</span></div><div class="casAuthors">Miyake, Kensuke; Shibata, Takuma; Ohto, Umeharu; Shimizu, Toshiyuki; Saitoh, Shin-Ichiroh; Fukui, Ryutaro; Murakami, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">43-51</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">1460-2377</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Nucleic acid (NA)-sensing Toll-like receptors (TLRs) respond to DNA/RNA derived from pathogens and dead cells.  Structural studies have revealed a variety of mol. mechanisms by which TLRs sense NAs.  Double-stranded RNA and single-stranded DNA directly bind to TLR3 and TLR9, resp., whereas TLR7 and TLR8 bind to nucleosides and oligoribonucleotides derived from RNAs.  Activation of ligand-bound TLRs is influenced by the functional status of TLRs.  Proteolytic cleavage of NA-sensing TLRs enables ligand-dependent TLR dimerization.  Trafficking of ligandactivated TLRs in endosomal and lysosomal compartments is requisite for prodn. of type I interferons.  Activation of NA-sensing TLRs is required for the control of viruses such as herpes simplex virus and endogenous retroviruses.  On the other hand, excessive activation of NA-sensing TLRs drives disease progression in a variety of inflammatory diseases including systemic lupus erythematosus, heart failure, arthritis and non-alc. steatohepatitis.  NA-sensing TLRs are targets for therapeutic intervention in these diseases.  We here focus on our recent progresses in our understanding of NA-sensing TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIplrEf8BiHLVg90H21EOLACvtfcHk0liDQBYV5_Uuxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGrsLfN&md5=a1fb12704dede2ee4861ab062274c81e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxy016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxy016%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSaitoh%26aufirst%3DS.-I.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DMurakami%26aufirst%3DY.%26atitle%3DMechanisms%2520Controlling%2520Nucleic%2520Acid-Sensing%2520Toll-like%2520Receptors%26jtitle%3DInt.%2520Immunol.%26date%3D2018%26volume%3D30%26spage%3D43%26epage%3D51%26doi%3D10.1093%2Fintimm%2Fdxy016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilliet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span> <span> </span><span class="NLM_article-title">Plasmacytoid Dendritic Cells: Sensing Nucleic Acids in Viral Infection and Autoimmune Diseases</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/nri2358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri2358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=18641647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=594-606&author=M.+Gillietauthor=W.+Caoauthor=Y.-J.+Liu&title=Plasmacytoid+Dendritic+Cells%3A+Sensing+Nucleic+Acids+in+Viral+Infection+and+Autoimmune+Diseases&doi=10.1038%2Fnri2358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases</span></div><div class="casAuthors">Gilliet, Michel; Cao, Wei; Liu, Yong-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">594-606</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Plasmacytoid dendritic cells (pDCs) are important mediators of antiviral immunity through their ability to produce large amts. of type I interferons (IFNs) on viral infection.  This function of pDCs is linked to their expression of Toll-like receptor 7 (TLR7) and TLR9, which sense viral nucleic acids within the early endosomes.  Exclusion of self nucleic acids from TLR-contg. early endosomes normally prevents pDC responses to them.  However, in some autoimmune diseases, self nucleic acids can be modified by host factors and gain entrance to pDC endosomes, where they activate TLR signaling.  Several pDC receptors neg. regulate type I IFN responses by pDCs during viral infection and for normal homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiqyQF42vzy7Vg90H21EOLACvtfcHk0lg-BclzGNauaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovV2gtrg%253D&md5=6c0b7d8d1163664e38000ebe6bb1e495</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnri2358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2358%26sid%3Dliteratum%253Aachs%26aulast%3DGilliet%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.-J.%26atitle%3DPlasmacytoid%2520Dendritic%2520Cells%253A%2520Sensing%2520Nucleic%2520Acids%2520in%2520Viral%2520Infection%2520and%2520Autoimmune%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D594%26epage%3D606%26doi%3D10.1038%2Fnri2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothenfusser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britsch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrsdörfer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span> <span> </span><span class="NLM_article-title">Quantitative Expression of Toll-Like Receptor 1–10 MRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">4531</span>– <span class="NLM_lpage">4537</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.168.9.4531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.4049%2Fjimmunol.168.9.4531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=11970999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt12jt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=4531-4537&author=V.+Hornungauthor=S.+Rothenfusserauthor=S.+Britschauthor=A.+Krugauthor=B.+Jahrsd%C3%B6rferauthor=T.+Gieseauthor=S.+Endresauthor=G.+Hartmann&title=Quantitative+Expression+of+Toll-Like+Receptor+1%E2%80%9310+MRNA+in+Cellular+Subsets+of+Human+Peripheral+Blood+Mononuclear+Cells+and+Sensitivity+to+CpG+Oligodeoxynucleotides&doi=10.4049%2Fjimmunol.168.9.4531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides</span></div><div class="casAuthors">Hornung, Veit; Rothenfusser, Simon; Britsch, Stefanie; Krug, Anne; Jahrsdorfer, Bernd; Giese, Thomas; Endres, Stefan; Hartmann, Gunther</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4531-4537</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The Toll-like receptor (TLR)9 is crit. for the recognition of immunostimulatory CpG motifs but may cooperate with other TLRs.  The authors analyzed TLR1-10 mRNA expression by using quant. real-time PCR in highly purified subsets of human PBMC and detd. the sensitivity of these subsets to CpG oligodeoxynucleotides (ODN).  TLR1 and TLR6 were expressed in all cell types examd.  TLR10 was highly expressed in B cells and weakly expressed in plasmacytoid dendritic cells (PDC).  High expression of TLR2 was characteristic for monocytes.  PDC and B cells expressed marked levels of TLR7 and TLR9 and were directly sensitive to CpG ODN.  In CpG ODN-stimulated PDC and B cells, TLR9 expression rapidly decreased, as opposed to TLR7, which was up-regulated in PDC and decreased in B cells.  In monocytes, NK cells, and T cells, TLR7 was absent.  Despite low expression of TLR9, monocytes, NK cells, and T cells did not respond to CpG ODN in the absence of PDC but were activated in the presence of PDC.  In conclusion, the authors' studies provide evidence that PDC and B cells, but not monocytes, NK cells, or T cells, are primary targets of CpG ODN in peripheral blood.  The characteristic expression pattern of TLR1-10 in cellular subsets of human PBMC is consistent with the concept that TLR9 is essential in the recognition of CpG ODN in PDC and B cells.  In addn., selective regulation of TLR7 expression in PDC and B cells by CpG ODN revealed TLR7 as a candidate TLR potentially involved in modulating the recognition of CpG motifs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3GcW82Ji8Q7Vg90H21EOLACvtfcHk0lg-BclzGNauaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt12jt7k%253D&md5=9612fe6d52ae1ccc6a92e583829ddce3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.168.9.4531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.168.9.4531%26sid%3Dliteratum%253Aachs%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DRothenfusser%26aufirst%3DS.%26aulast%3DBritsch%26aufirst%3DS.%26aulast%3DKrug%26aufirst%3DA.%26aulast%3DJahrsd%25C3%25B6rfer%26aufirst%3DB.%26aulast%3DGiese%26aufirst%3DT.%26aulast%3DEndres%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DG.%26atitle%3DQuantitative%2520Expression%2520of%2520Toll-Like%2520Receptor%25201%25E2%2580%259310%2520MRNA%2520in%2520Cellular%2520Subsets%2520of%2520Human%2520Peripheral%2520Blood%2520Mononuclear%2520Cells%2520and%2520Sensitivity%2520to%2520CpG%2520Oligodeoxynucleotides%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D4531%26epage%3D4537%26doi%3D10.4049%2Fjimmunol.168.9.4531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, B. A.</span></span> <span> </span><span class="NLM_article-title">TLRs and Innate Immunity</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1399</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1182/blood-2008-07-019307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1182%2Fblood-2008-07-019307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=18757776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1399-1407&author=B.+A.+Beutler&title=TLRs+and+Innate+Immunity&doi=10.1182%2Fblood-2008-07-019307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">TLRs and innate immunity</span></div><div class="casAuthors">Beutler, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-1407</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  One of the most fundamental questions in immunol. pertains to the recognition of non-self, which for the most part means microbes.  How do we initially realize that we have been inoculated with microbes, and how is the immune response ignited.  Genetic studies have made important inroads into this question during the past decade, and we now know that in mammals, a relatively small no. of receptors operate to detect signature mols. that herald infection.  One or more of these signature mols. are displayed by almost all microbes.  These receptors and the signals they initiate have been studied in depth by random germline mutagenesis and positional cloning (forward genetics).  Herein is a concise description of what has been learned about the Toll-like receptors, which play an essential part in the perception of microbes and shape the complex host responses that occur during infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGi2r7yRa-QLVg90H21EOLACvtfcHk0lg-BclzGNauaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlCrt7g%253D&md5=bf41d69d6ae7307e8daead5b359e8345</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-07-019307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-07-019307%26sid%3Dliteratum%253Aachs%26aulast%3DBeutler%26aufirst%3DB.%2BA.%26atitle%3DTLRs%2520and%2520Innate%2520Immunity%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D1399%26epage%3D1407%26doi%3D10.1182%2Fblood-2008-07-019307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palm, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Pattern Recognition Receptors and Control of Adaptive Immunity</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00731.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1111%2Fj.1600-065X.2008.00731.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=19120487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2009&pages=221-233&author=N.+W.+Palmauthor=R.+Medzhitov&title=Pattern+Recognition+Receptors+and+Control+of+Adaptive+Immunity&doi=10.1111%2Fj.1600-065X.2008.00731.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern recognition receptors and control of adaptive immunity</span></div><div class="casAuthors">Palm, Noah W.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">221-233</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The mammalian immune system effectively fights infection through the cooperation of two connected systems, innate and adaptive immunity.  Germ-line encoded pattern recognition receptors (PRRs) of the innate immune system sense the presence of infection and activate innate immunity.  Some PRRs also induce signals that lead to the activation of adaptive immunity.  Adaptive immunity is controlled by PRR-induced signals at multiple checkpoints dictating the initiation of a response, the type of response, the magnitude and duration of the response, and the prodn. of long-term memory.  PRRs thus instruct the adaptive immune system on when and how to best respond to a particular infection.  In this review, we discuss the roles of various PRRs in control of adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr22D-Htb6XSLVg90H21EOLACvtfcHk0lg-BclzGNauaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls73I&md5=a82aa9b95205d8a28940409d7c638f5d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00731.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00731.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DN.%2BW.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DPattern%2520Recognition%2520Receptors%2520and%2520Control%2520of%2520Adaptive%2520Immunity%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D227%26spage%3D221%26epage%3D233%26doi%3D10.1111%2Fj.1600-065X.2008.00731.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors in Innate Immunity</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxh186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1093%2Fintimm%2Fdxh186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=15585605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=1-14&author=K.+Takedaauthor=S.+Akira&title=Toll-like+Receptors+in+Innate+Immunity&doi=10.1093%2Fintimm%2Fdxh186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors in innate immunity</span></div><div class="casAuthors">Takeda, Kiyoshi; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Functional characterization of Toll-like receptors (TLRs) has established that innate immunity is a skillful system that detects invasion of microbial pathogens.  Recognition of microbial components by TLRs initiates signal transduction pathways, which triggers expression of genes.  These gene products control innate immune responses and further instruct development of antigen-specific acquired immunity.  TLR signaling pathways are finely regulated by TIR domain-contg. adaptors, such as MyD88, TIRAP/Mal, TRIF and TRAM.  Differential utilization of these TIR domain-contg. adaptors provides specificity of individual TLR-mediated signaling pathways.  Several mechanisms have been elucidated that neg. control TLR signaling pathways, and thereby prevent over activation of innate immunity leading to fatal immune disorders.  The involvement of TLR-mediated pathways in autoimmune and inflammatory diseases has been proposed.  Thus, TLR-mediated activation of innate immunity controls not only host defense against pathogens but also immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE41SReV_f5rVg90H21EOLACvtfcHk0ljoo7a2HZrEKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKru77P&md5=89e5132b6e14905b9799cc12eb5320aa</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxh186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxh186%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DToll-like%2520Receptors%2520in%2520Innate%2520Immunity%26jtitle%3DInt.%2520Immunol.%26date%3D2005%26volume%3D17%26spage%3D1%26epage%3D14%26doi%3D10.1093%2Fintimm%2Fdxh186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patinote, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karroum, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarbess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirnat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze-Masquéfa, C.</span></span> <span> </span><span class="NLM_article-title">Agonist and Antagonist Ligands of Toll-like Receptors 7 and 8: Ingenious Tools for Therapeutic Purposes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>193</i></span>, <span class="NLM_elocation-id">112238</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ejmech.2020.112238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=32203790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsVWjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2020&author=C.+Patinoteauthor=N.+B.+Karroumauthor=G.+Moarbessauthor=N.+Cirnatauthor=I.+Kassabauthor=P.-A.+Bonnetauthor=C.+Deleuze-Masqu%C3%A9fa&title=Agonist+and+Antagonist+Ligands+of+Toll-like+Receptors+7+and+8%3A+Ingenious+Tools+for+Therapeutic+Purposes&doi=10.1016%2Fj.ejmech.2020.112238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes</span></div><div class="casAuthors">Patinote, Cindy; Karroum, Nour Bou; Moarbess, Georges; Cirnat, Natalina; Kassab, Issam; Bonnet, Pierre-Antoine; Deleuze-Masquefa, Carine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112238</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The discovery of the TLRs family and more precisely its functions opened a variety of gates to modulate immunol. host responses.  TLRs 7/8 are located in the endosomal compartment and activate a specific signaling pathway in a MyD88-dependant manner.  According to their involvement into various autoimmune, inflammatory and malignant diseases, researchers have designed diverse TLRs 7/8 ligands able to boost or block the inherent signal transduction.  These modulators are often small synthetic compds. and most act as agonists and to a much lesser extent as antagonists.  Some of them have reached preclin. and clin. trials, and only one has been approved by the FDA and EMA, imiquimod.  The key to the success of these modulators probably lies in their combination with other therapies as recently demonstrated.  We gather in this review more than 360 scientific publications, reviews and patents, relating the extensive work carried out by researchers on the design of TLRs 7/8 modulators, which are classified firstly by their biol. activities (agonist or antagonist) and then by their chem. structures, which total syntheses are not discussed here.  This review also reports about 90 clin. cases, thereby showing the biol. interest of these modulators in multiple pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7KAldiwRFYrVg90H21EOLACvtfcHk0ljoo7a2HZrEKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsVWjt74%253D&md5=d11400c9ed60056bd0d33861aaeb5dba</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112238%26sid%3Dliteratum%253Aachs%26aulast%3DPatinote%26aufirst%3DC.%26aulast%3DKarroum%26aufirst%3DN.%2BB.%26aulast%3DMoarbess%26aufirst%3DG.%26aulast%3DCirnat%26aufirst%3DN.%26aulast%3DKassab%26aufirst%3DI.%26aulast%3DBonnet%26aufirst%3DP.-A.%26aulast%3DDeleuze-Masqu%25C3%25A9fa%26aufirst%3DC.%26atitle%3DAgonist%2520and%2520Antagonist%2520Ligands%2520of%2520Toll-like%2520Receptors%25207%2520and%25208%253A%2520Ingenious%2520Tools%2520for%2520Therapeutic%2520Purposes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D193%26doi%3D10.1016%2Fj.ejmech.2020.112238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Federico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carullo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relitti, N.</span></span> <span> </span><span class="NLM_article-title">Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">13466</span>– <span class="NLM_lpage">13513</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1OlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=13466-13513&author=S.+Federicoauthor=L.+Pozzettiauthor=A.+Papaauthor=G.+Carulloauthor=S.+Gemmaauthor=S.+Butiniauthor=G.+Campianiauthor=N.+Relitti&title=Modulation+of+the+Innate+Immune+Response+by+Targeting+Toll-like+Receptors%3A+A+Perspective+on+Their+Agonists+and+Antagonists&doi=10.1021%2Facs.jmedchem.0c01049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists</span></div><div class="casAuthors">Federico, Stefano; Pozzetti, Luca; Papa, Alessandro; Carullo, Gabriele; Gemma, Sandra; Butini, Stefania; Campiani, Giuseppe; Relitti, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13466-13513</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are a class of proteins that recognize pathogen-assocd. mol. patterns (PAMPs) and damaged-assocd. mol. patterns (DAMPs), and they are involved in the regulation of innate immune system.  These transmembrane receptors, localized at the cellular or endosomal membrane, trigger inflammatory processes through either myeloid differentiation primary response 88 (MyD88) or TIR-domain-contg. adapter-inducing interferon-β (TRIF) signaling pathways.  In the last decades, extensive research has been performed on TLR modulators and their therapeutic implication under several pathol. conditions, spanning from infections to cancer, from metabolic disorders to neurodegeneration and autoimmune diseases.  This Perspective will highlight the recent discoveries in this field, emphasizing the role of TLRs in different diseases and the therapeutic effect of their natural and synthetic modulators, and it will discuss insights for the future exploitation of TLR modulators in human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0aMw3NYlt0bVg90H21EOLACvtfcHk0ljoo7a2HZrEKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1OlsL%252FO&md5=c6ec1e59e89174d0fa6b50490f15882f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01049%26sid%3Dliteratum%253Aachs%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DPozzetti%26aufirst%3DL.%26aulast%3DPapa%26aufirst%3DA.%26aulast%3DCarullo%26aufirst%3DG.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DRelitti%26aufirst%3DN.%26atitle%3DModulation%2520of%2520the%2520Innate%2520Immune%2520Response%2520by%2520Targeting%2520Toll-like%2520Receptors%253A%2520A%2520Perspective%2520on%2520Their%2520Agonists%2520and%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D13466%26epage%3D13513%26doi%3D10.1021%2Facs.jmedchem.0c01049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Toll-like Receptors: Emerging Therapeutics?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1038/nrd3203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnrd3203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=20380038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=293-307&author=E.+J.+Hennessyauthor=A.+E.+Parkerauthor=L.+A.+J.+O%E2%80%99Neill&title=Targeting+Toll-like+Receptors%3A+Emerging+Therapeutics%3F&doi=10.1038%2Fnrd3203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Toll-like receptors: emerging therapeutics?</span></div><div class="casAuthors">Hennessy, Elizabeth J.; Parker, Andrew E.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-307</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a growing interest in the targeting of Toll-like receptors (TLRs) for the prevention and treatment of cancer, rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus (SLE).  Several new compds. are now undergoing preclin. and clin. evaluation, with a particular focus on TLR7 and TLR9 activators as adjuvants in infection and cancer, and inhibitors of TLR2, TLR4, TLR7 and TLR9 for the treatment of sepsis and inflammatory diseases.  Here, we focus on TLRs that hold the most promise for drug discovery research, highlighting agents that are in the discovery phase and in clin. trials, and on the emerging new aspects of TLR-mediated signaling - such as control by ubiquitination and regulation by microRNAs - that might offer further possibilities of therapeutic manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrGGa9XDou7Vg90H21EOLACvtfcHk0lizuH3cn9H35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D&md5=ed2da43668217c9d470f5a53dd214708</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3203%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DTargeting%2520Toll-like%2520Receptors%253A%2520Emerging%2520Therapeutics%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D293%26epage%3D307%26doi%3D10.1038%2Fnrd3203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshak-Rothstein, A.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors in Systemic Autoimmune Disease</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1038/nri1957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri1957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17063184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=823-835&author=A.+Marshak-Rothstein&title=Toll-like+Receptors+in+Systemic+Autoimmune+Disease&doi=10.1038%2Fnri1957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors in systemic autoimmune disease</span></div><div class="casAuthors">Marshak-Rothstein, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">823-835</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) have a crucial role in the early detection of pathogen-assocd. mol. patterns and the subsequent activation of the adaptive immune response.  Whether TLRs also have an important role in the recognition of endogenous ligands has been more controversial.  Numerous in vitro studies have documented activation of both autoreactive B cells and plasmacytoid dendritic cells by mammalian TLR ligands.  The issue of whether these in vitro observations translate to an in vivo role for TLRs in either the initiation or the progression of systemic autoimmune disease is a subject of intense research; data are beginning to emerge showing that this is the case.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ2AwllZLkmLVg90H21EOLACvtfcHk0lizuH3cn9H35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWns7fP&md5=03ad4120a1c7544c4a9693aa58665298</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnri1957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1957%26sid%3Dliteratum%253Aachs%26aulast%3DMarshak-Rothstein%26aufirst%3DA.%26atitle%3DToll-like%2520Receptors%2520in%2520Systemic%2520Autoimmune%2520Disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26spage%3D823%26epage%3D835%26doi%3D10.1038%2Fnri1957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Zayat, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibaii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannaa, F. A.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors Activation, Signaling, and Targeting: An Overview</span>. <i>Bull. Natl. Res. Cent.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>43</i></span>, <span class="NLM_elocation-id">187</span> <span class="refDoi"> DOI: 10.1186/s42269-019-0227-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1186%2Fs42269-019-0227-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2019&author=S.+R.+El-Zayatauthor=H.+Sibaiiauthor=F.+A.+Mannaa&title=Toll-like+Receptors+Activation%2C+Signaling%2C+and+Targeting%3A+An+Overview&doi=10.1186%2Fs42269-019-0227-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs42269-019-0227-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs42269-019-0227-2%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Zayat%26aufirst%3DS.%2BR.%26aulast%3DSibaii%26aufirst%3DH.%26aulast%3DMannaa%26aufirst%3DF.%2BA.%26atitle%3DToll-like%2520Receptors%2520Activation%252C%2520Signaling%252C%2520and%2520Targeting%253A%2520An%2520Overview%26jtitle%3DBull.%2520Natl.%2520Res.%2520Cent.%26date%3D2019%26volume%3D43%26doi%3D10.1186%2Fs42269-019-0227-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Recent Clinical Trends in Toll-like Receptor Targeting Therapeutics</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1002/med.21553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1002%2Fmed.21553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30450666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1053-1090&author=M.+A.+Anwarauthor=M.+Shahauthor=J.+Kimauthor=S.+Choi&title=Recent+Clinical+Trends+in+Toll-like+Receptor+Targeting+Therapeutics&doi=10.1002%2Fmed.21553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Recent clinical trends in Toll-like receptor targeting therapeutics</span></div><div class="casAuthors">Anwar, Muhammad Ayaz; Shah, Masaud; Kim, Jason; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1053-1090</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are germline-encoded receptors that are central to innate and adaptive immune responses.  Owing to their vital role in inflammation, TLRs are rational targets in clinics; thus, many ligands and biologics have been reported to overcome the progression of various inflammatory and malignant conditions and support the immune system.  For each TLR, at least one, and often many, drug formulations are being evaluated.  Ligands reported as stand-alone drugs may also be reported based on their use in combinatorial therapeutics as adjuvants.  Despite their profound efficacy in TLR-modulation in preclin. studies, multiple drugs have been terminated at different stages of clin. trials.  Here, TLR modulating drugs that have been evaluated in clin. trials are discussed, along with their mode of action, suggestive failure reasons, and ways to improve the clin. outcomes.  This review presents recent advances in TLR-targeting drugs and provides directions for more successful immune system manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk1adR2xVJUbVg90H21EOLACvtfcHk0lizuH3cn9H35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlGksbs%253D&md5=525a0020ddcf3bfd585e51a4f93e0265</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fmed.21553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21553%26sid%3Dliteratum%253Aachs%26aulast%3DAnwar%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DRecent%2520Clinical%2520Trends%2520in%2520Toll-like%2520Receptor%2520Targeting%2520Therapeutics%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1053%26epage%3D1090%26doi%3D10.1002%2Fmed.21553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregorio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nestle, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliet, M.</span></span> <span> </span><span class="NLM_article-title">Plasmacytoid Dendritic Cells Sense Self-DNA Coupled with Antimicrobial Peptide</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1038/nature06116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnature06116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17873860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2007&pages=564-569&author=R.+Landeauthor=J.+Gregorioauthor=V.+Facchinettiauthor=B.+Chatterjeeauthor=Y.-H.+Wangauthor=B.+Homeyauthor=W.+Caoauthor=Y.-H.+Wangauthor=B.+Suauthor=F.+O.+Nestleauthor=T.+Zalauthor=I.+Mellmanauthor=J.-M.+Schr%C3%B6derauthor=Y.-J.+Liuauthor=M.+Gilliet&title=Plasmacytoid+Dendritic+Cells+Sense+Self-DNA+Coupled+with+Antimicrobial+Peptide&doi=10.1038%2Fnature06116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide</span></div><div class="casAuthors">Lande, Roberto; Gregorio, Josh; Facchinetti, Valeria; Chatterjee, Bithi; Wang, Yi-Hong; Homey, Bernhard; Cao, Wei; Wang, Yui-Hsi; Su, Bing; Nestle, Frank O.; Zal, Tomasz; Mellman, Ira; Schroeder, Jens-Michael; Liu, Yong-Jun; Gilliet, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">7162</span>),
    <span class="NLM_cas:pages">564-569</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons.  PDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism.  Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin.  LL37 converts inert self-DNA into a potent trigger of interferon prodn. by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9.  Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ9AG-kAPprVg90H21EOLACvtfcHk0liEm7kSLmJS8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagtL7K&md5=4c443faee5b8f23612576e28d1a77f65</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature06116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06116%26sid%3Dliteratum%253Aachs%26aulast%3DLande%26aufirst%3DR.%26aulast%3DGregorio%26aufirst%3DJ.%26aulast%3DFacchinetti%26aufirst%3DV.%26aulast%3DChatterjee%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHomey%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DSu%26aufirst%3DB.%26aulast%3DNestle%26aufirst%3DF.%2BO.%26aulast%3DZal%26aufirst%3DT.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.-M.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DGilliet%26aufirst%3DM.%26atitle%3DPlasmacytoid%2520Dendritic%2520Cells%2520Sense%2520Self-DNA%2520Coupled%2520with%2520Antimicrobial%2520Peptide%26jtitle%3DNature%26date%3D2007%26volume%3D449%26spage%3D564%26epage%3D569%26doi%3D10.1038%2Fnature06116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregorio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamilos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebasigari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amuro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliet, M.</span></span> <span> </span><span class="NLM_article-title">Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">73ra19</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscitranslmed.3001180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=21389263" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=73ra19&author=R.+Landeauthor=D.+Gangulyauthor=V.+Facchinettiauthor=L.+Frascaauthor=C.+Conradauthor=J.+Gregorioauthor=S.+Mellerauthor=G.+Chamilosauthor=R.+Sebasigariauthor=V.+Riccieriauthor=R.+Bassettauthor=H.+Amuroauthor=S.+Fukuharaauthor=T.+Itoauthor=Y.-J.+Liuauthor=M.+Gilliet&title=Neutrophils+Activate+Plasmacytoid+Dendritic+Cells+by+Releasing+Self-DNA%E2%80%93Peptide+Complexes+in+Systemic+Lupus+Erythematosus&doi=10.1126%2Fscitranslmed.3001180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001180%26sid%3Dliteratum%253Aachs%26aulast%3DLande%26aufirst%3DR.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DFacchinetti%26aufirst%3DV.%26aulast%3DFrasca%26aufirst%3DL.%26aulast%3DConrad%26aufirst%3DC.%26aulast%3DGregorio%26aufirst%3DJ.%26aulast%3DMeller%26aufirst%3DS.%26aulast%3DChamilos%26aufirst%3DG.%26aulast%3DSebasigari%26aufirst%3DR.%26aulast%3DRiccieri%26aufirst%3DV.%26aulast%3DBassett%26aufirst%3DR.%26aulast%3DAmuro%26aufirst%3DH.%26aulast%3DFukuhara%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DGilliet%26aufirst%3DM.%26atitle%3DNeutrophils%2520Activate%2520Plasmacytoid%2520Dendritic%2520Cells%2520by%2520Releasing%2520Self-DNA%25E2%2580%2593Peptide%2520Complexes%2520in%2520Systemic%2520Lupus%2520Erythematosus%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D73ra19%26doi%3D10.1126%2Fscitranslmed.3001180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span> <span> </span><span class="NLM_article-title">Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum?</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.it.2017.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.it.2017.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=28826817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=28-43&author=D.+Ganguly&title=Do+Type+I+Interferons+Link+Systemic+Autoimmunities+and+Metabolic+Syndrome+in+a+Pathogenetic+Continuum%3F&doi=10.1016%2Fj.it.2017.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum?</span></div><div class="casAuthors">Ganguly, Dipyaman</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-43</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The central pathogenetic role of type I interferons (IFNs) in several systemic autoimmune diseases is well established.  Recent studies have also discovered a similar crucial role of type I IFNs in different components of metabolic disorders.  Self nucleic acid-driven Toll-like receptor (TLR) activation in plasmacytoid dendritic cells (pDCs) and type I IFN induction appear to be the key initiating events shared by most of these autoimmune and metabolic diseases.  Further strengthening this link, many patients with systemic autoimmunities also present with metabolic disorders.  This concurrence of autoimmunities and metabolic disorders may be explained by a single pathogenetic continuum, and suggests shared targets for potential new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR8KXQoS65GrVg90H21EOLACvtfcHk0liEm7kSLmJS8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7%252FN&md5=601d7487162333a517ad0d54804ec335</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2017.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2017.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DGanguly%26aufirst%3DD.%26atitle%3DDo%2520Type%2520I%2520Interferons%2520Link%2520Systemic%2520Autoimmunities%2520and%2520Metabolic%2520Syndrome%2520in%2520a%2520Pathogenetic%2520Continuum%253F%26jtitle%3DTrends%2520Immunol.%26date%3D2018%26volume%3D39%26spage%3D28%26epage%3D43%26doi%3D10.1016%2Fj.it.2017.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottenberg, J.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucchesi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letourneur, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazure, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ittah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepajolec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labetoulle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardizzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibilia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiocchia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariette, X.</span></span> <span> </span><span class="NLM_article-title">Activation of IFN Pathways and Plasmacytoid Dendritic Cell Recruitment in Target Organs of Primary Sjögren’s Syndrome</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2770</span>– <span class="NLM_lpage">2775</span>, <span class="refDoi"> DOI: 10.1073/pnas.0510837103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1073%2Fpnas.0510837103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=16477017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XksF2rt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2770-2775&author=J.-E.+Gottenbergauthor=N.+Cagnardauthor=C.+Lucchesiauthor=F.+Letourneurauthor=S.+Mistouauthor=T.+Lazureauthor=S.+Jacquesauthor=N.+Baauthor=M.+Ittahauthor=C.+Lepajolecauthor=M.+Labetoulleauthor=M.+Ardizzoneauthor=J.+Sibiliaauthor=C.+Fournierauthor=G.+Chiocchiaauthor=X.+Mariette&title=Activation+of+IFN+Pathways+and+Plasmacytoid+Dendritic+Cell+Recruitment+in+Target+Organs+of+Primary+Sj%C3%B6gren%E2%80%99s+Syndrome&doi=10.1073%2Fpnas.0510837103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome</span></div><div class="casAuthors">Gottenberg, Jacques-Eric; Cagnard, Nicolas; Lucchesi, Carlo; Letourneur, Franck; Mistou, Sylvie; Lazure, Thierry; Jacques, Sebastien; Ba, Nathalie; Ittah, Marc; Lepajolec, Christine; Labetoulle, Marc; Ardizzone, Marc; Sibilia, Jean; Fournier, Catherine; Chiocchia, Gilles; Mariette, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2770-2775</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gene expression anal. of target organs might help provide new insights into the pathogenesis of autoimmune diseases.  The authors used global gene expression profiling of minor salivary glands to identify patterns of gene expression in patients with primary Sjogren's syndrome (pSS), a common and prototypic systemic autoimmune disease.  Gene expression anal. allowed for differentiating most patients with pSS from controls.  The expression of 23 genes in the IFN pathways, including two Toll-like receptors (TLR8 and TLR9), was significantly different between patients and controls.  Furthermore, the increased expression of IFN-inducible genes, BAFF and IFN-induced transmembrane protein 1, was also demonstrated in ocular epithelial cells by quant. RT-PCR.  In vitro activation showed that these genes were effectively modulated by IFNs in salivary gland epithelial cells, the target cells of autoimmunity in pSS.  The activation of IFN pathways led the authors to investigate whether plasmacytoid dendritic cells were recruited in salivary glands.  These IFN-producing cells were detected by immunohistochem. in all patients with pSS, whereas none was obsd. in controls.  In conclusion, the authors' results support the pathogenic interaction between the innate and adaptive immune system in pSS.  The persistence of the IFN signature might be related to a vicious circle, in which the environment interacts with genetic factors to drive the stimulation of salivary TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprUrcXds1lqbVg90H21EOLACvtfcHk0lhHgrR6rulc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksF2rt7k%253D&md5=40acc8a756660663214994de86df4e3e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0510837103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0510837103%26sid%3Dliteratum%253Aachs%26aulast%3DGottenberg%26aufirst%3DJ.-E.%26aulast%3DCagnard%26aufirst%3DN.%26aulast%3DLucchesi%26aufirst%3DC.%26aulast%3DLetourneur%26aufirst%3DF.%26aulast%3DMistou%26aufirst%3DS.%26aulast%3DLazure%26aufirst%3DT.%26aulast%3DJacques%26aufirst%3DS.%26aulast%3DBa%26aufirst%3DN.%26aulast%3DIttah%26aufirst%3DM.%26aulast%3DLepajolec%26aufirst%3DC.%26aulast%3DLabetoulle%26aufirst%3DM.%26aulast%3DArdizzone%26aufirst%3DM.%26aulast%3DSibilia%26aufirst%3DJ.%26aulast%3DFournier%26aufirst%3DC.%26aulast%3DChiocchia%26aufirst%3DG.%26aulast%3DMariette%26aufirst%3DX.%26atitle%3DActivation%2520of%2520IFN%2520Pathways%2520and%2520Plasmacytoid%2520Dendritic%2520Cell%2520Recruitment%2520in%2520Target%2520Organs%2520of%2520Primary%2520Sj%25C3%25B6gren%25E2%2580%2599s%2520Syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D2770%26epage%3D2775%26doi%3D10.1073%2Fpnas.0510837103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mussari, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreekantha, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasunoori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schieven, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagore, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudhgaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyckman, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1758</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1751-1758&author=C.+P.+Mussariauthor=D.+S.+Doddauthor=R.+K.+Sreekanthaauthor=L.+Pasunooriauthor=H.+Wanauthor=S.+L.+Posyauthor=D.+Crittonauthor=S.+Rueppauthor=M.+Subramanianauthor=A.+Watsonauthor=P.+Daviesauthor=G.+L.+Schievenauthor=L.+M.+Salter-Cidauthor=R.+Srivastavaauthor=D.+M.+Tagoreauthor=S.+Dudhgaonkarauthor=M.+A.+Possauthor=P.+H.+Carterauthor=A.+J.+Dyckman&title=Discovery+of+Potent+and+Orally+Bioavailable+Small+Molecule+Antagonists+of+Toll-like+Receptors+7%2F8%2F9+%28TLR7%2F8%2F9%29&doi=10.1021%2Facsmedchemlett.0c00264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)</span></div><div class="casAuthors">Mussari, Christopher P.; Dodd, Dharmpal S.; Sreekantha, Ratna Kumar; Pasunoori, Laxman; Wan, Honghe; Posy, Shana L.; Critton, David; Ruepp, Stefan; Subramanian, Murali; Watson, Andrew; Davies, Paul; Schieven, Gary L.; Salter-Cid, Luisa M.; Srivastava, Ratika; Tagore, Debarati Mazumder; Dudhgaonkar, Shailesh; Poss, Michael A.; Carter, Percy H.; Dyckman, Alaric J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1751-1758</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The toll-like receptor (TLR) family is an evolutionarily conserved component of the innate immune system, responsible for the early detection of foreign or endogenous threat signals.  In the context of autoimmunity, the unintended recognition of self-motifs as foreign promotes initiation or propagation of disease.  Overactivation of TLR7 and TLR9 have been implicated as factors contributing to autoimmune disorders such as psoriasis, arthritis, and lupus.  In our search for small mol. antagonists of TLR7/9, 7f(I) was identified as possessing excellent on-target potency for human TLR7/9 as well as for TLR8, with selectivity against other representative TLR family members.  Good pharmacokinetic properties and a relatively balanced potency against TLR7 and TLR9 in mouse systems (systems which lack functional TLR8) made this an excellent in vivo tool compd., and efficacy from oral dosing in preclin. models of autoimmune disease was demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ZnIBuI6cJbVg90H21EOLACvtfcHk0lhHgrR6rulc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7fI&md5=6b8f4eab4c86da189fd4357399968bf6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00264%26sid%3Dliteratum%253Aachs%26aulast%3DMussari%26aufirst%3DC.%2BP.%26aulast%3DDodd%26aufirst%3DD.%2BS.%26aulast%3DSreekantha%26aufirst%3DR.%2BK.%26aulast%3DPasunoori%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DH.%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DCritton%26aufirst%3DD.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DSubramanian%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DSrivastava%26aufirst%3DR.%26aulast%3DTagore%26aufirst%3DD.%2BM.%26aulast%3DDudhgaonkar%26aufirst%3DS.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Orally%2520Bioavailable%2520Small%2520Molecule%2520Antagonists%2520of%2520Toll-like%2520Receptors%25207%252F8%252F9%2520%2528TLR7%252F8%252F9%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1751%26epage%3D1758%26doi%3D10.1021%2Facsmedchemlett.0c00264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshak-Rothstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rifkin, I. R.</span></span> <span> </span><span class="NLM_article-title">Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.22.012703.104514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1146%2Fannurev.immunol.22.012703.104514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17378763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlansr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=419-441&author=A.+Marshak-Rothsteinauthor=I.+R.+Rifkin&title=Immunologically+Active+Autoantigens%3A+The+Role+of+Toll-Like+Receptors+in+the+Development+of+Chronic+Inflammatory+Disease&doi=10.1146%2Fannurev.immunol.22.012703.104514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease</span></div><div class="casAuthors">Marshak-Rothstein, Ann; Rifkin, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">419-441</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Pattern recognition receptors (PRRs), expressed on cells of both the innate and adaptive immune systems, serve as sentinels, waiting to alert the host to the first signs of microbial infection and to activate the initial line of immune defense.  Research has increasingly demonstrated that many of the same PRRs also recognize self-epitopes that either are released from dying or damaged cells or are present at the surface of apoptotic cells or apoptotic bodies.  In this context, PRRs play a crit. role in tissue repair and the clearance of cellular debris.  However, failure to appropriately regulate self-responses triggered by certain PRRs can have serious pathol. consequences.  The Toll-like receptor (TLR) gene family represents a case in point.  TLR7, 8, and 9 were originally identified as receptors specific for bacterial and viral RNA and DNA, but more recent in vitro and in vivo studies have now linked these receptors to the detection of host RNA, DNA, and RNA- or DNA-assocd. proteins.  In this context, they likely play a key role in the development of systemic autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7agsRPL1cVrVg90H21EOLACvtfcHk0lhHgrR6rulc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlansr0%253D&md5=70353a067134a4fecce7b4b5aa43bd10</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.22.012703.104514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.22.012703.104514%26sid%3Dliteratum%253Aachs%26aulast%3DMarshak-Rothstein%26aufirst%3DA.%26aulast%3DRifkin%26aufirst%3DI.%2BR.%26atitle%3DImmunologically%2520Active%2520Autoantigens%253A%2520The%2520Role%2520of%2520Toll-Like%2520Receptors%2520in%2520the%2520Development%2520of%2520Chronic%2520Inflammatory%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D25%26spage%3D419%26epage%3D441%26doi%3D10.1146%2Fannurev.immunol.22.012703.104514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balak, D. M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doorn, M. B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbeit, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijneveld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brevard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thio, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prens, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burggraaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rissmann, R.</span></span> <span> </span><span class="NLM_article-title">IMO-8400, a Toll-like Receptor 7, 8, and 9 Antagonist, Demonstrates Clinical Activity in a Phase 2a, Randomized, Placebo-Controlled Trial in Patients with Moderate-to-Severe Plaque Psoriasis</span>. <i>Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.clim.2016.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.clim.2016.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27876460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWltrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=63-72&author=D.+M.+W.+Balakauthor=M.+B.+A.+van+Doornauthor=R.+D.+Arbeitauthor=R.+Rijneveldauthor=E.+Klaassenauthor=T.+Sullivanauthor=J.+Brevardauthor=H.+B.+Thioauthor=E.+P.+Prensauthor=J.+Burggraafauthor=R.+Rissmann&title=IMO-8400%2C+a+Toll-like+Receptor+7%2C+8%2C+and+9+Antagonist%2C+Demonstrates+Clinical+Activity+in+a+Phase+2a%2C+Randomized%2C+Placebo-Controlled+Trial+in+Patients+with+Moderate-to-Severe+Plaque+Psoriasis&doi=10.1016%2Fj.clim.2016.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis</span></div><div class="casAuthors">Balak, Deepak M. W.; van Doorn, Martijn B. A.; Arbeit, Robert D.; Rijneveld, Rianne; Klaassen, Erica; Sullivan, Tim; Brevard, Julie; Thio, Hok Bing; Prens, Errol P.; Burggraaf, Jacobus; Rissmann, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aberrant toll-like receptors (TLRs) 7, 8, and 9 activation by self-nucleic acids is implicated in immune-mediated inflammatory diseases (IMIDs) such as psoriasis.  In preclin. IMID models, blocking TLR-activation reduced disease severity.  IMO-8400 is a first-in-class, oligonucleotide-based antagonist of TLRs 7, 8, and 9.  We evaluated the short-term safety and proof-of-concept for efficacy of IMO-8400 in a first-in-patient phase 2 trial.  Forty-six psoriasis patients were randomly assigned to IMO-8400 in four dose levels or placebo for 12 wk.  Post-treatment follow-up was seven weeks.  Primary outcome was incidence of adverse events.  Secondary, exploratory outcomes included changes in psoriasis area and severity index (PASI).  IMO-8400 across all dose levels did not cause any serious or severe adverse events.  The most common treatment-related adverse events were dose-dependent injection-site reactions.  All IMO-8400 groups showed clin. improvement, but a clear dose-response relationship and statistically significant differences with placebo were not obsd. (P = 0.26).  Eleven (38%) of 29 subjects on IMO-8400 achieved ≥ 50% PASI-redn., compared to 1 (11%) of 9 subjects on placebo.  Five (17%) and 2 (7%) IMO-8400-treated subjects achieved PASI-75 and PASI-90, resp., compared to none on placebo.  Short-term IMO-8400-treatment was well tolerated and reduced psoriasis severity.  These findings warrant further investigation of endosomal TLR-antagonism as a therapeutic approach in psoriasis and other TLR-mediated IMIDs.  EudraCT 2013-000164-28 and Clinicaltrials.govNCT01899729.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUsKfTdCLFo7Vg90H21EOLACvtfcHk0li5XFebxbgsCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWltrbM&md5=0444bf4c23f31f9c67cd385311fc7152</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2016.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2016.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DBalak%26aufirst%3DD.%2BM.%2BW.%26aulast%3Dvan%2BDoorn%26aufirst%3DM.%2BB.%2BA.%26aulast%3DArbeit%26aufirst%3DR.%2BD.%26aulast%3DRijneveld%26aufirst%3DR.%26aulast%3DKlaassen%26aufirst%3DE.%26aulast%3DSullivan%26aufirst%3DT.%26aulast%3DBrevard%26aufirst%3DJ.%26aulast%3DThio%26aufirst%3DH.%2BB.%26aulast%3DPrens%26aufirst%3DE.%2BP.%26aulast%3DBurggraaf%26aufirst%3DJ.%26aulast%3DRissmann%26aufirst%3DR.%26atitle%3DIMO-8400%252C%2520a%2520Toll-like%2520Receptor%25207%252C%25208%252C%2520and%25209%2520Antagonist%252C%2520Demonstrates%2520Clinical%2520Activity%2520in%2520a%2520Phase%25202a%252C%2520Randomized%252C%2520Placebo-Controlled%2520Trial%2520in%2520Patients%2520with%2520Moderate-to-Severe%2520Plaque%2520Psoriasis%26jtitle%3DClin.%2520Immunol.%26date%3D2017%26volume%3D174%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.clim.2016.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Modulators of Toll-like Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6621</span>– <span class="NLM_lpage">6626</span>, <span class="refDoi"> DOI: 10.1021/jm800957k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800957k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SjtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6621-6626&author=M.+Czarniecki&title=Small+Molecule+Modulators+of+Toll-like+Receptors&doi=10.1021%2Fjm800957k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Toll-like Receptors</span></div><div class="casAuthors">Czarniecki, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6621-6626</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO6dCcRAY7FrVg90H21EOLACvtfcHk0li5XFebxbgsCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SjtL%252FF&md5=34a9045c921277f673155333c299c8d6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm800957k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800957k%26sid%3Dliteratum%253Aachs%26aulast%3DCzarniecki%26aufirst%3DM.%26atitle%3DSmall%2520Molecule%2520Modulators%2520of%2520Toll-like%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6621%26epage%3D6626%26doi%3D10.1021%2Fjm800957k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomizawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrrolo[2,3-d]Pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1235</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1021/ml5003184</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5003184" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OktLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1235-1239&author=M.+Watanabeauthor=M.+Kasaiauthor=H.+Tomizawaauthor=M.+Aokiauthor=K.+Eihoauthor=Y.+Isobeauthor=S.+Asano&title=Dihydropyrrolo%5B2%2C3-d%5DPyrimidines%3A+Selective+Toll-Like+Receptor+9+Antagonists+from+Scaffold+Morphing+Efforts&doi=10.1021%2Fml5003184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts</span></div><div class="casAuthors">Watanabe, Manabu; Kasai, Mai; Tomizawa, Hideyuki; Aoki, Masamitsu; Eiho, Kazuo; Isobe, Yoshiaki; Asano, Shigehiro</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1235-1239</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptors (TLRs) play important roles in the innate immune system.  In fact, recognition of endogenous immune complexes contg. self-nucleic acids as pathogen- or damage-assocd. mol. patterns contributes to certain autoimmune diseases, and inhibition of these recognition signals is expected to have therapeutic value.  The authors identified dihydropyrrolo[2,3-d]pyrimidines as novel selective TLR9 antagonists with high aq. soly.  A structure-activity relationship study of a known TLR9 antagonist led to the promising compd. I, which showed potent TLR9 antagonistic activity, sufficient aq. soly. for parenteral formulation, and druggable properties.  Compd. I suppressed the prodn. of the proinflammatory cytokine IL-6 in CpG-induced mouse model.  It is therefore believed that compd. I has great potential in the treatment of TLR9-mediated systemic uncontrollable inflammatory response like sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZdDe1jE6qibVg90H21EOLACvtfcHk0li5XFebxbgsCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OktLrJ&md5=b87ca0f44cc12f46fd2d640b9bd6aa50</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fml5003184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5003184%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DKasai%26aufirst%3DM.%26aulast%3DTomizawa%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DEiho%26aufirst%3DK.%26aulast%3DIsobe%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DS.%26atitle%3DDihydropyrrolo%255B2%252C3-d%255DPyrimidines%253A%2520Selective%2520Toll-Like%2520Receptor%25209%2520Antagonists%2520from%2520Scaffold%2520Morphing%2520Efforts%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1235%26epage%3D1239%26doi%3D10.1021%2Fml5003184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahaman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maithri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">Design and Development of Benzoxazole Derivatives with Toll-like Receptor 9 Antagonism</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ejmech.2017.03.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=28437629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFegs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=334-347&author=S.+Royauthor=A.+Mukherjeeauthor=B.+Paulauthor=O.+Rahamanauthor=S.+Royauthor=G.+Maithriauthor=B.+Ramyaauthor=S.+Palauthor=D.+Gangulyauthor=A.+Talukdar&title=Design+and+Development+of+Benzoxazole+Derivatives+with+Toll-like+Receptor+9+Antagonism&doi=10.1016%2Fj.ejmech.2017.03.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism</span></div><div class="casAuthors">Roy, Swarnali; Mukherjee, Ayan; Paul, Barnali; Rahaman, Oindrila; Roy, Shounak; Maithri, Gundaram; Ramya, Bandaru; Pal, Sourav; Ganguly, Dipyaman; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">334-347</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Toll-like receptor 9 (TLR9) is a major therapeutic target for numerous inflammatory disorders.  Development of small mol. inhibitors for TLR9 remains largely empirical due to lack of structural understanding of potential TLR9 antagonism by small mols. and due to the unusual topol. of the ligand binding surface of the receptor.  To develop a structural model for rational design of small mol. TLR9 antagonists, an enhanced homol. model of human TLR9 (hTLR9) was constructed.  Binding mode anal. of a series of mols. having characteristic mol. geometry, flexibility and basicity was conducted based on crystal structure of the inhibitory DNA (iDNA) bound to horse and bovine TLR9.  Interaction with specific amino acid residues in four leucine rich repeat (LRR) regions of TLR9 was identified to be crit. for antagonism by small mols.  The biol. validation of TLR9 antagonism and its correlation with probe-receptor interactions led to a reliable model that could be used for development of novel small mols. with potent TLR9 antagonism (IC50 30-100 nM) with excellent selectivity against TLR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT-5vh1WjBNbVg90H21EOLACvtfcHk0lizlVxfyCqibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFegs74%253D&md5=b5cc469bdd3ce063020126f6402bba5a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.086%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DRahaman%26aufirst%3DO.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMaithri%26aufirst%3DG.%26aulast%3DRamya%26aufirst%3DB.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DDesign%2520and%2520Development%2520of%2520Benzoxazole%2520Derivatives%2520with%2520Toll-like%2520Receptor%25209%2520Antagonism%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D334%26epage%3D347%26doi%3D10.1016%2Fj.ejmech.2017.03.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahaman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satish, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">Activity-Guided Development of Potent and Selective Toll-like Receptor 9 Antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ejmech.2018.09.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30292896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKntbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=187-205&author=B.+Paulauthor=O.+Rahamanauthor=S.+Royauthor=S.+Palauthor=S.+Satishauthor=A.+Mukherjeeauthor=A.+R.+Ghoshauthor=D.+Raychaudhuriauthor=R.+Bhattacharyaauthor=S.+Goonauthor=D.+Gangulyauthor=A.+Talukdar&title=Activity-Guided+Development+of+Potent+and+Selective+Toll-like+Receptor+9+Antagonists&doi=10.1016%2Fj.ejmech.2018.09.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-guided development of potent and selective toll-like receptor 9 antagonists</span></div><div class="casAuthors">Paul, Barnali; Rahaman, Oindrila; Roy, Swarnali; Pal, Sourav; Satish, Sohal; Mukherjee, Ayan; Ghosh, Amrit R.; Raychaudhuri, Deblina; Bhattacharya, Roopkatha; Goon, Sunny; Ganguly, Dipyaman; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187-205</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">TLR9 is one of the major innate immune receptors expressed in the endosomes of pDCs and B cells in humans.  Aberrant TLR9 activation is implicated in several autoimmune and metabolic disorders as well as in sepsis, making this receptor an important therapeutic target, though specific TLR9 antagonists are yet to be available for clin. use.  Here we elucidate the importance of specific physiochem. properties through substitution patterns in quinazoline scaffold to achieve potent hTLR9 inhibition at < 50 nM as well as > 600 fold selectivity against hTLR7, another closely related TLR that shares downstream signaling with TLR9 but plays distinct roles in physiol. and pathol.  Assays were performed using hPBMC and reporter cell lines.  Favorable in vitro ADME profile, pharmacokinetics as well as validation in a clin. relevant in vivo TLR9-inhibition efficacy model in mice establish these novel TLR9-antagonists as candidate therapeutic agents in relevant clin. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqSBumxFqKbVg90H21EOLACvtfcHk0lizlVxfyCqibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKntbbL&md5=2b30577538a603af0204de5edaf3f6cb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.058%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DRahaman%26aufirst%3DO.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DSatish%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DA.%2BR.%26aulast%3DRaychaudhuri%26aufirst%3DD.%26aulast%3DBhattacharya%26aufirst%3DR.%26aulast%3DGoon%26aufirst%3DS.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DActivity-Guided%2520Development%2520of%2520Potent%2520and%2520Selective%2520Toll-like%2520Receptor%25209%2520Antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D159%26spage%3D187%26epage%3D205%26doi%3D10.1016%2Fj.ejmech.2018.09.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamphier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyvee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genest, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mempel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twine, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusovsky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaka, S. T.</span></span> <span> </span><span class="NLM_article-title">Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy In Vivo</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1124%2Fmol.113.089821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24342772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=429-440&author=M.+Lamphierauthor=W.+Zhengauthor=E.+Latzauthor=M.+Spyveeauthor=H.+Hansenauthor=J.+Roseauthor=M.+Genestauthor=H.+Yangauthor=C.+Shafferauthor=Y.+Zhaoauthor=Y.+Shenauthor=C.+Liuauthor=D.+Liuauthor=T.+R.+Mempelauthor=C.+Rowbottomauthor=J.+Chowauthor=N.+C.+Twineauthor=M.+Yuauthor=F.+Gusovskyauthor=S.+T.+Ishizaka&title=Novel+Small+Molecule+Inhibitors+of+TLR7+and+TLR9%3A+Mechanism+of+Action+and+Efficacy+In+Vivo&doi=10.1124%2Fmol.113.089821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo</span></div><div class="casAuthors">Lamphier, Marc; Zheng, Wanjun; Latz, Eicke; Spyvee, Mark; Hansen, Hans; Rose, Jeffrey; Genest, Melinda; Yang, Hua; Shaffer, Christina; Zhao, Yan; Shen, Yongchun; Liu, Carrie; Liu, Diana; Mempel, Thorsten R.; Rowbottom, Christopher; Chow, Jesse; Twine, Natalie C.; Yu, Melvin; Gusovsky, Fabian; Ishizaka, Sally T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-440, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The discovery that circulating nucleic acid-contg. complexes in the serum of autoimmune lupus patients can stimulate B cells and plasmacytoid dendritic cells via Toll-like receptors 7 and 9 suggested that agents that block these receptors might be useful therapeutics.  We identified two compds., AT791 {3-[4-(6-(3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropan-1-amine} and E6446 {6-[3-(pyrrolidin-1-yl)propoxy)-2-(4-(3-(pyrrolidin-yl)propoxy)phenyl]benzo[d]oxazole}, that inhibit Toll-like receptor (TLR)7 and 9 signaling in a variety of human and mouse cell types and inhibit DNA-TLR9 interaction in vitro.  When administered to mice, these compds. suppress responses to challenge doses of cytidine-phosphate-guanidine (CpG)-contg. DNA, which stimulates TLR9.  When given chronically in spontaneous mouse lupus models, E6446 slowed development of circulating antinuclear antibodies and had a modest effect on anti-double-stranded DNA titers but showed no observable impact on proteinuria or mortality.  We discovered that the ability of AT791 and E6446 to inhibit TLR7 and 9 signaling depends on two properties: weak interaction with nucleic acids and high accumulation in the intracellular acidic compartments where TLR7 a nd 9 reside.  Binding of the compds. to DNA prevents DNA-TLR9 interaction in vitro and modulates signaling in vivo.  Our data also confirm an earlier report that this same mechanism may explain inhibition of TLR7 and 9 signaling by hydroxychloroquine (Plaquenil), a drug commonly prescribed to treat lupus.  Thus, very different structural classes of mols. can inhibit endosomal TLRs by essentially identical mechanisms of action, suggesting a general mechanism for targeting this group of TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIxcZmhieLrLVg90H21EOLACvtfcHk0lizlVxfyCqibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D&md5=ad98c0ad97065795983540f5caa2b4a5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089821%26sid%3Dliteratum%253Aachs%26aulast%3DLamphier%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DSpyvee%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DRose%26aufirst%3DJ.%26aulast%3DGenest%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DShaffer%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMempel%26aufirst%3DT.%2BR.%26aulast%3DRowbottom%26aufirst%3DC.%26aulast%3DChow%26aufirst%3DJ.%26aulast%3DTwine%26aufirst%3DN.%2BC.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DGusovsky%26aufirst%3DF.%26aulast%3DIshizaka%26aufirst%3DS.%2BT.%26atitle%3DNovel%2520Small%2520Molecule%2520Inhibitors%2520of%2520TLR7%2520and%2520TLR9%253A%2520Mechanism%2520of%2520Action%2520and%2520Efficacy%2520In%2520Vivo%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D429%26epage%3D440%26doi%3D10.1124%2Fmol.113.089821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutz, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malladi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshakoon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S. A.</span></span> <span> </span><span class="NLM_article-title">Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1021/jm2010207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1106-1116&author=N.+M.+Shuklaauthor=C.+A.+Mutzauthor=S.+S.+Malladiauthor=H.+J.+Warshakoonauthor=R.+Balakrishnaauthor=S.+A.+David&title=Toll-Like+Receptor+%28TLR%29-7+and+-8+Modulatory+Activities+of+Dimeric+Imidazoquinolines&doi=10.1021%2Fjm2010207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines</span></div><div class="casAuthors">Shukla, Nikunj M.; Mutz, Cole A.; Malladi, Subbalakshmi S.; Warshakoon, Hemamali J.; Balakrishna, Rajalakshmi; David, Sunil A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1106-1116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptors (TLRs) are pattern recognition receptors that recognize specific mol. patterns present in mols. that are broadly shared by pathogens but are structurally distinct from host mols.  The TLR7-agonistic imidazoquinolines are of interest as vaccine adjuvants given their ability to induce pronounced Th1-skewed humoral responses.  Minor modifications on the imidazoquinoline scaffold result in TLR7-antagonistic compds. which may be of value in addressing innate immune activation-driven immune exhaustion obsd. in HIV.  The syntheses and evaluation of TLR7 and TLR8 modulatory activities of dimeric constructs of imidazoquinoline linked at the C2, C4, C8, and N1-aryl positions, e.g., I, is described in this paper.  Dimers linked at the C4, C8, and N1-aryl positions were agonistic at TLR7; only the N1-aryl dimer with a 12-carbon linker was dual TLR7/8 agonistic.  Dimers linked at C2 position showed antagonistic activities at TLR7 and TLR8; the C2 dimer with a propylene spacer was maximally antagonistic at both TLR7 and TLR8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruL0YQd4ocfrVg90H21EOLACvtfcHk0liAo05LE73Amg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktw%253D%253D&md5=8885b3446c7fcf5058d5a45c48112524</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm2010207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010207%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DN.%2BM.%26aulast%3DMutz%26aufirst%3DC.%2BA.%26aulast%3DMalladi%26aufirst%3DS.%2BS.%26aulast%3DWarshakoon%26aufirst%3DH.%2BJ.%26aulast%3DBalakrishna%26aufirst%3DR.%26aulast%3DDavid%26aufirst%3DS.%2BA.%26atitle%3DToll-Like%2520Receptor%2520%2528TLR%2529-7%2520and%2520-8%2520Modulatory%2520Activities%2520of%2520Dimeric%2520Imidazoquinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1106%26epage%3D1116%26doi%3D10.1021%2Fjm2010207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandopadhyay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4776</span>– <span class="NLM_lpage">4789</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsVylu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4776-4789&author=A.+Mukherjeeauthor=D.+Raychaudhuriauthor=B.+P.+Sinhaauthor=B.+Kunduauthor=M.+Mitraauthor=B.+Paulauthor=P.+Bandopadhyayauthor=D.+Gangulyauthor=A.+Talukdar&title=A+Chemical+Switch+for+Transforming+a+Purine+Agonist+for+Toll-like+Receptor+7+to+a+Clinically+Relevant+Antagonist&doi=10.1021%2Facs.jmedchem.0c00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist</span></div><div class="casAuthors">Mukherjee, Ayan; Raychaudhuri, Deblina; Sinha, Bishnu Prasad; Kundu, Biswajit; Mitra, Mousumi; Paul, Barnali; Bandopadhyay, Purbita; Ganguly, Dipyaman; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4776-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is an established therapeutic target in myriad autoimmune disorders, but no TLR7 antagonist is available for clin. use to date.  Herein, we report a purine scaffold TLR7 antagonist, first-of-its-kind to our knowledge, which was developed by rationally dissecting the structural requirements for TLR7-targeted activity for a purine scaffold.  Specifically, we identified a singular chem. switch at C-2 that could make a potent purine scaffold TLR7 agonist to lose agonism and acquire antagonist activity, which could further be potentiated by the introduction of an addnl. basic center at C-6.  We ended up developing a clin. relevant TLR7 antagonist with favorable pharmacokinetics and 70.8% oral bioavailability in mice.  Moreover, the TLR7 antagonists depicted excellent selectivity against TLR8.  To further validate the in vivo applicability of this novel TLR7 antagonist, we demonstrated its excellent efficacy in preventing TLR7-induced pathol. in a preclin. murine model of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3YXtgyg7cHbVg90H21EOLACvtfcHk0liAo05LE73Amg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsVylu7o%253D&md5=d58504ff58f6e8a4636cc258384296a7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00011%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DRaychaudhuri%26aufirst%3DD.%26aulast%3DSinha%26aufirst%3DB.%2BP.%26aulast%3DKundu%26aufirst%3DB.%26aulast%3DMitra%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DBandopadhyay%26aufirst%3DP.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DA%2520Chemical%2520Switch%2520for%2520Transforming%2520a%2520Purine%2520Agonist%2520for%2520Toll-like%2520Receptor%25207%2520to%2520a%2520Clinically%2520Relevant%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4776%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.0c00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, M. J.</span></span> <span> </span><span class="NLM_article-title">Regiospecific N9 Alkylation of 6-(Heteroaryl)Purines: Shielding of N7 by a Proximal Heteroaryl C–H1</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">8901</span>– <span class="NLM_lpage">8906</span>, <span class="refDoi"> DOI: 10.1021/jo061759h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo061759h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyntbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=8901-8906&author=M.+Zhongauthor=M.+J.+Robins&title=Regiospecific+N9+Alkylation+of+6-%28Heteroaryl%29Purines%3A+Shielding+of+N7+by+a+Proximal+Heteroaryl+C%E2%80%93H1&doi=10.1021%2Fjo061759h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Regiospecific N9 Alkylation of 6-(Heteroaryl)purines: Shielding of N7 by a Proximal Heteroaryl C-H1</span></div><div class="casAuthors">Zhong, Minghong; Robins, Morris J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8901-8906</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-(Heteroaryl)-9-alkylpurines, e.g., I, were prepd. by regiospecific N-alkylation of 6-(heteroaryl)purines, e.g., II, with alkyl iodides under alk. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryZspAetdyTbVg90H21EOLACvtfcHk0liAo05LE73Amg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyntbvO&md5=e7b532ab482b2dd1be36d3ecb9360fbf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo061759h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061759h%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DRobins%26aufirst%3DM.%2BJ.%26atitle%3DRegiospecific%2520N9%2520Alkylation%2520of%25206-%2528Heteroaryl%2529Purines%253A%2520Shielding%2520of%2520N7%2520by%2520a%2520Proximal%2520Heteroaryl%2520C%25E2%2580%2593H1%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D8901%26epage%3D8906%26doi%3D10.1021%2Fjo061759h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuMontelle, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolodz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozier, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B.</span></span> <span> </span><span class="NLM_article-title">Use of Toll-Like Receptor Assays To Detect and Identify Microbial Contaminants in Biological Products</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3427</span>– <span class="NLM_lpage">3434</span>, <span class="refDoi"> DOI: 10.1128/JCM.00373-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1128%2FJCM.00373-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=19726599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFems77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=3427-3434&author=L.-Y.+Huangauthor=J.+L.+DuMontelleauthor=M.+Zolodzauthor=A.+Deoraauthor=N.+M.+Mozierauthor=B.+Golding&title=Use+of+Toll-Like+Receptor+Assays+To+Detect+and+Identify+Microbial+Contaminants+in+Biological+Products&doi=10.1128%2FJCM.00373-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Use of toll-like receptor assays to detect and identify microbial contaminants in biological products</span></div><div class="casAuthors">Huang, Li-Yun; Du Montelle, James L.; Zolodz, Melissa; Deora, Aparna; Mozier, Ned M.; Golding, Basil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3427-3434</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR)-expressing cells, for the first time, detected and identified a microbial contaminant in a product made in Escherichia coli using an old manufg. process.  It was suspected of having a microbial contaminant(s) because, although it tested neg. by std. pyrogen assays, it was assocd. with adverse events in early clin. trials.  The assay readout is the induction of NF-κB and/or cytokines in response to TLR activation.  Four coded samples, labeled A to D, including a sample prepd. by the older manufg. process, were submitted.  The cell lines were activated only by samples B and D.  Sample D stimulated only Mono-Mac 6 and HEK-human TLR4 (hTLR4) cells and was later identified as lipopolysaccharide.  Except for TLR3 cells, sample B stimulated cells bearing the different TLRs (TLRs 2, 4, 5, 7, 8, and 9) and nontransfected HEK293 cells.  These data suggested that flagellin was the microbial contaminant, since TLR5, the receptor for flagellin, is known to be expressed constitutively on HEK293 cells.  Moreover, purified flagellin from Salmonella enterica serovar Typhimurium behaved like sample B, stimulating HEK293 and HEK-hTLR5 cells but not HEK-hTLR3 cells, and this stimulation by flagellin and sample B was blocked by an anti-hTLR5 neutralizing antibody.  Western blots showed bands pos. for flagellin and sample B with the mol. sizes expected for the flagellins from S. Typhimurium and E. coli, resp.  Mass spectrometry data were consistent with the presence of flagellin in the manufacturer's sample B.  Taken together, these data indicate that the microbial contaminant in sample B was flagellin and may have been assocd. with adverse events when the recombinant product was administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm4mkpG3s3i7Vg90H21EOLACvtfcHk0liAo05LE73Amg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFems77M&md5=243ef257297cbd2ba61be7c4de9c1c60</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FJCM.00373-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00373-09%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.-Y.%26aulast%3DDuMontelle%26aufirst%3DJ.%2BL.%26aulast%3DZolodz%26aufirst%3DM.%26aulast%3DDeora%26aufirst%3DA.%26aulast%3DMozier%26aufirst%3DN.%2BM.%26aulast%3DGolding%26aufirst%3DB.%26atitle%3DUse%2520of%2520Toll-Like%2520Receptor%2520Assays%2520To%2520Detect%2520and%2520Identify%2520Microbial%2520Contaminants%2520in%2520Biological%2520Products%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2009%26volume%3D47%26spage%3D3427%26epage%3D3434%26doi%3D10.1128%2FJCM.00373-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in the Development of Toll-like Receptor (TLR) Antagonists</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1185415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1080%2F13543776.2016.1185415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27136061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=719-730&author=M.+C.+Patraauthor=S.+Choi&title=Recent+Progress+in+the+Development+of+Toll-like+Receptor+%28TLR%29+Antagonists&doi=10.1080%2F13543776.2016.1185415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of Toll-like receptor (TLR) antagonists</span></div><div class="casAuthors">Patra, Mahesh Chandra; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Pattern recognition receptors (PRRs) of the innate immune system mediate and control the activation and progression of adaptive immunity.  Toll-like receptors (TLRs) are the most notable of the PRRs: they play crucial roles in protecting the host body against invading pathogens or endogenously released hazardous mols.  Sustained TLR signaling even after the clearance of pathogens or failure to distinguish between 'self' and 'non-self' mols. can cause inflammatory disorders, autoimmune diseases, and cancer.  This review focuses on recently developed therapeutic agents with TLR-antagonistic activities.  In recent years, several research institutes and pharmaceutical companies have achieved fundamental successes in inhibiting or reducing TLR signaling and assocd. effector mechanisms by using novel inhibitors.  These inhibitory mols. include antibodies against TLRs, TLR-derived transmembrane (TM) peptides, bacterial-secreted proteins, and natural or synthetic small mols., peptides, and proteins.  Antagonist developers generally target the TLR ectodomain to block receptor activation.  The TM and cytosolic Toll/IL-1 receptor domains also have regions that should be explored for the design of peptide-based and small mol. blocking agents.  A no. of preclin. and clin. breakthroughs may result in the availability of improved TLR immunomodulatory drugs to address important unmet medical needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbKGU6yn83rVg90H21EOLACvtfcHk0lhh1-3GjvbK1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D&md5=11a223116a4186220fecbd19a4377cd6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1185415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1185415%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%2BC.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Toll-like%2520Receptor%2520%2528TLR%2529%2520Antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D719%26epage%3D730%26doi%3D10.1080%2F13543776.2016.1185415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akilesh, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presnell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkon, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacy-Hulbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamerman, J. A.</span></span> <span> </span><span class="NLM_article-title">Chronic TLR7 and TLR9 Signaling Drives Anemia via Differentiation of Specialized Hemophagocytes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>363</i></span>, <span class="NLM_elocation-id">eaao5213</span> <span class="refDoi"> DOI: 10.1126/science.aao5213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscience.aao5213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30630901" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2019&author=H.+M.+Akileshauthor=M.+B.+Buechlerauthor=J.+M.+Dugganauthor=W.+O.+Hahnauthor=B.+Mattaauthor=X.+Sunauthor=G.+Gessayauthor=E.+Whalenauthor=M.+Masonauthor=S.+R.+Presnellauthor=K.+B.+Elkonauthor=A.+Lacy-Hulbertauthor=B.+J.+Barnesauthor=M.+Pepperauthor=J.+A.+Hamerman&title=Chronic+TLR7+and+TLR9+Signaling+Drives+Anemia+via+Differentiation+of+Specialized+Hemophagocytes&doi=10.1126%2Fscience.aao5213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.aao5213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aao5213%26sid%3Dliteratum%253Aachs%26aulast%3DAkilesh%26aufirst%3DH.%2BM.%26aulast%3DBuechler%26aufirst%3DM.%2BB.%26aulast%3DDuggan%26aufirst%3DJ.%2BM.%26aulast%3DHahn%26aufirst%3DW.%2BO.%26aulast%3DMatta%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DGessay%26aufirst%3DG.%26aulast%3DWhalen%26aufirst%3DE.%26aulast%3DMason%26aufirst%3DM.%26aulast%3DPresnell%26aufirst%3DS.%2BR.%26aulast%3DElkon%26aufirst%3DK.%2BB.%26aulast%3DLacy-Hulbert%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DB.%2BJ.%26aulast%3DPepper%26aufirst%3DM.%26aulast%3DHamerman%26aufirst%3DJ.%2BA.%26atitle%3DChronic%2520TLR7%2520and%2520TLR9%2520Signaling%2520Drives%2520Anemia%2520via%2520Differentiation%2520of%2520Specialized%2520Hemophagocytes%26jtitle%3DScience%26date%3D2019%26volume%3D363%26doi%3D10.1126%2Fscience.aao5213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suthers, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarantopoulos, S.</span></span> <span> </span><span class="NLM_article-title">TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">775</span> <span class="refDoi"> DOI: 10.3389/fimmu.2017.00775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.3389%2Ffimmu.2017.00775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=28751890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWnsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=A.+N.+Suthersauthor=S.+Sarantopoulos&title=TLR7%2FTLR9-+and+B+Cell+Receptor-Signaling+Crosstalk%3A+Promotion+of+Potentially+Dangerous+B+Cells&doi=10.3389%2Ffimmu.2017.00775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">TLR7/TLR9- and B cell receptor-signaling crosstalk: promotion of potentially dangerous B cells</span></div><div class="casAuthors">Suthers, Amy N.; Sarantopoulos, Stefanie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">775/1-775/8</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  B cells are capable of receptor-mediated responses to foreign antigens.  Recognition of microbial-derived nucleic acid (NA) by toll-like receptors (TLRs) 7 and 9 in B cells has been substantiated.  Endogenous NA released from damaged or dying cells can also be immunogenic in certain contexts and can incite aberrant activation of B cells.  When TLR-driven B cell receptor (BCR)-activated B cells are not properly constrained, pathol. autoantibodies are produced.  It is also clear that endosomal TLR7/TLR9 can operate in conjunction with BCR.  In addn. to BCR signaling, a balance between TLR7 and TLR9 is pivotal in the development of B cell autoreactivity.  While TLR9 is important in normal memory Bcell responses through BCR, TLR9 activation has been implicated in autoantibody prodn.  Paradoxically, TLR9 also plays known protective roles against autoimmunity by directly and indirectly inhibiting TLR7-mediated autoantibody prodn.  Herein, we summarize literature supporting mechanisms underpinning the promotion of pathol. BCR-activated Bcells by TLR7 and TLR9.  We focus on the literature regarding known points of TLR7/TLR9 and BCR crosstalk.  Data also suggest that the degree of TLR responsiveness relies on alterations of certain intrinsic B-cell signaling mols. and is also context specific.  Because allogeneic hematopoietic stem cell transplantation is a high NA and B cell-activating factor environment, we conclude that B cell studies of synergistic TLR-BCR signaling in human diseases like chronic graft-vs.-host disease are warranted.  Further understanding of the distinct mol. pathways mediating TLR-BCR synergy will lead to the development of therapeutic strategies in autoimmune disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRSzu-xcEMG7Vg90H21EOLACvtfcHk0lhh1-3GjvbK1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWnsrfI&md5=0b6cba114061b711a6bf504524bdda19</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00775%26sid%3Dliteratum%253Aachs%26aulast%3DSuthers%26aufirst%3DA.%2BN.%26aulast%3DSarantopoulos%26aufirst%3DS.%26atitle%3DTLR7%252FTLR9-%2520and%2520B%2520Cell%2520Receptor-Signaling%2520Crosstalk%253A%2520Promotion%2520of%2520Potentially%2520Dangerous%2520B%2520Cells%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26doi%3D10.3389%2Ffimmu.2017.00775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkelmeier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger-Kentischer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldblum, A.</span></span> <span> </span><span class="NLM_article-title">Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1835</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKrsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1835-1846&author=M.+Zatsepinauthor=A.+Mattesauthor=S.+Ruppauthor=D.+Finkelmeierauthor=A.+Basuauthor=A.+Burger-Kentischerauthor=A.+Goldblum&title=Computational+Discovery+and+Experimental+Confirmation+of+TLR9+Receptor+Antagonist+Leads&doi=10.1021%2Facs.jcim.6b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads</span></div><div class="casAuthors">Zatsepin, Maria; Mattes, Angela; Rupp, Steffen; Finkelmeier, Doris; Basu, Arijit; Burger-Kentischer, Anke; Goldblum, Amiram</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1835-1846</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptors (TLR) are receptors of innate immunity that recognize Pathogen Assocd. Mol. Patterns.  They play a crit. role in many pathol. states, in acute and chronic inflammatory processes.  TLR9 is a promising target for drug discovery, since it has been implicated in several pathologies, including defense against viral infections and psoriasis.  Immune-modulators are promising mols. for therapeutic intervention in these indications.  TLR9 is located in the endosome and activated by dsDNA with CpG motives encountered in microbial DNA.  Here the authors report on a combined approach to discover new TLR9 antagonists by computational chem. and cell based assays.  The authors used the inhouse Iterative Stochastic Elimination (ISE) algorithm to create models that distinguish between TLR9 antagonists ("actives") and other mols. ("inactives"), based on mol. physico-chem. properties.  Subsequent screening and scoring of a dataset of 1.8 million com. available mols. led to the purchasing of top scored mols., which were tested in a new cell based system based on human PRRs stably expressed in NIH3T3 fibroblasts.  As described previously, this cell line shows a very low endogenous PRR-activity and contains a reporter gene which is selectively activated by the integrated human PRR enabling rapid screening of potential ligands.  IC50 values of each of these top scored mols. were detd.  Out of 60 mols. tested, 56 showed antagonistic activity.  The authors discovered 21 new highly potential antagonists with IC50 values lower than 10 μM, with five of them having IC50 values under 1 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz78TtRMfluLVg90H21EOLACvtfcHk0ljYiThilFhlxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKrsL7P&md5=b5abc215a2104b6f054e5f098e31982b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00070%26sid%3Dliteratum%253Aachs%26aulast%3DZatsepin%26aufirst%3DM.%26aulast%3DMattes%26aufirst%3DA.%26aulast%3DRupp%26aufirst%3DS.%26aulast%3DFinkelmeier%26aufirst%3DD.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBurger-Kentischer%26aufirst%3DA.%26aulast%3DGoldblum%26aufirst%3DA.%26atitle%3DComputational%2520Discovery%2520and%2520Experimental%2520Confirmation%2520of%2520TLR9%2520Receptor%2520Antagonist%2520Leads%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D1835%26epage%3D1846%26doi%3D10.1021%2Facs.jcim.6b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bou
Karroum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarbess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patinote, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouharoun-Tayoun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuq, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab-Assaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze-Masquefa, C.</span></span> <span> </span><span class="NLM_article-title">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]Pyrazines, Imidazo[1,5-a]Quinoxalines, and Pyrazolo[1,5-a]Quinoxalines Series</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7015</span>– <span class="NLM_lpage">7031</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7015-7031&author=N.+Bou%0AKarroumauthor=G.+Moarbessauthor=J.-F.+Guichouauthor=P.-A.+Bonnetauthor=C.+Patinoteauthor=H.+Bouharoun-Tayounauthor=S.+Chamatauthor=P.+Cuqauthor=M.+Diab-Assafauthor=I.+Kassabauthor=C.+Deleuze-Masquefa&title=Novel+and+Selective+TLR7+Antagonists+among+the+Imidazo%5B1%2C2-a%5DPyrazines%2C+Imidazo%5B1%2C5-a%5DQuinoxalines%2C+and+Pyrazolo%5B1%2C5-a%5DQuinoxalines+Series&doi=10.1021%2Facs.jmedchem.9b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series</span></div><div class="casAuthors">Bou Karroum, Nour; Moarbess, Georges; Guichou, Jean-Francois; Bonnet, Pierre-Antoine; Patinote, Cindy; Bouharoun-Tayoun, Hasnaa; Chamat, Soulaima; Cuq, Pierre; Diab-Assaf, Mona; Kassab, Issam; Deleuze-Masquefa, Carine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7015-7031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Toll-like receptors (TLRs) 7 and 8 play an important role in the immune system activation, and their agonists may therefore serve as promising candidate vaccine adjuvants.  However, the chronic immune activation by excessive TLR stimulation is a hallmark of several clin. important infectious and autoimmune diseases, which warrants the search for TLR antagonists.  In this study, a variety of compds. belonging to three heterocyclic chem. series: imidazo[1,2-a]pyrazine, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline have been synthesized and characterized.  These compds. have been tested for their TLR7 or TLR8 agonistic and antagonistic activities.  Several of them are shown to be selective TLR7 antagonists without any TLR7 or TLR8 agonistic activity.  The selectivity was confirmed by a comparative ligand-docking study in TLR7 antagonist pocket.  Two compds. of the pyrazolo[1,5-a]quinoxaline series I [R = n-Bu, i-Bu] are potent selective TLR7 antagonists and may be considered as promising starting points for the development of new therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3510Ht_ZHf7Vg90H21EOLACvtfcHk0ljYiThilFhlxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN&md5=b9ffc17dcae442102245eb76face7394</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00411%26sid%3Dliteratum%253Aachs%26aulast%3DBou%2BKarroum%26aufirst%3DN.%26aulast%3DMoarbess%26aufirst%3DG.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26aulast%3DBonnet%26aufirst%3DP.-A.%26aulast%3DPatinote%26aufirst%3DC.%26aulast%3DBouharoun-Tayoun%26aufirst%3DH.%26aulast%3DChamat%26aufirst%3DS.%26aulast%3DCuq%26aufirst%3DP.%26aulast%3DDiab-Assaf%26aufirst%3DM.%26aulast%3DKassab%26aufirst%3DI.%26aulast%3DDeleuze-Masquefa%26aufirst%3DC.%26atitle%3DNovel%2520and%2520Selective%2520TLR7%2520Antagonists%2520among%2520the%2520Imidazo%255B1%252C2-a%255DPyrazines%252C%2520Imidazo%255B1%252C5-a%255DQuinoxalines%252C%2520and%2520Pyrazolo%255B1%252C5-a%255DQuinoxalines%2520Series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7015%26epage%3D7031%26doi%3D10.1021%2Facs.jmedchem.9b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandimalla, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span> <span> </span><span class="NLM_article-title">Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5108</span>– <span class="NLM_lpage">5114</span>, <span class="refDoi"> DOI: 10.1021/jm900730r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900730r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlSmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5108-5114&author=D.+Yuauthor=D.+Wangauthor=F.-G.+Zhuauthor=L.+Bhagatauthor=M.+Daiauthor=E.+R.+Kandimallaauthor=S.+Agrawal&title=Modifications+Incorporated+in+CpG+Motifs+of+Oligodeoxynucleotides+Lead+to+Antagonist+Activity+of+Toll-like+Receptors+7+and+9&doi=10.1021%2Fjm900730r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9</span></div><div class="casAuthors">Yu, Dong; Wang, Daqing; Zhu, Fu-Gang; Bhagat, Lakshmi; Dai, Meiru; Kandimalla, Ekambar R.; Agrawal, Sudhir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5108-5114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligodeoxynucleotides (ODNs) contg. unmethylated CpG dinucleotides act as agonists of TLR9 and induce Th1-type immune responses.  In the present study, we synthesized CpG contg. ODNs in which C or G was substituted with 2'-O-methylribonucleotides, 5-methyl-dC, or 2'-O-methyl-5-methyl-C and studied their immune stimulatory activity alone and in combination with TLR agonists.  In mouse and human primary cell-based assays, modified ODNs did not stimulate immune responses but inhibited TLR9 agonist-induced immune stimulatory activity.  In mice, modified ODNs did not induce cytokines but inhibited immune responses induced by agonists of TLR7 and TLR9.  Modified ODNs did not inhibit endosomal TLR3- or cell-surface TLR4-agonist-induced cytokines.  This study demonstrates that ODNs incorporated with chem. modifications in CpG dinucleotides do not induce immune stimulatory activity but act as antagonists of TLR7 and TLR9 in vitro and in vivo.  These types of modifications are commonly employed in antisense sequences and thereby may affect the intended mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIUPJmgeCNS7Vg90H21EOLACvtfcHk0ljYiThilFhlxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlSmurg%253D&md5=ba7d00b1d1b139370a7983441f298867</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm900730r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900730r%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DF.-G.%26aulast%3DBhagat%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DKandimalla%26aufirst%3DE.%2BR.%26aulast%3DAgrawal%26aufirst%3DS.%26atitle%3DModifications%2520Incorporated%2520in%2520CpG%2520Motifs%2520of%2520Oligodeoxynucleotides%2520Lead%2520to%2520Antagonist%2520Activity%2520of%2520Toll-like%2520Receptors%25207%2520and%25209%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5108%26epage%3D5114%26doi%3D10.1021%2Fjm900730r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandimalla, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span> <span> </span><span class="NLM_article-title">Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1021/jm8014316</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFals7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=551-558&author=D.+Wangauthor=L.+Bhagatauthor=D.+Yuauthor=F.-G.+Zhuauthor=J.+X.+Tangauthor=E.+R.+Kandimallaauthor=S.+Agrawal&title=Oligodeoxyribonucleotide-Based+Antagonists+for+Toll-Like+Receptors+7+and+9&doi=10.1021%2Fjm8014316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9</span></div><div class="casAuthors">Wang, Daqing; Bhagat, Lakshmi; Yu, Dong; Zhu, Fu-Gang; Tang, Jimmy X.; Kandimalla, Ekambar R.; Agrawal, Sudhir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligodeoxyribonucleotides contg. unmethylated CpG motifs act as TLR9 agonists.  In this study, we evaluated oligonucleotides contg. an unmethylated CpG motif in which two nucleotides adjacent to the CpG dinucleotide were substituted with 2'-O-methylribonucleotides, resulting in TLR7 and TLR9 antagonists.  In mouse and human cell cultures, antagonists did not stimulate immune activation but inhibited TLR7 and TLR9 agonist-induced activity.  In mice, antagonists inhibited immune responses induced by TLR9 agonists for up to several days, and the inhibition was dose-dependent.  Antagonists also inhibited immune responses induced by an RNA-based TLR7/8 agonist but not TLRs 2, 3, 4, or 5 agonists in mice.  Addnl., antagonist inhibited TLR9 agonist-induced IL-6 in lupus-prone MRL/lpr mouse spleen cell cultures.  These results indicate that antagonists described herein can suppress immune responses induced by TLR7 and TLR9 agonists.  Antagonists may be suitable candidates for treating inflammatory and autoimmune diseases where inappropriate or uncontrolled TLR activation has been implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOPN-6_W0BcLVg90H21EOLACvtfcHk0ljYiThilFhlxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFals7nF&md5=74a55b8d4904e264769ef7eb873e533b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm8014316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014316%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DBhagat%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DF.-G.%26aulast%3DTang%26aufirst%3DJ.%2BX.%26aulast%3DKandimalla%26aufirst%3DE.%2BR.%26aulast%3DAgrawal%26aufirst%3DS.%26atitle%3DOligodeoxyribonucleotide-Based%2520Antagonists%2520for%2520Toll-Like%2520Receptors%25207%2520and%25209%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D551%26epage%3D558%26doi%3D10.1021%2Fjm8014316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, B.</span></span> <span> </span><span class="NLM_article-title">Intracellular Toll-like Receptors</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.immuni.2010.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=20346772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=305-315&author=A.+L.+Blasiusauthor=B.+Beutler&title=Intracellular+Toll-like+Receptors&doi=10.1016%2Fj.immuni.2010.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular toll-like receptors</span></div><div class="casAuthors">Blasius, Amanda L.; Beutler, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-315</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Foreign nucleic acids, the signature of invading viruses and certain bacteria, are sensed intracellularly.  The nucleic acid-specific Toll-like receptors (TLRs) detect and signal within endolysosomal compartments, triggering the induction of cytokines essential for the innate immune response.  These cytokines include proinflammatory mols. produced mainly by macrophages and conventional dendritic cells, as well as type I interferons, which are produced in great quantities by plasmacytoid dendritic cells.  The cellular and mol. pathways by which nucleic acids and TLRs meet within the endosome assure host protection yet also place the host at risk for the development of autoimmunity.  Here, we review the latest findings on the intracellular TLRs, with special emphasis on ligand uptake, receptor trafficking, signaling, and regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-SJKSbEwurVg90H21EOLACvtfcHk0liv7LbXMgEL1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D&md5=84f54e99249e52a6424c7c3975e8c7ea</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBlasius%26aufirst%3DA.%2BL.%26aulast%3DBeutler%26aufirst%3DB.%26atitle%3DIntracellular%2520Toll-like%2520Receptors%26jtitle%3DImmunity%26date%3D2010%26volume%3D32%26spage%3D305%26epage%3D315%26doi%3D10.1016%2Fj.immuni.2010.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krayukhina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis Reveals That Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.immuni.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27742543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=737-748&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=E.+Krayukhinaauthor=M.+Taokaauthor=Y.+Yamauchiauthor=H.+Tanjiauthor=T.+Isobeauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Analysis+Reveals+That+Toll-like+Receptor+7+Is+a+Dual+Receptor+for+Guanosine+and+Single-Stranded+RNA&doi=10.1016%2Fj.immuni.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chem. ligands, such as imidazoquinoline compds.  However, TLR7 activation mechanism by these ligands remain largely unknown.  Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites.  The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation.  The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands.  The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA.  Our structural, biochem., and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-contg. ssRNA.  Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQskd1L0XeX7Vg90H21EOLACvtfcHk0liv7LbXMgEL1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI&md5=194f87d5ea0e88009fd682c00e020f38</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Analysis%2520Reveals%2520That%2520Toll-like%2520Receptor%25207%2520Is%2520a%2520Dual%2520Receptor%2520for%2520Guanosine%2520and%2520Single-Stranded%2520RNA%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D737%26epage%3D748%26doi%3D10.1016%2Fj.immuni.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">TLR7 Structure: Cut in Z-Loop</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2016.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.immuni.2016.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27760331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSgsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=705-707&author=K.+Maedaauthor=S.+Akira&title=TLR7+Structure%3A+Cut+in+Z-Loop&doi=10.1016%2Fj.immuni.2016.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">TLR7 Structure: Cut in Z-Loop</span></div><div class="casAuthors">Maeda, Kazuhiko; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">705-707</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">TLRs play central roles in host defense.  In this issue of Immunity, Zhang et al. (2016) generate structures of TLR7 bound to multiple ligands and provide insight into the mechanism of TLR7 ligand recognition that highlights the differences in the features of the TLR subfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlH3PtnUPr4LVg90H21EOLACvtfcHk0liv7LbXMgEL1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSgsbjK&md5=ba5a66376216dc97033f2debbbf39bba</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DTLR7%2520Structure%253A%2520Cut%2520in%2520Z-Loop%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D705%26epage%3D707%26doi%3D10.1016%2Fj.immuni.2016.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deriu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licandro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuszynski, J. A.</span></span> <span> </span><span class="NLM_article-title">Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">8316</span>– <span class="NLM_lpage">8340</span>, <span class="refDoi"> DOI: 10.3390/molecules20058316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.3390%2Fmolecules20058316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=26007168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosV2rsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=8316-8340&author=F.+Gentileauthor=M.+A.+Deriuauthor=G.+Licandroauthor=A.+Prunottoauthor=A.+Dananiauthor=J.+A.+Tuszynski&title=Structure+Based+Modeling+of+Small+Molecules+Binding+to+the+TLR7+by+Atomistic+Level+Simulations&doi=10.3390%2Fmolecules20058316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based modeling of small molecules binding to the TLR7 by atomistic level simulations</span></div><div class="casAuthors">Gentile, Francesco; Deriu, Marco A.; Licandro, Ginevra; Prunotto, Alessio; Danani, Andrea; Tuszynski, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">8316-8340</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Toll-Like Receptors (TLR) are a large family of proteins involved in the immune system response.  Both the activation and the inhibition of these receptors can have pos. effects on several diseases, including viral pathologies and cancer, therefore prompting the development of new compds.  In order to provide new indications for the design of Toll-Like Receptor 7 (TLR7)-targeting drugs, the mechanism of interaction between the TLR7 and two important classes of agonists (imidazoquinoline and adenine derivs.) was investigated through docking and Mol. Dynamics simulations.  To perform the computational anal., a new model for the dimeric form of the receptors was necessary and therefore created.  Qual. and quant. differences between agonists and inactive compds. were detd.  The in silico results were compared with previous exptl. observations and employed to define the ligand binding mechanism of TLR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHuOwm1H1WEbVg90H21EOLACvtfcHk0lgQY7wjr6U_TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosV2rsLc%253D&md5=5c8db1afa6ecddfb527778cd4d4cf538</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20058316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20058316%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DF.%26aulast%3DDeriu%26aufirst%3DM.%2BA.%26aulast%3DLicandro%26aufirst%3DG.%26aulast%3DPrunotto%26aufirst%3DA.%26aulast%3DDanani%26aufirst%3DA.%26aulast%3DTuszynski%26aufirst%3DJ.%2BA.%26atitle%3DStructure%2520Based%2520Modeling%2520of%2520Small%2520Molecules%2520Binding%2520to%2520the%2520TLR7%2520by%2520Atomistic%2520Level%2520Simulations%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D8316%26epage%3D8340%26doi%3D10.3390%2Fmolecules20058316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuszynski, J. A.</span></span> <span> </span><span class="NLM_article-title">Homology and Molecular Dynamics Models of Toll-Like Receptor 7 Protein and Its Dimerization</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1111%2Fcbdd.12278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24406029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2htr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=656-665&author=C.-Y.+Tsengauthor=M.+Gajewskiauthor=A.+Dananiauthor=J.+A.+Tuszynski&title=Homology+and+Molecular+Dynamics+Models+of+Toll-Like+Receptor+7+Protein+and+Its+Dimerization&doi=10.1111%2Fcbdd.12278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Homology and Molecular Dynamics Models of Toll-Like Receptor 7 Protein and Its Dimerization</span></div><div class="casAuthors">Tseng, Chih-Yuan; Gajewski, Melissa; Danani, Andrea; Tuszynski, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">656-665</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Toll-like receptor protein 7 is a transmembrane protein playing a crucial role in the signaling pathways involved in innate immunity.  Its crystal structure is not yet available, but there are several proteins possessing domains of sufficiently high homol., which enabled us to build a model of the toll-like receptor protein 7 monomer and gain insights into dimer formation.  To obtain a reliable structure prediction, we subjected this model to equilibration using mol. dynamics simulations.  Furthermore, the equilibrated monomer structure was used to construct models of dimerization and to predict binding sites for small ligands.  Docking studies were performed for some of the known toll-like receptor protein 7 ligands.  We detd. that a new homol. model generated by the LOOPP server provides a good alternative to a previously reported model.  Our docking results indicate that the addn. of either imiquimod or 1V209 to a toll-like receptor protein 7 dimer changes an unfavorable interaction into a favorable one.  We found that eight small mols. docked to two pockets in toll-like receptor protein 7 bind to both pockets at pH 7 and at pH 5.5.  This work provides a realistic model that could be used for drug discovery aimed at finding toll-like receptor protein 7 dimerization activators, with potential clin. applications to a host of diseases, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE-sSRu58COLVg90H21EOLACvtfcHk0lgQY7wjr6U_TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2htr4%253D&md5=9b4d3f34cdb1f91a79d5427b2333fe0d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12278%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DC.-Y.%26aulast%3DGajewski%26aufirst%3DM.%26aulast%3DDanani%26aufirst%3DA.%26aulast%3DTuszynski%26aufirst%3DJ.%2BA.%26atitle%3DHomology%2520and%2520Molecular%2520Dynamics%2520Models%2520of%2520Toll-Like%2520Receptor%25207%2520Protein%2520and%2520Its%2520Dimerization%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D83%26spage%3D656%26epage%3D665%26doi%3D10.1111%2Fcbdd.12278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, B.</span></span> <span> </span><span class="NLM_article-title">Strategy for Extending Half-Life in Drug Design and Its Significance</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=528-533&author=H.+Gunaydinauthor=M.+D.+Altmanauthor=J.+M.+Ellisauthor=P.+Fullerauthor=S.+A.+Johnsonauthor=B.+Lahueauthor=B.+Lapointe&title=Strategy+for+Extending+Half-Life+in+Drug+Design+and+Its+Significance&doi=10.1021%2Facsmedchemlett.8b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Strategy for extending half-life in drug design and its significance</span></div><div class="casAuthors">Gunaydin, Hakan; Altman, Michael D.; Ellis, J. Michael; Fuller, Peter; Johnson, Scott A.; Lahue, Brian; Lapointe, Blair</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">528-533</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Preclin. optimization of compds. toward viable drug candidates requires an integrated understanding of properties that impact predictions of the clin. efficacious dose.  The importance of optimizing half-life, unbound clearance, and potency and how they impact dose predictions are discussed in this letter.  Modest half-life improvements for short half-life compds. can dramatically lower the efficacious dose.  The relationship between dose and half-life is nonlinear when unbound clearance is kept const., whereas the relationship between dose and unbound clearance is linear when half-life is kept const.  Due to this difference, we show that dose is more sensitive to changes in half-life than changes in unbound clearance when half-lives are shorter than 2 h.  Through matched mol. pair analyses, we also show that the strategic introduction of halogens is likely to increase half-life and lower projected human dose even though increased lipophilicity does not guarantee extended half-life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJU1an5zslYbVg90H21EOLACvtfcHk0lgQY7wjr6U_TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLk%253D&md5=497178d9c523a58e1fa70e34cdf09281</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00018%26sid%3Dliteratum%253Aachs%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DEllis%26aufirst%3DJ.%2BM.%26aulast%3DFuller%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DLahue%26aufirst%3DB.%26aulast%3DLapointe%26aufirst%3DB.%26atitle%3DStrategy%2520for%2520Extending%2520Half-Life%2520in%2520Drug%2520Design%2520and%2520Its%2520Significance%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D528%26epage%3D533%26doi%3D10.1021%2Facsmedchemlett.8b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgQY7wjr6U_TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span> <span> </span><span class="NLM_article-title">The Pharmacokinetics of Toll-like Receptor Agonists and the Impact on the Immune System</span>. <i>Expert Rev. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1586/ecp.11.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1586%2Fecp.11.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=21643519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1yqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=275-289&author=A.+L.+Engelauthor=G.+E.+Holtauthor=H.+Lu&title=The+Pharmacokinetics+of+Toll-like+Receptor+Agonists+and+the+Impact+on+the+Immune+System&doi=10.1586%2Fecp.11.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system</span></div><div class="casAuthors">Engel, Abbi L.; Holt, Gregory E.; Lu, Hailing</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-289</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptor (TLR) ligation activates both the innate and adaptive immune systems, and plays an important role in antiviral and anti-tumor immunity.  Therefore, a significant amt. of effort has been devoted to exploit the therapeutic potential of TLR agonists.  Depending on the therapeutic purpose, either as adjuvants to vaccine, chemotherapy or standalone therapy, TLR agonists have been administered via different routes.  Both preclin. and clin. studies have suggested that the route of administration has significant effects on pharmacokinetics, and that understanding these effects is crit. to the success of TLR agonist drug development.  This article will summarize the pharmacokinetics of TLR agonists with different administration routes, with an emphasis on clin. studies of TLR ligands in oncol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0NNpI7RjSLLVg90H21EOLACvtfcHk0ljO068q1I9Z9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1yqs7g%253D&md5=e3ccf9accdb9468cba58f60bd2172d0d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1586%2Fecp.11.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.11.5%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DA.%2BL.%26aulast%3DHolt%26aufirst%3DG.%2BE.%26aulast%3DLu%26aufirst%3DH.%26atitle%3DThe%2520Pharmacokinetics%2520of%2520Toll-like%2520Receptor%2520Agonists%2520and%2520the%2520Impact%2520on%2520the%2520Immune%2520System%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D4%26spage%3D275%26epage%3D289%26doi%3D10.1586%2Fecp.11.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jongh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertinez, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Steeg, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Graaf, P. H.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in Mice</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1128/AAC.00551-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1128%2FAAC.00551-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=20028817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1179-1185&author=N.+Bensonauthor=J.+de+Jonghauthor=J.+D.+Duckworthauthor=H.+M.+Jonesauthor=H.+E.+Pertinezauthor=J.+K.+Rawalauthor=T.+J.+van+Steegauthor=P.+H.+Van+der+Graaf&title=Pharmacokinetic-Pharmacodynamic+Modeling+of+Alpha+Interferon+Response+Induced+by+a+Toll-Like+7+Receptor+Agonist+in+Mice&doi=10.1128%2FAAC.00551-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice</span></div><div class="casAuthors">Benson, Neil; de Jongh, Joost; Duckworth, Jonathan D.; Jones, Hannah M.; Pertinez, Henry E.; Rawal, Jaiessh K.; van Steeg, Tamara J.; Van der Graaf, Piet H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1185</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Recombinant alpha interferon (IFN-α) is used in the treatment of hepatitis C virus (HCV)-infected patients but is not optimal in terms of efficacy or tolerability.  Toll-like 7 receptor (TLR-7) agonists stimulate the innate immune system to produce, among other cytokines, IFN-α and are being evaluated as alternative drugs to treat HCV infection.  This paper describes the application of pharmacokinetic-pharmacodynamic (PK-PD) modeling to understanding the behavior of a TLR-7 agonist [9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine (BHMA)] in mice, using IFN-α as a biomarker.  This is the first report of such a PK-PD model, and the conclusions may be of utility in the clin. development of TLR-7 agonists for HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyYjsqRMvn9rVg90H21EOLACvtfcHk0ljO068q1I9Z9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsLY%253D&md5=09a660d40336da560f38ce66101ff3b9</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FAAC.00551-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00551-09%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DN.%26aulast%3Dde%2BJongh%26aufirst%3DJ.%26aulast%3DDuckworth%26aufirst%3DJ.%2BD.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DPertinez%26aufirst%3DH.%2BE.%26aulast%3DRawal%26aufirst%3DJ.%2BK.%26aulast%3Dvan%2BSteeg%26aufirst%3DT.%2BJ.%26aulast%3DVan%2Bder%2BGraaf%26aufirst%3DP.%2BH.%26atitle%3DPharmacokinetic-Pharmacodynamic%2520Modeling%2520of%2520Alpha%2520Interferon%2520Response%2520Induced%2520by%2520a%2520Toll-Like%25207%2520Receptor%2520Agonist%2520in%2520Mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1179%26epage%3D1185%26doi%3D10.1128%2FAAC.00551-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Fits, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourits, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voerman, J. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelissen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mus, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florencia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prens, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubberts, E.</span></span> <span> </span><span class="NLM_article-title">Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">5836</span>– <span class="NLM_lpage">5845</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.4049%2Fjimmunol.0802999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=19380832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=5836-5845&author=L.+van%0Ader+Fitsauthor=S.+Mouritsauthor=J.+S.+A.+Voermanauthor=M.+Kantauthor=L.+Boonauthor=J.+D.+Lamanauthor=F.+Cornelissenauthor=A.-M.+Musauthor=E.+Florenciaauthor=E.+P.+Prensauthor=E.+Lubberts&title=Imiquimod-Induced+Psoriasis-Like+Skin+Inflammation+in+Mice+Is+Mediated+via+the+IL-23%2FIL-17+Axis&doi=10.4049%2Fjimmunol.0802999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis</span></div><div class="casAuthors">van der Fits, Leslie; Mourits, Sabine; Voerman, Jane S. A.; Kant, Marius; Boon, Louis; Laman, Jon D.; Cornelissen, Ferry; Mus, Anne-Marie; Florencia, Edwin; Prens, Errol P.; Lubberts, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5836-5845</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Topical application of imiquimod (IMQ), a TLR7/8 ligand and potent immune activator, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder.  Recently, a crucial role was proposed for the IL-23/IL-17 axis in psoriasis.  The authors hypothesized that IMQ-induced dermatitis in mice can serve as a model for the anal. of pathogenic mechanisms in psoriasis-like dermatitis and assessed its IL-23/IL-17 axis dependency.  Daily application of IMQ on mouse back skin induced inflamed scaly skin lesions resembling plaque type psoriasis.  These lesions showed increased epidermal proliferation, abnormal differentiation, epidermal accumulation of neutrophils in microabcesses, neoangiogenesis, and infiltrates consisting of CD4+ T cells, CD11c+ dendritic cells, and plasmacytoid dendritic cells.  IMQ induced epidermal expression of IL-23, IL-17A, and IL-17F, as well as an increase in splenic Th17 cells.  IMQ-induced dermatitis was partially dependent on the presence of T cells, whereas disease development was almost completely blocked in mice deficient for IL-23 or the IL-17 receptor, demonstrating a pivotal role of the IL-23/IL-17 axis.  In conclusion, the sole application of the innate TLR7/8 ligand IMQ rapidly induces a dermatitis closely resembling human psoriasis, critically dependent on the IL-23/IL-17 axis.  This rapid and convenient model allows further elucidation of pathogenic mechanisms and evaluation of new therapies in psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWu9yN1SM3ibVg90H21EOLACvtfcHk0ljO068q1I9Z9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKhtrs%253D&md5=3e895f11e5cbfd9ee20a83ad34a4f419</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802999%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BFits%26aufirst%3DL.%26aulast%3DMourits%26aufirst%3DS.%26aulast%3DVoerman%26aufirst%3DJ.%2BS.%2BA.%26aulast%3DKant%26aufirst%3DM.%26aulast%3DBoon%26aufirst%3DL.%26aulast%3DLaman%26aufirst%3DJ.%2BD.%26aulast%3DCornelissen%26aufirst%3DF.%26aulast%3DMus%26aufirst%3DA.-M.%26aulast%3DFlorencia%26aufirst%3DE.%26aulast%3DPrens%26aufirst%3DE.%2BP.%26aulast%3DLubberts%26aufirst%3DE.%26atitle%3DImiquimod-Induced%2520Psoriasis-Like%2520Skin%2520Inflammation%2520in%2520Mice%2520Is%2520Mediated%2520via%2520the%2520IL-23%252FIL-17%2520Axis%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D5836%26epage%3D5845%26doi%3D10.4049%2Fjimmunol.0802999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adalsteinsson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudjonsson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, N. L.</span></span> <span> </span><span class="NLM_article-title">Research Techniques Made Simple: Murine Models of Human Psoriasis</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">e1</span>– <span class="NLM_lpage">e8</span>, <span class="refDoi"> DOI: 10.1016/j.jid.2017.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.jid.2017.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=29273150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWlsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=e1-e8&author=J.+E.+Hawkesauthor=J.+A.+Adalsteinssonauthor=J.+E.+Gudjonssonauthor=N.+L.+Ward&title=Research+Techniques+Made+Simple%3A+Murine+Models+of+Human+Psoriasis&doi=10.1016%2Fj.jid.2017.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Research Techniques Made Simple: Murine Models of Human Psoriasis</span></div><div class="casAuthors">Hawkes, Jason E.; Adalsteinsson, Jonas A.; Gudjonsson, Johann E.; Ward, Nicole L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1-e8</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Psoriasis vulgaris is a common, inflammatory skin disease affecting approx. 3% of the population in the United States.  The etiol. of psoriasis and its assocd. comorbidities are complex and the result of complicated interactions between the skin, immune system, disease-assocd. susceptibility loci, and multiple environmental triggers.  The modeling of human disease in vivo through the use of murine models represents a powerful, indispensable tool for investigating the immune and genetic mechanisms contributing to a clin. disease phenotype.  Nevertheless, modeling a complex, multigenic disease like psoriasis in mice has proven to be extremely challenging and is assocd. with significant limitations.  Over the last four decades, more than 40 unique mouse models for psoriasis have been described.  These models can be categorized into three major types: acute (inducible), genetically engineered (transgenic), and xenograft (humanized).  The purpose of this Research Techniques Made Simple article is to provide an overview of the common types of psoriasis-like mouse models currently in use and their inherent advantages and limitations.  We also highlight the need for improved psoriasis mouse model systems and several key factors to be considered as this field of lab. science advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomDNzzRqGmirVg90H21EOLACvtfcHk0ljYePjFQZI_DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWlsrjK&md5=ab0897692828c6aae463ea818c10b66f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.jid.2017.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jid.2017.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DHawkes%26aufirst%3DJ.%2BE.%26aulast%3DAdalsteinsson%26aufirst%3DJ.%2BA.%26aulast%3DGudjonsson%26aufirst%3DJ.%2BE.%26aulast%3DWard%26aufirst%3DN.%2BL.%26atitle%3DResearch%2520Techniques%2520Made%2520Simple%253A%2520Murine%2520Models%2520of%2520Human%2520Psoriasis%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2018%26volume%3D138%26spage%3De1%26epage%3De8%26doi%3D10.1016%2Fj.jid.2017.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preethy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">Ligand-Based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors</span>. <i>Comput. Struct. Biotechnol. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.csbj.2019.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.csbj.2019.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30867893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=291-310&author=S.+Palauthor=V.+Kumarauthor=B.+Kunduauthor=D.+Bhattacharyaauthor=N.+Preethyauthor=M.+P.+Reddyauthor=A.+Talukdar&title=Ligand-Based+Pharmacophore+Modeling%2C+Virtual+Screening+and+Molecular+Docking+Studies+for+Discovery+of+Potential+Topoisomerase+I+Inhibitors&doi=10.1016%2Fj.csbj.2019.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors</span></div><div class="casAuthors">Pal, Sourav; Kumar, Vinay; Kundu, Biswajit; Bhattacharya, Debomita; Preethy, Nagothy; Reddy, Mamindla Prashanth; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">Computational and Structural Biotechnology Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-310</span>CODEN:
                <span class="NLM_cas:coden">CSBJAC</span>;
        ISSN:<span class="NLM_cas:issn">2001-0370</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Camptothecin (CPT), a natural product and its synthetic derivs. exert potent anticancer activity by selectively targeting DNA Topoisomerase I (Top1) enzyme.  CPT and its clin. approved derivs. are used as Top1 poisons for cancer therapy suffer from many limitations related to stability and toxicity.  In order to envisage structurally diverse novel chem. entity as Top1 poison with better efficacy, Ligand-based-pharmacophore model was developed using 3D QSAR pharmacophore generation (HypoGen algorithm) methodol. in Discovery studio 4.1 clients.  The chem. features of 29 CPT derivs. were taken as the training set.  The selected pharmacophore model Hypo1 was further validated by 33 test set mols. and used as a query model for further screening of 1,087,724 drug-like mols. from ZINC databases.  These mols. were subjected to several assessments such as Lipinski rule of 5, SMART filtration and activity filtration.  The mol. obtained after filtration was further scrutinized by mol. docking anal. on the active site of Top1 crystal structure (PDB ID: 1T8I).  Six potential inhibitory mols. have been selected by analyzing the binding interaction and Ligand-Pharmacophore mapping with the validated pharmacophore model.  Toxicity assessment TOPKAT program provided three potential inhibitory 'hit mols.' ZINC68997780, ZINC15018994 and ZINC38550809.  MD simulation of these three mols. proved that the ligand binding into the protein-DNA cleavage complex is stable and the protein-ligands conformation remains unchanged.  These three hit mols. can be utilized for designing future class of potential topoisomerase I inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFv_Sj2pKedrVg90H21EOLACvtfcHk0ljYePjFQZI_DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOksL8%253D&md5=fdce9fc105b2af3c317cd44946699a31</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.csbj.2019.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.csbj.2019.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DKundu%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DD.%26aulast%3DPreethy%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DM.%2BP.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DLigand-Based%2520Pharmacophore%2520Modeling%252C%2520Virtual%2520Screening%2520and%2520Molecular%2520Docking%2520Studies%2520for%2520Discovery%2520of%2520Potential%2520Topoisomerase%2520I%2520Inhibitors%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2019%26volume%3D17%26spage%3D291%26epage%3D310%26doi%3D10.1016%2Fj.csbj.2019.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and Validation of a Genetic Algorithm for Flexible Docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+Validation+of+a+Genetic+Algorithm+for+Flexible+Docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljYePjFQZI_DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520a%2520Genetic%2520Algorithm%2520for%2520Flexible%2520Docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbasi, S. W.</span></span> <span> </span><span class="NLM_article-title">Molecular Docking Studies for the Identification of Novel Melatoninergic Inhibitors for Acetylserotonin-O-Methyltransferase Using Different Docking Routines</span>. <i>Theor. Biol. Med. Modell.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">63</span> <span class="refDoi"> DOI: 10.1186/1742-4682-10-63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1186%2F1742-4682-10-63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24156411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVaru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&author=S.+S.+Azamauthor=S.+W.+Abbasi&title=Molecular+Docking+Studies+for+the+Identification+of+Novel+Melatoninergic+Inhibitors+for+Acetylserotonin-O-Methyltransferase+Using+Different+Docking+Routines&doi=10.1186%2F1742-4682-10-63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines</span></div><div class="casAuthors">Azam, Syed Sikander; Abbasi, Sumra Wajid</div><div class="citationInfo"><span class="NLM_cas:title">Theoretical Biology and Medical Modelling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63/1-63/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">TBMMA8</span>;
        ISSN:<span class="NLM_cas:issn">1742-4682</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: N-acetylserotonin O-methyltransferase (ASMT) is an enzyme which by converting nor-melatonin to melatonin catalyzes the final reaction in melatonin biosynthesis in tryptophan metab. pathway.  High Expression of ASMT gene is evident in PPTs.  The presence of abnormally high levels of ASMT in pineal gland could serve as an indication of the existence of pineal parenchymal tumors (PPTs) in the brain.  Different levels of melatonin are used as a trait marker for prescribing the mood disorders e.g.  Seasonal affective disorder, bipolar disorder, or major depressive disorder.  In addn., melatonin levels can also be used to calc. the severity of a patient's illness at a given point in time.  Methods: Seventy three melatoninergic inhibitors were docked with acetylserotonin-O-methyltransferase in order to identify the potent inhibitor against the enzyme.  The chem. nature of the protein and ligands greatly influence the performance of docking routines.  Keeping this fact in view, crit. evaluation of the performance of four different commonly used docking routines: AutoDock/Vina, GOLD, FlexX and FRED were performed.  An evaluation criterion was based on the binding affinities/docking scores and exptl. bioactivities.  Results and Conclusion: Results indicated that both hydrogen bonding and hydrophobic interactions contributed significantly for its ligand binding and the compd. selected as potent inhibitor is having min. binding affinity, max. GoldScore and min. FlexX energy.  The correlation value of r2 = 0.66 may be useful in the selection of correct docked complexes based on the energy without having prior knowledge of the active site.  This may lead to further understanding of structures, their reliability and Biomol. activity esp. in connection with bipolar disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrctjiRVd4gHbVg90H21EOLACvtfcHk0ljZ19TAzz2tMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVaru7k%253D&md5=a50912719533bb86307b397b4f88d43c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1186%2F1742-4682-10-63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4682-10-63%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DS.%2BS.%26aulast%3DAbbasi%26aufirst%3DS.%2BW.%26atitle%3DMolecular%2520Docking%2520Studies%2520for%2520the%2520Identification%2520of%2520Novel%2520Melatoninergic%2520Inhibitors%2520for%2520Acetylserotonin-O-Methyltransferase%2520Using%2520Different%2520Docking%2520Routines%26jtitle%3DTheor.%2520Biol.%2520Med.%2520Modell.%26date%3D2013%26volume%3D10%26doi%3D10.1186%2F1742-4682-10-63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, T.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Evaluation of Ten Docking Programs on a Diverse Set of Protein–Ligand Complexes: The Prediction Accuracy of Sampling Power and Scoring Power</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">12964</span>– <span class="NLM_lpage">12975</span>, <span class="refDoi"> DOI: 10.1039/C6CP01555G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1039%2FC6CP01555G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27108770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFOns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=12964-12975&author=Z.+Wangauthor=H.+Sunauthor=X.+Yaoauthor=D.+Liauthor=L.+Xuauthor=Y.+Liauthor=S.+Tianauthor=T.+Hou&title=Comprehensive+Evaluation+of+Ten+Docking+Programs+on+a+Diverse+Set+of+Protein%E2%80%93Ligand+Complexes%3A+The+Prediction+Accuracy+of+Sampling+Power+and+Scoring+Power&doi=10.1039%2FC6CP01555G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power</span></div><div class="casAuthors">Wang, Zhe; Sun, Huiyong; Yao, Xiaojun; Li, Dan; Xu, Lei; Li, Youyong; Tian, Sheng; Hou, Tingjun</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12964-12975</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As one of the most popular computational approaches in modern structure-based drug design, mol. docking can be used not only to identify the correct conformation of a ligand within the target binding pocket but also to est. the strength of the interaction between a target and a ligand.  Nowadays, as a variety of docking programs are available for the scientific community, a comprehensive understanding of the advantages and limitations of each docking program is fundamentally important to conduct more reasonable docking studies and docking-based virtual screening.  In the present study, based on an extensive dataset of 2002 protein-ligand complexes from the PDBbind database (version 2014), the performance of ten docking programs, including five com. programs (LigandFit, Glide, GOLD, MOE Dock, and Surflex-Dock) and five academic programs (AutoDock, AutoDock Vina, LeDock, rDock, and UCSF DOCK), was systematically evaluated by examg. the accuracies of binding pose prediction (sampling power) and binding affinity estn. (scoring power).  Our results showed that GOLD and LeDock had the best sampling power (GOLD: 59.8% accuracy for the top scored poses; LeDock: 80.8% accuracy for the best poses) and AutoDock Vina had the best scoring power (rp/rs of 0.564/0.580 and 0.569/0.584 for the top scored poses and best poses), suggesting that the com. programs did not show the expected better performance than the academic ones.  Overall, the ligand binding poses could be identified in most cases by the evaluated docking programs but the ranks of the binding affinities for the entire dataset could not be well predicted by most docking programs.  However, for some types of protein families, relatively high linear correlations between docking scores and exptl. binding affinities could be achieved.  To our knowledge, this study has been the most extensive evaluation of popular mol. docking programs in the last five years.  It is expected that our work can offer useful information for the successful application of these docking tools to different requirements and targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7PQalJNVCubVg90H21EOLACvtfcHk0ljZ19TAzz2tMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFOns7g%253D&md5=5bedadbb6b4eb4dafa95a48701ac720d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2FC6CP01555G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CP01555G%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DT.%26atitle%3DComprehensive%2520Evaluation%2520of%2520Ten%2520Docking%2520Programs%2520on%2520a%2520Diverse%2520Set%2520of%2520Protein%25E2%2580%2593Ligand%2520Complexes%253A%2520The%2520Prediction%2520Accuracy%2520of%2520Sampling%2520Power%2520and%2520Scoring%2520Power%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2016%26volume%3D18%26spage%3D12964%26epage%3D12975%26doi%3D10.1039%2FC6CP01555G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurkinen, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lätti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentikäinen, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postila, P. A.</span></span> <span> </span><span class="NLM_article-title">Getting Docking into Shape Using Negative Image-Based Rescoring</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3584</span>– <span class="NLM_lpage">3599</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.9b00383</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.9b00383" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlCit7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=3584-3599&author=S.+T.+Kurkinenauthor=S.+L%C3%A4ttiauthor=O.+T.+Pentik%C3%A4inenauthor=P.+A.+Postila&title=Getting+Docking+into+Shape+Using+Negative+Image-Based+Rescoring&doi=10.1021%2Facs.jcim.9b00383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Getting Docking into Shape Using Negative Image-Based Rescoring</span></div><div class="casAuthors">Kurkinen, Sami T.; Latti, Sakari; Pentikainen, Olli T.; Postila, Pekka A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3584-3599</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The failure of default scoring functions to ensure virtual screening enrichment is a persistent problem for the mol. docking algorithms used in structure-based drug discovery.  To remedy this problem, elaborate rescoring and postprocessing schemes have been developed with a varying degree of success, specificity, and cost.  The neg. image-based rescoring (R-NiB) has been shown to improve the flexible docking performance markedly with a variety of drug targets.  The yield improvement is achieved by comparing the alternative docking poses against the neg. image of the target protein's ligand-binding cavity.  In other words, the shape and electrostatics of the binding pocket is directly used in the similarity comparison to rank the explicit docking poses.  Here, the PANTHER/ShaEP-based R-NiB methodol. is tested with six popular docking softwares, including GLIDE, PLANTS, GOLD, DOCK, AUTODOCK, and AUTODOCK VINA, using five validated benchmark sets.  Overall, the results indicate that R-NiB outperforms the default docking scoring consistently and inexpensively, demonstrating that the methodol. is ready for wide-scale virtual screening usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsMAV2Do_yo7Vg90H21EOLACvtfcHk0li_n0v0S-7XZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlCit7rF&md5=49c32be0c52097eaa1bf8d55ad47e037</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.9b00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.9b00383%26sid%3Dliteratum%253Aachs%26aulast%3DKurkinen%26aufirst%3DS.%2BT.%26aulast%3DL%25C3%25A4tti%26aufirst%3DS.%26aulast%3DPentik%25C3%25A4inen%26aufirst%3DO.%2BT.%26aulast%3DPostila%26aufirst%3DP.%2BA.%26atitle%3DGetting%2520Docking%2520into%2520Shape%2520Using%2520Negative%2520Image-Based%2520Rescoring%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D3584%26epage%3D3599%26doi%3D10.1021%2Facs.jcim.9b00383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibition of TLR8 through Stabilization of Its Resting State</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnchembio.2518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=29155428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=58-64&author=S.+Zhangauthor=Z.+Huauthor=H.+Tanjiauthor=S.+Jiangauthor=N.+Dasauthor=J.+Liauthor=K.+Sakaniwaauthor=J.+Jinauthor=Y.+Bianauthor=U.+Ohtoauthor=T.+Shimizuauthor=H.+Yin&title=Small-Molecule+Inhibition+of+TLR8+through+Stabilization+of+Its+Resting+State&doi=10.1038%2Fnchembio.2518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of TLR8 through stabilization of its resting state</span></div><div class="casAuthors">Zhang, Shuting; Hu, Zhenyi; Tanji, Hiromi; Jiang, Shuangshuang; Das, Nabanita; Li, Jing; Sakaniwa, Kentaro; Jin, Jin; Bian, Yanyan; Ohto, Umeharu; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Endosomal Toll-like receptors (TLR3, TLR7, TLR8, and TLR9) are highly analogous sensors for various viral or bacterial RNA and DNA mol. patterns.  Nonetheless, few small mols. can selectively modulate these TLRs.  In this manuscript, we identified the first human TLR8-specific small-mol. antagonists via a novel inhibition mechanism.  Crystal structures of two distinct TLR8-ligand complexes validated a unique binding site on the protein-protein interface of the TLR8 homodimer.  Upon binding to this new site, the small-mol. ligands stabilize the preformed TLR8 dimer in its resting state, preventing activation.  As a proof of concept of their therapeutic potential, we have demonstrated that these drug-like inhibitors are able to suppress TLR8-mediated proinflammatory signaling in various cell lines, human primary cells, and patient specimens.  These results not only suggest a novel strategy for TLR inhibitor design, but also shed crit. mechanistic insight into these clin. important immune receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPrewccnFLv7Vg90H21EOLACvtfcHk0li_n0v0S-7XZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN&md5=1b43da16d6670324d77bb5e2c417cfe6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2518%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520Inhibition%2520of%2520TLR8%2520through%2520Stabilization%2520of%2520Its%2520Resting%2520State%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D58%26epage%3D64%26doi%3D10.1038%2Fnchembio.2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cascade development of potent dual TLR7/9 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Reagents and Conditions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1-Ethylpiperazine (1.5 equiv, for compound <b>3</b>) or 1-cyclopentylpiperazine (1.5 equiv, for compound <b>4</b>), K<sub>2</sub>CO<sub>3</sub> (2 equiv), ACN, reflux, 4–6 h; (b) 1-(3-chloropropyl)-4-ethylpiperazine (1.5 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF, 100 °C, 12 h; (c) (i) various aromatic aldehydes (1.2 equiv), toluene, reflux, 12 h; (ii) sodium triacetoxyborohydride (2 equiv), dichloroethane (DCE), rt, 2 h; (d) benzoyl chloride (3 equiv), pyridine (6.0 equiv), DCM, rt, 10 h; (e) 1,4-dibromobutane (1.2 equiv), sodium hydride (1.5 equiv), DMF, 80 °C, 12 h; and (f) 4-((dimethylamino)methyl)benzoic acid (1.2 equiv), POCl<sub>3</sub> (1.5 equiv), pyridine, rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Reagents and Conditions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1-(3-Chloropropyl)-4-ethylpiperazine (1.5 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF, 80 °C, 12 h; (b) phenyl(piperazin-1-yl)methanone (1.5 equiv, for compound <b>18</b>), cyclopentyl(piperazin-1-yl)methanone (1.5 equiv, for compound <b>19</b>), potassium carbonate (2 equiv), ACN, reflux, 4 h; (c) (i) appropriate aromatic aldehydes (1.2 equiv), toluene, 12 h, reflux, (ii) sodium triacetoxyborohydride (2 equiv), DCE, 2 h, rt; and (d) 1,4-dibromobutane (1.2 equiv), sodium hydride (1.5 equiv), DMF, 80 °C, 12 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Reagents and Conditions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1-(3-Chloropropyl)pyrrolidine (1.5 equiv), K<sub>2</sub>CO<sub>3</sub> (2 equiv), DMF, 80 °C, 12 h; (b) (i) various aromatic aldehydes (1.2 equiv), toluene, 12 h, reflux; (ii) sodium triacetoxyborohydride (2 equiv), DCE, 1–2 h, rt; and (c) 4-((dimethylamino)methyl)benzoic acid (1.2 equiv), POCl<sub>3</sub> (1.5 equiv), pyridine, rt, 2 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Molecular interaction between the homology model of the homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>1</b>. (B) Molecular overlapping of the docked conformation of compound <b>1</b> and compound <b>5</b>. Compound <b>1</b> is represented as a yellowish-orange stick representation, whereas the green stick representation depicts compound <b>5</b>. (C) Interaction between the TLR7 ectodomain and compound <b>10</b>. Hydrogen bonds and hydrophobic interactions are shown by green dashed lines and gray dashed lines, respectively. *Indicates residues in chain B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Molecular interaction between the homology-built homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>27</b>. The two chains are represented by teal and pink cartoon representations, respectively. Hydrogen bonds and hydrophobic interactions are shown by green dashed lines and gray dashed lines, respectively. (B) Molecular overlapping of the docked conformation of compound <b>1</b> and compound <b>27</b>. Compound <b>1</b> is represented as a yellowish-orange stick representation, whereas the pale-green stick representation depicts compound <b>27</b>. *Indicates residues in chain B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reporter assays of potent TLR7 and TLR9 antagonists. (A) The compounds were assessed for dose-dependent inhibition of TLR7, using a HEK-Blue TLR7 cell line expressing a TLR7-responsive, NF-κB-inducible SEAP. Data are shown as mean ± SD, <i>n</i> = 3. (B) The compounds were assessed for dose-dependent inhibition of TLR9, using a HEK-Blue TLR9 cell line expressing a TLR9-responsive, NF-κB-inducible SEAP. Data are shown as mean ± SD, <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Molecular interaction between the homology-built homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>29</b>. The two chains are represented by teal and pink cartoon representations, respectively. Hydrogen bonds and hydrophobic interactions are shown by the green dashed line and the gray dashed line, respectively. (B) Molecular interaction between the homology-built homodimerized TLR7 ectodomain (template PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ">5WYZ</a>) and compound <b>30</b>. The two chains are represented by teal and pink cartoon representations, respectively. Hydrogen bonds, halogen bonds, and hydrophobic interactions are shown by green and magenta dashed lines and gray dashed lines, respectively. *Indicates residues in chain B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Determination of <i>in vitro</i> cytotoxicity of potent TLR9 antagonists. (A) Human PBMCs, (B) HCT116, (C) HepG2, and (D) H9C2 cells were treated with mentioned concentrations of the compounds overnight and assessed by propidium iodide staining and flow cytometry to determine the percentage of live/dead cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Study of <i>in vivo</i> efficacy of compound <b>29</b>. (A) Oral administration of compound <b>29</b> at a dose of 10 mg/kg body weight of mice was performed in the target group of mice 1 h before ip injection of a mixture of CpGA and CpGB. After 18 h, the peritoneal wash was collected. The IFNα enzyme-linked immunosorbent assay (ELISA) was performed using the peritoneal fluid, while the expression of target genes was monitored in the cellular component. (B) Flow cytometric analysis of a cellular component of peritoneal wash was performed to determine the infiltration of immune cells, especially pDCs into mouse peritoneum. (C) The concentration of IFNα in mice peritoneal fluid w/o administration of compound <b>29</b> was measured by IFNα ELISA (two independent experiments). (D, E) The mRNA expression levels of IFIT1 (D) and ISG15 (E) in the peritoneal infiltrating cells of mice w/o exposure to compound <b>29</b> were quantified by real-time polymerase chain reaction (PCR; two independent experiments).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Efficacy of compound <b>29</b> in preventing psoriasis-like inflammation in a rodent model. (A) (Left) Representative image of murine skin before starting of imiquimod application (on day 0). (Middle) Representative image of control murine skin on day 7 following topical application of imiquimod for 6 days and oral administration of vehicle for 7 days, showing extensive scale formation on skin. (Right) Posterior skin of mouse on day 7 following 6 days of imiquimod application and 7 days of compound <b>29</b> administration showing drastic reduction of scale formation. (B) (Left) H&E-stained section from imiquimod-exposed skin of vehicle-treated mouse showing remarkable broadening of the epidermal layer, (right) H&E-stained section from imiquimod-exposed skin of mouse treated with compound <b>29</b>, showing lesser broadening of the epidermis compared to the vehicle-treated group (objective magnification 20×). (C) Severity of psoriasis was scored based on clinically relevant histopathological features (where 1 is the least severe and 3 is the most severe). (D) Difference in scores representing the severity of indicated histopathological parameters in psoriatic skin sections derived from seven control mice and six compound-treated mice. The Mann–Whitney test was performed (*<i>p</i> < 0.05, **<i>p</i> < 0.01). (E) Plotting of overall severity scores for each mouse of both control and treatment groups based on all evaluated histopathological features. Unpaired <i>t</i>-test was done (*<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/medium/jm1c00532_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Short-term toxicity evaluation for control and compound-treated mice. (A–F) Representative images showing H&E-stained sections of indicated organs of mice, which have received either vehicle (A, C, E) or compound <b>29</b> (B, D, F) for 7 consecutive days (objective magnification 10×).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00532/20210629/images/large/jm1c00532_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00532&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 68 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">Toll-Like Receptors</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.21.120601.141126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1146%2Fannurev.immunol.21.120601.141126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=12524386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtF2isrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=335-376&author=K.+Takedaauthor=T.+Kaishoauthor=S.+Akira&title=Toll-Like+Receptors&doi=10.1146%2Fannurev.immunol.21.120601.141126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors</span></div><div class="casAuthors">Takeda, Kiyoshi; Kaisho, Tsuneyasu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-376</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The innate immune system in drosophila and mammals senses the invasion of microorganisms using the family of Toll receptors, stimulation of which initiates a range of host defense mechanisms.  In drosophila antimicrobial responses rely on two signaling pathways: the Toll pathway and the IMD pathway.  In mammals there are at least 10 members of the Toll-like receptor (TLR) family that recognize specific components conserved among microorganisms.  Activation of the TLRs leads not only to the induction of inflammatory responses but also to the development of antigenspecific adaptive immunity.  The TLR-induced inflammatory response is dependent on a common signaling pathway that is mediated by the adaptor mol. MyD88.  However, there is evidence for addnl. pathways that mediate TLR ligand-specific biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnTUaIjFGoVrVg90H21EOLACvtfcHk0ljddkYDiVyFbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtF2isrg%253D&md5=e757bd9618284b2883d6314729712967</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.21.120601.141126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.21.120601.141126%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DToll-Like%2520Receptors%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D21%26spage%3D335%26epage%3D376%26doi%3D10.1146%2Fannurev.immunol.21.120601.141126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, O.</span></span> <span> </span><span class="NLM_article-title">Pathogen Recognition and Innate Immunity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.02.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.cell.2006.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=16497588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Kltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=783-801&author=S.+Akiraauthor=S.+Uematsuauthor=O.+Takeuchi&title=Pathogen+Recognition+and+Innate+Immunity&doi=10.1016%2Fj.cell.2006.02.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogen recognition and innate immunity</span></div><div class="casAuthors">Akira, Shizuo; Uematsu, Satoshi; Takeuchi, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">783-801</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Microorganisms that invade a vertebrate host are initially recognized by the innate immune system through germline-encoded pattern-recognition receptors (PRRs).  Several classes of PRRs, including Toll-like receptors and cytoplasmic receptors, recognize distinct microbial components and directly activate immune cells.  Exposure of immune cells to the ligands of these receptors activates intracellular signaling cascades that rapidly induce the expression of a variety of overlapping and unique genes involved in the inflammatory and immune responses.  New insights into innate immunity are changing the way we think about pathogenesis and the treatment of infectious diseases, allergy, and autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEZpCMLVNgq7Vg90H21EOLACvtfcHk0ljddkYDiVyFbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Kltb8%253D&md5=8b85d998957b36d67865ca30dbfedfbd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DTakeuchi%26aufirst%3DO.%26atitle%3DPathogen%2520Recognition%2520and%2520Innate%2520Immunity%26jtitle%3DCell%26date%3D2006%26volume%3D124%26spage%3D783%26epage%3D801%26doi%3D10.1016%2Fj.cell.2006.02.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptor Signalling</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nri1391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri1391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=15229469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Cqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=499-511&author=S.+Akiraauthor=K.+Takeda&title=Toll-like+Receptor+Signalling&doi=10.1038%2Fnri1391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor signalling</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">499-511</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One of the mechanisms by which the innate immune system senses the invasion of pathogenic microorganisms is through the Toll-like receptors (TLRs), which recognize specific mol. patterns that are present in microbial components.  Stimulation of different TLRs induces distinct patterns of gene expression, which not only leads to the activation of innate immunity but also instructs the development of antigen-specific acquired immunity.  Here, the authors review the rapid progress that has recently improved the authors' understanding of the mol. mechanisms that mediate TLR signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCtsuKm49fcLVg90H21EOLACvtfcHk0ljddkYDiVyFbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Cqur0%253D&md5=979700b403e0f8b062b69906cf07b289</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri1391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1391%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26atitle%3DToll-like%2520Receptor%2520Signalling%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2004%26volume%3D4%26spage%3D499%26epage%3D511%26doi%3D10.1038%2Fnri1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors: Critical Proteins Linking Innate and Acquired Immunity</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">675</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1038/90609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2F90609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=11477402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=675-680&author=S.+Akiraauthor=K.+Takedaauthor=T.+Kaisho&title=Toll-like+Receptors%3A+Critical+Proteins+Linking+Innate+and+Acquired+Immunity&doi=10.1038%2F90609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors: Critical proteins linking innate and acquired immunity</span></div><div class="casAuthors">Akira, Shizuo; Takeda, Kiyoshi; Kaisho, Tsuneyasu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-680</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A review with 84 refs.  Recognition of pathogens is mediated by a set of germline-encoded receptors that are referred to as pattern-recognition receptors (PRRs).  These receptors recognize conserved mol. patterns (pathogen-assocd. mol. patterns), which are shared by large groups of microorganisms.  Toll-like receptors (TLRs) function as the PRRs in mammals and play an essential role in the recognition of microbial components.  The TLRs may also recognize endogenous ligands induced during the inflammatory response.  Similar cytoplasmic domains allow TLRs to use the same signaling mols. used by the interleukin 1 receptors (IL-1Rs): these include MyD88, IL-1R-assocd. protein kinase and tumor necrosis factor receptor-activated factor 6.  However, evidence is accumulating that the signaling pathways assocd. with each TLR are not identical and may, therefore, result in different biol. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom8I2sSl7FK7Vg90H21EOLACvtfcHk0ljOibFsMXb4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGjtLs%253D&md5=3fd5a975d63e0384c8cffa960159b063</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F90609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F90609%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DKaisho%26aufirst%3DT.%26atitle%3DToll-like%2520Receptors%253A%2520Critical%2520Proteins%2520Linking%2520Innate%2520and%2520Acquired%2520Immunity%26jtitle%3DNat.%2520Immunol.%26date%3D2001%26volume%3D2%26spage%3D675%26epage%3D680%26doi%3D10.1038%2F90609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gay, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symmons, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangloff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, C. E.</span></span> <span> </span><span class="NLM_article-title">Assembly and Localization of Toll-like Receptor Signalling Complexes</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/nri3713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri3713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=25060580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1WksbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=546-558&author=N.+J.+Gayauthor=M.+F.+Symmonsauthor=M.+Gangloffauthor=C.+E.+Bryant&title=Assembly+and+Localization+of+Toll-like+Receptor+Signalling+Complexes&doi=10.1038%2Fnri3713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Assembly and localization of Toll-like receptor signalling complexes</span></div><div class="casAuthors">Gay, Nicholas J.; Symmons, Martyn F.; Gangloff, Monique; Bryant, Clare E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">546-558</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Signal transduction by the Toll-like receptors (TLRs) is central to host defense against many pathogenic microorganisms and also underlies a large burden of human disease.  Thus, the mechanisms and regulation of signalling by TLRs are of considerable interest.  In this Review, we discuss the mol. basis for the recognition of pathogen-assocd. mol. patterns, the nature of the protein complexes that mediate signalling, and the way in which signals are regulated and integrated at the level of allosteric assembly, post-translational modification and subcellular trafficking of the components of the signalling complexes.  These fundamental mol. mechanisms det. whether the signalling output leads to a protective immune response or to serious pathologies such as sepsis.  A detailed understanding of these processes at the mol. level provides a rational framework for the development of new drugs that can specifically target pathol. rather than protective signalling in inflammatory and autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwmfOHjdJ29rVg90H21EOLACvtfcHk0ljOibFsMXb4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1WksbnN&md5=7370b6f825d2a8070806850d43566ec4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnri3713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3713%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DN.%2BJ.%26aulast%3DSymmons%26aufirst%3DM.%2BF.%26aulast%3DGangloff%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DC.%2BE.%26atitle%3DAssembly%2520and%2520Localization%2520of%2520Toll-like%2520Receptor%2520Signalling%2520Complexes%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D546%26epage%3D558%26doi%3D10.1038%2Fnri3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gay, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangloff, M.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Toll Receptors and Their Ligands</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1146/annurev.biochem.76.060305.151318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1146%2Fannurev.biochem.76.060305.151318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17362201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2007&pages=141-165&author=N.+J.+Gayauthor=M.+Gangloff&title=Structure+and+Function+of+Toll+Receptors+and+Their+Ligands&doi=10.1146%2Fannurev.biochem.76.060305.151318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of Toll receptors and their ligands</span></div><div class="casAuthors">Gay, Nicholas J.; Gangloff, Monique</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-165</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The Toll family of class I transmembrane receptors recognizes and responds to diverse structures assocd. with pathogenic microorganisms.  These receptors mediate initial responses in innate immunity and are required for the development of the adaptive immune response.  Toll receptor signaling pathways are also implicated in serious autoimmune diseases such as endotoxic shock and thus are important therapeutic targets.  In this review we discuss how microbial structures as different as nucleic acids and lipoproteins can be recognized by the extracellular domains of Toll receptors.  We review recent evidence that the mechanism of signal transduction is complex and involves sequential changes in the conformation of the receptor induced by binding of the ligand.  Finally, we assess the emerging area of cross talk in the Toll pathways.  Recent work suggests that signaling through TLR4 in response to endotoxin is modified by inputs from at least two other pathways acting through β2 integrins and protein kinase Cε.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn3CtNWyA1pLVg90H21EOLACvtfcHk0ljOibFsMXb4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVehtb7J&md5=8500c7f551b106bc0ca7266d8ced1821</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.76.060305.151318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.76.060305.151318%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DN.%2BJ.%26aulast%3DGangloff%26aufirst%3DM.%26atitle%3DStructure%2520and%2520Function%2520of%2520Toll%2520Receptors%2520and%2520Their%2520Ligands%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2007%26volume%3D76%26spage%3D141%26epage%3D165%26doi%3D10.1146%2Fannurev.biochem.76.060305.151318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golenbock, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowie, A. G.</span></span> <span> </span><span class="NLM_article-title">The History of Toll-like Receptors — Redefining Innate Immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1038/nri3446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri3446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=23681101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslaisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=453-460&author=L.+A.+J.+O%E2%80%99Neillauthor=D.+Golenbockauthor=A.+G.+Bowie&title=The+History+of+Toll-like+Receptors+%E2%80%94+Redefining+Innate+Immunity&doi=10.1038%2Fnri3446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The history of Toll-like receptors - redefining innate immunity</span></div><div class="casAuthors">O'Neill, Luke A. J.; Golenbock, Douglas; Bowie, Andrew G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of Toll-like receptors (TLRs) was an important event for immunol. research and was recognized as such with the awarding of the 2011 Nobel Prize in Physiol. or Medicine to Jules Hoffmann and Bruce Beutler, who, together with Ralph Steinman, the third winner of the 2011 Nobel Prize and the person who discovered the dendritic cell, were pioneers in the field of innate immunity.  TLRs have a central role in immunity - in this Timeline article, we describe the landmark findings that gave rise to this important field of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNQuHgmx29MrVg90H21EOLACvtfcHk0ljOibFsMXb4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslaisLc%253D&md5=4d5ca89abf3932000ae422d79ecbe93f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnri3446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3446%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26aulast%3DGolenbock%26aufirst%3DD.%26aulast%3DBowie%26aufirst%3DA.%2BG.%26atitle%3DThe%2520History%2520of%2520Toll-like%2520Receptors%2520%25E2%2580%2594%2520Redefining%2520Innate%2520Immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2013%26volume%3D13%26spage%3D453%26epage%3D460%26doi%3D10.1038%2Fnri3446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">Signaling Pathways Activated by Microorganisms</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2007.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ceb.2007.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17303405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=185-191&author=O.+Takeuchiauthor=S.+Akira&title=Signaling+Pathways+Activated+by+Microorganisms&doi=10.1016%2Fj.ceb.2007.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling pathways activated by microorganisms</span></div><div class="casAuthors">Takeuchi, Osamu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-191</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Invasion of viruses and bacteria is initially sensed by the host innate immune system, and evokes a rapid inflammatory response.  Nucleotides from RNA viruses are recognized by retinoic-acid-inducible gene I-like helicases and Toll-like receptors, and this recognition triggers signaling cascades that induce antiviral mediators such as type I interferons.  By contrast, Toll-like receptors recognizing bacterial components induce the expression of proinflammatory cytokines.  Furthermore, recent studies suggest that viral and bacterial DNA also induce interferons in a Toll-independent mechanism, possibly through unidentified cytoplasmic receptor(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVjTX-dD6TtbVg90H21EOLACvtfcHk0liGzdw_FAXQ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu7c%253D&md5=86991f25b0d7e6b164e3f327b193fe3c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2007.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2007.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DSignaling%2520Pathways%2520Activated%2520by%2520Microorganisms%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2007%26volume%3D19%26spage%3D185%26epage%3D191%26doi%3D10.1016%2Fj.ceb.2007.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barchet, W.</span></span> <span> </span><span class="NLM_article-title">Translating Nucleic Acid-Sensing Pathways into Therapies</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/nri3875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri3875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=26292638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=529-544&author=T.+Juntauthor=W.+Barchet&title=Translating+Nucleic+Acid-Sensing+Pathways+into+Therapies&doi=10.1038%2Fnri3875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Translating nucleic acid-sensing pathways into therapies</span></div><div class="casAuthors">Junt, Tobias; Barchet, Winfried</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">529-544</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleic acid sensing by innate receptors initiates immune defences against viruses and other pathogens.  A hallmark of this response is the release of interferons (IFNs), which promote protective immunity by inducing IFN-stimulated genes (ISGs).  A similar ISG signature is found in autoinflammatory and autoimmune conditions, indicating that chronic activation of nucleic acid-sensing pathways may contribute to these diseases.  Here, we review how nucleic acid-sensing pathways are currently being targeted pharmacol. with both agonists and antagonists.  We discuss how an improved understanding of the biol. of these pathways is leading to novel therapies for infections, cancer, and autoimmune and autoinflammatory disorders, and how new therapeutics will, in turn, generate a deeper understanding of these complex diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYKnDGOTSvbVg90H21EOLACvtfcHk0liGzdw_FAXQ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM&md5=3afa98f84abcce81338604d3c3c5075c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnri3875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3875%26sid%3Dliteratum%253Aachs%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DBarchet%26aufirst%3DW.%26atitle%3DTranslating%2520Nucleic%2520Acid-Sensing%2520Pathways%2520into%2520Therapies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D529%26epage%3D544%26doi%3D10.1038%2Fnri3875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Potential Therapeutic Targets in the Process of Nucleic Acid Recognition: Opportunities and Challenges</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.tips.2014.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=25479797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2mt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=51-64&author=S.+Heauthor=X.+Maoauthor=H.+Sunauthor=T.+Shirakawaauthor=H.+Zhangauthor=X.+Wang&title=Potential+Therapeutic+Targets+in+the+Process+of+Nucleic+Acid+Recognition%3A+Opportunities+and+Challenges&doi=10.1016%2Fj.tips.2014.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic targets in the process of nucleic acid recognition: opportunities and challenges</span></div><div class="casAuthors">He, Shaoheng; Mao, Xiaoquan; Sun, Hongzhi; Shirakawa, Taro; Zhang, Huiyun; Wang, Xiangdong</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Nucleic acid recognition or sensing (NAS) is accepted as a fundamental function in the host defense against self or foreign genetic elements.  Abnormal recognition or interpretation of microbial-origin pathogen-assocd. mol. patterns (PAMPs) or damage-assocd. mol. patterns (DAMPs) can lead to infections or autoimmune diseases (ADs).  Modulation of the NAS process represents a path toward the development of novel vaccines or drugs, through targets such as myeloid differentiation primary-response protein 88 (MyD88) and tumor necrosis factor (TNF) receptor-assocd. factor (TRAF) 3 and 6 in Toll-like receptor (TLR)-mediated signaling pathways.  DNA helicases can be targeted by arresting replication and the breakage of DNA double strands.  Stimulator of interferon (IFN) genes (STING) may act as a therapeutic target by upregulation of the STING-dependent pathway or vaccination with cyclic GMP-AMP (cGAMP) synthase (cGAS)-catalyzed reaction products.  Several challenges are faced before and during clin. therapy.  NAS can be an important breakthrough for mol. targets and therapies.  The specificity of drug delivery, potential of long-term genotoxicity, risk of tumorigenesis, duration of drug efficacy, and drug metab. should be further validated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJyrw2cvLTrrVg90H21EOLACvtfcHk0liGzdw_FAXQ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2mt7jE&md5=1cb8ef263c2ead972f6bf854ebd527e9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShirakawa%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DPotential%2520Therapeutic%2520Targets%2520in%2520the%2520Process%2520of%2520Nucleic%2520Acid%2520Recognition%253A%2520Opportunities%2520and%2520Challenges%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D51%26epage%3D64%26doi%3D10.1016%2Fj.tips.2014.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, G. M.</span></span> <span> </span><span class="NLM_article-title">Trafficking of Endosomal Toll-like Receptors</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2013.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.tcb.2013.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24439965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Kjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=360-369&author=B.+L.+Leeauthor=G.+M.+Barton&title=Trafficking+of+Endosomal+Toll-like+Receptors&doi=10.1016%2Fj.tcb.2013.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Trafficking of endosomal Toll-like receptors</span></div><div class="casAuthors">Lee, Bettina L.; Barton, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">360-369</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade we have learned much about nucleic acid recognition by the innate immune system and in particular by Toll-like receptors (TLRs).  These receptors localize to endosomal compartments where they are poised to recognize microbial nucleic acids.  Multiple regulatory mechanisms function to limit responses to self DNA or RNA, and breakdowns in these mechanisms can contribute to autoimmune or inflammatory disorders.  In this review we discuss our current understanding of the cell biol. of TLRs involved in nucleic acid recognition and how localization and trafficking of these receptors regulates their function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYP1LYUhAD17Vg90H21EOLACvtfcHk0liDejju7vBREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Kjs7g%253D&md5=9716c3b0ddd6a8f8427eecd31f7f0acf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2013.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BL.%26aulast%3DBarton%26aufirst%3DG.%2BM.%26atitle%3DTrafficking%2520of%2520Endosomal%2520Toll-like%2520Receptors%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26spage%3D360%26epage%3D369%26doi%3D10.1016%2Fj.tcb.2013.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dammer, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, R.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span> <span> </span><span class="NLM_article-title">The Endosomal-Lysosomal System: From Acidification and Cargo Sorting to Neurodegeneration</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">18</span> <span class="refDoi"> DOI: 10.1186/s40035-015-0041-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1186%2Fs40035-015-0041-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=26448863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&author=Y.-B.+Huauthor=E.+B.+Dammerauthor=R.-J.+Renauthor=G.+Wang&title=The+Endosomal-Lysosomal+System%3A+From+Acidification+and+Cargo+Sorting+to+Neurodegeneration&doi=10.1186%2Fs40035-015-0041-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</span></div><div class="casAuthors">Hu, Yong-Bo; Dammer, Eric B.; Ren, Ru-Jing; Wang, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18/1-18/10</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The endosomal-lysosomal system is made up of a set of intracellular membranous compartments that dynamically interconvert, which is comprised of early endosomes, recycling endosomes, late endosomes, and the lysosome.  In addn., autophagosomes execute autophagy, which delivers intracellular contents to the lysosome.  Maturation of endosomes and/or autophagosomes into a lysosome creates an unique acidic environment within the cell for proteolysis and recycling of unneeded cellular components into usable amino acids and other biomol. building blocks.  In the endocytic pathway, gradual maturation of endosomes into a lysosome and acidification of the late endosome are accompanied by vesicle trafficking, protein sorting and targeted degrdn. of some sorted cargo.  Two opposing sorting systems are operating in these processes: the endosomal sorting complex required for transport (ESCRT) supports targeted degrdn. and the retromer supports retrograde retrieval of certain cargo.  The endosomal-lysosomal system is emerging as a central player in a host of neurodegenerative diseases, demonstrating potential roles which are likely to be revealed in pathogenesis and for viable therapeutic strategies.  Here we focus on the physiol. process of endosomal-lysosomal maturation, acidification and sorting systems along the endocytic pathway, and further discuss relationships between abnormalities in the endosomal-lysosomal system and neurodegenerative diseases, esp. Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79sz_jogdArVg90H21EOLACvtfcHk0liDejju7vBREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVChtLc%253D&md5=819113d11b363b56845873309c4219ef</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs40035-015-0041-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-015-0041-1%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.-B.%26aulast%3DDammer%26aufirst%3DE.%2BB.%26aulast%3DRen%26aufirst%3DR.-J.%26aulast%3DWang%26aufirst%3DG.%26atitle%3DThe%2520Endosomal-Lysosomal%2520System%253A%2520From%2520Acidification%2520and%2520Cargo%2520Sorting%2520to%2520Neurodegeneration%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2015%26volume%3D4%26doi%3D10.1186%2Fs40035-015-0041-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochrein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ampenberger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschning, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipford, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span> <span> </span><span class="NLM_article-title">Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1526</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.1126/science.1093620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscience.1093620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=14976262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslCgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1526-1529&author=F.+Heilauthor=H.+Hemmiauthor=H.+Hochreinauthor=F.+Ampenbergerauthor=C.+Kirschningauthor=S.+Akiraauthor=G.+Lipfordauthor=H.+Wagnerauthor=S.+Bauer&title=Species-Specific+Recognition+of+Single-Stranded+RNA+via+Toll-like+Receptor+7+and+8&doi=10.1126%2Fscience.1093620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8</span></div><div class="casAuthors">Heil, Florian; Hemmi, Hiroaki; Hochrein, Hubertus; Ampenberger, Franziska; Kirschning, Carsten; Akira, Shizuo; Lipford, Grayson; Wagner, Hermann; Bauer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5663</span>),
    <span class="NLM_cas:pages">1526-1529</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Double-stranded RNA (dsRNA) serves as a danger signal assocd. with viral infection and leads to stimulation of innate immune cells.  In contrast, the immunostimulatory potential of single-stranded RNA (ssRNA) is poorly understood and innate immune receptors for ssRNA are unknown.  The authors report that guanosine (G)- and uridine (U)-rich ssRNA oligonucleotides derived from human immunodeficiency virus-1 (HIV-1) stimulate dendritic cells (DC) and macrophages to secrete interferon-α and proinflammatory, as well as regulatory, cytokines.  By using Toll-like receptor (TLR)-deficient mice and genetic complementation, the authors show that murine TLR7 and human TLR8 mediate species-specific recognition of GU-rich ssRNA.  These data suggest that ssRNA represents a physiol. ligand for TLR7 and TLR8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaDTp7TLlTxLVg90H21EOLACvtfcHk0liDejju7vBREA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslCgsLc%253D&md5=33596446b6a66f5d3f9137eb83aaa242</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1093620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1093620%26sid%3Dliteratum%253Aachs%26aulast%3DHeil%26aufirst%3DF.%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DHochrein%26aufirst%3DH.%26aulast%3DAmpenberger%26aufirst%3DF.%26aulast%3DKirschning%26aufirst%3DC.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DLipford%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DH.%26aulast%3DBauer%26aufirst%3DS.%26atitle%3DSpecies-Specific%2520Recognition%2520of%2520Single-Stranded%2520RNA%2520via%2520Toll-like%2520Receptor%25207%2520and%25208%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1526%26epage%3D1529%26doi%3D10.1126%2Fscience.1093620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis e Sousa, C.</span></span> <span> </span><span class="NLM_article-title">Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1529</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.1126/science.1093616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscience.1093616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=14976261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1529-1531&author=S.+S.+Dieboldauthor=T.+Kaishoauthor=H.+Hemmiauthor=S.+Akiraauthor=C.+Reis+e+Sousa&title=Innate+Antiviral+Responses+by+Means+of+TLR7-Mediated+Recognition+of+Single-Stranded+RNA&doi=10.1126%2Fscience.1093616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA</span></div><div class="casAuthors">Diebold, Sandra S.; Kaisho, Tsuneyasu; Hemmi, Hiroaki; Akira, Shizuo; Reis e Sousa, Caetano</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5663</span>),
    <span class="NLM_cas:pages">1529-1532</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Interferons (IFNs) are crit. for protection from viral infection, but the pathways linking virus recognition to IFN induction remain poorly understood.  Plasmacytoid dendritic cells produce vast amts. of IFN-α in response to the wild-type influenza virus.  Here, the authors show that this requires endosomal recognition of influenza genomic RNA and signaling by Toll-like receptor 7 (TLR7) and MyD88.  Single-stranded RNA (ssRNA) mols. of nonviral origin also induce TLR7-dependent prodn. of inflammatory cytokines.  These results identify ssRNA as a ligand for TLR7 and suggest that cells of the innate immune system sense endosomal ssRNA to detect infection by RNA viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtBc4fjjNOxLVg90H21EOLACvtfcHk0liqmjmNbw5R8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslCgsb4%253D&md5=0cda7727b7f1dfc08f183bc23c0224d2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.1093616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1093616%26sid%3Dliteratum%253Aachs%26aulast%3DDiebold%26aufirst%3DS.%2BS.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DReis%2Be%2BSousa%26aufirst%3DC.%26atitle%3DInnate%2520Antiviral%2520Responses%2520by%2520Means%2520of%2520TLR7-Mediated%2520Recognition%2520of%2520Single-Stranded%2520RNA%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1529%26epage%3D1531%26doi%3D10.1126%2Fscience.1093616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hemmi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaisho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanjo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoshino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">A Toll-like Receptor Recognizes Bacterial DNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1038/35047123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2F35047123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=11130078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVCqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=740-745&author=H.+Hemmiauthor=O.+Takeuchiauthor=T.+Kawaiauthor=T.+Kaishoauthor=S.+Satoauthor=H.+Sanjoauthor=M.+Matsumotoauthor=K.+Hoshinoauthor=H.+Wagnerauthor=K.+Takedaauthor=S.+Akira&title=A+Toll-like+Receptor+Recognizes+Bacterial+DNA&doi=10.1038%2F35047123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Toll-like receptor recognizes bacterial DNA</span></div><div class="casAuthors">Hemmi, Hiroaki; Takeuchi, Osamu; Kawai, Taro; Kaisho, Tsuneyasu; Sato, Shintaro; Sanjo, Hideki; Matsumoto, Makoto; Hoshino, Katsuaki; Wagner, Hermann; Takeda, Kiyoshi; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6813</span>),
    <span class="NLM_cas:pages">740-745</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">DNA from bacteria has stimulatory effects on mammalian immune cells, which depend on the presence of unmethylated CpG dinudeotides in the bacterial DNA.  In contrast, mammalian DNA has a low frequency of CpG dinucleotides, and these are mostly methylated; therefore, mammalian DNA does not have immuno-stimulatory activity.  CpG DNA induces a strong T-helper-1-like inflammatory response.  Accumulating evidence has revealed the therapeutic potential of CpG DNA as adjuvants for vaccination strategies for cancer, allergy and infectious diseases.  Despite its promising clin. use, the mol. mechanism by which CpG DNA activates immune cells remains unclear.  Here the authors show that cellular response to CpG DNA is mediated by a Toll-like receptor, TLR9.  TLR9-deficient (TLR9-/-) mice did not show any response to CpG DNA, including proliferation of splenocytes, inflammatory cytokine prodn. from macrophages and maturation of dendritic cells.  TLR9-/- mice showed resistance to the lethal effect of CpG DNA without any elevation of serum pro-inflammatory cytokine levels.  The in vivo CpG-DNA-mediated T-helper type-1 response was also abolished in TLR9-/- mice.  Thus, vertebrate immune systems appear to have evolved a specific Toll-like receptor that distinguishes bacterial DNA from self-DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOZ-nQmoTgLVg90H21EOLACvtfcHk0liqmjmNbw5R8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVCqsL0%253D&md5=70d56020c85d5754be6ff47a17eb19e1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2F35047123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35047123%26sid%3Dliteratum%253Aachs%26aulast%3DHemmi%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DKaisho%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DK.%26aulast%3DWagner%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DA%2520Toll-like%2520Receptor%2520Recognizes%2520Bacterial%2520DNA%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D740%26epage%3D745%26doi%3D10.1038%2F35047123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krayukhina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of CpG and Inhibitory DNA Recognition by Toll-like Receptor 9</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>520</i></span>,  <span class="NLM_fpage">702</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/nature14138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnature14138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=25686612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1Snurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=520&publication_year=2015&pages=702-705&author=U.+Ohtoauthor=T.+Shibataauthor=H.+Tanjiauthor=H.+Ishidaauthor=E.+Krayukhinaauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Basis+of+CpG+and+Inhibitory+DNA+Recognition+by+Toll-like+Receptor+9&doi=10.1038%2Fnature14138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9</span></div><div class="casAuthors">Ohto, Umeharu; Shibata, Takuma; Tanji, Hiromi; Ishida, Hanako; Krayukhina, Elena; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">520</span>
        (<span class="NLM_cas:issue">7549</span>),
    <span class="NLM_cas:pages">702-705</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Innate immunity serves as the first line of defense against invading pathogens such as bacteria and viruses.  Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific mol. patterns from pathogens and activate immune responses.  TLR9 recognizes bacterial and viral DNA contg. the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif.  The mol. basis by which CpG-contg. DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated.  Here the authors show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA).  Agonistic-CpG-DNA-bound TLR9 formed a sym. TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer.  CpG-DNA was recognized by both protomers in the dimer, in particular by the N-terminal fragment (LRRNT-LRR10) from one protomer and the C-terminal fragment (LRR20-LRR22) from the other.  The iDNA, which formed a stem-loop structure suitable for binding by intramol. base pairing, bound to the concave surface from LRR2-LRR10.  This structure serves as an important basis for improving the authors' understanding of the functional mechanisms of TLR9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXq7p7veo0T7Vg90H21EOLACvtfcHk0liqmjmNbw5R8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1Snurw%253D&md5=beb602641357658548c28edc0526a91d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature14138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14138%26sid%3Dliteratum%253Aachs%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Basis%2520of%2520CpG%2520and%2520Inhibitory%2520DNA%2520Recognition%2520by%2520Toll-like%2520Receptor%25209%26jtitle%3DNature%26date%3D2015%26volume%3D520%26spage%3D702%26epage%3D705%26doi%3D10.1038%2Fnature14138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span> <span> </span><span class="NLM_article-title">Mechanisms Controlling Nucleic Acid-Sensing Toll-like Receptors</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxy016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1093%2Fintimm%2Fdxy016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=29452403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlGrsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2018&pages=43-51&author=K.+Miyakeauthor=T.+Shibataauthor=U.+Ohtoauthor=T.+Shimizuauthor=S.-I.+Saitohauthor=R.+Fukuiauthor=Y.+Murakami&title=Mechanisms+Controlling+Nucleic+Acid-Sensing+Toll-like+Receptors&doi=10.1093%2Fintimm%2Fdxy016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms controlling nucleic acid-sensing Toll-like receptors</span></div><div class="casAuthors">Miyake, Kensuke; Shibata, Takuma; Ohto, Umeharu; Shimizu, Toshiyuki; Saitoh, Shin-Ichiroh; Fukui, Ryutaro; Murakami, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">43-51</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">1460-2377</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Nucleic acid (NA)-sensing Toll-like receptors (TLRs) respond to DNA/RNA derived from pathogens and dead cells.  Structural studies have revealed a variety of mol. mechanisms by which TLRs sense NAs.  Double-stranded RNA and single-stranded DNA directly bind to TLR3 and TLR9, resp., whereas TLR7 and TLR8 bind to nucleosides and oligoribonucleotides derived from RNAs.  Activation of ligand-bound TLRs is influenced by the functional status of TLRs.  Proteolytic cleavage of NA-sensing TLRs enables ligand-dependent TLR dimerization.  Trafficking of ligandactivated TLRs in endosomal and lysosomal compartments is requisite for prodn. of type I interferons.  Activation of NA-sensing TLRs is required for the control of viruses such as herpes simplex virus and endogenous retroviruses.  On the other hand, excessive activation of NA-sensing TLRs drives disease progression in a variety of inflammatory diseases including systemic lupus erythematosus, heart failure, arthritis and non-alc. steatohepatitis.  NA-sensing TLRs are targets for therapeutic intervention in these diseases.  We here focus on our recent progresses in our understanding of NA-sensing TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIplrEf8BiHLVg90H21EOLACvtfcHk0liqmjmNbw5R8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlGrsLfN&md5=a1fb12704dede2ee4861ab062274c81e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxy016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxy016%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DSaitoh%26aufirst%3DS.-I.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DMurakami%26aufirst%3DY.%26atitle%3DMechanisms%2520Controlling%2520Nucleic%2520Acid-Sensing%2520Toll-like%2520Receptors%26jtitle%3DInt.%2520Immunol.%26date%3D2018%26volume%3D30%26spage%3D43%26epage%3D51%26doi%3D10.1093%2Fintimm%2Fdxy016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilliet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span> <span> </span><span class="NLM_article-title">Plasmacytoid Dendritic Cells: Sensing Nucleic Acids in Viral Infection and Autoimmune Diseases</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/nri2358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri2358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=18641647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=594-606&author=M.+Gillietauthor=W.+Caoauthor=Y.-J.+Liu&title=Plasmacytoid+Dendritic+Cells%3A+Sensing+Nucleic+Acids+in+Viral+Infection+and+Autoimmune+Diseases&doi=10.1038%2Fnri2358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases</span></div><div class="casAuthors">Gilliet, Michel; Cao, Wei; Liu, Yong-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">594-606</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Plasmacytoid dendritic cells (pDCs) are important mediators of antiviral immunity through their ability to produce large amts. of type I interferons (IFNs) on viral infection.  This function of pDCs is linked to their expression of Toll-like receptor 7 (TLR7) and TLR9, which sense viral nucleic acids within the early endosomes.  Exclusion of self nucleic acids from TLR-contg. early endosomes normally prevents pDC responses to them.  However, in some autoimmune diseases, self nucleic acids can be modified by host factors and gain entrance to pDC endosomes, where they activate TLR signaling.  Several pDC receptors neg. regulate type I IFN responses by pDCs during viral infection and for normal homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiqyQF42vzy7Vg90H21EOLACvtfcHk0lhNrOnrcX9xVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovV2gtrg%253D&md5=6c0b7d8d1163664e38000ebe6bb1e495</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnri2358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2358%26sid%3Dliteratum%253Aachs%26aulast%3DGilliet%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.-J.%26atitle%3DPlasmacytoid%2520Dendritic%2520Cells%253A%2520Sensing%2520Nucleic%2520Acids%2520in%2520Viral%2520Infection%2520and%2520Autoimmune%2520Diseases%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D594%26epage%3D606%26doi%3D10.1038%2Fnri2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornung, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothenfusser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britsch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrsdörfer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span> <span> </span><span class="NLM_article-title">Quantitative Expression of Toll-Like Receptor 1–10 MRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">4531</span>– <span class="NLM_lpage">4537</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.168.9.4531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.4049%2Fjimmunol.168.9.4531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=11970999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt12jt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=4531-4537&author=V.+Hornungauthor=S.+Rothenfusserauthor=S.+Britschauthor=A.+Krugauthor=B.+Jahrsd%C3%B6rferauthor=T.+Gieseauthor=S.+Endresauthor=G.+Hartmann&title=Quantitative+Expression+of+Toll-Like+Receptor+1%E2%80%9310+MRNA+in+Cellular+Subsets+of+Human+Peripheral+Blood+Mononuclear+Cells+and+Sensitivity+to+CpG+Oligodeoxynucleotides&doi=10.4049%2Fjimmunol.168.9.4531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides</span></div><div class="casAuthors">Hornung, Veit; Rothenfusser, Simon; Britsch, Stefanie; Krug, Anne; Jahrsdorfer, Bernd; Giese, Thomas; Endres, Stefan; Hartmann, Gunther</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4531-4537</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The Toll-like receptor (TLR)9 is crit. for the recognition of immunostimulatory CpG motifs but may cooperate with other TLRs.  The authors analyzed TLR1-10 mRNA expression by using quant. real-time PCR in highly purified subsets of human PBMC and detd. the sensitivity of these subsets to CpG oligodeoxynucleotides (ODN).  TLR1 and TLR6 were expressed in all cell types examd.  TLR10 was highly expressed in B cells and weakly expressed in plasmacytoid dendritic cells (PDC).  High expression of TLR2 was characteristic for monocytes.  PDC and B cells expressed marked levels of TLR7 and TLR9 and were directly sensitive to CpG ODN.  In CpG ODN-stimulated PDC and B cells, TLR9 expression rapidly decreased, as opposed to TLR7, which was up-regulated in PDC and decreased in B cells.  In monocytes, NK cells, and T cells, TLR7 was absent.  Despite low expression of TLR9, monocytes, NK cells, and T cells did not respond to CpG ODN in the absence of PDC but were activated in the presence of PDC.  In conclusion, the authors' studies provide evidence that PDC and B cells, but not monocytes, NK cells, or T cells, are primary targets of CpG ODN in peripheral blood.  The characteristic expression pattern of TLR1-10 in cellular subsets of human PBMC is consistent with the concept that TLR9 is essential in the recognition of CpG ODN in PDC and B cells.  In addn., selective regulation of TLR7 expression in PDC and B cells by CpG ODN revealed TLR7 as a candidate TLR potentially involved in modulating the recognition of CpG motifs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3GcW82Ji8Q7Vg90H21EOLACvtfcHk0lhNrOnrcX9xVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt12jt7k%253D&md5=9612fe6d52ae1ccc6a92e583829ddce3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.168.9.4531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.168.9.4531%26sid%3Dliteratum%253Aachs%26aulast%3DHornung%26aufirst%3DV.%26aulast%3DRothenfusser%26aufirst%3DS.%26aulast%3DBritsch%26aufirst%3DS.%26aulast%3DKrug%26aufirst%3DA.%26aulast%3DJahrsd%25C3%25B6rfer%26aufirst%3DB.%26aulast%3DGiese%26aufirst%3DT.%26aulast%3DEndres%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DG.%26atitle%3DQuantitative%2520Expression%2520of%2520Toll-Like%2520Receptor%25201%25E2%2580%259310%2520MRNA%2520in%2520Cellular%2520Subsets%2520of%2520Human%2520Peripheral%2520Blood%2520Mononuclear%2520Cells%2520and%2520Sensitivity%2520to%2520CpG%2520Oligodeoxynucleotides%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D4531%26epage%3D4537%26doi%3D10.4049%2Fjimmunol.168.9.4531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, B. A.</span></span> <span> </span><span class="NLM_article-title">TLRs and Innate Immunity</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1399</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1182/blood-2008-07-019307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1182%2Fblood-2008-07-019307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=18757776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlCrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1399-1407&author=B.+A.+Beutler&title=TLRs+and+Innate+Immunity&doi=10.1182%2Fblood-2008-07-019307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">TLRs and innate immunity</span></div><div class="casAuthors">Beutler, Bruce A.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-1407</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  One of the most fundamental questions in immunol. pertains to the recognition of non-self, which for the most part means microbes.  How do we initially realize that we have been inoculated with microbes, and how is the immune response ignited.  Genetic studies have made important inroads into this question during the past decade, and we now know that in mammals, a relatively small no. of receptors operate to detect signature mols. that herald infection.  One or more of these signature mols. are displayed by almost all microbes.  These receptors and the signals they initiate have been studied in depth by random germline mutagenesis and positional cloning (forward genetics).  Herein is a concise description of what has been learned about the Toll-like receptors, which play an essential part in the perception of microbes and shape the complex host responses that occur during infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGi2r7yRa-QLVg90H21EOLACvtfcHk0lhNrOnrcX9xVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlCrt7g%253D&md5=bf41d69d6ae7307e8daead5b359e8345</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-07-019307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-07-019307%26sid%3Dliteratum%253Aachs%26aulast%3DBeutler%26aufirst%3DB.%2BA.%26atitle%3DTLRs%2520and%2520Innate%2520Immunity%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D1399%26epage%3D1407%26doi%3D10.1182%2Fblood-2008-07-019307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palm, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Pattern Recognition Receptors and Control of Adaptive Immunity</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>227</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00731.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1111%2Fj.1600-065X.2008.00731.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=19120487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2009&pages=221-233&author=N.+W.+Palmauthor=R.+Medzhitov&title=Pattern+Recognition+Receptors+and+Control+of+Adaptive+Immunity&doi=10.1111%2Fj.1600-065X.2008.00731.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pattern recognition receptors and control of adaptive immunity</span></div><div class="casAuthors">Palm, Noah W.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">227</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">221-233</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The mammalian immune system effectively fights infection through the cooperation of two connected systems, innate and adaptive immunity.  Germ-line encoded pattern recognition receptors (PRRs) of the innate immune system sense the presence of infection and activate innate immunity.  Some PRRs also induce signals that lead to the activation of adaptive immunity.  Adaptive immunity is controlled by PRR-induced signals at multiple checkpoints dictating the initiation of a response, the type of response, the magnitude and duration of the response, and the prodn. of long-term memory.  PRRs thus instruct the adaptive immune system on when and how to best respond to a particular infection.  In this review, we discuss the roles of various PRRs in control of adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr22D-Htb6XSLVg90H21EOLACvtfcHk0lhEXY_p4uPA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls73I&md5=a82aa9b95205d8a28940409d7c638f5d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00731.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00731.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalm%26aufirst%3DN.%2BW.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DPattern%2520Recognition%2520Receptors%2520and%2520Control%2520of%2520Adaptive%2520Immunity%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D227%26spage%3D221%26epage%3D233%26doi%3D10.1111%2Fj.1600-065X.2008.00731.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors in Innate Immunity</span>. <i>Int. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1093/intimm/dxh186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1093%2Fintimm%2Fdxh186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=15585605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=1-14&author=K.+Takedaauthor=S.+Akira&title=Toll-like+Receptors+in+Innate+Immunity&doi=10.1093%2Fintimm%2Fdxh186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors in innate immunity</span></div><div class="casAuthors">Takeda, Kiyoshi; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Functional characterization of Toll-like receptors (TLRs) has established that innate immunity is a skillful system that detects invasion of microbial pathogens.  Recognition of microbial components by TLRs initiates signal transduction pathways, which triggers expression of genes.  These gene products control innate immune responses and further instruct development of antigen-specific acquired immunity.  TLR signaling pathways are finely regulated by TIR domain-contg. adaptors, such as MyD88, TIRAP/Mal, TRIF and TRAM.  Differential utilization of these TIR domain-contg. adaptors provides specificity of individual TLR-mediated signaling pathways.  Several mechanisms have been elucidated that neg. control TLR signaling pathways, and thereby prevent over activation of innate immunity leading to fatal immune disorders.  The involvement of TLR-mediated pathways in autoimmune and inflammatory diseases has been proposed.  Thus, TLR-mediated activation of innate immunity controls not only host defense against pathogens but also immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE41SReV_f5rVg90H21EOLACvtfcHk0lhEXY_p4uPA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKru77P&md5=89e5132b6e14905b9799cc12eb5320aa</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxh186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxh186%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DToll-like%2520Receptors%2520in%2520Innate%2520Immunity%26jtitle%3DInt.%2520Immunol.%26date%3D2005%26volume%3D17%26spage%3D1%26epage%3D14%26doi%3D10.1093%2Fintimm%2Fdxh186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patinote, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karroum, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarbess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirnat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze-Masquéfa, C.</span></span> <span> </span><span class="NLM_article-title">Agonist and Antagonist Ligands of Toll-like Receptors 7 and 8: Ingenious Tools for Therapeutic Purposes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>193</i></span>, <span class="NLM_elocation-id">112238</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ejmech.2020.112238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=32203790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlsVWjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2020&author=C.+Patinoteauthor=N.+B.+Karroumauthor=G.+Moarbessauthor=N.+Cirnatauthor=I.+Kassabauthor=P.-A.+Bonnetauthor=C.+Deleuze-Masqu%C3%A9fa&title=Agonist+and+Antagonist+Ligands+of+Toll-like+Receptors+7+and+8%3A+Ingenious+Tools+for+Therapeutic+Purposes&doi=10.1016%2Fj.ejmech.2020.112238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes</span></div><div class="casAuthors">Patinote, Cindy; Karroum, Nour Bou; Moarbess, Georges; Cirnat, Natalina; Kassab, Issam; Bonnet, Pierre-Antoine; Deleuze-Masquefa, Carine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112238</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The discovery of the TLRs family and more precisely its functions opened a variety of gates to modulate immunol. host responses.  TLRs 7/8 are located in the endosomal compartment and activate a specific signaling pathway in a MyD88-dependant manner.  According to their involvement into various autoimmune, inflammatory and malignant diseases, researchers have designed diverse TLRs 7/8 ligands able to boost or block the inherent signal transduction.  These modulators are often small synthetic compds. and most act as agonists and to a much lesser extent as antagonists.  Some of them have reached preclin. and clin. trials, and only one has been approved by the FDA and EMA, imiquimod.  The key to the success of these modulators probably lies in their combination with other therapies as recently demonstrated.  We gather in this review more than 360 scientific publications, reviews and patents, relating the extensive work carried out by researchers on the design of TLRs 7/8 modulators, which are classified firstly by their biol. activities (agonist or antagonist) and then by their chem. structures, which total syntheses are not discussed here.  This review also reports about 90 clin. cases, thereby showing the biol. interest of these modulators in multiple pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7KAldiwRFYrVg90H21EOLACvtfcHk0lhEXY_p4uPA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlsVWjt74%253D&md5=d11400c9ed60056bd0d33861aaeb5dba</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112238%26sid%3Dliteratum%253Aachs%26aulast%3DPatinote%26aufirst%3DC.%26aulast%3DKarroum%26aufirst%3DN.%2BB.%26aulast%3DMoarbess%26aufirst%3DG.%26aulast%3DCirnat%26aufirst%3DN.%26aulast%3DKassab%26aufirst%3DI.%26aulast%3DBonnet%26aufirst%3DP.-A.%26aulast%3DDeleuze-Masqu%25C3%25A9fa%26aufirst%3DC.%26atitle%3DAgonist%2520and%2520Antagonist%2520Ligands%2520of%2520Toll-like%2520Receptors%25207%2520and%25208%253A%2520Ingenious%2520Tools%2520for%2520Therapeutic%2520Purposes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D193%26doi%3D10.1016%2Fj.ejmech.2020.112238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Federico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carullo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gemma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relitti, N.</span></span> <span> </span><span class="NLM_article-title">Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">13466</span>– <span class="NLM_lpage">13513</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01049</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1OlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=13466-13513&author=S.+Federicoauthor=L.+Pozzettiauthor=A.+Papaauthor=G.+Carulloauthor=S.+Gemmaauthor=S.+Butiniauthor=G.+Campianiauthor=N.+Relitti&title=Modulation+of+the+Innate+Immune+Response+by+Targeting+Toll-like+Receptors%3A+A+Perspective+on+Their+Agonists+and+Antagonists&doi=10.1021%2Facs.jmedchem.0c01049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists</span></div><div class="casAuthors">Federico, Stefano; Pozzetti, Luca; Papa, Alessandro; Carullo, Gabriele; Gemma, Sandra; Butini, Stefania; Campiani, Giuseppe; Relitti, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13466-13513</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are a class of proteins that recognize pathogen-assocd. mol. patterns (PAMPs) and damaged-assocd. mol. patterns (DAMPs), and they are involved in the regulation of innate immune system.  These transmembrane receptors, localized at the cellular or endosomal membrane, trigger inflammatory processes through either myeloid differentiation primary response 88 (MyD88) or TIR-domain-contg. adapter-inducing interferon-β (TRIF) signaling pathways.  In the last decades, extensive research has been performed on TLR modulators and their therapeutic implication under several pathol. conditions, spanning from infections to cancer, from metabolic disorders to neurodegeneration and autoimmune diseases.  This Perspective will highlight the recent discoveries in this field, emphasizing the role of TLRs in different diseases and the therapeutic effect of their natural and synthetic modulators, and it will discuss insights for the future exploitation of TLR modulators in human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0aMw3NYlt0bVg90H21EOLACvtfcHk0lhEXY_p4uPA0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1OlsL%252FO&md5=c6ec1e59e89174d0fa6b50490f15882f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01049%26sid%3Dliteratum%253Aachs%26aulast%3DFederico%26aufirst%3DS.%26aulast%3DPozzetti%26aufirst%3DL.%26aulast%3DPapa%26aufirst%3DA.%26aulast%3DCarullo%26aufirst%3DG.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DRelitti%26aufirst%3DN.%26atitle%3DModulation%2520of%2520the%2520Innate%2520Immune%2520Response%2520by%2520Targeting%2520Toll-like%2520Receptors%253A%2520A%2520Perspective%2520on%2520Their%2520Agonists%2520and%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D13466%26epage%3D13513%26doi%3D10.1021%2Facs.jmedchem.0c01049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hennessy, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, L. A. J.</span></span> <span> </span><span class="NLM_article-title">Targeting Toll-like Receptors: Emerging Therapeutics?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.1038/nrd3203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnrd3203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=20380038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=293-307&author=E.+J.+Hennessyauthor=A.+E.+Parkerauthor=L.+A.+J.+O%E2%80%99Neill&title=Targeting+Toll-like+Receptors%3A+Emerging+Therapeutics%3F&doi=10.1038%2Fnrd3203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Toll-like receptors: emerging therapeutics?</span></div><div class="casAuthors">Hennessy, Elizabeth J.; Parker, Andrew E.; O'Neill, Luke A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-307</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a growing interest in the targeting of Toll-like receptors (TLRs) for the prevention and treatment of cancer, rheumatoid arthritis, inflammatory bowel disease and systemic lupus erythematosus (SLE).  Several new compds. are now undergoing preclin. and clin. evaluation, with a particular focus on TLR7 and TLR9 activators as adjuvants in infection and cancer, and inhibitors of TLR2, TLR4, TLR7 and TLR9 for the treatment of sepsis and inflammatory diseases.  Here, we focus on TLRs that hold the most promise for drug discovery research, highlighting agents that are in the discovery phase and in clin. trials, and on the emerging new aspects of TLR-mediated signaling - such as control by ubiquitination and regulation by microRNAs - that might offer further possibilities of therapeutic manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHrGGa9XDou7Vg90H21EOLACvtfcHk0lhmZw1_lPr5ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2itb4%253D&md5=ed2da43668217c9d470f5a53dd214708</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3203%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DParker%26aufirst%3DA.%2BE.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DL.%2BA.%2BJ.%26atitle%3DTargeting%2520Toll-like%2520Receptors%253A%2520Emerging%2520Therapeutics%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D293%26epage%3D307%26doi%3D10.1038%2Fnrd3203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshak-Rothstein, A.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors in Systemic Autoimmune Disease</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">823</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1038/nri1957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnri1957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17063184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWns7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=823-835&author=A.+Marshak-Rothstein&title=Toll-like+Receptors+in+Systemic+Autoimmune+Disease&doi=10.1038%2Fnri1957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptors in systemic autoimmune disease</span></div><div class="casAuthors">Marshak-Rothstein, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">823-835</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) have a crucial role in the early detection of pathogen-assocd. mol. patterns and the subsequent activation of the adaptive immune response.  Whether TLRs also have an important role in the recognition of endogenous ligands has been more controversial.  Numerous in vitro studies have documented activation of both autoreactive B cells and plasmacytoid dendritic cells by mammalian TLR ligands.  The issue of whether these in vitro observations translate to an in vivo role for TLRs in either the initiation or the progression of systemic autoimmune disease is a subject of intense research; data are beginning to emerge showing that this is the case.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ2AwllZLkmLVg90H21EOLACvtfcHk0lhmZw1_lPr5ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWns7fP&md5=03ad4120a1c7544c4a9693aa58665298</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnri1957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1957%26sid%3Dliteratum%253Aachs%26aulast%3DMarshak-Rothstein%26aufirst%3DA.%26atitle%3DToll-like%2520Receptors%2520in%2520Systemic%2520Autoimmune%2520Disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26spage%3D823%26epage%3D835%26doi%3D10.1038%2Fnri1957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Zayat, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibaii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannaa, F. A.</span></span> <span> </span><span class="NLM_article-title">Toll-like Receptors Activation, Signaling, and Targeting: An Overview</span>. <i>Bull. Natl. Res. Cent.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>43</i></span>, <span class="NLM_elocation-id">187</span> <span class="refDoi"> DOI: 10.1186/s42269-019-0227-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1186%2Fs42269-019-0227-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2019&author=S.+R.+El-Zayatauthor=H.+Sibaiiauthor=F.+A.+Mannaa&title=Toll-like+Receptors+Activation%2C+Signaling%2C+and+Targeting%3A+An+Overview&doi=10.1186%2Fs42269-019-0227-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs42269-019-0227-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs42269-019-0227-2%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Zayat%26aufirst%3DS.%2BR.%26aulast%3DSibaii%26aufirst%3DH.%26aulast%3DMannaa%26aufirst%3DF.%2BA.%26atitle%3DToll-like%2520Receptors%2520Activation%252C%2520Signaling%252C%2520and%2520Targeting%253A%2520An%2520Overview%26jtitle%3DBull.%2520Natl.%2520Res.%2520Cent.%26date%3D2019%26volume%3D43%26doi%3D10.1186%2Fs42269-019-0227-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Recent Clinical Trends in Toll-like Receptor Targeting Therapeutics</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1090</span>, <span class="refDoi"> DOI: 10.1002/med.21553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1002%2Fmed.21553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30450666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntlGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=1053-1090&author=M.+A.+Anwarauthor=M.+Shahauthor=J.+Kimauthor=S.+Choi&title=Recent+Clinical+Trends+in+Toll-like+Receptor+Targeting+Therapeutics&doi=10.1002%2Fmed.21553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Recent clinical trends in Toll-like receptor targeting therapeutics</span></div><div class="casAuthors">Anwar, Muhammad Ayaz; Shah, Masaud; Kim, Jason; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1053-1090</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) are germline-encoded receptors that are central to innate and adaptive immune responses.  Owing to their vital role in inflammation, TLRs are rational targets in clinics; thus, many ligands and biologics have been reported to overcome the progression of various inflammatory and malignant conditions and support the immune system.  For each TLR, at least one, and often many, drug formulations are being evaluated.  Ligands reported as stand-alone drugs may also be reported based on their use in combinatorial therapeutics as adjuvants.  Despite their profound efficacy in TLR-modulation in preclin. studies, multiple drugs have been terminated at different stages of clin. trials.  Here, TLR modulating drugs that have been evaluated in clin. trials are discussed, along with their mode of action, suggestive failure reasons, and ways to improve the clin. outcomes.  This review presents recent advances in TLR-targeting drugs and provides directions for more successful immune system manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk1adR2xVJUbVg90H21EOLACvtfcHk0lhmZw1_lPr5ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntlGksbs%253D&md5=525a0020ddcf3bfd585e51a4f93e0265</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fmed.21553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21553%26sid%3Dliteratum%253Aachs%26aulast%3DAnwar%26aufirst%3DM.%2BA.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DRecent%2520Clinical%2520Trends%2520in%2520Toll-like%2520Receptor%2520Targeting%2520Therapeutics%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2019%26volume%3D39%26spage%3D1053%26epage%3D1090%26doi%3D10.1002%2Fmed.21553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregorio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nestle, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliet, M.</span></span> <span> </span><span class="NLM_article-title">Plasmacytoid Dendritic Cells Sense Self-DNA Coupled with Antimicrobial Peptide</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>449</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1038/nature06116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnature06116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17873860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=2007&pages=564-569&author=R.+Landeauthor=J.+Gregorioauthor=V.+Facchinettiauthor=B.+Chatterjeeauthor=Y.-H.+Wangauthor=B.+Homeyauthor=W.+Caoauthor=Y.-H.+Wangauthor=B.+Suauthor=F.+O.+Nestleauthor=T.+Zalauthor=I.+Mellmanauthor=J.-M.+Schr%C3%B6derauthor=Y.-J.+Liuauthor=M.+Gilliet&title=Plasmacytoid+Dendritic+Cells+Sense+Self-DNA+Coupled+with+Antimicrobial+Peptide&doi=10.1038%2Fnature06116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide</span></div><div class="casAuthors">Lande, Roberto; Gregorio, Josh; Facchinetti, Valeria; Chatterjee, Bithi; Wang, Yi-Hong; Homey, Bernhard; Cao, Wei; Wang, Yui-Hsi; Su, Bing; Nestle, Frank O.; Zal, Tomasz; Mellman, Ira; Schroeder, Jens-Michael; Liu, Yong-Jun; Gilliet, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">449</span>
        (<span class="NLM_cas:issue">7162</span>),
    <span class="NLM_cas:pages">564-569</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons.  PDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism.  Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin.  LL37 converts inert self-DNA into a potent trigger of interferon prodn. by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9.  Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ9AG-kAPprVg90H21EOLACvtfcHk0liESOO8Ugi-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagtL7K&md5=4c443faee5b8f23612576e28d1a77f65</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature06116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06116%26sid%3Dliteratum%253Aachs%26aulast%3DLande%26aufirst%3DR.%26aulast%3DGregorio%26aufirst%3DJ.%26aulast%3DFacchinetti%26aufirst%3DV.%26aulast%3DChatterjee%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHomey%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DSu%26aufirst%3DB.%26aulast%3DNestle%26aufirst%3DF.%2BO.%26aulast%3DZal%26aufirst%3DT.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DJ.-M.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DGilliet%26aufirst%3DM.%26atitle%3DPlasmacytoid%2520Dendritic%2520Cells%2520Sense%2520Self-DNA%2520Coupled%2520with%2520Antimicrobial%2520Peptide%26jtitle%3DNature%26date%3D2007%26volume%3D449%26spage%3D564%26epage%3D569%26doi%3D10.1038%2Fnature06116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lande, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Facchinetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregorio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamilos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebasigari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccieri, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassett, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amuro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuhara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliet, M.</span></span> <span> </span><span class="NLM_article-title">Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">73ra19</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscitranslmed.3001180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=21389263" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=73ra19&author=R.+Landeauthor=D.+Gangulyauthor=V.+Facchinettiauthor=L.+Frascaauthor=C.+Conradauthor=J.+Gregorioauthor=S.+Mellerauthor=G.+Chamilosauthor=R.+Sebasigariauthor=V.+Riccieriauthor=R.+Bassettauthor=H.+Amuroauthor=S.+Fukuharaauthor=T.+Itoauthor=Y.-J.+Liuauthor=M.+Gilliet&title=Neutrophils+Activate+Plasmacytoid+Dendritic+Cells+by+Releasing+Self-DNA%E2%80%93Peptide+Complexes+in+Systemic+Lupus+Erythematosus&doi=10.1126%2Fscitranslmed.3001180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001180%26sid%3Dliteratum%253Aachs%26aulast%3DLande%26aufirst%3DR.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DFacchinetti%26aufirst%3DV.%26aulast%3DFrasca%26aufirst%3DL.%26aulast%3DConrad%26aufirst%3DC.%26aulast%3DGregorio%26aufirst%3DJ.%26aulast%3DMeller%26aufirst%3DS.%26aulast%3DChamilos%26aufirst%3DG.%26aulast%3DSebasigari%26aufirst%3DR.%26aulast%3DRiccieri%26aufirst%3DV.%26aulast%3DBassett%26aufirst%3DR.%26aulast%3DAmuro%26aufirst%3DH.%26aulast%3DFukuhara%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DGilliet%26aufirst%3DM.%26atitle%3DNeutrophils%2520Activate%2520Plasmacytoid%2520Dendritic%2520Cells%2520by%2520Releasing%2520Self-DNA%25E2%2580%2593Peptide%2520Complexes%2520in%2520Systemic%2520Lupus%2520Erythematosus%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D73ra19%26doi%3D10.1126%2Fscitranslmed.3001180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span> <span> </span><span class="NLM_article-title">Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum?</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.it.2017.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.it.2017.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=28826817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2018&pages=28-43&author=D.+Ganguly&title=Do+Type+I+Interferons+Link+Systemic+Autoimmunities+and+Metabolic+Syndrome+in+a+Pathogenetic+Continuum%3F&doi=10.1016%2Fj.it.2017.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum?</span></div><div class="casAuthors">Ganguly, Dipyaman</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-43</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The central pathogenetic role of type I interferons (IFNs) in several systemic autoimmune diseases is well established.  Recent studies have also discovered a similar crucial role of type I IFNs in different components of metabolic disorders.  Self nucleic acid-driven Toll-like receptor (TLR) activation in plasmacytoid dendritic cells (pDCs) and type I IFN induction appear to be the key initiating events shared by most of these autoimmune and metabolic diseases.  Further strengthening this link, many patients with systemic autoimmunities also present with metabolic disorders.  This concurrence of autoimmunities and metabolic disorders may be explained by a single pathogenetic continuum, and suggests shared targets for potential new therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR8KXQoS65GrVg90H21EOLACvtfcHk0liESOO8Ugi-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Sgt7%252FN&md5=601d7487162333a517ad0d54804ec335</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2017.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2017.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DGanguly%26aufirst%3DD.%26atitle%3DDo%2520Type%2520I%2520Interferons%2520Link%2520Systemic%2520Autoimmunities%2520and%2520Metabolic%2520Syndrome%2520in%2520a%2520Pathogenetic%2520Continuum%253F%26jtitle%3DTrends%2520Immunol.%26date%3D2018%26volume%3D39%26spage%3D28%26epage%3D43%26doi%3D10.1016%2Fj.it.2017.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gottenberg, J.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucchesi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letourneur, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazure, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ittah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepajolec, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labetoulle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardizzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibilia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiocchia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariette, X.</span></span> <span> </span><span class="NLM_article-title">Activation of IFN Pathways and Plasmacytoid Dendritic Cell Recruitment in Target Organs of Primary Sjögren’s Syndrome</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2770</span>– <span class="NLM_lpage">2775</span>, <span class="refDoi"> DOI: 10.1073/pnas.0510837103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1073%2Fpnas.0510837103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=16477017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XksF2rt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2770-2775&author=J.-E.+Gottenbergauthor=N.+Cagnardauthor=C.+Lucchesiauthor=F.+Letourneurauthor=S.+Mistouauthor=T.+Lazureauthor=S.+Jacquesauthor=N.+Baauthor=M.+Ittahauthor=C.+Lepajolecauthor=M.+Labetoulleauthor=M.+Ardizzoneauthor=J.+Sibiliaauthor=C.+Fournierauthor=G.+Chiocchiaauthor=X.+Mariette&title=Activation+of+IFN+Pathways+and+Plasmacytoid+Dendritic+Cell+Recruitment+in+Target+Organs+of+Primary+Sj%C3%B6gren%E2%80%99s+Syndrome&doi=10.1073%2Fpnas.0510837103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome</span></div><div class="casAuthors">Gottenberg, Jacques-Eric; Cagnard, Nicolas; Lucchesi, Carlo; Letourneur, Franck; Mistou, Sylvie; Lazure, Thierry; Jacques, Sebastien; Ba, Nathalie; Ittah, Marc; Lepajolec, Christine; Labetoulle, Marc; Ardizzone, Marc; Sibilia, Jean; Fournier, Catherine; Chiocchia, Gilles; Mariette, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2770-2775</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Gene expression anal. of target organs might help provide new insights into the pathogenesis of autoimmune diseases.  The authors used global gene expression profiling of minor salivary glands to identify patterns of gene expression in patients with primary Sjogren's syndrome (pSS), a common and prototypic systemic autoimmune disease.  Gene expression anal. allowed for differentiating most patients with pSS from controls.  The expression of 23 genes in the IFN pathways, including two Toll-like receptors (TLR8 and TLR9), was significantly different between patients and controls.  Furthermore, the increased expression of IFN-inducible genes, BAFF and IFN-induced transmembrane protein 1, was also demonstrated in ocular epithelial cells by quant. RT-PCR.  In vitro activation showed that these genes were effectively modulated by IFNs in salivary gland epithelial cells, the target cells of autoimmunity in pSS.  The activation of IFN pathways led the authors to investigate whether plasmacytoid dendritic cells were recruited in salivary glands.  These IFN-producing cells were detected by immunohistochem. in all patients with pSS, whereas none was obsd. in controls.  In conclusion, the authors' results support the pathogenic interaction between the innate and adaptive immune system in pSS.  The persistence of the IFN signature might be related to a vicious circle, in which the environment interacts with genetic factors to drive the stimulation of salivary TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprUrcXds1lqbVg90H21EOLACvtfcHk0liESOO8Ugi-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksF2rt7k%253D&md5=40acc8a756660663214994de86df4e3e</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0510837103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0510837103%26sid%3Dliteratum%253Aachs%26aulast%3DGottenberg%26aufirst%3DJ.-E.%26aulast%3DCagnard%26aufirst%3DN.%26aulast%3DLucchesi%26aufirst%3DC.%26aulast%3DLetourneur%26aufirst%3DF.%26aulast%3DMistou%26aufirst%3DS.%26aulast%3DLazure%26aufirst%3DT.%26aulast%3DJacques%26aufirst%3DS.%26aulast%3DBa%26aufirst%3DN.%26aulast%3DIttah%26aufirst%3DM.%26aulast%3DLepajolec%26aufirst%3DC.%26aulast%3DLabetoulle%26aufirst%3DM.%26aulast%3DArdizzone%26aufirst%3DM.%26aulast%3DSibilia%26aufirst%3DJ.%26aulast%3DFournier%26aufirst%3DC.%26aulast%3DChiocchia%26aufirst%3DG.%26aulast%3DMariette%26aufirst%3DX.%26atitle%3DActivation%2520of%2520IFN%2520Pathways%2520and%2520Plasmacytoid%2520Dendritic%2520Cell%2520Recruitment%2520in%2520Target%2520Organs%2520of%2520Primary%2520Sj%25C3%25B6gren%25E2%2580%2599s%2520Syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D2770%26epage%3D2775%26doi%3D10.1073%2Fpnas.0510837103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mussari, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreekantha, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasunoori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruepp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schieven, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagore, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudhgaonkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poss, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyckman, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1758</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1751-1758&author=C.+P.+Mussariauthor=D.+S.+Doddauthor=R.+K.+Sreekanthaauthor=L.+Pasunooriauthor=H.+Wanauthor=S.+L.+Posyauthor=D.+Crittonauthor=S.+Rueppauthor=M.+Subramanianauthor=A.+Watsonauthor=P.+Daviesauthor=G.+L.+Schievenauthor=L.+M.+Salter-Cidauthor=R.+Srivastavaauthor=D.+M.+Tagoreauthor=S.+Dudhgaonkarauthor=M.+A.+Possauthor=P.+H.+Carterauthor=A.+J.+Dyckman&title=Discovery+of+Potent+and+Orally+Bioavailable+Small+Molecule+Antagonists+of+Toll-like+Receptors+7%2F8%2F9+%28TLR7%2F8%2F9%29&doi=10.1021%2Facsmedchemlett.0c00264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)</span></div><div class="casAuthors">Mussari, Christopher P.; Dodd, Dharmpal S.; Sreekantha, Ratna Kumar; Pasunoori, Laxman; Wan, Honghe; Posy, Shana L.; Critton, David; Ruepp, Stefan; Subramanian, Murali; Watson, Andrew; Davies, Paul; Schieven, Gary L.; Salter-Cid, Luisa M.; Srivastava, Ratika; Tagore, Debarati Mazumder; Dudhgaonkar, Shailesh; Poss, Michael A.; Carter, Percy H.; Dyckman, Alaric J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1751-1758</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The toll-like receptor (TLR) family is an evolutionarily conserved component of the innate immune system, responsible for the early detection of foreign or endogenous threat signals.  In the context of autoimmunity, the unintended recognition of self-motifs as foreign promotes initiation or propagation of disease.  Overactivation of TLR7 and TLR9 have been implicated as factors contributing to autoimmune disorders such as psoriasis, arthritis, and lupus.  In our search for small mol. antagonists of TLR7/9, 7f(I) was identified as possessing excellent on-target potency for human TLR7/9 as well as for TLR8, with selectivity against other representative TLR family members.  Good pharmacokinetic properties and a relatively balanced potency against TLR7 and TLR9 in mouse systems (systems which lack functional TLR8) made this an excellent in vivo tool compd., and efficacy from oral dosing in preclin. models of autoimmune disease was demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ZnIBuI6cJbVg90H21EOLACvtfcHk0lgINYQzX7RvwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVOrs7fI&md5=6b8f4eab4c86da189fd4357399968bf6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00264%26sid%3Dliteratum%253Aachs%26aulast%3DMussari%26aufirst%3DC.%2BP.%26aulast%3DDodd%26aufirst%3DD.%2BS.%26aulast%3DSreekantha%26aufirst%3DR.%2BK.%26aulast%3DPasunoori%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DH.%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DCritton%26aufirst%3DD.%26aulast%3DRuepp%26aufirst%3DS.%26aulast%3DSubramanian%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DSrivastava%26aufirst%3DR.%26aulast%3DTagore%26aufirst%3DD.%2BM.%26aulast%3DDudhgaonkar%26aufirst%3DS.%26aulast%3DPoss%26aufirst%3DM.%2BA.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520Potent%2520and%2520Orally%2520Bioavailable%2520Small%2520Molecule%2520Antagonists%2520of%2520Toll-like%2520Receptors%25207%252F8%252F9%2520%2528TLR7%252F8%252F9%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D1751%26epage%3D1758%26doi%3D10.1021%2Facsmedchemlett.0c00264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marshak-Rothstein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rifkin, I. R.</span></span> <span> </span><span class="NLM_article-title">Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.22.012703.104514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1146%2Fannurev.immunol.22.012703.104514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17378763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlansr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=419-441&author=A.+Marshak-Rothsteinauthor=I.+R.+Rifkin&title=Immunologically+Active+Autoantigens%3A+The+Role+of+Toll-Like+Receptors+in+the+Development+of+Chronic+Inflammatory+Disease&doi=10.1146%2Fannurev.immunol.22.012703.104514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease</span></div><div class="casAuthors">Marshak-Rothstein, Ann; Rifkin, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">419-441</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Pattern recognition receptors (PRRs), expressed on cells of both the innate and adaptive immune systems, serve as sentinels, waiting to alert the host to the first signs of microbial infection and to activate the initial line of immune defense.  Research has increasingly demonstrated that many of the same PRRs also recognize self-epitopes that either are released from dying or damaged cells or are present at the surface of apoptotic cells or apoptotic bodies.  In this context, PRRs play a crit. role in tissue repair and the clearance of cellular debris.  However, failure to appropriately regulate self-responses triggered by certain PRRs can have serious pathol. consequences.  The Toll-like receptor (TLR) gene family represents a case in point.  TLR7, 8, and 9 were originally identified as receptors specific for bacterial and viral RNA and DNA, but more recent in vitro and in vivo studies have now linked these receptors to the detection of host RNA, DNA, and RNA- or DNA-assocd. proteins.  In this context, they likely play a key role in the development of systemic autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7agsRPL1cVrVg90H21EOLACvtfcHk0lgINYQzX7RvwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlansr0%253D&md5=70353a067134a4fecce7b4b5aa43bd10</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.22.012703.104514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.22.012703.104514%26sid%3Dliteratum%253Aachs%26aulast%3DMarshak-Rothstein%26aufirst%3DA.%26aulast%3DRifkin%26aufirst%3DI.%2BR.%26atitle%3DImmunologically%2520Active%2520Autoantigens%253A%2520The%2520Role%2520of%2520Toll-Like%2520Receptors%2520in%2520the%2520Development%2520of%2520Chronic%2520Inflammatory%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D25%26spage%3D419%26epage%3D441%26doi%3D10.1146%2Fannurev.immunol.22.012703.104514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balak, D. M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Doorn, M. B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbeit, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijneveld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaassen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brevard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thio, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prens, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burggraaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rissmann, R.</span></span> <span> </span><span class="NLM_article-title">IMO-8400, a Toll-like Receptor 7, 8, and 9 Antagonist, Demonstrates Clinical Activity in a Phase 2a, Randomized, Placebo-Controlled Trial in Patients with Moderate-to-Severe Plaque Psoriasis</span>. <i>Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.clim.2016.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.clim.2016.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27876460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWltrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=63-72&author=D.+M.+W.+Balakauthor=M.+B.+A.+van+Doornauthor=R.+D.+Arbeitauthor=R.+Rijneveldauthor=E.+Klaassenauthor=T.+Sullivanauthor=J.+Brevardauthor=H.+B.+Thioauthor=E.+P.+Prensauthor=J.+Burggraafauthor=R.+Rissmann&title=IMO-8400%2C+a+Toll-like+Receptor+7%2C+8%2C+and+9+Antagonist%2C+Demonstrates+Clinical+Activity+in+a+Phase+2a%2C+Randomized%2C+Placebo-Controlled+Trial+in+Patients+with+Moderate-to-Severe+Plaque+Psoriasis&doi=10.1016%2Fj.clim.2016.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis</span></div><div class="casAuthors">Balak, Deepak M. W.; van Doorn, Martijn B. A.; Arbeit, Robert D.; Rijneveld, Rianne; Klaassen, Erica; Sullivan, Tim; Brevard, Julie; Thio, Hok Bing; Prens, Errol P.; Burggraaf, Jacobus; Rissmann, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-72</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aberrant toll-like receptors (TLRs) 7, 8, and 9 activation by self-nucleic acids is implicated in immune-mediated inflammatory diseases (IMIDs) such as psoriasis.  In preclin. IMID models, blocking TLR-activation reduced disease severity.  IMO-8400 is a first-in-class, oligonucleotide-based antagonist of TLRs 7, 8, and 9.  We evaluated the short-term safety and proof-of-concept for efficacy of IMO-8400 in a first-in-patient phase 2 trial.  Forty-six psoriasis patients were randomly assigned to IMO-8400 in four dose levels or placebo for 12 wk.  Post-treatment follow-up was seven weeks.  Primary outcome was incidence of adverse events.  Secondary, exploratory outcomes included changes in psoriasis area and severity index (PASI).  IMO-8400 across all dose levels did not cause any serious or severe adverse events.  The most common treatment-related adverse events were dose-dependent injection-site reactions.  All IMO-8400 groups showed clin. improvement, but a clear dose-response relationship and statistically significant differences with placebo were not obsd. (P = 0.26).  Eleven (38%) of 29 subjects on IMO-8400 achieved ≥ 50% PASI-redn., compared to 1 (11%) of 9 subjects on placebo.  Five (17%) and 2 (7%) IMO-8400-treated subjects achieved PASI-75 and PASI-90, resp., compared to none on placebo.  Short-term IMO-8400-treatment was well tolerated and reduced psoriasis severity.  These findings warrant further investigation of endosomal TLR-antagonism as a therapeutic approach in psoriasis and other TLR-mediated IMIDs.  EudraCT 2013-000164-28 and Clinicaltrials.govNCT01899729.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUsKfTdCLFo7Vg90H21EOLACvtfcHk0lhLq_8nD9_dHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWltrbM&md5=0444bf4c23f31f9c67cd385311fc7152</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2016.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2016.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DBalak%26aufirst%3DD.%2BM.%2BW.%26aulast%3Dvan%2BDoorn%26aufirst%3DM.%2BB.%2BA.%26aulast%3DArbeit%26aufirst%3DR.%2BD.%26aulast%3DRijneveld%26aufirst%3DR.%26aulast%3DKlaassen%26aufirst%3DE.%26aulast%3DSullivan%26aufirst%3DT.%26aulast%3DBrevard%26aufirst%3DJ.%26aulast%3DThio%26aufirst%3DH.%2BB.%26aulast%3DPrens%26aufirst%3DE.%2BP.%26aulast%3DBurggraaf%26aufirst%3DJ.%26aulast%3DRissmann%26aufirst%3DR.%26atitle%3DIMO-8400%252C%2520a%2520Toll-like%2520Receptor%25207%252C%25208%252C%2520and%25209%2520Antagonist%252C%2520Demonstrates%2520Clinical%2520Activity%2520in%2520a%2520Phase%25202a%252C%2520Randomized%252C%2520Placebo-Controlled%2520Trial%2520in%2520Patients%2520with%2520Moderate-to-Severe%2520Plaque%2520Psoriasis%26jtitle%3DClin.%2520Immunol.%26date%3D2017%26volume%3D174%26spage%3D63%26epage%3D72%26doi%3D10.1016%2Fj.clim.2016.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Modulators of Toll-like Receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">6621</span>– <span class="NLM_lpage">6626</span>, <span class="refDoi"> DOI: 10.1021/jm800957k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800957k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SjtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6621-6626&author=M.+Czarniecki&title=Small+Molecule+Modulators+of+Toll-like+Receptors&doi=10.1021%2Fjm800957k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Modulators of Toll-like Receptors</span></div><div class="casAuthors">Czarniecki, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6621-6626</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO6dCcRAY7FrVg90H21EOLACvtfcHk0lhLq_8nD9_dHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SjtL%252FF&md5=34a9045c921277f673155333c299c8d6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm800957k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800957k%26sid%3Dliteratum%253Aachs%26aulast%3DCzarniecki%26aufirst%3DM.%26atitle%3DSmall%2520Molecule%2520Modulators%2520of%2520Toll-like%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6621%26epage%3D6626%26doi%3D10.1021%2Fjm800957k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomizawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, S.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrrolo[2,3-d]Pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1235</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1021/ml5003184</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5003184" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OktLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1235-1239&author=M.+Watanabeauthor=M.+Kasaiauthor=H.+Tomizawaauthor=M.+Aokiauthor=K.+Eihoauthor=Y.+Isobeauthor=S.+Asano&title=Dihydropyrrolo%5B2%2C3-d%5DPyrimidines%3A+Selective+Toll-Like+Receptor+9+Antagonists+from+Scaffold+Morphing+Efforts&doi=10.1021%2Fml5003184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts</span></div><div class="casAuthors">Watanabe, Manabu; Kasai, Mai; Tomizawa, Hideyuki; Aoki, Masamitsu; Eiho, Kazuo; Isobe, Yoshiaki; Asano, Shigehiro</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1235-1239</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptors (TLRs) play important roles in the innate immune system.  In fact, recognition of endogenous immune complexes contg. self-nucleic acids as pathogen- or damage-assocd. mol. patterns contributes to certain autoimmune diseases, and inhibition of these recognition signals is expected to have therapeutic value.  The authors identified dihydropyrrolo[2,3-d]pyrimidines as novel selective TLR9 antagonists with high aq. soly.  A structure-activity relationship study of a known TLR9 antagonist led to the promising compd. I, which showed potent TLR9 antagonistic activity, sufficient aq. soly. for parenteral formulation, and druggable properties.  Compd. I suppressed the prodn. of the proinflammatory cytokine IL-6 in CpG-induced mouse model.  It is therefore believed that compd. I has great potential in the treatment of TLR9-mediated systemic uncontrollable inflammatory response like sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZdDe1jE6qibVg90H21EOLACvtfcHk0lhLq_8nD9_dHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OktLrJ&md5=b87ca0f44cc12f46fd2d640b9bd6aa50</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fml5003184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5003184%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DKasai%26aufirst%3DM.%26aulast%3DTomizawa%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DEiho%26aufirst%3DK.%26aulast%3DIsobe%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DS.%26atitle%3DDihydropyrrolo%255B2%252C3-d%255DPyrimidines%253A%2520Selective%2520Toll-Like%2520Receptor%25209%2520Antagonists%2520from%2520Scaffold%2520Morphing%2520Efforts%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1235%26epage%3D1239%26doi%3D10.1021%2Fml5003184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahaman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maithri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">Design and Development of Benzoxazole Derivatives with Toll-like Receptor 9 Antagonism</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ejmech.2017.03.086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=28437629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFegs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=334-347&author=S.+Royauthor=A.+Mukherjeeauthor=B.+Paulauthor=O.+Rahamanauthor=S.+Royauthor=G.+Maithriauthor=B.+Ramyaauthor=S.+Palauthor=D.+Gangulyauthor=A.+Talukdar&title=Design+and+Development+of+Benzoxazole+Derivatives+with+Toll-like+Receptor+9+Antagonism&doi=10.1016%2Fj.ejmech.2017.03.086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism</span></div><div class="casAuthors">Roy, Swarnali; Mukherjee, Ayan; Paul, Barnali; Rahaman, Oindrila; Roy, Shounak; Maithri, Gundaram; Ramya, Bandaru; Pal, Sourav; Ganguly, Dipyaman; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">334-347</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Toll-like receptor 9 (TLR9) is a major therapeutic target for numerous inflammatory disorders.  Development of small mol. inhibitors for TLR9 remains largely empirical due to lack of structural understanding of potential TLR9 antagonism by small mols. and due to the unusual topol. of the ligand binding surface of the receptor.  To develop a structural model for rational design of small mol. TLR9 antagonists, an enhanced homol. model of human TLR9 (hTLR9) was constructed.  Binding mode anal. of a series of mols. having characteristic mol. geometry, flexibility and basicity was conducted based on crystal structure of the inhibitory DNA (iDNA) bound to horse and bovine TLR9.  Interaction with specific amino acid residues in four leucine rich repeat (LRR) regions of TLR9 was identified to be crit. for antagonism by small mols.  The biol. validation of TLR9 antagonism and its correlation with probe-receptor interactions led to a reliable model that could be used for development of novel small mols. with potent TLR9 antagonism (IC50 30-100 nM) with excellent selectivity against TLR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT-5vh1WjBNbVg90H21EOLACvtfcHk0lhLq_8nD9_dHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFegs74%253D&md5=b5cc469bdd3ce063020126f6402bba5a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.086%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DRahaman%26aufirst%3DO.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMaithri%26aufirst%3DG.%26aulast%3DRamya%26aufirst%3DB.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DDesign%2520and%2520Development%2520of%2520Benzoxazole%2520Derivatives%2520with%2520Toll-like%2520Receptor%25209%2520Antagonism%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D134%26spage%3D334%26epage%3D347%26doi%3D10.1016%2Fj.ejmech.2017.03.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahaman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satish, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">Activity-Guided Development of Potent and Selective Toll-like Receptor 9 Antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.09.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.ejmech.2018.09.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30292896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKntbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=187-205&author=B.+Paulauthor=O.+Rahamanauthor=S.+Royauthor=S.+Palauthor=S.+Satishauthor=A.+Mukherjeeauthor=A.+R.+Ghoshauthor=D.+Raychaudhuriauthor=R.+Bhattacharyaauthor=S.+Goonauthor=D.+Gangulyauthor=A.+Talukdar&title=Activity-Guided+Development+of+Potent+and+Selective+Toll-like+Receptor+9+Antagonists&doi=10.1016%2Fj.ejmech.2018.09.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-guided development of potent and selective toll-like receptor 9 antagonists</span></div><div class="casAuthors">Paul, Barnali; Rahaman, Oindrila; Roy, Swarnali; Pal, Sourav; Satish, Sohal; Mukherjee, Ayan; Ghosh, Amrit R.; Raychaudhuri, Deblina; Bhattacharya, Roopkatha; Goon, Sunny; Ganguly, Dipyaman; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187-205</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">TLR9 is one of the major innate immune receptors expressed in the endosomes of pDCs and B cells in humans.  Aberrant TLR9 activation is implicated in several autoimmune and metabolic disorders as well as in sepsis, making this receptor an important therapeutic target, though specific TLR9 antagonists are yet to be available for clin. use.  Here we elucidate the importance of specific physiochem. properties through substitution patterns in quinazoline scaffold to achieve potent hTLR9 inhibition at < 50 nM as well as > 600 fold selectivity against hTLR7, another closely related TLR that shares downstream signaling with TLR9 but plays distinct roles in physiol. and pathol.  Assays were performed using hPBMC and reporter cell lines.  Favorable in vitro ADME profile, pharmacokinetics as well as validation in a clin. relevant in vivo TLR9-inhibition efficacy model in mice establish these novel TLR9-antagonists as candidate therapeutic agents in relevant clin. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqSBumxFqKbVg90H21EOLACvtfcHk0ljBDRy2i9oeLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKntbbL&md5=2b30577538a603af0204de5edaf3f6cb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.09.058%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DRahaman%26aufirst%3DO.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DSatish%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DA.%2BR.%26aulast%3DRaychaudhuri%26aufirst%3DD.%26aulast%3DBhattacharya%26aufirst%3DR.%26aulast%3DGoon%26aufirst%3DS.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DActivity-Guided%2520Development%2520of%2520Potent%2520and%2520Selective%2520Toll-like%2520Receptor%25209%2520Antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D159%26spage%3D187%26epage%3D205%26doi%3D10.1016%2Fj.ejmech.2018.09.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamphier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyvee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genest, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mempel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twine, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusovsky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaka, S. T.</span></span> <span> </span><span class="NLM_article-title">Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy In Vivo</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1124%2Fmol.113.089821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24342772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=429-440&author=M.+Lamphierauthor=W.+Zhengauthor=E.+Latzauthor=M.+Spyveeauthor=H.+Hansenauthor=J.+Roseauthor=M.+Genestauthor=H.+Yangauthor=C.+Shafferauthor=Y.+Zhaoauthor=Y.+Shenauthor=C.+Liuauthor=D.+Liuauthor=T.+R.+Mempelauthor=C.+Rowbottomauthor=J.+Chowauthor=N.+C.+Twineauthor=M.+Yuauthor=F.+Gusovskyauthor=S.+T.+Ishizaka&title=Novel+Small+Molecule+Inhibitors+of+TLR7+and+TLR9%3A+Mechanism+of+Action+and+Efficacy+In+Vivo&doi=10.1124%2Fmol.113.089821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo</span></div><div class="casAuthors">Lamphier, Marc; Zheng, Wanjun; Latz, Eicke; Spyvee, Mark; Hansen, Hans; Rose, Jeffrey; Genest, Melinda; Yang, Hua; Shaffer, Christina; Zhao, Yan; Shen, Yongchun; Liu, Carrie; Liu, Diana; Mempel, Thorsten R.; Rowbottom, Christopher; Chow, Jesse; Twine, Natalie C.; Yu, Melvin; Gusovsky, Fabian; Ishizaka, Sally T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-440, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The discovery that circulating nucleic acid-contg. complexes in the serum of autoimmune lupus patients can stimulate B cells and plasmacytoid dendritic cells via Toll-like receptors 7 and 9 suggested that agents that block these receptors might be useful therapeutics.  We identified two compds., AT791 {3-[4-(6-(3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropan-1-amine} and E6446 {6-[3-(pyrrolidin-1-yl)propoxy)-2-(4-(3-(pyrrolidin-yl)propoxy)phenyl]benzo[d]oxazole}, that inhibit Toll-like receptor (TLR)7 and 9 signaling in a variety of human and mouse cell types and inhibit DNA-TLR9 interaction in vitro.  When administered to mice, these compds. suppress responses to challenge doses of cytidine-phosphate-guanidine (CpG)-contg. DNA, which stimulates TLR9.  When given chronically in spontaneous mouse lupus models, E6446 slowed development of circulating antinuclear antibodies and had a modest effect on anti-double-stranded DNA titers but showed no observable impact on proteinuria or mortality.  We discovered that the ability of AT791 and E6446 to inhibit TLR7 and 9 signaling depends on two properties: weak interaction with nucleic acids and high accumulation in the intracellular acidic compartments where TLR7 a nd 9 reside.  Binding of the compds. to DNA prevents DNA-TLR9 interaction in vitro and modulates signaling in vivo.  Our data also confirm an earlier report that this same mechanism may explain inhibition of TLR7 and 9 signaling by hydroxychloroquine (Plaquenil), a drug commonly prescribed to treat lupus.  Thus, very different structural classes of mols. can inhibit endosomal TLRs by essentially identical mechanisms of action, suggesting a general mechanism for targeting this group of TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIxcZmhieLrLVg90H21EOLACvtfcHk0ljBDRy2i9oeLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D&md5=ad98c0ad97065795983540f5caa2b4a5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089821%26sid%3Dliteratum%253Aachs%26aulast%3DLamphier%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DSpyvee%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DRose%26aufirst%3DJ.%26aulast%3DGenest%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DShaffer%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMempel%26aufirst%3DT.%2BR.%26aulast%3DRowbottom%26aufirst%3DC.%26aulast%3DChow%26aufirst%3DJ.%26aulast%3DTwine%26aufirst%3DN.%2BC.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DGusovsky%26aufirst%3DF.%26aulast%3DIshizaka%26aufirst%3DS.%2BT.%26atitle%3DNovel%2520Small%2520Molecule%2520Inhibitors%2520of%2520TLR7%2520and%2520TLR9%253A%2520Mechanism%2520of%2520Action%2520and%2520Efficacy%2520In%2520Vivo%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D429%26epage%3D440%26doi%3D10.1124%2Fmol.113.089821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutz, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malladi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshakoon, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balakrishna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S. A.</span></span> <span> </span><span class="NLM_article-title">Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1021/jm2010207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1106-1116&author=N.+M.+Shuklaauthor=C.+A.+Mutzauthor=S.+S.+Malladiauthor=H.+J.+Warshakoonauthor=R.+Balakrishnaauthor=S.+A.+David&title=Toll-Like+Receptor+%28TLR%29-7+and+-8+Modulatory+Activities+of+Dimeric+Imidazoquinolines&doi=10.1021%2Fjm2010207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines</span></div><div class="casAuthors">Shukla, Nikunj M.; Mutz, Cole A.; Malladi, Subbalakshmi S.; Warshakoon, Hemamali J.; Balakrishna, Rajalakshmi; David, Sunil A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1106-1116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptors (TLRs) are pattern recognition receptors that recognize specific mol. patterns present in mols. that are broadly shared by pathogens but are structurally distinct from host mols.  The TLR7-agonistic imidazoquinolines are of interest as vaccine adjuvants given their ability to induce pronounced Th1-skewed humoral responses.  Minor modifications on the imidazoquinoline scaffold result in TLR7-antagonistic compds. which may be of value in addressing innate immune activation-driven immune exhaustion obsd. in HIV.  The syntheses and evaluation of TLR7 and TLR8 modulatory activities of dimeric constructs of imidazoquinoline linked at the C2, C4, C8, and N1-aryl positions, e.g., I, is described in this paper.  Dimers linked at the C4, C8, and N1-aryl positions were agonistic at TLR7; only the N1-aryl dimer with a 12-carbon linker was dual TLR7/8 agonistic.  Dimers linked at C2 position showed antagonistic activities at TLR7 and TLR8; the C2 dimer with a propylene spacer was maximally antagonistic at both TLR7 and TLR8.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruL0YQd4ocfrVg90H21EOLACvtfcHk0ljBDRy2i9oeLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktw%253D%253D&md5=8885b3446c7fcf5058d5a45c48112524</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm2010207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010207%26sid%3Dliteratum%253Aachs%26aulast%3DShukla%26aufirst%3DN.%2BM.%26aulast%3DMutz%26aufirst%3DC.%2BA.%26aulast%3DMalladi%26aufirst%3DS.%2BS.%26aulast%3DWarshakoon%26aufirst%3DH.%2BJ.%26aulast%3DBalakrishna%26aufirst%3DR.%26aulast%3DDavid%26aufirst%3DS.%2BA.%26atitle%3DToll-Like%2520Receptor%2520%2528TLR%2529-7%2520and%2520-8%2520Modulatory%2520Activities%2520of%2520Dimeric%2520Imidazoquinolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1106%26epage%3D1116%26doi%3D10.1021%2Fjm2010207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandopadhyay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4776</span>– <span class="NLM_lpage">4789</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsVylu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4776-4789&author=A.+Mukherjeeauthor=D.+Raychaudhuriauthor=B.+P.+Sinhaauthor=B.+Kunduauthor=M.+Mitraauthor=B.+Paulauthor=P.+Bandopadhyayauthor=D.+Gangulyauthor=A.+Talukdar&title=A+Chemical+Switch+for+Transforming+a+Purine+Agonist+for+Toll-like+Receptor+7+to+a+Clinically+Relevant+Antagonist&doi=10.1021%2Facs.jmedchem.0c00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist</span></div><div class="casAuthors">Mukherjee, Ayan; Raychaudhuri, Deblina; Sinha, Bishnu Prasad; Kundu, Biswajit; Mitra, Mousumi; Paul, Barnali; Bandopadhyay, Purbita; Ganguly, Dipyaman; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4776-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is an established therapeutic target in myriad autoimmune disorders, but no TLR7 antagonist is available for clin. use to date.  Herein, we report a purine scaffold TLR7 antagonist, first-of-its-kind to our knowledge, which was developed by rationally dissecting the structural requirements for TLR7-targeted activity for a purine scaffold.  Specifically, we identified a singular chem. switch at C-2 that could make a potent purine scaffold TLR7 agonist to lose agonism and acquire antagonist activity, which could further be potentiated by the introduction of an addnl. basic center at C-6.  We ended up developing a clin. relevant TLR7 antagonist with favorable pharmacokinetics and 70.8% oral bioavailability in mice.  Moreover, the TLR7 antagonists depicted excellent selectivity against TLR8.  To further validate the in vivo applicability of this novel TLR7 antagonist, we demonstrated its excellent efficacy in preventing TLR7-induced pathol. in a preclin. murine model of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3YXtgyg7cHbVg90H21EOLACvtfcHk0lgdNW0RYjsKBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsVylu7o%253D&md5=d58504ff58f6e8a4636cc258384296a7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00011%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DA.%26aulast%3DRaychaudhuri%26aufirst%3DD.%26aulast%3DSinha%26aufirst%3DB.%2BP.%26aulast%3DKundu%26aufirst%3DB.%26aulast%3DMitra%26aufirst%3DM.%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DBandopadhyay%26aufirst%3DP.%26aulast%3DGanguly%26aufirst%3DD.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DA%2520Chemical%2520Switch%2520for%2520Transforming%2520a%2520Purine%2520Agonist%2520for%2520Toll-like%2520Receptor%25207%2520to%2520a%2520Clinically%2520Relevant%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4776%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.0c00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, M. J.</span></span> <span> </span><span class="NLM_article-title">Regiospecific N9 Alkylation of 6-(Heteroaryl)Purines: Shielding of N7 by a Proximal Heteroaryl C–H1</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">8901</span>– <span class="NLM_lpage">8906</span>, <span class="refDoi"> DOI: 10.1021/jo061759h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo061759h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyntbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=8901-8906&author=M.+Zhongauthor=M.+J.+Robins&title=Regiospecific+N9+Alkylation+of+6-%28Heteroaryl%29Purines%3A+Shielding+of+N7+by+a+Proximal+Heteroaryl+C%E2%80%93H1&doi=10.1021%2Fjo061759h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Regiospecific N9 Alkylation of 6-(Heteroaryl)purines: Shielding of N7 by a Proximal Heteroaryl C-H1</span></div><div class="casAuthors">Zhong, Minghong; Robins, Morris J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8901-8906</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-(Heteroaryl)-9-alkylpurines, e.g., I, were prepd. by regiospecific N-alkylation of 6-(heteroaryl)purines, e.g., II, with alkyl iodides under alk. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryZspAetdyTbVg90H21EOLACvtfcHk0lgdNW0RYjsKBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyntbvO&md5=e7b532ab482b2dd1be36d3ecb9360fbf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo061759h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061759h%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DRobins%26aufirst%3DM.%2BJ.%26atitle%3DRegiospecific%2520N9%2520Alkylation%2520of%25206-%2528Heteroaryl%2529Purines%253A%2520Shielding%2520of%2520N7%2520by%2520a%2520Proximal%2520Heteroaryl%2520C%25E2%2580%2593H1%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D8901%26epage%3D8906%26doi%3D10.1021%2Fjo061759h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuMontelle, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolodz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozier, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, B.</span></span> <span> </span><span class="NLM_article-title">Use of Toll-Like Receptor Assays To Detect and Identify Microbial Contaminants in Biological Products</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3427</span>– <span class="NLM_lpage">3434</span>, <span class="refDoi"> DOI: 10.1128/JCM.00373-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1128%2FJCM.00373-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=19726599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFems77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=3427-3434&author=L.-Y.+Huangauthor=J.+L.+DuMontelleauthor=M.+Zolodzauthor=A.+Deoraauthor=N.+M.+Mozierauthor=B.+Golding&title=Use+of+Toll-Like+Receptor+Assays+To+Detect+and+Identify+Microbial+Contaminants+in+Biological+Products&doi=10.1128%2FJCM.00373-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Use of toll-like receptor assays to detect and identify microbial contaminants in biological products</span></div><div class="casAuthors">Huang, Li-Yun; Du Montelle, James L.; Zolodz, Melissa; Deora, Aparna; Mozier, Ned M.; Golding, Basil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3427-3434</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toll-like receptor (TLR)-expressing cells, for the first time, detected and identified a microbial contaminant in a product made in Escherichia coli using an old manufg. process.  It was suspected of having a microbial contaminant(s) because, although it tested neg. by std. pyrogen assays, it was assocd. with adverse events in early clin. trials.  The assay readout is the induction of NF-κB and/or cytokines in response to TLR activation.  Four coded samples, labeled A to D, including a sample prepd. by the older manufg. process, were submitted.  The cell lines were activated only by samples B and D.  Sample D stimulated only Mono-Mac 6 and HEK-human TLR4 (hTLR4) cells and was later identified as lipopolysaccharide.  Except for TLR3 cells, sample B stimulated cells bearing the different TLRs (TLRs 2, 4, 5, 7, 8, and 9) and nontransfected HEK293 cells.  These data suggested that flagellin was the microbial contaminant, since TLR5, the receptor for flagellin, is known to be expressed constitutively on HEK293 cells.  Moreover, purified flagellin from Salmonella enterica serovar Typhimurium behaved like sample B, stimulating HEK293 and HEK-hTLR5 cells but not HEK-hTLR3 cells, and this stimulation by flagellin and sample B was blocked by an anti-hTLR5 neutralizing antibody.  Western blots showed bands pos. for flagellin and sample B with the mol. sizes expected for the flagellins from S. Typhimurium and E. coli, resp.  Mass spectrometry data were consistent with the presence of flagellin in the manufacturer's sample B.  Taken together, these data indicate that the microbial contaminant in sample B was flagellin and may have been assocd. with adverse events when the recombinant product was administered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm4mkpG3s3i7Vg90H21EOLACvtfcHk0lgdNW0RYjsKBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFems77M&md5=243ef257297cbd2ba61be7c4de9c1c60</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FJCM.00373-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00373-09%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.-Y.%26aulast%3DDuMontelle%26aufirst%3DJ.%2BL.%26aulast%3DZolodz%26aufirst%3DM.%26aulast%3DDeora%26aufirst%3DA.%26aulast%3DMozier%26aufirst%3DN.%2BM.%26aulast%3DGolding%26aufirst%3DB.%26atitle%3DUse%2520of%2520Toll-Like%2520Receptor%2520Assays%2520To%2520Detect%2520and%2520Identify%2520Microbial%2520Contaminants%2520in%2520Biological%2520Products%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2009%26volume%3D47%26spage%3D3427%26epage%3D3434%26doi%3D10.1128%2FJCM.00373-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in the Development of Toll-like Receptor (TLR) Antagonists</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1185415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1080%2F13543776.2016.1185415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27136061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=719-730&author=M.+C.+Patraauthor=S.+Choi&title=Recent+Progress+in+the+Development+of+Toll-like+Receptor+%28TLR%29+Antagonists&doi=10.1080%2F13543776.2016.1185415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of Toll-like receptor (TLR) antagonists</span></div><div class="casAuthors">Patra, Mahesh Chandra; Choi, Sangdun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">719-730</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Pattern recognition receptors (PRRs) of the innate immune system mediate and control the activation and progression of adaptive immunity.  Toll-like receptors (TLRs) are the most notable of the PRRs: they play crucial roles in protecting the host body against invading pathogens or endogenously released hazardous mols.  Sustained TLR signaling even after the clearance of pathogens or failure to distinguish between 'self' and 'non-self' mols. can cause inflammatory disorders, autoimmune diseases, and cancer.  This review focuses on recently developed therapeutic agents with TLR-antagonistic activities.  In recent years, several research institutes and pharmaceutical companies have achieved fundamental successes in inhibiting or reducing TLR signaling and assocd. effector mechanisms by using novel inhibitors.  These inhibitory mols. include antibodies against TLRs, TLR-derived transmembrane (TM) peptides, bacterial-secreted proteins, and natural or synthetic small mols., peptides, and proteins.  Antagonist developers generally target the TLR ectodomain to block receptor activation.  The TM and cytosolic Toll/IL-1 receptor domains also have regions that should be explored for the design of peptide-based and small mol. blocking agents.  A no. of preclin. and clin. breakthroughs may result in the availability of improved TLR immunomodulatory drugs to address important unmet medical needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqbKGU6yn83rVg90H21EOLACvtfcHk0lgWbSjFenOWpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOrurc%253D&md5=11a223116a4186220fecbd19a4377cd6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1185415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1185415%26sid%3Dliteratum%253Aachs%26aulast%3DPatra%26aufirst%3DM.%2BC.%26aulast%3DChoi%26aufirst%3DS.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Toll-like%2520Receptor%2520%2528TLR%2529%2520Antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D719%26epage%3D730%26doi%3D10.1080%2F13543776.2016.1185415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akilesh, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessay, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Presnell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkon, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacy-Hulbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamerman, J. A.</span></span> <span> </span><span class="NLM_article-title">Chronic TLR7 and TLR9 Signaling Drives Anemia via Differentiation of Specialized Hemophagocytes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>363</i></span>, <span class="NLM_elocation-id">eaao5213</span> <span class="refDoi"> DOI: 10.1126/science.aao5213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1126%2Fscience.aao5213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30630901" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2019&author=H.+M.+Akileshauthor=M.+B.+Buechlerauthor=J.+M.+Dugganauthor=W.+O.+Hahnauthor=B.+Mattaauthor=X.+Sunauthor=G.+Gessayauthor=E.+Whalenauthor=M.+Masonauthor=S.+R.+Presnellauthor=K.+B.+Elkonauthor=A.+Lacy-Hulbertauthor=B.+J.+Barnesauthor=M.+Pepperauthor=J.+A.+Hamerman&title=Chronic+TLR7+and+TLR9+Signaling+Drives+Anemia+via+Differentiation+of+Specialized+Hemophagocytes&doi=10.1126%2Fscience.aao5213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.aao5213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aao5213%26sid%3Dliteratum%253Aachs%26aulast%3DAkilesh%26aufirst%3DH.%2BM.%26aulast%3DBuechler%26aufirst%3DM.%2BB.%26aulast%3DDuggan%26aufirst%3DJ.%2BM.%26aulast%3DHahn%26aufirst%3DW.%2BO.%26aulast%3DMatta%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DGessay%26aufirst%3DG.%26aulast%3DWhalen%26aufirst%3DE.%26aulast%3DMason%26aufirst%3DM.%26aulast%3DPresnell%26aufirst%3DS.%2BR.%26aulast%3DElkon%26aufirst%3DK.%2BB.%26aulast%3DLacy-Hulbert%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DB.%2BJ.%26aulast%3DPepper%26aufirst%3DM.%26aulast%3DHamerman%26aufirst%3DJ.%2BA.%26atitle%3DChronic%2520TLR7%2520and%2520TLR9%2520Signaling%2520Drives%2520Anemia%2520via%2520Differentiation%2520of%2520Specialized%2520Hemophagocytes%26jtitle%3DScience%26date%3D2019%26volume%3D363%26doi%3D10.1126%2Fscience.aao5213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suthers, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarantopoulos, S.</span></span> <span> </span><span class="NLM_article-title">TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">775</span> <span class="refDoi"> DOI: 10.3389/fimmu.2017.00775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.3389%2Ffimmu.2017.00775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=28751890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWnsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=A.+N.+Suthersauthor=S.+Sarantopoulos&title=TLR7%2FTLR9-+and+B+Cell+Receptor-Signaling+Crosstalk%3A+Promotion+of+Potentially+Dangerous+B+Cells&doi=10.3389%2Ffimmu.2017.00775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">TLR7/TLR9- and B cell receptor-signaling crosstalk: promotion of potentially dangerous B cells</span></div><div class="casAuthors">Suthers, Amy N.; Sarantopoulos, Stefanie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">775/1-775/8</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  B cells are capable of receptor-mediated responses to foreign antigens.  Recognition of microbial-derived nucleic acid (NA) by toll-like receptors (TLRs) 7 and 9 in B cells has been substantiated.  Endogenous NA released from damaged or dying cells can also be immunogenic in certain contexts and can incite aberrant activation of B cells.  When TLR-driven B cell receptor (BCR)-activated B cells are not properly constrained, pathol. autoantibodies are produced.  It is also clear that endosomal TLR7/TLR9 can operate in conjunction with BCR.  In addn. to BCR signaling, a balance between TLR7 and TLR9 is pivotal in the development of B cell autoreactivity.  While TLR9 is important in normal memory Bcell responses through BCR, TLR9 activation has been implicated in autoantibody prodn.  Paradoxically, TLR9 also plays known protective roles against autoimmunity by directly and indirectly inhibiting TLR7-mediated autoantibody prodn.  Herein, we summarize literature supporting mechanisms underpinning the promotion of pathol. BCR-activated Bcells by TLR7 and TLR9.  We focus on the literature regarding known points of TLR7/TLR9 and BCR crosstalk.  Data also suggest that the degree of TLR responsiveness relies on alterations of certain intrinsic B-cell signaling mols. and is also context specific.  Because allogeneic hematopoietic stem cell transplantation is a high NA and B cell-activating factor environment, we conclude that B cell studies of synergistic TLR-BCR signaling in human diseases like chronic graft-vs.-host disease are warranted.  Further understanding of the distinct mol. pathways mediating TLR-BCR synergy will lead to the development of therapeutic strategies in autoimmune disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRSzu-xcEMG7Vg90H21EOLACvtfcHk0lgWbSjFenOWpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWnsrfI&md5=0b6cba114061b711a6bf504524bdda19</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00775%26sid%3Dliteratum%253Aachs%26aulast%3DSuthers%26aufirst%3DA.%2BN.%26aulast%3DSarantopoulos%26aufirst%3DS.%26atitle%3DTLR7%252FTLR9-%2520and%2520B%2520Cell%2520Receptor-Signaling%2520Crosstalk%253A%2520Promotion%2520of%2520Potentially%2520Dangerous%2520B%2520Cells%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26doi%3D10.3389%2Ffimmu.2017.00775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zatsepin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkelmeier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger-Kentischer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldblum, A.</span></span> <span> </span><span class="NLM_article-title">Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1835</span>– <span class="NLM_lpage">1846</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.6b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.6b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKrsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2016&pages=1835-1846&author=M.+Zatsepinauthor=A.+Mattesauthor=S.+Ruppauthor=D.+Finkelmeierauthor=A.+Basuauthor=A.+Burger-Kentischerauthor=A.+Goldblum&title=Computational+Discovery+and+Experimental+Confirmation+of+TLR9+Receptor+Antagonist+Leads&doi=10.1021%2Facs.jcim.6b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads</span></div><div class="casAuthors">Zatsepin, Maria; Mattes, Angela; Rupp, Steffen; Finkelmeier, Doris; Basu, Arijit; Burger-Kentischer, Anke; Goldblum, Amiram</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1835-1846</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toll-like receptors (TLR) are receptors of innate immunity that recognize Pathogen Assocd. Mol. Patterns.  They play a crit. role in many pathol. states, in acute and chronic inflammatory processes.  TLR9 is a promising target for drug discovery, since it has been implicated in several pathologies, including defense against viral infections and psoriasis.  Immune-modulators are promising mols. for therapeutic intervention in these indications.  TLR9 is located in the endosome and activated by dsDNA with CpG motives encountered in microbial DNA.  Here the authors report on a combined approach to discover new TLR9 antagonists by computational chem. and cell based assays.  The authors used the inhouse Iterative Stochastic Elimination (ISE) algorithm to create models that distinguish between TLR9 antagonists ("actives") and other mols. ("inactives"), based on mol. physico-chem. properties.  Subsequent screening and scoring of a dataset of 1.8 million com. available mols. led to the purchasing of top scored mols., which were tested in a new cell based system based on human PRRs stably expressed in NIH3T3 fibroblasts.  As described previously, this cell line shows a very low endogenous PRR-activity and contains a reporter gene which is selectively activated by the integrated human PRR enabling rapid screening of potential ligands.  IC50 values of each of these top scored mols. were detd.  Out of 60 mols. tested, 56 showed antagonistic activity.  The authors discovered 21 new highly potential antagonists with IC50 values lower than 10 μM, with five of them having IC50 values under 1 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz78TtRMfluLVg90H21EOLACvtfcHk0lgWbSjFenOWpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKrsL7P&md5=b5abc215a2104b6f054e5f098e31982b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.6b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.6b00070%26sid%3Dliteratum%253Aachs%26aulast%3DZatsepin%26aufirst%3DM.%26aulast%3DMattes%26aufirst%3DA.%26aulast%3DRupp%26aufirst%3DS.%26aulast%3DFinkelmeier%26aufirst%3DD.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBurger-Kentischer%26aufirst%3DA.%26aulast%3DGoldblum%26aufirst%3DA.%26atitle%3DComputational%2520Discovery%2520and%2520Experimental%2520Confirmation%2520of%2520TLR9%2520Receptor%2520Antagonist%2520Leads%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2016%26volume%3D56%26spage%3D1835%26epage%3D1846%26doi%3D10.1021%2Facs.jcim.6b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bou
Karroum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarbess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patinote, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouharoun-Tayoun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuq, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab-Assaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze-Masquefa, C.</span></span> <span> </span><span class="NLM_article-title">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]Pyrazines, Imidazo[1,5-a]Quinoxalines, and Pyrazolo[1,5-a]Quinoxalines Series</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7015</span>– <span class="NLM_lpage">7031</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7015-7031&author=N.+Bou%0AKarroumauthor=G.+Moarbessauthor=J.-F.+Guichouauthor=P.-A.+Bonnetauthor=C.+Patinoteauthor=H.+Bouharoun-Tayounauthor=S.+Chamatauthor=P.+Cuqauthor=M.+Diab-Assafauthor=I.+Kassabauthor=C.+Deleuze-Masquefa&title=Novel+and+Selective+TLR7+Antagonists+among+the+Imidazo%5B1%2C2-a%5DPyrazines%2C+Imidazo%5B1%2C5-a%5DQuinoxalines%2C+and+Pyrazolo%5B1%2C5-a%5DQuinoxalines+Series&doi=10.1021%2Facs.jmedchem.9b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series</span></div><div class="casAuthors">Bou Karroum, Nour; Moarbess, Georges; Guichou, Jean-Francois; Bonnet, Pierre-Antoine; Patinote, Cindy; Bouharoun-Tayoun, Hasnaa; Chamat, Soulaima; Cuq, Pierre; Diab-Assaf, Mona; Kassab, Issam; Deleuze-Masquefa, Carine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7015-7031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Toll-like receptors (TLRs) 7 and 8 play an important role in the immune system activation, and their agonists may therefore serve as promising candidate vaccine adjuvants.  However, the chronic immune activation by excessive TLR stimulation is a hallmark of several clin. important infectious and autoimmune diseases, which warrants the search for TLR antagonists.  In this study, a variety of compds. belonging to three heterocyclic chem. series: imidazo[1,2-a]pyrazine, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline have been synthesized and characterized.  These compds. have been tested for their TLR7 or TLR8 agonistic and antagonistic activities.  Several of them are shown to be selective TLR7 antagonists without any TLR7 or TLR8 agonistic activity.  The selectivity was confirmed by a comparative ligand-docking study in TLR7 antagonist pocket.  Two compds. of the pyrazolo[1,5-a]quinoxaline series I [R = n-Bu, i-Bu] are potent selective TLR7 antagonists and may be considered as promising starting points for the development of new therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3510Ht_ZHf7Vg90H21EOLACvtfcHk0ljb-HvfFNS8Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN&md5=b9ffc17dcae442102245eb76face7394</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00411%26sid%3Dliteratum%253Aachs%26aulast%3DBou%2BKarroum%26aufirst%3DN.%26aulast%3DMoarbess%26aufirst%3DG.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26aulast%3DBonnet%26aufirst%3DP.-A.%26aulast%3DPatinote%26aufirst%3DC.%26aulast%3DBouharoun-Tayoun%26aufirst%3DH.%26aulast%3DChamat%26aufirst%3DS.%26aulast%3DCuq%26aufirst%3DP.%26aulast%3DDiab-Assaf%26aufirst%3DM.%26aulast%3DKassab%26aufirst%3DI.%26aulast%3DDeleuze-Masquefa%26aufirst%3DC.%26atitle%3DNovel%2520and%2520Selective%2520TLR7%2520Antagonists%2520among%2520the%2520Imidazo%255B1%252C2-a%255DPyrazines%252C%2520Imidazo%255B1%252C5-a%255DQuinoxalines%252C%2520and%2520Pyrazolo%255B1%252C5-a%255DQuinoxalines%2520Series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7015%26epage%3D7031%26doi%3D10.1021%2Facs.jmedchem.9b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandimalla, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span> <span> </span><span class="NLM_article-title">Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5108</span>– <span class="NLM_lpage">5114</span>, <span class="refDoi"> DOI: 10.1021/jm900730r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900730r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlSmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5108-5114&author=D.+Yuauthor=D.+Wangauthor=F.-G.+Zhuauthor=L.+Bhagatauthor=M.+Daiauthor=E.+R.+Kandimallaauthor=S.+Agrawal&title=Modifications+Incorporated+in+CpG+Motifs+of+Oligodeoxynucleotides+Lead+to+Antagonist+Activity+of+Toll-like+Receptors+7+and+9&doi=10.1021%2Fjm900730r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9</span></div><div class="casAuthors">Yu, Dong; Wang, Daqing; Zhu, Fu-Gang; Bhagat, Lakshmi; Dai, Meiru; Kandimalla, Ekambar R.; Agrawal, Sudhir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5108-5114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligodeoxynucleotides (ODNs) contg. unmethylated CpG dinucleotides act as agonists of TLR9 and induce Th1-type immune responses.  In the present study, we synthesized CpG contg. ODNs in which C or G was substituted with 2'-O-methylribonucleotides, 5-methyl-dC, or 2'-O-methyl-5-methyl-C and studied their immune stimulatory activity alone and in combination with TLR agonists.  In mouse and human primary cell-based assays, modified ODNs did not stimulate immune responses but inhibited TLR9 agonist-induced immune stimulatory activity.  In mice, modified ODNs did not induce cytokines but inhibited immune responses induced by agonists of TLR7 and TLR9.  Modified ODNs did not inhibit endosomal TLR3- or cell-surface TLR4-agonist-induced cytokines.  This study demonstrates that ODNs incorporated with chem. modifications in CpG dinucleotides do not induce immune stimulatory activity but act as antagonists of TLR7 and TLR9 in vitro and in vivo.  These types of modifications are commonly employed in antisense sequences and thereby may affect the intended mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIUPJmgeCNS7Vg90H21EOLACvtfcHk0ljb-HvfFNS8Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlSmurg%253D&md5=ba7d00b1d1b139370a7983441f298867</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm900730r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900730r%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DF.-G.%26aulast%3DBhagat%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DKandimalla%26aufirst%3DE.%2BR.%26aulast%3DAgrawal%26aufirst%3DS.%26atitle%3DModifications%2520Incorporated%2520in%2520CpG%2520Motifs%2520of%2520Oligodeoxynucleotides%2520Lead%2520to%2520Antagonist%2520Activity%2520of%2520Toll-like%2520Receptors%25207%2520and%25209%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5108%26epage%3D5114%26doi%3D10.1021%2Fjm900730r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandimalla, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span> <span> </span><span class="NLM_article-title">Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1021/jm8014316</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014316" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFals7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=551-558&author=D.+Wangauthor=L.+Bhagatauthor=D.+Yuauthor=F.-G.+Zhuauthor=J.+X.+Tangauthor=E.+R.+Kandimallaauthor=S.+Agrawal&title=Oligodeoxyribonucleotide-Based+Antagonists+for+Toll-Like+Receptors+7+and+9&doi=10.1021%2Fjm8014316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9</span></div><div class="casAuthors">Wang, Daqing; Bhagat, Lakshmi; Yu, Dong; Zhu, Fu-Gang; Tang, Jimmy X.; Kandimalla, Ekambar R.; Agrawal, Sudhir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligodeoxyribonucleotides contg. unmethylated CpG motifs act as TLR9 agonists.  In this study, we evaluated oligonucleotides contg. an unmethylated CpG motif in which two nucleotides adjacent to the CpG dinucleotide were substituted with 2'-O-methylribonucleotides, resulting in TLR7 and TLR9 antagonists.  In mouse and human cell cultures, antagonists did not stimulate immune activation but inhibited TLR7 and TLR9 agonist-induced activity.  In mice, antagonists inhibited immune responses induced by TLR9 agonists for up to several days, and the inhibition was dose-dependent.  Antagonists also inhibited immune responses induced by an RNA-based TLR7/8 agonist but not TLRs 2, 3, 4, or 5 agonists in mice.  Addnl., antagonist inhibited TLR9 agonist-induced IL-6 in lupus-prone MRL/lpr mouse spleen cell cultures.  These results indicate that antagonists described herein can suppress immune responses induced by TLR7 and TLR9 agonists.  Antagonists may be suitable candidates for treating inflammatory and autoimmune diseases where inappropriate or uncontrolled TLR activation has been implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOPN-6_W0BcLVg90H21EOLACvtfcHk0ljb-HvfFNS8Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFals7nF&md5=74a55b8d4904e264769ef7eb873e533b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm8014316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014316%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DBhagat%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DF.-G.%26aulast%3DTang%26aufirst%3DJ.%2BX.%26aulast%3DKandimalla%26aufirst%3DE.%2BR.%26aulast%3DAgrawal%26aufirst%3DS.%26atitle%3DOligodeoxyribonucleotide-Based%2520Antagonists%2520for%2520Toll-Like%2520Receptors%25207%2520and%25209%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D551%26epage%3D558%26doi%3D10.1021%2Fjm8014316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blasius, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beutler, B.</span></span> <span> </span><span class="NLM_article-title">Intracellular Toll-like Receptors</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.immuni.2010.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=20346772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=305-315&author=A.+L.+Blasiusauthor=B.+Beutler&title=Intracellular+Toll-like+Receptors&doi=10.1016%2Fj.immuni.2010.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular toll-like receptors</span></div><div class="casAuthors">Blasius, Amanda L.; Beutler, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-315</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Foreign nucleic acids, the signature of invading viruses and certain bacteria, are sensed intracellularly.  The nucleic acid-specific Toll-like receptors (TLRs) detect and signal within endolysosomal compartments, triggering the induction of cytokines essential for the innate immune response.  These cytokines include proinflammatory mols. produced mainly by macrophages and conventional dendritic cells, as well as type I interferons, which are produced in great quantities by plasmacytoid dendritic cells.  The cellular and mol. pathways by which nucleic acids and TLRs meet within the endosome assure host protection yet also place the host at risk for the development of autoimmunity.  Here, we review the latest findings on the intracellular TLRs, with special emphasis on ligand uptake, receptor trafficking, signaling, and regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5-SJKSbEwurVg90H21EOLACvtfcHk0lj3a0dBi-4OXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSntr4%253D&md5=84f54e99249e52a6424c7c3975e8c7ea</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DBlasius%26aufirst%3DA.%2BL.%26aulast%3DBeutler%26aufirst%3DB.%26atitle%3DIntracellular%2520Toll-like%2520Receptors%26jtitle%3DImmunity%26date%3D2010%26volume%3D32%26spage%3D305%26epage%3D315%26doi%3D10.1016%2Fj.immuni.2010.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krayukhina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis Reveals That Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.immuni.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27742543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=737-748&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=E.+Krayukhinaauthor=M.+Taokaauthor=Y.+Yamauchiauthor=H.+Tanjiauthor=T.+Isobeauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Analysis+Reveals+That+Toll-like+Receptor+7+Is+a+Dual+Receptor+for+Guanosine+and+Single-Stranded+RNA&doi=10.1016%2Fj.immuni.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chem. ligands, such as imidazoquinoline compds.  However, TLR7 activation mechanism by these ligands remain largely unknown.  Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites.  The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation.  The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands.  The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA.  Our structural, biochem., and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-contg. ssRNA.  Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQskd1L0XeX7Vg90H21EOLACvtfcHk0lj3a0dBi-4OXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI&md5=194f87d5ea0e88009fd682c00e020f38</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Analysis%2520Reveals%2520That%2520Toll-like%2520Receptor%25207%2520Is%2520a%2520Dual%2520Receptor%2520for%2520Guanosine%2520and%2520Single-Stranded%2520RNA%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D737%26epage%3D748%26doi%3D10.1016%2Fj.immuni.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">TLR7 Structure: Cut in Z-Loop</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">707</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2016.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.immuni.2016.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27760331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSgsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=705-707&author=K.+Maedaauthor=S.+Akira&title=TLR7+Structure%3A+Cut+in+Z-Loop&doi=10.1016%2Fj.immuni.2016.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">TLR7 Structure: Cut in Z-Loop</span></div><div class="casAuthors">Maeda, Kazuhiko; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">705-707</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">TLRs play central roles in host defense.  In this issue of Immunity, Zhang et al. (2016) generate structures of TLR7 bound to multiple ligands and provide insight into the mechanism of TLR7 ligand recognition that highlights the differences in the features of the TLR subfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlH3PtnUPr4LVg90H21EOLACvtfcHk0lj3a0dBi-4OXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSgsbjK&md5=ba5a66376216dc97033f2debbbf39bba</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DTLR7%2520Structure%253A%2520Cut%2520in%2520Z-Loop%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D705%26epage%3D707%26doi%3D10.1016%2Fj.immuni.2016.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentile, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deriu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licandro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuszynski, J. A.</span></span> <span> </span><span class="NLM_article-title">Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">8316</span>– <span class="NLM_lpage">8340</span>, <span class="refDoi"> DOI: 10.3390/molecules20058316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.3390%2Fmolecules20058316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=26007168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosV2rsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=8316-8340&author=F.+Gentileauthor=M.+A.+Deriuauthor=G.+Licandroauthor=A.+Prunottoauthor=A.+Dananiauthor=J.+A.+Tuszynski&title=Structure+Based+Modeling+of+Small+Molecules+Binding+to+the+TLR7+by+Atomistic+Level+Simulations&doi=10.3390%2Fmolecules20058316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based modeling of small molecules binding to the TLR7 by atomistic level simulations</span></div><div class="casAuthors">Gentile, Francesco; Deriu, Marco A.; Licandro, Ginevra; Prunotto, Alessio; Danani, Andrea; Tuszynski, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">8316-8340</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Toll-Like Receptors (TLR) are a large family of proteins involved in the immune system response.  Both the activation and the inhibition of these receptors can have pos. effects on several diseases, including viral pathologies and cancer, therefore prompting the development of new compds.  In order to provide new indications for the design of Toll-Like Receptor 7 (TLR7)-targeting drugs, the mechanism of interaction between the TLR7 and two important classes of agonists (imidazoquinoline and adenine derivs.) was investigated through docking and Mol. Dynamics simulations.  To perform the computational anal., a new model for the dimeric form of the receptors was necessary and therefore created.  Qual. and quant. differences between agonists and inactive compds. were detd.  The in silico results were compared with previous exptl. observations and employed to define the ligand binding mechanism of TLR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHuOwm1H1WEbVg90H21EOLACvtfcHk0lj3a0dBi-4OXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosV2rsLc%253D&md5=5c8db1afa6ecddfb527778cd4d4cf538</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20058316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20058316%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DF.%26aulast%3DDeriu%26aufirst%3DM.%2BA.%26aulast%3DLicandro%26aufirst%3DG.%26aulast%3DPrunotto%26aufirst%3DA.%26aulast%3DDanani%26aufirst%3DA.%26aulast%3DTuszynski%26aufirst%3DJ.%2BA.%26atitle%3DStructure%2520Based%2520Modeling%2520of%2520Small%2520Molecules%2520Binding%2520to%2520the%2520TLR7%2520by%2520Atomistic%2520Level%2520Simulations%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D8316%26epage%3D8340%26doi%3D10.3390%2Fmolecules20058316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuszynski, J. A.</span></span> <span> </span><span class="NLM_article-title">Homology and Molecular Dynamics Models of Toll-Like Receptor 7 Protein and Its Dimerization</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">656</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1111%2Fcbdd.12278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24406029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvF2htr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=656-665&author=C.-Y.+Tsengauthor=M.+Gajewskiauthor=A.+Dananiauthor=J.+A.+Tuszynski&title=Homology+and+Molecular+Dynamics+Models+of+Toll-Like+Receptor+7+Protein+and+Its+Dimerization&doi=10.1111%2Fcbdd.12278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Homology and Molecular Dynamics Models of Toll-Like Receptor 7 Protein and Its Dimerization</span></div><div class="casAuthors">Tseng, Chih-Yuan; Gajewski, Melissa; Danani, Andrea; Tuszynski, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">656-665</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Toll-like receptor protein 7 is a transmembrane protein playing a crucial role in the signaling pathways involved in innate immunity.  Its crystal structure is not yet available, but there are several proteins possessing domains of sufficiently high homol., which enabled us to build a model of the toll-like receptor protein 7 monomer and gain insights into dimer formation.  To obtain a reliable structure prediction, we subjected this model to equilibration using mol. dynamics simulations.  Furthermore, the equilibrated monomer structure was used to construct models of dimerization and to predict binding sites for small ligands.  Docking studies were performed for some of the known toll-like receptor protein 7 ligands.  We detd. that a new homol. model generated by the LOOPP server provides a good alternative to a previously reported model.  Our docking results indicate that the addn. of either imiquimod or 1V209 to a toll-like receptor protein 7 dimer changes an unfavorable interaction into a favorable one.  We found that eight small mols. docked to two pockets in toll-like receptor protein 7 bind to both pockets at pH 7 and at pH 5.5.  This work provides a realistic model that could be used for drug discovery aimed at finding toll-like receptor protein 7 dimerization activators, with potential clin. applications to a host of diseases, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE-sSRu58COLVg90H21EOLACvtfcHk0lhcaG43Zfm3AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvF2htr4%253D&md5=9b4d3f34cdb1f91a79d5427b2333fe0d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12278%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DC.-Y.%26aulast%3DGajewski%26aufirst%3DM.%26aulast%3DDanani%26aufirst%3DA.%26aulast%3DTuszynski%26aufirst%3DJ.%2BA.%26atitle%3DHomology%2520and%2520Molecular%2520Dynamics%2520Models%2520of%2520Toll-Like%2520Receptor%25207%2520Protein%2520and%2520Its%2520Dimerization%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D83%26spage%3D656%26epage%3D665%26doi%3D10.1111%2Fcbdd.12278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, B.</span></span> <span> </span><span class="NLM_article-title">Strategy for Extending Half-Life in Drug Design and Its Significance</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=528-533&author=H.+Gunaydinauthor=M.+D.+Altmanauthor=J.+M.+Ellisauthor=P.+Fullerauthor=S.+A.+Johnsonauthor=B.+Lahueauthor=B.+Lapointe&title=Strategy+for+Extending+Half-Life+in+Drug+Design+and+Its+Significance&doi=10.1021%2Facsmedchemlett.8b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Strategy for extending half-life in drug design and its significance</span></div><div class="casAuthors">Gunaydin, Hakan; Altman, Michael D.; Ellis, J. Michael; Fuller, Peter; Johnson, Scott A.; Lahue, Brian; Lapointe, Blair</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">528-533</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Preclin. optimization of compds. toward viable drug candidates requires an integrated understanding of properties that impact predictions of the clin. efficacious dose.  The importance of optimizing half-life, unbound clearance, and potency and how they impact dose predictions are discussed in this letter.  Modest half-life improvements for short half-life compds. can dramatically lower the efficacious dose.  The relationship between dose and half-life is nonlinear when unbound clearance is kept const., whereas the relationship between dose and unbound clearance is linear when half-life is kept const.  Due to this difference, we show that dose is more sensitive to changes in half-life than changes in unbound clearance when half-lives are shorter than 2 h.  Through matched mol. pair analyses, we also show that the strategic introduction of halogens is likely to increase half-life and lower projected human dose even though increased lipophilicity does not guarantee extended half-life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJU1an5zslYbVg90H21EOLACvtfcHk0lhcaG43Zfm3AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLk%253D&md5=497178d9c523a58e1fa70e34cdf09281</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00018%26sid%3Dliteratum%253Aachs%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DEllis%26aufirst%3DJ.%2BM.%26aulast%3DFuller%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DLahue%26aufirst%3DB.%26aulast%3DLapointe%26aufirst%3DB.%26atitle%3DStrategy%2520for%2520Extending%2520Half-Life%2520in%2520Drug%2520Design%2520and%2520Its%2520Significance%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D528%26epage%3D533%26doi%3D10.1021%2Facsmedchemlett.8b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhcaG43Zfm3AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engel, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span> <span> </span><span class="NLM_article-title">The Pharmacokinetics of Toll-like Receptor Agonists and the Impact on the Immune System</span>. <i>Expert Rev. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1586/ecp.11.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1586%2Fecp.11.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=21643519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1yqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=275-289&author=A.+L.+Engelauthor=G.+E.+Holtauthor=H.+Lu&title=The+Pharmacokinetics+of+Toll-like+Receptor+Agonists+and+the+Impact+on+the+Immune+System&doi=10.1586%2Fecp.11.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system</span></div><div class="casAuthors">Engel, Abbi L.; Holt, Gregory E.; Lu, Hailing</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-289</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Toll-like receptor (TLR) ligation activates both the innate and adaptive immune systems, and plays an important role in antiviral and anti-tumor immunity.  Therefore, a significant amt. of effort has been devoted to exploit the therapeutic potential of TLR agonists.  Depending on the therapeutic purpose, either as adjuvants to vaccine, chemotherapy or standalone therapy, TLR agonists have been administered via different routes.  Both preclin. and clin. studies have suggested that the route of administration has significant effects on pharmacokinetics, and that understanding these effects is crit. to the success of TLR agonist drug development.  This article will summarize the pharmacokinetics of TLR agonists with different administration routes, with an emphasis on clin. studies of TLR ligands in oncol. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0NNpI7RjSLLVg90H21EOLACvtfcHk0lhV2e2reyfZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1yqs7g%253D&md5=e3ccf9accdb9468cba58f60bd2172d0d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1586%2Fecp.11.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.11.5%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DA.%2BL.%26aulast%3DHolt%26aufirst%3DG.%2BE.%26aulast%3DLu%26aufirst%3DH.%26atitle%3DThe%2520Pharmacokinetics%2520of%2520Toll-like%2520Receptor%2520Agonists%2520and%2520the%2520Impact%2520on%2520the%2520Immune%2520System%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D4%26spage%3D275%26epage%3D289%26doi%3D10.1586%2Fecp.11.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jongh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duckworth, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pertinez, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Steeg, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Graaf, P. H.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in Mice</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1179</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1128/AAC.00551-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1128%2FAAC.00551-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=20028817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1179-1185&author=N.+Bensonauthor=J.+de+Jonghauthor=J.+D.+Duckworthauthor=H.+M.+Jonesauthor=H.+E.+Pertinezauthor=J.+K.+Rawalauthor=T.+J.+van+Steegauthor=P.+H.+Van+der+Graaf&title=Pharmacokinetic-Pharmacodynamic+Modeling+of+Alpha+Interferon+Response+Induced+by+a+Toll-Like+7+Receptor+Agonist+in+Mice&doi=10.1128%2FAAC.00551-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice</span></div><div class="casAuthors">Benson, Neil; de Jongh, Joost; Duckworth, Jonathan D.; Jones, Hannah M.; Pertinez, Henry E.; Rawal, Jaiessh K.; van Steeg, Tamara J.; Van der Graaf, Piet H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1185</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Recombinant alpha interferon (IFN-α) is used in the treatment of hepatitis C virus (HCV)-infected patients but is not optimal in terms of efficacy or tolerability.  Toll-like 7 receptor (TLR-7) agonists stimulate the innate immune system to produce, among other cytokines, IFN-α and are being evaluated as alternative drugs to treat HCV infection.  This paper describes the application of pharmacokinetic-pharmacodynamic (PK-PD) modeling to understanding the behavior of a TLR-7 agonist [9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine (BHMA)] in mice, using IFN-α as a biomarker.  This is the first report of such a PK-PD model, and the conclusions may be of utility in the clin. development of TLR-7 agonists for HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyYjsqRMvn9rVg90H21EOLACvtfcHk0lhV2e2reyfZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFWqsLY%253D&md5=09a660d40336da560f38ce66101ff3b9</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2FAAC.00551-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00551-09%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DN.%26aulast%3Dde%2BJongh%26aufirst%3DJ.%26aulast%3DDuckworth%26aufirst%3DJ.%2BD.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DPertinez%26aufirst%3DH.%2BE.%26aulast%3DRawal%26aufirst%3DJ.%2BK.%26aulast%3Dvan%2BSteeg%26aufirst%3DT.%2BJ.%26aulast%3DVan%2Bder%2BGraaf%26aufirst%3DP.%2BH.%26atitle%3DPharmacokinetic-Pharmacodynamic%2520Modeling%2520of%2520Alpha%2520Interferon%2520Response%2520Induced%2520by%2520a%2520Toll-Like%25207%2520Receptor%2520Agonist%2520in%2520Mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1179%26epage%3D1185%26doi%3D10.1128%2FAAC.00551-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Fits, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mourits, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voerman, J. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelissen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mus, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florencia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prens, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubberts, E.</span></span> <span> </span><span class="NLM_article-title">Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">5836</span>– <span class="NLM_lpage">5845</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.4049%2Fjimmunol.0802999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=19380832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=5836-5845&author=L.+van%0Ader+Fitsauthor=S.+Mouritsauthor=J.+S.+A.+Voermanauthor=M.+Kantauthor=L.+Boonauthor=J.+D.+Lamanauthor=F.+Cornelissenauthor=A.-M.+Musauthor=E.+Florenciaauthor=E.+P.+Prensauthor=E.+Lubberts&title=Imiquimod-Induced+Psoriasis-Like+Skin+Inflammation+in+Mice+Is+Mediated+via+the+IL-23%2FIL-17+Axis&doi=10.4049%2Fjimmunol.0802999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis</span></div><div class="casAuthors">van der Fits, Leslie; Mourits, Sabine; Voerman, Jane S. A.; Kant, Marius; Boon, Louis; Laman, Jon D.; Cornelissen, Ferry; Mus, Anne-Marie; Florencia, Edwin; Prens, Errol P.; Lubberts, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5836-5845</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Topical application of imiquimod (IMQ), a TLR7/8 ligand and potent immune activator, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder.  Recently, a crucial role was proposed for the IL-23/IL-17 axis in psoriasis.  The authors hypothesized that IMQ-induced dermatitis in mice can serve as a model for the anal. of pathogenic mechanisms in psoriasis-like dermatitis and assessed its IL-23/IL-17 axis dependency.  Daily application of IMQ on mouse back skin induced inflamed scaly skin lesions resembling plaque type psoriasis.  These lesions showed increased epidermal proliferation, abnormal differentiation, epidermal accumulation of neutrophils in microabcesses, neoangiogenesis, and infiltrates consisting of CD4+ T cells, CD11c+ dendritic cells, and plasmacytoid dendritic cells.  IMQ induced epidermal expression of IL-23, IL-17A, and IL-17F, as well as an increase in splenic Th17 cells.  IMQ-induced dermatitis was partially dependent on the presence of T cells, whereas disease development was almost completely blocked in mice deficient for IL-23 or the IL-17 receptor, demonstrating a pivotal role of the IL-23/IL-17 axis.  In conclusion, the sole application of the innate TLR7/8 ligand IMQ rapidly induces a dermatitis closely resembling human psoriasis, critically dependent on the IL-23/IL-17 axis.  This rapid and convenient model allows further elucidation of pathogenic mechanisms and evaluation of new therapies in psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWu9yN1SM3ibVg90H21EOLACvtfcHk0lhV2e2reyfZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKhtrs%253D&md5=3e895f11e5cbfd9ee20a83ad34a4f419</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802999%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BFits%26aufirst%3DL.%26aulast%3DMourits%26aufirst%3DS.%26aulast%3DVoerman%26aufirst%3DJ.%2BS.%2BA.%26aulast%3DKant%26aufirst%3DM.%26aulast%3DBoon%26aufirst%3DL.%26aulast%3DLaman%26aufirst%3DJ.%2BD.%26aulast%3DCornelissen%26aufirst%3DF.%26aulast%3DMus%26aufirst%3DA.-M.%26aulast%3DFlorencia%26aufirst%3DE.%26aulast%3DPrens%26aufirst%3DE.%2BP.%26aulast%3DLubberts%26aufirst%3DE.%26atitle%3DImiquimod-Induced%2520Psoriasis-Like%2520Skin%2520Inflammation%2520in%2520Mice%2520Is%2520Mediated%2520via%2520the%2520IL-23%252FIL-17%2520Axis%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D5836%26epage%3D5845%26doi%3D10.4049%2Fjimmunol.0802999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adalsteinsson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudjonsson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, N. L.</span></span> <span> </span><span class="NLM_article-title">Research Techniques Made Simple: Murine Models of Human Psoriasis</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">e1</span>– <span class="NLM_lpage">e8</span>, <span class="refDoi"> DOI: 10.1016/j.jid.2017.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.jid.2017.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=29273150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWlsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=e1-e8&author=J.+E.+Hawkesauthor=J.+A.+Adalsteinssonauthor=J.+E.+Gudjonssonauthor=N.+L.+Ward&title=Research+Techniques+Made+Simple%3A+Murine+Models+of+Human+Psoriasis&doi=10.1016%2Fj.jid.2017.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Research Techniques Made Simple: Murine Models of Human Psoriasis</span></div><div class="casAuthors">Hawkes, Jason E.; Adalsteinsson, Jonas A.; Gudjonsson, Johann E.; Ward, Nicole L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1-e8</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Psoriasis vulgaris is a common, inflammatory skin disease affecting approx. 3% of the population in the United States.  The etiol. of psoriasis and its assocd. comorbidities are complex and the result of complicated interactions between the skin, immune system, disease-assocd. susceptibility loci, and multiple environmental triggers.  The modeling of human disease in vivo through the use of murine models represents a powerful, indispensable tool for investigating the immune and genetic mechanisms contributing to a clin. disease phenotype.  Nevertheless, modeling a complex, multigenic disease like psoriasis in mice has proven to be extremely challenging and is assocd. with significant limitations.  Over the last four decades, more than 40 unique mouse models for psoriasis have been described.  These models can be categorized into three major types: acute (inducible), genetically engineered (transgenic), and xenograft (humanized).  The purpose of this Research Techniques Made Simple article is to provide an overview of the common types of psoriasis-like mouse models currently in use and their inherent advantages and limitations.  We also highlight the need for improved psoriasis mouse model systems and several key factors to be considered as this field of lab. science advances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomDNzzRqGmirVg90H21EOLACvtfcHk0ljxNeYhQExYcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWlsrjK&md5=ab0897692828c6aae463ea818c10b66f</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.jid.2017.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jid.2017.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DHawkes%26aufirst%3DJ.%2BE.%26aulast%3DAdalsteinsson%26aufirst%3DJ.%2BA.%26aulast%3DGudjonsson%26aufirst%3DJ.%2BE.%26aulast%3DWard%26aufirst%3DN.%2BL.%26atitle%3DResearch%2520Techniques%2520Made%2520Simple%253A%2520Murine%2520Models%2520of%2520Human%2520Psoriasis%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2018%26volume%3D138%26spage%3De1%26epage%3De8%26doi%3D10.1016%2Fj.jid.2017.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preethy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talukdar, A.</span></span> <span> </span><span class="NLM_article-title">Ligand-Based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors</span>. <i>Comput. Struct. Biotechnol. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">310</span>, <span class="refDoi"> DOI: 10.1016/j.csbj.2019.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1016%2Fj.csbj.2019.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=30867893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=291-310&author=S.+Palauthor=V.+Kumarauthor=B.+Kunduauthor=D.+Bhattacharyaauthor=N.+Preethyauthor=M.+P.+Reddyauthor=A.+Talukdar&title=Ligand-Based+Pharmacophore+Modeling%2C+Virtual+Screening+and+Molecular+Docking+Studies+for+Discovery+of+Potential+Topoisomerase+I+Inhibitors&doi=10.1016%2Fj.csbj.2019.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors</span></div><div class="casAuthors">Pal, Sourav; Kumar, Vinay; Kundu, Biswajit; Bhattacharya, Debomita; Preethy, Nagothy; Reddy, Mamindla Prashanth; Talukdar, Arindam</div><div class="citationInfo"><span class="NLM_cas:title">Computational and Structural Biotechnology Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-310</span>CODEN:
                <span class="NLM_cas:coden">CSBJAC</span>;
        ISSN:<span class="NLM_cas:issn">2001-0370</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Camptothecin (CPT), a natural product and its synthetic derivs. exert potent anticancer activity by selectively targeting DNA Topoisomerase I (Top1) enzyme.  CPT and its clin. approved derivs. are used as Top1 poisons for cancer therapy suffer from many limitations related to stability and toxicity.  In order to envisage structurally diverse novel chem. entity as Top1 poison with better efficacy, Ligand-based-pharmacophore model was developed using 3D QSAR pharmacophore generation (HypoGen algorithm) methodol. in Discovery studio 4.1 clients.  The chem. features of 29 CPT derivs. were taken as the training set.  The selected pharmacophore model Hypo1 was further validated by 33 test set mols. and used as a query model for further screening of 1,087,724 drug-like mols. from ZINC databases.  These mols. were subjected to several assessments such as Lipinski rule of 5, SMART filtration and activity filtration.  The mol. obtained after filtration was further scrutinized by mol. docking anal. on the active site of Top1 crystal structure (PDB ID: 1T8I).  Six potential inhibitory mols. have been selected by analyzing the binding interaction and Ligand-Pharmacophore mapping with the validated pharmacophore model.  Toxicity assessment TOPKAT program provided three potential inhibitory 'hit mols.' ZINC68997780, ZINC15018994 and ZINC38550809.  MD simulation of these three mols. proved that the ligand binding into the protein-DNA cleavage complex is stable and the protein-ligands conformation remains unchanged.  These three hit mols. can be utilized for designing future class of potential topoisomerase I inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFv_Sj2pKedrVg90H21EOLACvtfcHk0ljxNeYhQExYcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOksL8%253D&md5=fdce9fc105b2af3c317cd44946699a31</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.csbj.2019.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.csbj.2019.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DKundu%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DD.%26aulast%3DPreethy%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DM.%2BP.%26aulast%3DTalukdar%26aufirst%3DA.%26atitle%3DLigand-Based%2520Pharmacophore%2520Modeling%252C%2520Virtual%2520Screening%2520and%2520Molecular%2520Docking%2520Studies%2520for%2520Discovery%2520of%2520Potential%2520Topoisomerase%2520I%2520Inhibitors%26jtitle%3DComput.%2520Struct.%2520Biotechnol.%2520J.%26date%3D2019%26volume%3D17%26spage%3D291%26epage%3D310%26doi%3D10.1016%2Fj.csbj.2019.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and Validation of a Genetic Algorithm for Flexible Docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+Validation+of+a+Genetic+Algorithm+for+Flexible+Docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljxNeYhQExYcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520a%2520Genetic%2520Algorithm%2520for%2520Flexible%2520Docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbasi, S. W.</span></span> <span> </span><span class="NLM_article-title">Molecular Docking Studies for the Identification of Novel Melatoninergic Inhibitors for Acetylserotonin-O-Methyltransferase Using Different Docking Routines</span>. <i>Theor. Biol. Med. Modell.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">63</span> <span class="refDoi"> DOI: 10.1186/1742-4682-10-63</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1186%2F1742-4682-10-63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=24156411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVaru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&author=S.+S.+Azamauthor=S.+W.+Abbasi&title=Molecular+Docking+Studies+for+the+Identification+of+Novel+Melatoninergic+Inhibitors+for+Acetylserotonin-O-Methyltransferase+Using+Different+Docking+Routines&doi=10.1186%2F1742-4682-10-63"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines</span></div><div class="casAuthors">Azam, Syed Sikander; Abbasi, Sumra Wajid</div><div class="citationInfo"><span class="NLM_cas:title">Theoretical Biology and Medical Modelling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63/1-63/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">TBMMA8</span>;
        ISSN:<span class="NLM_cas:issn">1742-4682</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: N-acetylserotonin O-methyltransferase (ASMT) is an enzyme which by converting nor-melatonin to melatonin catalyzes the final reaction in melatonin biosynthesis in tryptophan metab. pathway.  High Expression of ASMT gene is evident in PPTs.  The presence of abnormally high levels of ASMT in pineal gland could serve as an indication of the existence of pineal parenchymal tumors (PPTs) in the brain.  Different levels of melatonin are used as a trait marker for prescribing the mood disorders e.g.  Seasonal affective disorder, bipolar disorder, or major depressive disorder.  In addn., melatonin levels can also be used to calc. the severity of a patient's illness at a given point in time.  Methods: Seventy three melatoninergic inhibitors were docked with acetylserotonin-O-methyltransferase in order to identify the potent inhibitor against the enzyme.  The chem. nature of the protein and ligands greatly influence the performance of docking routines.  Keeping this fact in view, crit. evaluation of the performance of four different commonly used docking routines: AutoDock/Vina, GOLD, FlexX and FRED were performed.  An evaluation criterion was based on the binding affinities/docking scores and exptl. bioactivities.  Results and Conclusion: Results indicated that both hydrogen bonding and hydrophobic interactions contributed significantly for its ligand binding and the compd. selected as potent inhibitor is having min. binding affinity, max. GoldScore and min. FlexX energy.  The correlation value of r2 = 0.66 may be useful in the selection of correct docked complexes based on the energy without having prior knowledge of the active site.  This may lead to further understanding of structures, their reliability and Biomol. activity esp. in connection with bipolar disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrctjiRVd4gHbVg90H21EOLACvtfcHk0ljxNeYhQExYcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVaru7k%253D&md5=a50912719533bb86307b397b4f88d43c</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1186%2F1742-4682-10-63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4682-10-63%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DS.%2BS.%26aulast%3DAbbasi%26aufirst%3DS.%2BW.%26atitle%3DMolecular%2520Docking%2520Studies%2520for%2520the%2520Identification%2520of%2520Novel%2520Melatoninergic%2520Inhibitors%2520for%2520Acetylserotonin-O-Methyltransferase%2520Using%2520Different%2520Docking%2520Routines%26jtitle%3DTheor.%2520Biol.%2520Med.%2520Modell.%26date%3D2013%26volume%3D10%26doi%3D10.1186%2F1742-4682-10-63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, T.</span></span> <span> </span><span class="NLM_article-title">Comprehensive Evaluation of Ten Docking Programs on a Diverse Set of Protein–Ligand Complexes: The Prediction Accuracy of Sampling Power and Scoring Power</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">12964</span>– <span class="NLM_lpage">12975</span>, <span class="refDoi"> DOI: 10.1039/C6CP01555G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1039%2FC6CP01555G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=27108770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFOns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=12964-12975&author=Z.+Wangauthor=H.+Sunauthor=X.+Yaoauthor=D.+Liauthor=L.+Xuauthor=Y.+Liauthor=S.+Tianauthor=T.+Hou&title=Comprehensive+Evaluation+of+Ten+Docking+Programs+on+a+Diverse+Set+of+Protein%E2%80%93Ligand+Complexes%3A+The+Prediction+Accuracy+of+Sampling+Power+and+Scoring+Power&doi=10.1039%2FC6CP01555G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power</span></div><div class="casAuthors">Wang, Zhe; Sun, Huiyong; Yao, Xiaojun; Li, Dan; Xu, Lei; Li, Youyong; Tian, Sheng; Hou, Tingjun</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12964-12975</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As one of the most popular computational approaches in modern structure-based drug design, mol. docking can be used not only to identify the correct conformation of a ligand within the target binding pocket but also to est. the strength of the interaction between a target and a ligand.  Nowadays, as a variety of docking programs are available for the scientific community, a comprehensive understanding of the advantages and limitations of each docking program is fundamentally important to conduct more reasonable docking studies and docking-based virtual screening.  In the present study, based on an extensive dataset of 2002 protein-ligand complexes from the PDBbind database (version 2014), the performance of ten docking programs, including five com. programs (LigandFit, Glide, GOLD, MOE Dock, and Surflex-Dock) and five academic programs (AutoDock, AutoDock Vina, LeDock, rDock, and UCSF DOCK), was systematically evaluated by examg. the accuracies of binding pose prediction (sampling power) and binding affinity estn. (scoring power).  Our results showed that GOLD and LeDock had the best sampling power (GOLD: 59.8% accuracy for the top scored poses; LeDock: 80.8% accuracy for the best poses) and AutoDock Vina had the best scoring power (rp/rs of 0.564/0.580 and 0.569/0.584 for the top scored poses and best poses), suggesting that the com. programs did not show the expected better performance than the academic ones.  Overall, the ligand binding poses could be identified in most cases by the evaluated docking programs but the ranks of the binding affinities for the entire dataset could not be well predicted by most docking programs.  However, for some types of protein families, relatively high linear correlations between docking scores and exptl. binding affinities could be achieved.  To our knowledge, this study has been the most extensive evaluation of popular mol. docking programs in the last five years.  It is expected that our work can offer useful information for the successful application of these docking tools to different requirements and targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7PQalJNVCubVg90H21EOLACvtfcHk0lhVCP9QJSAiKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFOns7g%253D&md5=5bedadbb6b4eb4dafa95a48701ac720d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2FC6CP01555G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CP01555G%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DT.%26atitle%3DComprehensive%2520Evaluation%2520of%2520Ten%2520Docking%2520Programs%2520on%2520a%2520Diverse%2520Set%2520of%2520Protein%25E2%2580%2593Ligand%2520Complexes%253A%2520The%2520Prediction%2520Accuracy%2520of%2520Sampling%2520Power%2520and%2520Scoring%2520Power%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2016%26volume%3D18%26spage%3D12964%26epage%3D12975%26doi%3D10.1039%2FC6CP01555G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurkinen, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lätti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentikäinen, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postila, P. A.</span></span> <span> </span><span class="NLM_article-title">Getting Docking into Shape Using Negative Image-Based Rescoring</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3584</span>– <span class="NLM_lpage">3599</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.9b00383</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.9b00383" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlCit7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=3584-3599&author=S.+T.+Kurkinenauthor=S.+L%C3%A4ttiauthor=O.+T.+Pentik%C3%A4inenauthor=P.+A.+Postila&title=Getting+Docking+into+Shape+Using+Negative+Image-Based+Rescoring&doi=10.1021%2Facs.jcim.9b00383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Getting Docking into Shape Using Negative Image-Based Rescoring</span></div><div class="casAuthors">Kurkinen, Sami T.; Latti, Sakari; Pentikainen, Olli T.; Postila, Pekka A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3584-3599</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The failure of default scoring functions to ensure virtual screening enrichment is a persistent problem for the mol. docking algorithms used in structure-based drug discovery.  To remedy this problem, elaborate rescoring and postprocessing schemes have been developed with a varying degree of success, specificity, and cost.  The neg. image-based rescoring (R-NiB) has been shown to improve the flexible docking performance markedly with a variety of drug targets.  The yield improvement is achieved by comparing the alternative docking poses against the neg. image of the target protein's ligand-binding cavity.  In other words, the shape and electrostatics of the binding pocket is directly used in the similarity comparison to rank the explicit docking poses.  Here, the PANTHER/ShaEP-based R-NiB methodol. is tested with six popular docking softwares, including GLIDE, PLANTS, GOLD, DOCK, AUTODOCK, and AUTODOCK VINA, using five validated benchmark sets.  Overall, the results indicate that R-NiB outperforms the default docking scoring consistently and inexpensively, demonstrating that the methodol. is ready for wide-scale virtual screening usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsMAV2Do_yo7Vg90H21EOLACvtfcHk0lhVCP9QJSAiKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlCit7rF&md5=49c32be0c52097eaa1bf8d55ad47e037</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.9b00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.9b00383%26sid%3Dliteratum%253Aachs%26aulast%3DKurkinen%26aufirst%3DS.%2BT.%26aulast%3DL%25C3%25A4tti%26aufirst%3DS.%26aulast%3DPentik%25C3%25A4inen%26aufirst%3DO.%2BT.%26aulast%3DPostila%26aufirst%3DP.%2BA.%26atitle%3DGetting%2520Docking%2520into%2520Shape%2520Using%2520Negative%2520Image-Based%2520Rescoring%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D3584%26epage%3D3599%26doi%3D10.1021%2Facs.jcim.9b00383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibition of TLR8 through Stabilization of Its Resting State</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=10.1038%2Fnchembio.2518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=29155428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=58-64&author=S.+Zhangauthor=Z.+Huauthor=H.+Tanjiauthor=S.+Jiangauthor=N.+Dasauthor=J.+Liauthor=K.+Sakaniwaauthor=J.+Jinauthor=Y.+Bianauthor=U.+Ohtoauthor=T.+Shimizuauthor=H.+Yin&title=Small-Molecule+Inhibition+of+TLR8+through+Stabilization+of+Its+Resting+State&doi=10.1038%2Fnchembio.2518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of TLR8 through stabilization of its resting state</span></div><div class="casAuthors">Zhang, Shuting; Hu, Zhenyi; Tanji, Hiromi; Jiang, Shuangshuang; Das, Nabanita; Li, Jing; Sakaniwa, Kentaro; Jin, Jin; Bian, Yanyan; Ohto, Umeharu; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Endosomal Toll-like receptors (TLR3, TLR7, TLR8, and TLR9) are highly analogous sensors for various viral or bacterial RNA and DNA mol. patterns.  Nonetheless, few small mols. can selectively modulate these TLRs.  In this manuscript, we identified the first human TLR8-specific small-mol. antagonists via a novel inhibition mechanism.  Crystal structures of two distinct TLR8-ligand complexes validated a unique binding site on the protein-protein interface of the TLR8 homodimer.  Upon binding to this new site, the small-mol. ligands stabilize the preformed TLR8 dimer in its resting state, preventing activation.  As a proof of concept of their therapeutic potential, we have demonstrated that these drug-like inhibitors are able to suppress TLR8-mediated proinflammatory signaling in various cell lines, human primary cells, and patient specimens.  These results not only suggest a novel strategy for TLR inhibitor design, but also shed crit. mechanistic insight into these clin. important immune receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPrewccnFLv7Vg90H21EOLACvtfcHk0lhVCP9QJSAiKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN&md5=1b43da16d6670324d77bb5e2c417cfe6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2518%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520Inhibition%2520of%2520TLR8%2520through%2520Stabilization%2520of%2520Its%2520Resting%2520State%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D58%26epage%3D64%26doi%3D10.1038%2Fnchembio.2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5WYZ','PDB','5WYZ'); return false;">PDB: 5WYZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMF','PDB','5GMF'); return false;">PDB: 5GMF</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00532">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_38340"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00532?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00532</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">TLR9 antagonistic reporter assay, TLR7 antagonistic reporter assay, TLR8 antagonistic reporter assay, TLR9 antagonism assay in human PBMCs, molecular docking score table, selectivity against TLR8 through computational study, aqueous solubility assay data, plasma stability assay data, Caco-2 permeability assay data, microsomal stability assay data, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of compounds <b>3</b>–<b>34</b>, 2D NMR data of compound <b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf">PDF</a>)</p></li><li><p class="inline">TLR7_Homology model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_001.pdf">jm1c00532_si_001.pdf (5.22 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_002.pdb">jm1c00532_si_002.pdb (2.02 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00532/suppl_file/jm1c00532_si_003.csv">jm1c00532_si_003.csv (2.82 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00532&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00532%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00532" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a150bd8913c9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
